Clinical Trials

• S Japonicum and Pregnancy Outcomes
  ClinicalTrials.gov Identifier: NCT00486863 - Suspended
  Schistosomiasis [Bilharziasis]
  
• S tudy of Usher Syndromes, Type 1 and Type 2
  ClinicalTrials.gov Identifier: NCT00001347 - Completed
  Retinitis Pigmentosa
  
• S(+)-Ibuprofen Effects on Asprin Treated Volunteers
  ClinicalTrials.gov Identifier: NCT00442585 - Completed
  Drug Interactions
  
• S-1 and Cisplatin as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00227578 - Active, not recruiting
  Lung Cancer
  
• S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00088816 - Recruiting
  stage IV gastric cancer; adenocarcinoma of the stomach
  
• S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00182611 - Recruiting
  Gastric Cancer
  
• S-1 and Cisplatin or Fluorouracil and Cisplatin in Treating Patients With Locally Advanced or Metastatic Gastric Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00128609 - Recruiting
  stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
  
• S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00343668 - Recruiting
  Gastric Cancer
  
• S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery For Locally Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00134095 - Recruiting
  adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
  
• S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00227604 - Active, not recruiting
  Pancreatic Cancer
  
• S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00227552 - Active, not recruiting
  Lung Cancer
  
• S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00336947 - Recruiting
  Head and Neck Cancer
  
• S-3304 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00033566 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00475176 - Not yet recruiting
  Chronic Hepatitis C
  
• S-Adenosyl Methionine for Symptomatic Treatment of Primary Biliary Cirrhosis
  ClinicalTrials.gov Identifier: NCT00125281 - Recruiting
  
  
• S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate in Preventing Liver Cancer in Patients With Chronic Hepatitis C Infection
  ClinicalTrials.gov Identifier: NCT00513461 - Recruiting
  Infection; Liver Cancer
  
• S-adenosylmethionine Therapy for Non-alcoholic Steatohepatitis
  ClinicalTrials.gov Identifier: NCT00108589 - Completed
  Hepatitis
  
• S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults
  ClinicalTrials.gov Identifier: NCT00110734 - Completed
  Pain
  
• S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults
  ClinicalTrials.gov Identifier: NCT00110747 - Completed
  Pain
  
• S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults
  ClinicalTrials.gov Identifier: NCT00110773 - Completed
  Pain
  
• S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face
  ClinicalTrials.gov Identifier: NCT00110760 - Completed
  Pain
  
• S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children
  ClinicalTrials.gov Identifier: NCT00125255 - Completed
  Pain
  
• S-Citalopram for the Prevention of PEGASYS-Induced Depression
  ClinicalTrials.gov Identifier: NCT00136318 - Active, not recruiting
  Pegasys-Induced depression
  
• S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00252473 - Recruiting
  Head and Neck Neoplasms
  
• S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation.
  ClinicalTrials.gov Identifier: NCT00244426 - Recruiting
  Atrial Fibrillation
  
• S90652 in Paediatric Hypertension
  ClinicalTrials.gov Identifier: NCT00202553 - Recruiting
  Hypertension
  
• S90652 in Paediatric Hypertension
  ClinicalTrials.gov Identifier: NCT00202592 - Recruiting
  Hypertension
  
• SA4503 8-Week Study in Major Depressive Disorder (MDD)
  ClinicalTrials.gov Identifier: NCT00551109 - Recruiting
  Depressive Disorder, Major
  
• Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease
  ClinicalTrials.gov Identifier: NCT00316498 - Completed
  Niemann Pick Diseases
  
• Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00543478 - Recruiting
  Irritable Bowel Syndrome
  
• Sacral Nerve Stimulation for Anal Incontinence(Version 1.1). Sacral Nerve Stimulation for Bowel Control (Amendment II)
  ClinicalTrials.gov Identifier: NCT00200005 - Active, not recruiting
  Fecal Incontinence and Constipation
  
• Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence
  ClinicalTrials.gov Identifier: NCT00200057 - Active, not recruiting
  Fecal Incontinence
  
• Sacroiliac Orthopedic Blocking and Cervical Spine Function
  ClinicalTrials.gov Identifier: NCT00523822 - Recruiting
  Musculoskeletal Diseases
  
• Saeboflex Dynamic Hand Orthosis for Inpatient Rehabilitation Stroke Patients
  ClinicalTrials.gov Identifier: NCT00485641 - Completed
  Stroke
  
• SAFE or SORRY? Patient Safety Study of the Prevention of Common Complications
  ClinicalTrials.gov Identifier: NCT00365430 - Recruiting
  Pressure Ulcer; Urinary Tract Infection; Accidental Falls
  
• Safe Pregnancy by Infectious Disease Control
  ClinicalTrials.gov Identifier: NCT00489619 - Completed
  Pregnancy; Malaria
  
• Safe Renal Function In Long Term Heart Transplanted Patients
  ClinicalTrials.gov Identifier: NCT00505102 - Recruiting
  Kidney Diseases; Heart Transplantation
  
• SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation
  ClinicalTrials.gov Identifier: NCT00419640 - Recruiting
  Atrial Fibrillation
  
• Safe Water Techniques in Kenya
  ClinicalTrials.gov Identifier: NCT00531869 - Not yet recruiting
  Consumer Willingness to Pay for POU Products; Consumer Preferences and Use of POU Products
  
• SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients
  ClinicalTrials.gov Identifier: NCT00274105 - Terminated
  Hypertension; Coronary Arteriosclerosis
  
• Safe-Grip Fall/Injuries Intervention: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00013078 - Completed
  Aging; Frail Elderly; Homebound Persons; Accidental Falls
  
• Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program
  ClinicalTrials.gov Identifier: NCT00223314 - Completed
  HIV; Sexually Transmitted Diseases; Pregnancy; HIV Infections
  
• SAFEstart Feeding Intolerance Study Phase II
  ClinicalTrials.gov Identifier: NCT00331201 - Completed
  Feeding Intolerance; Abdominal Distention; Gastric Residual; Emesis and Diarrhea; Blood in Stool
  
• Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients with Dyslipidemia: A Dose-Ranging Study - SEACOAST
  ClinicalTrials.gov Identifier: NCT00082251 - Completed
  Hypercholesterolemia
  
• Safety & Efficacy of Buprenorphine Transdermal Delivery System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement
  ClinicalTrials.gov Identifier: NCT00403234 - Terminated
  Postoperative Pain
  
• Safety & Efficacy of Certican in Pediatric de novo Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00098241 - Recruiting
  Kidney Transplantation
  
• Safety & Efficacy of ICL670 vs. deferoxamine in Beta-thalassemia patients with iron overload due to blood transfusions
  ClinicalTrials.gov Identifier: NCT00061750 - Completed
  beta-Thalassemia
  
• Safety & Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
  ClinicalTrials.gov Identifier: NCT00065130 - Completed
  Gestational Diabetes
  
• Safety & Efficacy of Omega-3 Fish Oil in Overweight Children & Adolescents
  ClinicalTrials.gov Identifier: NCT00447291 - Recruiting
  Overweight; Obesity
  
• Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
  ClinicalTrials.gov Identifier: NCT00045799 - Completed
  Upper gastrointestinal bleeding
  
• Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00255255 - Active, not recruiting
  Asthma
  
• Safety & Efficacy of Toremifene Citrate for Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy
  ClinicalTrials.gov Identifier: NCT00129142 - Active, not recruiting
  Prostate Cancer; Osteoporosis; Bone Loss; Fractures
  
• Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD
  ClinicalTrials.gov Identifier: NCT00499590 - Recruiting
  Macular Degeneration
  
• Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)
  ClinicalTrials.gov Identifier: NCT00557791 - Not yet recruiting
  Age Related Macular Degeneration
  
• Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00366132 - Recruiting
  Chronic Diabetic Foot Ulcers
  
• Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00440388 - Recruiting
  Follicular Lymphoma
  
• Safety & Efficacy Study of Benzydamine Oral Rinse for the treatment of oral mucositis (mouth sores) resulting from radiation therapy for cancer of the oral cavity, oropharynx, or nasopharynx
  ClinicalTrials.gov Identifier: NCT00051441 - Terminated
  Mouth Neoplasms
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00329446 - Completed
  Generalized Anxiety Disorder
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00321490 - Completed
  Major Depressive Disorder
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00329264 - Completed
  Generalized Anxiety Disorder
  
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00320268 - Completed
  Major Depressive Disorder
  
• Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00204386 - Completed
  Posttraumatic Stress Disorder
  
• Safety & Immunogenicity of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 Months of Age.
  ClinicalTrials.gov Identifier: NCT00345579 - Active, not recruiting
  Haemophilus Infections; Meningococcal Infections
  
• Safety & Immunogenicity Study of a Prime Boost Concept of GSK Biologicals’ Pandemic Influenza Vaccine (GSK1119711A)
  ClinicalTrials.gov Identifier: NCT00430521 - Active, not recruiting
  Pandemic Influenza
  
• Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children.
  ClinicalTrials.gov Identifier: NCT00474266 - Active, not recruiting
  Meningococcal Serogroups A, C, W-135 and/or Y Disease; Measles; Mumps; Rubella; Varicella
  
• Safety & Immunogenicity: Primary Study: Zoster-003, Extension Studies: Zoster-011,012&013 (EXT Zoster-003 Y1,Y2 &Y3)
  ClinicalTrials.gov Identifier: NCT00434577 - Recruiting
  Herpes Zoster; Shingles
  
• Safety & Performance Randomized Study of the CiTop™ Guidewire for Peripheral CTO
  ClinicalTrials.gov Identifier: NCT00482742 - Recruiting
  Catheterization, Peripheral
  
• Safety and Acceptability of a Vaginal Microbicide
  ClinicalTrials.gov Identifier: NCT00111943 - Active, not recruiting
  HIV Infections; Hepatitis B, Chronic
  
• Safety and Acceptability of Carraguard™ Among HIV-Negative Couples in Thailand
  ClinicalTrials.gov Identifier: NCT00213057 - Completed
  HIV Infections; Chlamydia Trachomatis; Nesseria Gonorrhea; Trichomonas Vaginitis; Syphilis
  
• Safety and Acceptability of Carraguard® in HIV Positive Women and Men
  ClinicalTrials.gov Identifier: NCT00213005 - Completed
  HIV Infections
  
• Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India
  ClinicalTrials.gov Identifier: NCT00081640 - Completed
  HIV Infections
  
• Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel
  ClinicalTrials.gov Identifier: NCT00028132 - Completed
  HIV Infections
  
• Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally
  ClinicalTrials.gov Identifier: NCT00408538 - Recruiting
  HIV Infections
  
• Safety and Accuracy of Alveoscopy in Interstitial Lung Diseases
  ClinicalTrials.gov Identifier: NCT00377338 - Recruiting
  Interstitial Lung Disease
  
• Safety and Activity of 90Y-Labeled IDEC 159 in Subjects With Metastatic Colorectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00102024 - Terminated
  Colorectal Cancer; Metastases
  
• Safety and Activity of SDX-105 (Bendamustine) in Patients with Rituximab Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00069758 - Completed
  Non-Hodgkin's Lymphoma
  
• Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00089466 - Suspended
  HIV Infections
  
• Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00102921 - Completed
  Crohn Disease
  
• Safety and Anti-HIV Activity of Capravirine Alone and in Combination with Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00005673 - Completed
  Healthy; HIV Infection
  
• Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00144859 - Completed
  COPD
  
• Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00446719 - Recruiting
  Depression
  
• Safety and Antifungal Activity of Recombinant Interferon-gamma 1b (rIFN-gamma 1b) Given with Standard Therapy in Patients with Cryptococcal Meningitis
  ClinicalTrials.gov Identifier: NCT00012467 - Active, not recruiting
  Meningitis, Cryptococcal; HIV Infections
  
• Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
  ClinicalTrials.gov Identifier: NCT00305019 - Terminated
  Hepatitis B
  
• Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
  ClinicalTrials.gov Identifier: NCT00362505 - Terminated
  Hepatitis B
  
• Safety and antiviral activity study of ACH-126,443 (beta-L-Fd4C) in treatment naive adults with chronic Hepatitis B Virus infection
  ClinicalTrials.gov Identifier: NCT00034359 - Completed
  Hepatitis B, Chronic
  
• Safety and Antiviral Activity Study of Clevudine 30 Mg QD in Patient With Chronic HBV
  ClinicalTrials.gov Identifier: NCT00313287 - Terminated
  Hepatitis B
  
• Safety and Antiviral Activity Study of Clevudine 30 Mg QD in Patients With HBeAg(-) Chronic HBV
  ClinicalTrials.gov Identifier: NCT00313274 - Terminated
  Hepatitis B
  
• Safety and Antiviral Activuty of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilto Evaluation
  ClinicalTrials.gov Identifier: NCT00447902 - Recruiting
  HIV Infections
  
• Safety and antiviral study of ACH-126, 443 (beta-L-Fd4C) in the treatment of adults with chronic Hepatitis B infection.
  ClinicalTrials.gov Identifier: NCT00037622 - Active, not recruiting
  Chronic Hepatitis B
  
• Safety and antiviral study of ACH-126, 443 (beta-L-Fd4C) in the treatment of adults with HIV infection and modestly detectable viral load.
  ClinicalTrials.gov Identifier: NCT00040157 - Active, not recruiting
  HIV Infections
  
• Safety and antiviral study of ACH126, 433 (b-L-Fd4C) in adults with lamivudine-resistant chronic hepatitis B
  ClinicalTrials.gov Identifier: NCT00040144 - Active, not recruiting
  Chronic Hepatitis B
  
• Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity
  ClinicalTrials.gov Identifier: NCT00437528 - Recruiting
  Overactive Bladder; Urge Urinary Incontinence; Enuresis; Self Clean Intermittent Catheterization
  
• Safety and Behavior of S. aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients with S. aureus Bacteremia and Continuing Fever
  ClinicalTrials.gov Identifier: NCT00063089 - Completed
  Staphylococcal Infections
  
• Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
  ClinicalTrials.gov Identifier: NCT00120471 - Recruiting
  HIV Infections
  
• Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i’s vs. Single Maximal Dose PDE5i
  ClinicalTrials.gov Identifier: NCT00498680 - Recruiting
  Impotence
  
• Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00349388 - Recruiting
  Ulcerative Colitis
  
• Safety and Dose Study of GRN163L Administered Weekly to Treat Patients with Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00124189 - Recruiting
  Lymphocytic Leukemia, Chronic
  
• Safety and Dose Study of GRN163L Administered Weekly to Treat Patients With Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00310895 - Recruiting
  Tumors
  
• Safety and Dose Study of GRN163L With Paclitaxel and Carboplatin to Treat Patients With Advanced or Metastatic Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00510445 - Recruiting
  Lung Cancer
  
• Safety and Dose Study of Peramivir for Influenza Treatment
  ClinicalTrials.gov Identifier: NCT00297050 - Active, not recruiting
  Influenza
  
• Safety and Dosing Evaluation of REG1 Anticoagulation System
  ClinicalTrials.gov Identifier: NCT00113997 - Completed
  
  
• Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
  ClinicalTrials.gov Identifier: NCT00476437 - Completed
  Diabetes Mellitus, Type 2
  
• Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00562614 - Enrolling by invitation
  Hypertension
  
• Safety and Effect of Pertuzumab in Patients with Advanced Non-Small Cell Lung Cancer, which has Progressed After Prior Chemotherapy
  ClinicalTrials.gov Identifier: NCT00063154 - Active, not recruiting
  Non-small cell lung cancer
  
• Safety and Effect on Memory of PYM50028 in Mild Alzheimer''s Disease
  ClinicalTrials.gov Identifier: NCT00130429 - Completed
  Alzheimer''s Disease
  
• Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis
  ClinicalTrials.gov Identifier: NCT00460967 - Suspended
  Age-Related Maculopathy
  
• Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
  ClinicalTrials.gov Identifier: NCT00006326 - Terminated
  HIV Infections
  
• Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea
  ClinicalTrials.gov Identifier: NCT00547898 - Recruiting
  Diarrhea; HIV Infections; Gastrointestinal Disease
  
• Safety and Effectiveness of a Combination Anti-HIV Drug Treatment
  ClinicalTrials.gov Identifier: NCT00005018 - Completed
  HIV Infections
  
• Safety and Effectiveness of a Computer-Assisted Personalized Sedation (CAPS) Device for Propofol Delivery During Endoscopy
  ClinicalTrials.gov Identifier: NCT00452426 - Completed
  Colonoscopy; Endoscopy, Digestive System; Conscious Sedation
  
• Safety and Effectiveness of a Four-Drug Combination Treatment in HIV-infected Subjects Failing Therapy with Antiretroviral Regimens
  ClinicalTrials.gov Identifier: NCT00052117 - Completed
  HIV Infections
  
• Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00004998 - Suspended
  HIV Infections
  
• Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
  ClinicalTrials.gov Identifier: NCT00004584 - Completed
  HIV Infections
  
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients
  ClinicalTrials.gov Identifier: NCT00007202 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects with Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00061646 - Terminated
  Carcinoma, Non-Small-Cell Lung
  
• Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00002219 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
  ClinicalTrials.gov Identifier: NCT00006291 - Completed
  HIV Infections
  
• Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002415 - Completed
  HIV Infections
  
• Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002229 - Completed
  HIV Infections
  
• Safety and Effectiveness of Administering an HIV Vaccine in the Groin versus the Arm
  ClinicalTrials.gov Identifier: NCT00076817 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
  ClinicalTrials.gov Identifier: NCT00272493 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment with Protease Inhibitors
  ClinicalTrials.gov Identifier: NCT00002361 - Completed
  HIV Infections
  
• Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
  ClinicalTrials.gov Identifier: NCT00002241 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00006339 - Terminated
  HIV Infections
  
• Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
  ClinicalTrials.gov Identifier: NCT00002445 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
  ClinicalTrials.gov Identifier: NCT00498056 - Not yet recruiting
  HIV Infections
  
• Safety and effectiveness of an investigational agent (GM-611) in patients with diabetic gastroparesis
  ClinicalTrials.gov Identifier: NCT00050882 - Completed
  Gastroparesis
  
• Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
  ClinicalTrials.gov Identifier: NCT00000904 - Completed
  HIV Infections
  
• Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds
  ClinicalTrials.gov Identifier: NCT00407914 - Active, not recruiting
  Facial Wrinkles
  
• Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in Alzheimer''s Disease (AD) Patients
  ClinicalTrials.gov Identifier: NCT00151502 - Completed
  Alzheimer''s Disease
  
• Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients with Hemophilia
  ClinicalTrials.gov Identifier: NCT00000705 - Completed
  HIV Infections; Hemophilia A
  
• Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.
  ClinicalTrials.gov Identifier: NCT00313833 - Completed
  Chronic Pain
  
• Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation
  ClinicalTrials.gov Identifier: NCT00387803 - Completed
  Heart Failure, Congestive; Ventricular Fibrillation; Tachycardia, Ventricular
  
• Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
  ClinicalTrials.gov Identifier: NCT00000876 - Completed
  HIV Infections
  
• Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)
  ClinicalTrials.gov Identifier: NCT00163514 - Completed
  Perennial Allergic Rhinitis; Allergic Rhinitis; Hay Fever
  
• Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)
  ClinicalTrials.gov Identifier: NCT00163501 - Completed
  Perennial Allergic Rhinitis; Allergic Rhinitis; Hay Fever
  
• Safety and Effectiveness of Combining Hydroxyurea (HU) with Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults
  ClinicalTrials.gov Identifier: NCT00002427 - Completed
  HIV Infections
  
• Safety and Effectiveness of Combretastatin A-4 Phosphate Combined with Chemotherapy in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00113438 - Active, not recruiting
  Cancer; Tumor
  
• Safety and Effectiveness of Computer Screening for Intimate Partner Violence
  ClinicalTrials.gov Identifier: NCT00166062 - Recruiting
  Intimate Partner Violence; Perpetration
  
• Safety and Effectiveness of Coronary Magnetic Resonance Angiography (CMRA) Imaging
  ClinicalTrials.gov Identifier: NCT00001633 - Completed
  Coronary Disease
  
• Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis
  ClinicalTrials.gov Identifier: NCT00170716 - Active, not recruiting
  Stroke; Hemiparesis
  
• Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy
  ClinicalTrials.gov Identifier: NCT00002209 - Completed
  AIDS Dementia Complex; HIV Infections
  
• Safety and Effectiveness of D-Cycloserine in Children With Autism
  ClinicalTrials.gov Identifier: NCT00198120 - Active, not recruiting
  Autistic Disorder
  
• Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00338884 - Recruiting
  Carcinoma, Renal Cell
  
• Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors
  ClinicalTrials.gov Identifier: NCT00372567 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00133107 - Recruiting
  Oral Lichen Planus
  
• Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00016718 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients with Abnormal Blood Lipids
  ClinicalTrials.gov Identifier: NCT00006412 - Completed
  HIV Infections; Lipodystrophy
  
• Safety and Effectiveness of Flaxseed for Reducing High Cholesterol
  ClinicalTrials.gov Identifier: NCT00051415 - Completed
  Hypercholesterolemia
  
• Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00002446 - Completed
  Candidiasis, Oral; HIV Infections
  
• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
  ClinicalTrials.gov Identifier: NCT00001091 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
  ClinicalTrials.gov Identifier: NCT00002398 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
  ClinicalTrials.gov Identifier: NCT00002419 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002234 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002211 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients with AIDS Dementia
  ClinicalTrials.gov Identifier: NCT00002414 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002375 - Completed
  HIV Infections
  
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00000901 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002451 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
  ClinicalTrials.gov Identifier: NCT00001073 - Completed
  HIV Infections; Cervix, Dysplasia
  
• Safety and Effectiveness of Giving L-743,872 to Patients with Thrush That Has Not Been Cured With Fluconazole
  ClinicalTrials.gov Identifier: NCT00005920 - Terminated
  Candidiasis, Oral; HIV Infections
  
• Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
  ClinicalTrials.gov Identifier: NCT00002394 - Completed
  Candidiasis, Oral; HIV Infections
  
• Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients with AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002226 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination with 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors
  ClinicalTrials.gov Identifier: NCT00002193 - Completed
  HIV Infections
  
• Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
  ClinicalTrials.gov Identifier: NCT00005571 - Completed
  Dermatomyositis
  
• Safety and Effectiveness of Immunotherapy with Autologous HIV-Specific CD8 Cells in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00110578 - Completed
  HIV Infections
  
• Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
  ClinicalTrials.gov Identifier: NCT00002449 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Lamivudine When Given Once a Day versus Twice a Day in Combination with Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00004852 - Completed
  HIV Infections
  
• Safety and Effectiveness of Left Atrial Appendage Occlusion
  ClinicalTrials.gov Identifier: NCT00567515 - Recruiting
  Atrial Fibrillation
  
• Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants
  ClinicalTrials.gov Identifier: NCT00038480 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
  ClinicalTrials.gov Identifier: NCT00357552 - Not yet recruiting
  HIV Infections
  
• Safety and Effectiveness of Melperone (an Anti-Psychotic) in Patients with Psychosis Associated with Parkinson''s Disease
  ClinicalTrials.gov Identifier: NCT00125138 - Recruiting
  Parkinson Disease; Psychotic Disorders
  
• Safety and Effectiveness of NicVAX in Treating Nicotine Dependent Individuals
  ClinicalTrials.gov Identifier: NCT00218413 - Active, not recruiting
  Nicotine Cessation Therapies; Smoking Cessation; Tobacco Use Cessation
  
• Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
  ClinicalTrials.gov Identifier: NCT00004986 - Terminated
  Cryptosporidiosis; HIV Infections
  
• Safety and Effectiveness of NXY-059 for the Treatment of Patients who have Suffered from a Stroke
  ClinicalTrials.gov Identifier: NCT00061022 - Completed
  Cerebral Stroke; Stroke, Acute; Cerebrovascular Stroke; Ischemic Attack, Transient
  
• Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered from a Stroke
  ClinicalTrials.gov Identifier: NCT00119626 - Completed
  Cerebral Stroke; Ischemic Attack, Transient
  
• Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
  ClinicalTrials.gov Identifier: NCT00361374 - Recruiting
  Major Depressive Disorder
  
• Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00005012 - Completed
  HIV Infections
  
• Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults.
  ClinicalTrials.gov Identifier: NCT00528489 - Recruiting
  HIV Infections
  
• Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00345774 - Active, not recruiting
  Pulmonary Hypertension; Chronic Obstructive Pulmonary Disease
  
• Safety and Effectiveness of Raltegravir (MK-0518) in Treatment-Experienced, HIV Infected Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00485264 - Recruiting
  HIV Infections
  
• Safety and Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
  ClinicalTrials.gov Identifier: NCT00518024 - Not yet recruiting
  Tinnitus
  
• Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
  ClinicalTrials.gov Identifier: NCT00534495 - Not yet recruiting
  Juvenile Idiopathic Arthritis
  
• Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies
  ClinicalTrials.gov Identifier: NCT00000888 - Completed
  HIV Infections; Pregnancy
  
• Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression
  ClinicalTrials.gov Identifier: NCT00101452 - Recruiting
  Depression
  
• Safety and Effectiveness of SeeMore (EVP 1001-1 Injection) for MRI in Heart Patients
  ClinicalTrials.gov Identifier: NCT00340925 - Recruiting
  Myocardial Infarction
  
• Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00414518 - Recruiting
  HIV Infections
  
• Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
  ClinicalTrials.gov Identifier: NCT00307203 - Active, not recruiting
  Tobacco-Use Disorder; Schizophrenia; Psychotic Disorders
  
• Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development
  ClinicalTrials.gov Identifier: NCT00332124 - Not yet recruiting
  Pregnancy; Child Development
  
• Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002450 - Completed
  HIV Infections
  
• Safety and Effectiveness of the Drug DPC 083 in Combination with Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment with Nonnucleoside Reverse Transcriptase Inhibitors
  ClinicalTrials.gov Identifier: NCT00007449 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients
  ClinicalTrials.gov Identifier: NCT00303641 - Completed
  Coronary Artery Bypass Surgery; Cardiopulmonary Bypass
  
• Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System
  ClinicalTrials.gov Identifier: NCT00390702 - Recruiting
  Heart Septal Defects, Ventricular
  
• Safety and Effectiveness of the Oral HIV Entry Inhibitor SCH 417690 in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00082498 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
  ClinicalTrials.gov Identifier: NCT00013585 - Active, not recruiting
  Cognition Disorders; HIV Infections
  
• Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda
  ClinicalTrials.gov Identifier: NCT00007423 - Completed
  HIV Infections; HIV Seronegativity
  
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
  ClinicalTrials.gov Identifier: NCT00004981 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients with AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)
  ClinicalTrials.gov Identifier: NCT00002395 - Completed
  HIV Infections; Leukoencephalopathy, Progressive Multifocal
  
• Safety and Effectiveness of tPA in Intra-Abdominal Abscesses
  ClinicalTrials.gov Identifier: NCT00417768 - Recruiting
  Abscess
  
• Safety and Effectiveness of Treating HIV-Positive Patients with an HIV Vaccine (Remune)
  ClinicalTrials.gov Identifier: NCT00005001 - Completed
  HIV Infections
  
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) with Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00011895 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women
  ClinicalTrials.gov Identifier: NCT00000809 - Terminated
  HIV Infections; HIV Seronegativity
  
• Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects with Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00086671 - Completed
  Multiple Sclerosis; Multiple Sclerosis, Relapsing Remitting; Multiple Sclerosis, Secondary Progressive
  
• Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast–Enhanced CT Angiography of Arteries of the Heart
  ClinicalTrials.gov Identifier: NCT00335335 - Completed
  Coronary Artery Disease
  
• Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast–Enhanced CT Angiography of Arteries of the Heart
  ClinicalTrials.gov Identifier: NCT00348608 - Completed
  Coronary Artery Disease
  
• Safety and Effectiveness of Zemplar Injection in decreasing iPTH levels in pediatric ESRD subjects on hemodialysis
  ClinicalTrials.gov Identifier: NCT00053547 - Completed
  Secondary Hyperparathyroidism; End Stage Renal Disease
  
• Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002403 - Completed
  HIV Infections
  
• Safety and Effectiveness Study for Treating Older Men With Testosterone
  ClinicalTrials.gov Identifier: NCT00475501 - Recruiting
  Sarcopenia; Male Hypogonadism; Prostate Enlargement; Muscle Atrophy
  
• Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
  ClinicalTrials.gov Identifier: NCT00441298 - Recruiting
  HIV Infections
  
• Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
  ClinicalTrials.gov Identifier: NCT00499967 - Recruiting
  Genital Warts
  
• Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00242918 - Completed
  Prostate Cancer
  
• Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.
  ClinicalTrials.gov Identifier: NCT00190905 - Completed
  Stress Urinary Incontinence
  
• Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-Popliteal Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00530712 - Recruiting
  Peripheral Vascular Diseases
  
• Safety and effectiveness study of G207, a tumor-killing virus, in patients with recurrent brain cancer
  ClinicalTrials.gov Identifier: NCT00028158 - Completed
  Glioma; Astrocytoma; Glioblastoma
  
• Safety and Effectiveness Study of Maca Root to Treat Antidepressant-Induced Sexual Dysfunction
  ClinicalTrials.gov Identifier: NCT00181961 - Active, not recruiting
  Depression; Sexual Dysfunction
  
• Safety and Effectiveness Study of Prodisc to Spinal Fusion Surgery
  ClinicalTrials.gov Identifier: NCT00295009 - Active, not recruiting
  Spinal Diseases
  
• Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
  ClinicalTrials.gov Identifier: NCT00425321 - Recruiting
  Rheumatoid Arthritis
  
• Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device
  ClinicalTrials.gov Identifier: NCT00345631 - Active, not recruiting
  Angioplasty, Transluminal, Percutaneous Coronary; Coronary Arteriosclerosis
  
• Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease
  ClinicalTrials.gov Identifier: NCT00180544 - Terminated
  Renal Artery Obstruction
  
• Safety and Effectiveness Study of the Solysafe Septal Occluder
  ClinicalTrials.gov Identifier: NCT00353509 - Active, not recruiting
  Atrial Septal Defects
  
• Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale
  ClinicalTrials.gov Identifier: NCT00207376 - Active, not recruiting
  Atrial Septal Defect; Patent Foramen Ovale
  
• Safety and Effectiveness Study of The Swedish Adjustable Gastric Band (SAGB) in the Treatment of Morbid Obesity
  ClinicalTrials.gov Identifier: NCT00166205 - Completed
  Obesity, Morbid
  
• Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
  ClinicalTrials.gov Identifier: NCT00405691 - Recruiting
  Low Back Pain; Leg Pain; Spondylolisthesis; Lumbar Spinal Stenosis
  
• Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and 0.5% PRO 2000/5 Gel (P) for the Prevention of HIV Infection in Women
  ClinicalTrials.gov Identifier: NCT00197665 - Recruiting
  HIV Infections
  
• Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C
  ClinicalTrials.gov Identifier: NCT00275548 - Recruiting
  Liver Transplant; Hepatitis C
  
• Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers
  ClinicalTrials.gov Identifier: NCT00002231 - Completed
  HIV Infections; HIV Seronegativity
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Safety and Effects of Ramipril Combined With Candesartan
  ClinicalTrials.gov Identifier: NCT00356395 - Completed
  Hypertension
  
• Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00562549 - Enrolling by invitation
  Hypertension
  
• Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00252382 - Completed
  Carcinoma, Non-Small-Cell Lung
  
• Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00298896 - Active, not recruiting
  Carcinoma, Small Cell; Small Cell Lung Cancer
  
• Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00408603 - Recruiting
  Epithelial Ovarian Cancer
  
• Safety and Efficacy Comparison Ketotifen Ophthalmic Solution with Emedastine in Patients with Seasonal Allergic Conjunctivitis
  ClinicalTrials.gov Identifier: NCT00133627 - Completed
  Seasonal allergic conjunctivitis
  
• Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia
  ClinicalTrials.gov Identifier: NCT00434291 - Completed
  Community-Acquired Pneumonia
  
• Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria
  ClinicalTrials.gov Identifier: NCT00519467 - Completed
  Malaria
  
• Safety And Efficacy In Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin’s Lymphoma
  ClinicalTrials.gov Identifier: NCT00179660 - Completed
  Non-Hodgkins Lymphoma
  
• Safety and Efficacy Iodofiltic Acid I 123 in the Treatment of Acute Coronary Syndrome
  ClinicalTrials.gov Identifier: NCT00514501 - Recruiting
  Acute Coronary Syndrome
  
• Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
  ClinicalTrials.gov Identifier: NCT00314210 - Completed
  Anxiety Disorders
  
• Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
  ClinicalTrials.gov Identifier: NCT00228969 - Completed
  Refractory Epilepsy
  
• Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies
  ClinicalTrials.gov Identifier: NCT00048737 - Recruiting
  Lymphoma; Chronic Lymphocytic Leukemia
  
• Safety and Efficacy of a Contraceptive Vaginal Ring Delivering Nestorone® and Ethinyl Estradiol
  ClinicalTrials.gov Identifier: NCT00263341 - Recruiting
  Contraception
  
• Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
  ClinicalTrials.gov Identifier: NCT00000119 - Active, not recruiting
  Cataract; Uveitis
  
• Safety and efficacy of a monoclonal antibody for treatment of rheumatoid arthritis.
  ClinicalTrials.gov Identifier: NCT00034203 - Completed
  Rheumatoid Arthritis
  
• Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
  ClinicalTrials.gov Identifier: NCT00244439 - Active, not recruiting
  Lice Infestations
  
• Safety and Efficacy of a Pre-Defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing IVF
  ClinicalTrials.gov Identifier: NCT00249834 - Active, not recruiting
  Healthy Female Partners of Infertile Couples Justifying Assisted Reproductive Technology (ART) Treatment.
  
• Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
  ClinicalTrials.gov Identifier: NCT00309621 - Active, not recruiting
  Hand Dermatoses
  
• Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
  ClinicalTrials.gov Identifier: NCT00264459 - Active, not recruiting
  Grass Pollen Allergy
  
• Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
  ClinicalTrials.gov Identifier: NCT00413725 - Suspended
  HIV Infections
  
• Safety and Efficacy of AAE581 in Postmenopausal Women with Osteoporosis
  ClinicalTrials.gov Identifier: NCT00100607 - Completed
  Osteoporosis
  
• Safety and Efficacy of Abatacept Versus Placebo in Subjects With Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00534313 - Recruiting
  Psoriatic Arthritis
  
• Safety and efficacy of ABR-217620 in patients with advanced non-small cell lung cancer.
  ClinicalTrials.gov Identifier: NCT00056537 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Safety and Efficacy of ABT-335 and Statin Combination Therapy in the Treatment of Subjects With Mixed Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00300430 - Active, not recruiting
  Dyslipidemia
  
• Safety and Efficacy of ABT-510 in Subjects with Advanced Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00073125 - Completed
  Carcinoma, Renal Cell
  
• Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00504595 - Recruiting
  Rheumatoid Arthritis
  
• Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00195819 - Active, not recruiting
  Ankylosing Spondylitis
  
• Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00195689 - Completed
  Psoriatic Arthritis
  
• Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00507065 - Completed
  ADHD
  
• Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00095121 - Active, not recruiting
  Chronic Hepatitis B
  
• Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor
  ClinicalTrials.gov Identifier: NCT00262327 - Active, not recruiting
  Advanced Solid Tumor
  
• Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome
  ClinicalTrials.gov Identifier: NCT00445705 - Recruiting
  Fibromyalgia
  
• Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis
  ClinicalTrials.gov Identifier: NCT00380783 - Terminated
  Cystitis, Interstitial
  
• Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00381719 - Completed
  Diabetic Neuropathy, Painful
  
• Safety and Efficacy of AGN201781 in Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00533351 - Not yet recruiting
  Neuralgia
  
• Safety and Efficacy of ALC in Breast Cancer Subjects With Fatigue
  ClinicalTrials.gov Identifier: NCT00555841 - Recruiting
  Breast Cancer
  
• Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00259857 - Active, not recruiting
  Osteoporosis
  
• Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
  ClinicalTrials.gov Identifier: NCT00529451 - Recruiting
  Hypertension
  
• Safety and Efficacy of Aliskiren in Patients with Hypertension, Type 2 Diabetes and Proteinuria
  ClinicalTrials.gov Identifier: NCT00097955 - Completed
  Diabetic Nephropathy
  
• Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)
  ClinicalTrials.gov Identifier: NCT00414609 - Recruiting
  Myocardial Infarction
  
• Safety and Efficacy of Aliskiren on the Renin-Angiotensin System in Obese Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00498433 - Recruiting
  Hypertension
  
• Safety and Efficacy of ALX-0600 in Subjects with Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00072839 - Active, not recruiting
  Crohn's Disease
  
• Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
  ClinicalTrials.gov Identifier: NCT00308438 - Active, not recruiting
  Crohn Disease
  
• Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
  ClinicalTrials.gov Identifier: NCT00002019 - Completed
  Meningitis, Cryptococcal; HIV Infections
  
• Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
  ClinicalTrials.gov Identifier: NCT00035581 - Recruiting
  HIV Seropositivity; HIV Infection
  
• Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00195871 - Recruiting
  Lymphoblastic Lymphoma
  
• Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy
  ClinicalTrials.gov Identifier: NCT00293904 - Completed
  Hypersensitivity
  
• Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00415714 - Recruiting
  Primary Insomnia
  
• Safety and efficacy of an anti-psychotic in subjects with schizophrenia
  ClinicalTrials.gov Identifier: NCT00074477 - Completed
  Schizophrenia
  
• Safety and Efficacy of an Anti-Psychotic Versus Placebo in Subjects with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00101634 - Completed
  Schizophrenia
  
• Safety and Efficacy of an Anti-Psychotic Versus Placebo in Subjects with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00147173 - Completed
  Schizophrenia
  
• Safety and Efficacy of an Antibody to CCR5 in Individuals with HIV who Are Not Currently on Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00114699 - Completed
  HIV Infections
  
• Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye
  ClinicalTrials.gov Identifier: NCT00514852 - Recruiting
  Dry Eye
  
• Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
  ClinicalTrials.gov Identifier: NCT00091689 - Completed
  Melanoma
  
• Safety and Efficacy of an Infant Formula Supplemented With Galacto-Oligosaccharides (GOS)
  ClinicalTrials.gov Identifier: NCT00486148 - Recruiting
  Formula Feeding of Healthy Full Term Infants
  
• Safety and Efficacy of an Investigational Drug in HIV-infected Patients Failing Current Antiretroviral Therapies
  ClinicalTrials.gov Identifier: NCT00105157 - Active, not recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• Safety and efficacy of an investigational drug in the prevention of thrombocytopenia administered to patients with high-risk sarcoma receiving intensive chemotherapy (Adriamycin and Ifosfamide (AI))
  ClinicalTrials.gov Identifier: NCT00038311 - Completed
  Sarcoma
  
• Safety and efficacy of an investigational drug in the prevention of thrombocytopenia in patients receiving myelosuppressive treatment regimens requiring platelet transfusion support.
  ClinicalTrials.gov Identifier: NCT00037791 - Completed
  Neoplasms; Thrombocytopenia; Multiple Myeloma; Lymphoma, Malignant
  
• Safety and efficacy of an investigational drug in the prevention of thrombocytopenia in recurrent or refractory non-Burkitt's, non-Hodgkin's lymphoma (NHL) or Hodgkin's disease receiving DHAP (Dexamethasone, high-dose Cytarabine and Cisplatin) chemotherap
  ClinicalTrials.gov Identifier: NCT00039910 - Completed
  Non-Hodgkin Lymphoma; Hodgkin Disease; Thrombocytopenia
  
• Safety and Efficacy of an Investigational Drug versus Placebo in the Treatment of Cancer Pain
  ClinicalTrials.gov Identifier: NCT00095017 - Terminated
  Bone Neoplasms
  
• Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
  ClinicalTrials.gov Identifier: NCT00451152 - Recruiting
  Open-Angle Glaucoma
  
• Safety and Efficacy of Angiotech Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access
  ClinicalTrials.gov Identifier: NCT00448708 - Recruiting
  Hemodialysis Access; Kidney Diseases
  
• Safety and Efficacy of APD356 in the Treatment of Obesity
  ClinicalTrials.gov Identifier: NCT00104507 - Completed
  Obesity
  
• Safety and Efficacy of APD356 in the Treatment of Obesity
  ClinicalTrials.gov Identifier: NCT00116740 - Completed
  Obesity
  
• Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
  ClinicalTrials.gov Identifier: NCT00568594 - Recruiting
  Coronary Heart Disease (CHD)
  
• Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00250679 - Completed
  Chronic Obstructive Pulmonary Disease; Bronchitis; Emphysema
  
• Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
  ClinicalTrials.gov Identifier: NCT00487656 - Recruiting
  Sepsis; Disseminated Intravascular Coagulation
  
• Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00101426 - Completed
  Diabetic Neuropathy
  
• Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
  ClinicalTrials.gov Identifier: NCT00577473 - Completed
  Ulcerative Colitis
  
• Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
  ClinicalTrials.gov Identifier: NCT00558038 - Recruiting
  Hepatic Encephalopathy
  
• Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas
  ClinicalTrials.gov Identifier: NCT00321412 - Active, not recruiting
  Inflammatory Bowel Disease; Intestinal Fistula
  
• Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00583128 - Recruiting
  Irritable Bowel Syndrome
  
• Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis
  ClinicalTrials.gov Identifier: NCT00583531 - Recruiting
  Pouchitis
  
• Safety and Efficacy of AST-120 in the Treatment of Pouchitis
  ClinicalTrials.gov Identifier: NCT00583076 - Recruiting
  Pouchitis
  
• Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00414206 - Recruiting
  Macular Degeneration
  
• Safety and Efficacy of Atiprimod for Patients with Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00086216 - Completed
  Multiple Myeloma
  
• Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00388063 - Completed
  Neuroendocrine Carcinoma
  
• Safety and Efficacy of Atrasentan in Men with Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
  ClinicalTrials.gov Identifier: NCT00038662 - Completed
  Prostatic Neoplasms
  
• Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
  ClinicalTrials.gov Identifier: NCT00365326 - Recruiting
  Coronary Occlusion
  
• Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
  ClinicalTrials.gov Identifier: NCT00335660 - Recruiting
  Overactive Bladder Syndrome
  
• Safety and Efficacy of Avonex in Subjects with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
  ClinicalTrials.gov Identifier: NCT00099489 - Completed
  Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Guillain-Barre Syndrome
  
• Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients
  ClinicalTrials.gov Identifier: NCT00050232 - Completed
  Multiple Sclerosis
  
• Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS
  ClinicalTrials.gov Identifier: NCT00573443 - Recruiting
  Pseudobulbar Affect (PBA)
  
• Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-Term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids
  ClinicalTrials.gov Identifier: NCT00284947 - Active, not recruiting
  Kidney Transplantation; Adverse Effects
  
• Safety and Efficacy of BAY 50-4798 in Patients with HIV Infection
  ClinicalTrials.gov Identifier: NCT00059462 - Completed
  HIV Infections
  
• Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant
  ClinicalTrials.gov Identifier: NCT00434629 - Recruiting
  B-Cell Lymphoma; Non-Hodgkin's Lymphoma
  
• Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00514683 - Recruiting
  Pulmonary Fibrosis
  
• Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00437710 - Recruiting
  Acute Myocardial Infarction
  
• Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Joint
  ClinicalTrials.gov Identifier: NCT00403273 - Recruiting
  Arthroplasty, Replacement, Knee
  
• Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD
  ClinicalTrials.gov Identifier: NCT00524004 - Completed
  Travelers' Diarrhea
  
• Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00168363 - Completed
  Glaucoma; Ocular Hypertension
  
• Safety and Efficacy of Bronchitol in Bronchiectasis
  ClinicalTrials.gov Identifier: NCT00277537 - Active, not recruiting
  Bronchiectasis
  
• Safety and Efficacy of Buprenorphine Transdermal Delivery System in Subjects With Chronic Non-Malignant Pain
  ClinicalTrials.gov Identifier: NCT00312195 - Completed
  Chronic Non-Malignant Pain
  
• Safety and Efficacy of Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Osteoarthritis Pain
  ClinicalTrials.gov Identifier: NCT00312221 - Terminated
  Osteoarthritis
  
• Safety and Efficacy of Buprenorphine Transdermal Delivery System in Subjects With Moderate to Severe Low Back Pain.
  ClinicalTrials.gov Identifier: NCT00313014 - Terminated
  Chronic Low Back Pain
  
• Safety and Efficacy of Campath in Nonmyeloablative Transplantation
  ClinicalTrials.gov Identifier: NCT00038844 - Active, not recruiting
  Non Hodgkin's Lymphoma; Hodgkin's Disease; Chronic Lymphocytic Leukemia
  
• Safety and efficacy of CC-4047 in subjects with metastatic hormone refractory prostate cancer (HRPC)
  ClinicalTrials.gov Identifier: NCT00072722 - Completed
  Prostate Cancer
  
• Safety and efficacy of CC-5013 monotherapy in subjects with myelodysplastic syndromes associated with a del (5q) cytogenetic abnormality
  ClinicalTrials.gov Identifier: NCT00065156 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Safety and Efficacy of CDB-2914 for Emergency Contraception
  ClinicalTrials.gov Identifier: NCT00411684 - Recruiting
  Emergency Contraception
  
• Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
  ClinicalTrials.gov Identifier: NCT00551616 - Recruiting
  Contraception
  
• Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00324506 - Recruiting
  Multiple Sclerosis
  
• Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00364858 - Active, not recruiting
  Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
  
• Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00104065 - Completed
  Stomatitis
  
• Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria
  ClinicalTrials.gov Identifier: NCT00442403 - Suspended
  Malaria
  
• Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
  ClinicalTrials.gov Identifier: NCT00305487 - Completed
  Hay Fever; Seasonal Allergic Rhinitis
  
• Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment
  ClinicalTrials.gov Identifier: NCT00386191 - Active, not recruiting
  Cerebral Infarction
  
• Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients with Abnormal Glucose Metabolism from Tacrolimus to Cyclosporine Micro-Emulsion
  ClinicalTrials.gov Identifier: NCT00150085 - Active, not recruiting
  Tacrolimus-associated abnormal glucose metabolism in kidney and liver transplant recipients
  
• Safety and Efficacy of CryoCor™ Cryoablation for PAF
  ClinicalTrials.gov Identifier: NCT00231296 - Recruiting
  Atrial Fibrillation
  
• Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections
  ClinicalTrials.gov Identifier: NCT00057369 - Active, not recruiting
  Bacteremia
  
• Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections
  ClinicalTrials.gov Identifier: NCT00463801 - Recruiting
  Staphylococcal Skin Infections
  
• Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
  ClinicalTrials.gov Identifier: NCT00395629 - Recruiting
  Hereditary Hemochromatosis
  
• Safety and Efficacy of DepoDur in Lumbar Spine Surgery Patients
  ClinicalTrials.gov Identifier: NCT00335517 - Recruiting
  Lumbar Surgery
  
• Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00113620 - Completed
  Pain; Diabetic Neuropathies
  
• Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity
  ClinicalTrials.gov Identifier: NCT00339014 - Completed
  Obesity
  
• Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
  ClinicalTrials.gov Identifier: NCT00434148 - Recruiting
  Cushing's Disease
  
• Safety and Efficacy of Different Intervals of Pulsed Dye Laser Sessions on Improvement of Surgical Scars
  ClinicalTrials.gov Identifier: NCT00506090 - Recruiting
  Scar
  
• Safety and Efficacy of Different Onset Times of Treatment With Pulsed Dye Laser on Improvement of Surgical Scars
  ClinicalTrials.gov Identifier: NCT00506363 - Recruiting
  Scar
  
• Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients
  ClinicalTrials.gov Identifier: NCT00375557 - Terminated
  Alzheimer's Disease; Dementia; Behavioral Symptoms
  
• Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System in Subjects With Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00312572 - Completed
  Osteoarthritis
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads vs. IV Doxorubicin in Treating Liver Cancer
  ClinicalTrials.gov Identifier: NCT00034333 - Terminated
  Carcinoma, Hepatocellular
  
• Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00473954 - Recruiting
  Ovarian Neoplasms
  
• Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins
  ClinicalTrials.gov Identifier: NCT00565604 - Recruiting
  Incompetent Perforator Veins
  
• Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)
  ClinicalTrials.gov Identifier: NCT00077844 - Completed
  Percutaneous Coronary Intervention
  
• Safety and Efficacy of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS
  ClinicalTrials.gov Identifier: NCT00308425 - Active, not recruiting
  De Novo Renal Transplantation
  
• Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00235508 - Active, not recruiting
  Insomnia Associated With Generalized Anxiety Disorder
  
• Safety and Efficacy of Exenatide as Monotherapy
  ClinicalTrials.gov Identifier: NCT00381342 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin
  ClinicalTrials.gov Identifier: NCT00324363 - Completed
  Type 2 Diabetes Mellitus
  
• Safety and Efficacy of Exenatide in Patients with Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
  ClinicalTrials.gov Identifier: NCT00099320 - Completed
  Type 2 Diabetes Mellitus
  
• Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries
  ClinicalTrials.gov Identifier: NCT00352222 - Completed
  Arterial Occlusive Disease; Intermittent Claudication; Atherosclerotic Disease; Thrombosis
  
• Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00282503 - Recruiting
  Acute Graft-Versus-Host Disease
  
• Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00221026 - Active, not recruiting
  Crohn's Disease
  
• Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00221000 - Active, not recruiting
  Rheumatoid Arthritis
  
• Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents
  ClinicalTrials.gov Identifier: NCT00479258 - Not yet recruiting
  Diabetes Mellitus, Type 1
  
• Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00529152 - Recruiting
  Iron Overload
  
• Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab
  ClinicalTrials.gov Identifier: NCT00393107 - Completed
  Follicular Lymphoma
  
• Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant
  ClinicalTrials.gov Identifier: NCT00456482 - Terminated
  Non-Infectious Uveitis
  
• Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
  ClinicalTrials.gov Identifier: NCT00468871 - Completed
  Non-Infectious Uveitis
  
• Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
  ClinicalTrials.gov Identifier: NCT00407082 - Active, not recruiting
  Noninfectious Posterior Uveitis
  
• Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00479752 - Not yet recruiting
  Colorectal Cancer
  
• Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00286130 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• Safety and Efficacy of Freezing and Thawing of Human Eggs in Assisted Reproductive Technology
  ClinicalTrials.gov Identifier: NCT00451009 - Recruiting
  Infertility
  
• Safety and Efficacy of FTY720 in Adult Patients who Receive a Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00099749 - Completed
  Kidney Transplantation
  
• Safety and Efficacy of FTY720 in Adult Patients who Receive a Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00099801 - Active, not recruiting
  Kidney Transplantation
  
• Safety and Efficacy of G17DT Immunogen in the Treatment of Advanced Pancreatic Carcinoma
  ClinicalTrials.gov Identifier: NCT00044031 - Active, not recruiting
  Pancreatic Cancer
  
• Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer
  ClinicalTrials.gov Identifier: NCT00042510 - Active, not recruiting
  Stomach Neoplasms; Esophageal Neoplasms
  
• Safety and Efficacy of Gabapentin in Postherpetic Neuralgia
  ClinicalTrials.gov Identifier: NCT00335933 - Completed
  Neuralgia, Postherpetic
  
• Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
  ClinicalTrials.gov Identifier: NCT00230997 - Completed
  Lewy Body Disease
  
• Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
  ClinicalTrials.gov Identifier: NCT00573651 - Recruiting
  Arthritis
  
• Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
  ClinicalTrials.gov Identifier: NCT00545298 - Recruiting
  Venous Stasis Ulcers
  
• Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00457574 - Recruiting
  Solid Tumors and Lymphomas
  
• Safety and Efficacy of GPI 15715 for Sedation in the ICU Setting.
  ClinicalTrials.gov Identifier: NCT00125398 - Completed
  Postoperative sedation
  
• Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00263601 - Active, not recruiting
  Grass Pollen Allergy
  
• Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00422604 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Safety and Efficacy of GTS21 in Adults With Attention-Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00419445 - Not yet recruiting
  Attention-Deficit Hyperactivity Disorder
  
• Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine
  ClinicalTrials.gov Identifier: NCT00435812 - Active, not recruiting
  Hepatitis B
  
• Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00338117 - Completed
  Alzheimer's Disease; Dementia
  
• Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00330317 - Recruiting
  Breast Cancer
  
• Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00263549 - Active, not recruiting
  House Dust Mite Allergy
  
• Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00263640 - Active, not recruiting
  Respiratory Hypersensitivity
  
• Safety and Efficacy of Hum195/rGel in Patients with Advanced Myeloid Malignancies
  ClinicalTrials.gov Identifier: NCT00038051 - Recruiting
  Myelodysplastic Syndromes; Leukemia, Myelocytic, Acute; Anemia, Refractory, with Excess of Blasts; Myeloproliferative Disorders
  
• Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
  ClinicalTrials.gov Identifier: NCT00063128 - Completed
  Diabetes Mellitus, Type 1
  
• Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting
  ClinicalTrials.gov Identifier: NCT00409799 - Recruiting
  Tibia Plateau Fractures
  
• Safety and Efficacy of I-020502 in Meshed Skin Autografting
  ClinicalTrials.gov Identifier: NCT00471939 - Recruiting
  Burns
  
• Safety and Efficacy of IDEC-114 in Combination with Rituxan in the Treatment of Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00048555 - Completed
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00575068 - Completed
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00046488 - Completed
  Leukemia, Lymphocytic, Chronic
  
• Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
  ClinicalTrials.gov Identifier: NCT00471094 - Active, not recruiting
  Esophagitis
  
• Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children (ESPHALL)
  ClinicalTrials.gov Identifier: NCT00287105 - Recruiting
  Acute Lymphoblastic Leukemia; Philadelphia Chromosome
  
• Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00219726 - Recruiting
  Chronic Myeloid Leukemia
  
• Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years
  ClinicalTrials.gov Identifier: NCT00219752 - Completed
  Chronic Myeloid Leukemia
  
• Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients
  ClinicalTrials.gov Identifier: NCT00219765 - Terminated
  Chronic Myeloid Leukemia
  
• Safety and Efficacy of Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
  ClinicalTrials.gov Identifier: NCT00122473 - Active, not recruiting
  Dermatofibrosarcoma
  
• Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00477269 - Recruiting
  Pulmonary Arterial Hypertension
  
• Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00333840 - Active, not recruiting
  Chronic Myelogenous Leukemia
  
• Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00175643 - Completed
  Actinic Keratoses
  
• Safety and Efficacy of Implanting Skeletal Muscle Cells to Scarred Areas of Heart Muscle after Heart Attack
  ClinicalTrials.gov Identifier: NCT00102128 - Terminated
  Ischemic Heart Disease; Cardiomyopathies
  
• Safety and Efficacy of INGAP-Peptide in Patients with Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00071409 - Completed
  Diabetes Mellitus, Insulin-Dependent
  
• Safety and Efficacy of INGAP-Peptide in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00071422 - Completed
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00453414 - Terminated
  Pulmonary Arterial Hypertension
  
• Safety and Efficacy of Inhaled Insulin in Patients with Diabetes and Asthma or COPD
  ClinicalTrials.gov Identifier: NCT00157339 - Recruiting
  Diabetes Mellitus; Asthma; Pulmonary Disease, Chronic Obstructive
  
• Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00322257 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00331604 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection
  ClinicalTrials.gov Identifier: NCT00043355 - Terminated
  Lung Infection
  
• Safety and Efficacy of Inhaled Pre-Prandial Human Insulin in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00343980 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Safety and Efficacy of Insulin Detemir plus Insulin Aspart vs. Insulin Glargine plus Insulin Aspart as Mealtime Insulin in Type I Diabetes
  ClinicalTrials.gov Identifier: NCT00095082 - Completed
  Diabetes Mellitus, Type I
  
• Safety and Efficacy of Interferon Beta-1a Rebif® for Treating Patients With Acute Symptoms of Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00303381 - Completed
  Ulcerative Colitis
  
• Safety and efficacy of Interferon gamma-1b plus chemotherapy for ovarian and peritoneal cancer
  ClinicalTrials.gov Identifier: NCT00047632 - Terminated
  Ovarian Carcinoma; Peritoneal Carcinoma
  
• Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina
  ClinicalTrials.gov Identifier: NCT00185263 - Active, not recruiting
  Stable Angina
  
• Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-Infected Patients ANRS 132 SMILE
  ClinicalTrials.gov Identifier: NCT00383734 - Recruiting
  HIV-Associated Lipodystrophy Syndrome
  
• Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain
  ClinicalTrials.gov Identifier: NCT00488787 - Completed
  Pain, Postoperative
  
• Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss
  ClinicalTrials.gov Identifier: NCT00335920 - Recruiting
  Sudden Deafness
  
• Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00487825 - Recruiting
  Rheumatoid Arthritis
  
• Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)
  ClinicalTrials.gov Identifier: NCT00322556 - Active, not recruiting
  Agammaglobulinemia; IgG Deficiency; Common Variable Immunodeficiency
  
• Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
  ClinicalTrials.gov Identifier: NCT00002146 - Completed
  Cytomegalovirus Infections; HIV Infections; Hypocalcemia
  
• Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00576459 - Completed
  Diabetic Macular Edema
  
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade non-Hodgkin's Lymphoma Following First Line CHOP
  ClinicalTrials.gov Identifier: NCT00022932 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement
  ClinicalTrials.gov Identifier: NCT00022906 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux.
  ClinicalTrials.gov Identifier: NCT00369265 - Recruiting
  Laryngopharyngeal Reflux
  
• Safety and Efficacy of LAP-BAND® Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2
  ClinicalTrials.gov Identifier: NCT00580502 - Completed
  Obesity; Diabetes Mellitus
  
• Safety and Efficacy of Laparoscopic Truncal Vagotomy for the Treatment of Obesity
  ClinicalTrials.gov Identifier: NCT00285220 - Active, not recruiting
  Morbid Obesity
  
• Safety and Efficacy of Larger Dose of Spironolactone for the Treatment of Patients with Nonischemic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00125437 - Recruiting
  Heart Failure, Congestive
  
• Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome
  ClinicalTrials.gov Identifier: NCT00266214 - Terminated
  Carpal Tunnel Syndrome
  
• Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-naïve Patients With Acromegaly
  ClinicalTrials.gov Identifier: NCT00225979 - Completed
  Acromegaly
  
• Safety and Efficacy of Longterm HPN With Two Lipid Emulsions
  ClinicalTrials.gov Identifier: NCT00530738 - Not yet recruiting
  Malnutrition
  
• Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00317980 - Active, not recruiting
  Cutaneous Leishmaniasis
  
• Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
  ClinicalTrials.gov Identifier: NCT00452335 - Recruiting
  Constipation
  
• Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension
  ClinicalTrials.gov Identifier: NCT00267176 - Completed
  Osteoarthritis,; Controlled Hypertension
  
• Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain
  ClinicalTrials.gov Identifier: NCT00170898 - Completed
  Musculoskeletal Pain
  
• Safety and Efficacy of Marqibo in Metastastic Malignant Uveal Melanoma
  ClinicalTrials.gov Identifier: NCT00506142 - Recruiting
  Metastatic Malignant Uveal Melanoma
  
• Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00495079 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne
  ClinicalTrials.gov Identifier: NCT00211497 - Completed
  Acne Vulgaris; Acne; Propionibacterium Acnes
  
• Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne
  ClinicalTrials.gov Identifier: NCT00211523 - Completed
  Acne Vulgaris; Acne; Propionibacterium Acnes
  
• Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-related Bloodstream Infections
  ClinicalTrials.gov Identifier: NCT00027248 - Completed
  Sepsis; Bacteremia; Fungemia
  
• Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00307749 - Completed
  Diabetic Polyneuropathy
  
• Safety and Efficacy of MCG for Diagnosing Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00170027 - Recruiting
  Myocardial Ischemia
  
• Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00374920 - Active, not recruiting
  Bipolar Disorder With Manic or Mixed Episodes
  
• Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer’s Disease
  ClinicalTrials.gov Identifier: NCT00257673 - Active, not recruiting
  Alzheimer's Disease
  
• Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00454870 - Active, not recruiting
  Alzheimer's Disease
  
• Safety and Efficacy of Methoxyflurane for Treatment of Incident Pain
  ClinicalTrials.gov Identifier: NCT00524927 - Recruiting
  Pain Measurement
  
• Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso
  ClinicalTrials.gov Identifier: NCT00545935 - Recruiting
  Malaria
  
• Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study
  ClinicalTrials.gov Identifier: NCT00354380 - Completed
  Malaria
  
• Safety and Efficacy of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00428792 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Safety and Efficacy of Methylphenidate Transdermal System (MTS) Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD
  ClinicalTrials.gov Identifier: NCT00444574 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Safety and Efficacy of MK0736 & MK0916 in Patients With Hypertension (High Blood Pressure)
  ClinicalTrials.gov Identifier: NCT00274716 - Active, not recruiting
  Hypertension
  
• Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease.
  ClinicalTrials.gov Identifier: NCT00159172 - Recruiting
  Parkinson disease C10.574.812; Electric Stimulation Therapy E02.831.580.438; Neuronavigation E05.873.249
  
• Safety and Efficacy of MultiHance in Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00323310 - Recruiting
  Central Nervous System Diseases
  
• Safety and Efficacy of Multiple Doses of ACZ885 in Chronic Obstructive Pulmonary Disease (COPD) Patients
  ClinicalTrials.gov Identifier: NCT00581945 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery
  ClinicalTrials.gov Identifier: NCT00266786 - Completed
  Postoperative Pain
  
• Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00030966 - Completed
  Multiple Sclerosis, Relapsing-Remitting
  
• Safety and Efficacy of Natalizumab in Combination with Remicade in the Treatment of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00055536 - Completed
  Crohn's Disease
  
• Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00032786 - Completed
  Crohn's Disease
  
• Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00032799 - Completed
  Crohn's Disease
  
• Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00027300 - Completed
  Multiple Sclerosis, Relapsing-Remitting
  
• Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
  ClinicalTrials.gov Identifier: NCT00402909 - Completed
  Type 2 Diabetes
  
• Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans
  ClinicalTrials.gov Identifier: NCT00145210 - Recruiting
  Hypertension
  
• Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-Oesophageal Junction
  ClinicalTrials.gov Identifier: NCT00374985 - Recruiting
  Esophageal Neoplasms; Stomach Neoplasms
  
• Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients
  ClinicalTrials.gov Identifier: NCT00436592 - Recruiting
  Cerebrovascular Accident
  
• Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS)
  ClinicalTrials.gov Identifier: NCT00119717 - Recruiting
  Cerebrovascular Accident
  
• Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
  ClinicalTrials.gov Identifier: NCT00333268 - Completed
  Cataract
  
• Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
  ClinicalTrials.gov Identifier: NCT00490464 - Completed
  Subarachnoid Hemorrhage; Intracerebral Hemorrhage
  
• Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00168064 - Recruiting
  CTCL - Mycosis Fungoides
  
• Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00097071 - Completed
  Diabetes Mellitus, Type I
  
• Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches
  ClinicalTrials.gov Identifier: NCT00172094 - Terminated
  Migraine Headache
  
• Safety and Efficacy of NT 201 in the Treatment of Glabellar Frown Lines
  ClinicalTrials.gov Identifier: NCT00512135 - Recruiting
  Treatment of Glabellar Frown Lines
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies
  ClinicalTrials.gov Identifier: NCT00438178 - Recruiting
  Hematological Malignancies
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
  ClinicalTrials.gov Identifier: NCT00407303 - Recruiting
  Mantle-Cell Lymphoma
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00359892 - Active, not recruiting
  Hodgkin's Lymphoma
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia
  ClinicalTrials.gov Identifier: NCT00360035 - Recruiting
  Myelofibrosis
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)
  ClinicalTrials.gov Identifier: NCT00413114 - Recruiting
  Myelodysplastic Syndromes
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00405951 - Recruiting
  Lung Cancer
  
• Safety and Efficacy of Octreotide LAR in Treatment naïve Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00128232 - Completed
  Acromegaly
  
• Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
  ClinicalTrials.gov Identifier: NCT00578929 - Recruiting
  Seasonal Allergic Rhinitis
  
• Safety and Efficacy of OP2000 (deligoparin) in the Treatment of Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00033943 - Completed
  Ulcerative Colitis
  
• Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes
  ClinicalTrials.gov Identifier: NCT00469573 - Recruiting
  Dry Eye
  
• Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain
  ClinicalTrials.gov Identifier: NCT00441766 - Recruiting
  Irritable Bowel Syndrome
  
• Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting from Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00041717 - Completed
  Spinal Cord Injury; Muscle Spasticity
  
• Safety and Efficacy of Oral Midazolam for Preioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
  ClinicalTrials.gov Identifier: NCT00578214 - Recruiting
  Basal Cell Carcinoma; Squamous Cell Caricnoma; Skin Cancer; Anxiety
  
• Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)
  ClinicalTrials.gov Identifier: NCT00509145 - Recruiting
  Multiple Sclerosis
  
• Safety and Efficacy of OSTEOFORM (rhPTH [1-34]) in Increasing Bone Mineral Density in Osteoporosis
  ClinicalTrials.gov Identifier: NCT00500409 - Completed
  Osteoporosis
  
• Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
  ClinicalTrials.gov Identifier: NCT00275925 - Completed
  Epilepsy, Partial Seizures
  
• Safety and Efficacy of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00503386 - Completed
  Nausea; Vomiting; Chemotherapy
  
• Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients
  ClinicalTrials.gov Identifier: NCT00260234 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00571662 - Recruiting
  Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic Syndromes; Multiple Myeloma; Non-Hodgkins Lymphoma; Hodgkins Disease; Peripheral T-Cell Lymphoma
  
• Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.
  ClinicalTrials.gov Identifier: NCT00572455 - Not yet recruiting
  Primary Open-Angle Glaucoma; Primary Ocular Hypertension
  
• Safety and Efficacy of PHP in the Treatment of Shock Associated with Systemic Inflammatory Response Syndrome (SIRS)
  ClinicalTrials.gov Identifier: NCT00021502 - Active, not recruiting
  Shock; Systemic Inflammatory Response Syndrome
  
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
  ClinicalTrials.gov Identifier: NCT00124709 - Active, not recruiting
  Atopic Dermatitis
  
• Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients
  ClinicalTrials.gov Identifier: NCT00121316 - Completed
  Atopic Dermatitis
  
• Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients with Moderate to Severe Keratoconjunctivitis Sicca
  ClinicalTrials.gov Identifier: NCT00128245 - Completed
  Keratoconjunctivitis sicca (dry eye syndrome)
  
• Safety and Efficacy of Pioglitazone as an Anti-Inflammatory for the Treatment of CF Lung Disease
  ClinicalTrials.gov Identifier: NCT00322868 - Completed
  Cystic Fibrosis
  
• Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00287729 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
  ClinicalTrials.gov Identifier: NCT00048776 - Completed
  Raynaud's Disease
  
• Safety and efficacy of Pletal(cilostazol) for the treatment of juvenile primary and secondary Raynaud's phenomenon
  ClinicalTrials.gov Identifier: NCT00048763 - Completed
  Raynaud's Disease
  
• Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00492388 - Recruiting
  Pain; Cancer
  
• Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals
  ClinicalTrials.gov Identifier: NCT00000664 - Completed
  HIV Infections
  
• Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals
  ClinicalTrials.gov Identifier: NCT00001997 - Completed
  HIV Infections
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Safety and Efficacy of Pravastatin in Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00200655 - Recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Safety and Efficacy of Pregabalin in Patients with Diabetic Peripheral Neuropathy.
  ClinicalTrials.gov Identifier: NCT00141401 - Completed
  Diabetic Neuropathy, Painful
  
• Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00055185 - Active, not recruiting
  HIV Infections; Acquired Immune Deficiency Syndrome
  
• Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
  ClinicalTrials.gov Identifier: NCT00447564 - Recruiting
  Opioid Dependence
  
• Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD Patients
  ClinicalTrials.gov Identifier: NCT00284986 - Completed
  Graft Versus Host Disease
  
• Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secrectory Conversion
  ClinicalTrials.gov Identifier: NCT00160199 - Recruiting
  Secondary Amenorrhea
  
• Safety and Efficacy of Proprionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
  ClinicalTrials.gov Identifier: NCT00399919 - Recruiting
  Peripheral Vascular Diseases; Intermittent Claudication
  
• Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea
  ClinicalTrials.gov Identifier: NCT00392574 - Recruiting
  Acute Gastroenteritis in Adult Travelers
  
• Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers
  ClinicalTrials.gov Identifier: NCT00448422 - Recruiting
  Acute Bacterial Gastroenteritis
  
• Safety and Efficacy of PTC124 for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00237380 - Active, not recruiting
  Cystic Fibrosis
  
• Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00366119 - Active, not recruiting
  Essential Hypertension
  
• Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00284089 - Completed
  Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-Related Macular Degeneration (AMD)
  
• Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
  ClinicalTrials.gov Identifier: NCT00219817 - Active, not recruiting
  Cancer Cachexia
  
• Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00073463 - Terminated
  Cystic Fibrosis
  
• Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00309062 - Active, not recruiting
  Birch Pollen Allergy
  
• Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00309036 - Active, not recruiting
  Grass Pollen Allergy
  
• Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease
  ClinicalTrials.gov Identifier: NCT00025896 - Completed
  Pompe Disease; Glycogen Storage Disease Type II; Acid Maltase Deficiency Disease; Glycogenosis 2
  
• Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00037687 - Terminated
  Sepsis
  
• Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00320788 - Active, not recruiting
  Macular Degeneration
  
• Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries
  ClinicalTrials.gov Identifier: NCT00248066 - Completed
  Coronary Artery Disease; Coronary Restenosis
  
• Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
  ClinicalTrials.gov Identifier: NCT00106028 - Active, not recruiting
  Osteogenesis Imperfecta
  
• Safety and Efficacy of Rituximab in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNFα Therapies
  ClinicalTrials.gov Identifier: NCT00468546 - Active, not recruiting
  Arthritis, Rheumatoid
  
• Safety and Efficacy of RK0202 in Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00230191 - Completed
  Mouth Diseases; Mouth Ulcers; Oral Mucositis; Head and Neck Cancer
  
• Safety and Efficacy of RT-CGMS in Patients With Type 1 Diabetes Mellitus Treated With an Implantable Pump
  ClinicalTrials.gov Identifier: NCT00501072 - Recruiting
  Diabetes Mellitus, Type 1
  
• Safety and Efficacy of S-8184 in Second Line Treatment of Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium
  ClinicalTrials.gov Identifier: NCT00034177 - Active, not recruiting
  Urologic Neoplasms
  
• Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00034164 - Active, not recruiting
  Non Small Cell Lung Cancer
  
• Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00034190 - Active, not recruiting
  Colorectal Adenocarcinoma
  
• Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00034151 - Active, not recruiting
  Ovarian Cancer
  
• Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)
  ClinicalTrials.gov Identifier: NCT00423670 - Active, not recruiting
  Chronic Hepatitis C
  
• Safety and Efficacy of SCH 503034 Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin
  ClinicalTrials.gov Identifier: NCT00160251 - Completed
  Chronic Hepatitis C
  
• Safety and Efficacy of SDX-101 (R-Etodolac) in Combination with Chlorambucil, and That of Chlorambucil Alone, in Patients with Chronic Lymphocytic Leukemia (CLL)
  ClinicalTrials.gov Identifier: NCT00151736 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)
  ClinicalTrials.gov Identifier: NCT00293111 - Terminated
  Multiple Myeloma
  
• Safety and Efficacy of Seroquel in First Episode Schizophrenia
  ClinicalTrials.gov Identifier: NCT00254241 - Completed
  Schizophrenia
  
• Safety and Efficacy of SH T00660AA in Treatment of Endometriosis
  ClinicalTrials.gov Identifier: NCT00225186 - Completed
  Endometriosis
  
• Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-Untreated Follicular Lymphoma (FL)
  ClinicalTrials.gov Identifier: NCT00427856 - Recruiting
  Lymphoma, Follicular
  
• Safety and efficacy of single-agent CC-5013 in subjects with relapsed and refractory multiple myeloma
  ClinicalTrials.gov Identifier: NCT00065351 - Active, not recruiting
  Multiple Myeloma
  
• Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00034307 - Active, not recruiting
  Pulmonary Hypertension
  
• Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)
  ClinicalTrials.gov Identifier: NCT00508833 - Completed
  Hepatitis B Disease
  
• Safety and Efficacy of Solifenacin in Men With OAB and Detrusor Underactivity
  ClinicalTrials.gov Identifier: NCT00441428 - Recruiting
  Overactive Bladder; Detrusor Underactivity
  
• Safety and Efficacy of Somatropin (rhGH) in Short Children Born Small for Gestational Age (SGA)
  ClinicalTrials.gov Identifier: NCT00537914 - Not yet recruiting
  Infant, Small for Gestational Age, SGA
  
• Safety and Efficacy of SPD465 in Adults with ADHD
  ClinicalTrials.gov Identifier: NCT00202605 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00503243 - Completed
  Colitis, Ulcerative
  
• Safety and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17
  ClinicalTrials.gov Identifier: NCT00152009 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17
  ClinicalTrials.gov Identifier: NCT00150618 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-Adsorbed Allergoid Preparation of Birch Pollen Allergens
  ClinicalTrials.gov Identifier: NCT00263627 - Active, not recruiting
  Pollen Allergy
  
• Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
  ClinicalTrials.gov Identifier: NCT00264914 - Completed
  Inappropriate ADH Syndrome; Hyponatremia
  
• Safety and efficacy of study drug versus placebo for negative symptoms of schizophrenia
  ClinicalTrials.gov Identifier: NCT00063297 - Completed
  Schizophrenia
  
• Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00367640 - Terminated
  Allergy
  
• Safety and Efficacy of Sustained Erythropoietin Therapy
  ClinicalTrials.gov Identifier: NCT00542568 - Not yet recruiting
  Anemia
  
• Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD
  ClinicalTrials.gov Identifier: NCT00485875 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children (Ages 2- <12)
  ClinicalTrials.gov Identifier: NCT00528957 - Recruiting
  HIV Infections
  
• Safety and Efficacy of T Cell Genetic Immunotherapy for HIV
  ClinicalTrials.gov Identifier: NCT00131560 - Recruiting
  HIV Infection
  
• Safety and Efficacy of Talampanel in Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00267592 - Active, not recruiting
  Glioblastoma Multiforme
  
• Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver
  ClinicalTrials.gov Identifier: NCT00035919 - Recruiting
  Colorectal Neoplasms
  
• Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain.
  ClinicalTrials.gov Identifier: NCT00399659 - Terminated
  Opioid-Induced Constipation
  
• Safety and Efficacy of Tegaserod in Opioid-Induced Constipation in Patients With Non-Cancer Pain.
  ClinicalTrials.gov Identifier: NCT00414024 - Terminated
  Opioid-Induced Constipation
  
• Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00352053 - Recruiting
  HIV Infections
  
• Safety and Efficacy of Teriflunomide (HMR 1726) in Multiple Sclerosis With Relapses
  ClinicalTrials.gov Identifier: NCT00228163 - Completed
  Multiple Sclerosis
  
• Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction
  ClinicalTrials.gov Identifier: NCT00254228 - Active, not recruiting
  Vestibular Disease
  
• Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Osteoarthritis Pain
  ClinicalTrials.gov Identifier: NCT00320801 - Terminated
  Osteoarthritis
  
• Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Osteoarthritis Pain.
  ClinicalTrials.gov Identifier: NCT00315458 - Terminated
  Osteoarthritis
  
• Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
  ClinicalTrials.gov Identifier: NCT00314652 - Completed
  Osteoarthritis
  
• Safety and Efficacy of the Buprenorphine Transdermal System in Subjects With Mod-to-Sev Osteoarthritis of Hip or Knee
  ClinicalTrials.gov Identifier: NCT00313846 - Completed
  Osteoarthritis
  
• Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter
  ClinicalTrials.gov Identifier: NCT00113178 - Active, not recruiting
  Atrial Flutter
  
• Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation
  ClinicalTrials.gov Identifier: NCT00568230 - Enrolling by invitation
  Heart Failure; Mitral Regurgitation
  
• Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-Metastatic, Post-Resection Pancreas Cancer
  ClinicalTrials.gov Identifier: NCT00300950 - Recruiting
  Pancreas Cancer
  
• Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection.
  ClinicalTrials.gov Identifier: NCT00124215 - Active, not recruiting
  Hepatitis C Infection
  
• Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration
  ClinicalTrials.gov Identifier: NCT00286273 - Active, not recruiting
  Kidney Failure, Acute
  
• Safety and Efficacy of the WaisFix100i for Intracapsular Femoral Fracture Fixation
  ClinicalTrials.gov Identifier: NCT00521716 - Not yet recruiting
  Hip Fracture
  
• Safety and Efficacy of the ZoMaxx(TM) Drug-Eluting Stent System in Coronary Arteries
  ClinicalTrials.gov Identifier: NCT00148356 - Completed
  Coronary Disease; Coronary Atherosclerosis; Arterial Occlusive Diseases
  
• Safety and Efficacy of the ZoMaxx(TM) Drug-Eluting Stent System in Coronary Arteries
  ClinicalTrials.gov Identifier: NCT00140101 - Recruiting
  Coronary Disease; Coronary Atherosclerosis; Arterial Occlusive Diseases
  
• Safety and Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00365365 - Recruiting
  Breast Cancer
  
• Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
  ClinicalTrials.gov Identifier: NCT00216567 - Completed
  Epilepsy, Rolandic
  
• Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00384098 - Completed
  Psoriasis
  
• Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00082121 - Completed
  Myocardial Ischemia; Coronary Arteriosclerosis; Aortic Valve Insufficiency; Mitral Valve Insufficiency
  
• Safety and Efficacy of tPA in Neonates and Infants
  ClinicalTrials.gov Identifier: NCT00265005 - Recruiting
  Catheterization
  
• Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients with Indolent Non-Hodgkin''s Lymphoma (NHL) Who Are Refractory to Rituximab
  ClinicalTrials.gov Identifier: NCT00139841 - Active, not recruiting
  Non-Hodgkin''s Lymphoma
  
• Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn’s Disease
  ClinicalTrials.gov Identifier: NCT00304252 - Terminated
  Crohn’s Disease
  
• Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00073021 - Completed
  Ulcerative Colitis
  
• Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients
  ClinicalTrials.gov Identifier: NCT00402948 - Recruiting
  Asthma
  
• Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-Tuberculosis Treatment
  ClinicalTrials.gov Identifier: NCT00332306 - Recruiting
  Tuberculosis; Human Immunodeficiency Virus
  
• Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
  ClinicalTrials.gov Identifier: NCT00430300 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen
  ClinicalTrials.gov Identifier: NCT00518518 - Active, not recruiting
  Asthma
  
• Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00270881 - Recruiting
  Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome
  
• Safety and Efficacy of Using CBUS™ System for Ultrasound Breast Imaging Designed for Breast Tumor Diagnosis
  ClinicalTrials.gov Identifier: NCT00355745 - Recruiting
  Breast Cancer
  
• Safety and Efficacy of Using GlucoSat Technology For Non-Invasive Glucose Measurement
  ClinicalTrials.gov Identifier: NCT00451334 - Not yet recruiting
  Diabetes
  
• Safety and Efficacy of Using LEORTEC-300 System For Hair Removal Treatment
  ClinicalTrials.gov Identifier: NCT00348257 - Completed
  Epilation
  
• Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment
  ClinicalTrials.gov Identifier: NCT00398203 - Not yet recruiting
  Intestinal Diseases
  
• Safety and Efficacy of Using the Endodontic Self Adjusting File - SAF for Root Canal Treatment
  ClinicalTrials.gov Identifier: NCT00497042 - Not yet recruiting
  Teeth, Endodontically-Treated
  
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00409643 - Completed
  Hypertension
  
• Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.
  ClinicalTrials.gov Identifier: NCT00409760 - Completed
  Hypertension
  
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
  Hypertension
  
• Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
  Hypertension
  
• Safety and Efficacy of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00437645 - Active, not recruiting
  Essential Hypertension
  
• Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00490945 - Completed
  Circadian Rhythm Sleep Disorders
  
• Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
  ClinicalTrials.gov Identifier: NCT00177528 - Completed
  Depression
  
• Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
  ClinicalTrials.gov Identifier: NCT00113191 - Completed
  Nosocomial Infections; Sepsis; Staphylococcal Infections; Candidemia
  
• Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as Add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
  ClinicalTrials.gov Identifier: NCT00396227 - Completed
  Diabetes Mellitus, Type 2
  
• Safety and Efficacy of VIT45 in the Treatment of Postpartum Patients
  ClinicalTrials.gov Identifier: NCT00354484 - Completed
  Postpartum Anemia
  
• Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy
  ClinicalTrials.gov Identifier: NCT00532415 - Active, not recruiting
  Vitrectomy
  
• Safety and Efficacy of Xenical in Children and Adolescents with Obesity-Related Diseases
  ClinicalTrials.gov Identifier: NCT00001723 - Recruiting
  Diabetes Mellitus; Hypertension; Metabolic Disease; Obesity; Sleep Apnea Syndrome
  
• Safety and efficacy of Xyrem oral solution (sodium oxybate) compared with placebo in narcoleptic patients
  ClinicalTrials.gov Identifier: NCT00049803 - Completed
  Narcolepsy
  
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (daily dosing)
  ClinicalTrials.gov Identifier: NCT00048516 - Completed
  Renal Insufficiency, Chronic
  
• Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three times weekly)
  ClinicalTrials.gov Identifier: NCT00048438 - Completed
  Renal Insufficiency, Chronic
  
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three times weekly)
  ClinicalTrials.gov Identifier: NCT00048451 - Completed
  Renal Insufficiency, Chronic
  
• Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00057343 - Terminated
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy of Zidovudine for Asymptomatic HIV-Infected Individuals
  ClinicalTrials.gov Identifier: NCT00000736 - Completed
  HIV Infections
  
• Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa.
  ClinicalTrials.gov Identifier: NCT00138047 - Completed
  HIV Infection
  
• Safety and Efficacy of Ziprasidone in Adolescents With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00257192 - Recruiting
  Schizophrenia
  
• Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00257166 - Completed
  Bipolar Disorder
  
• Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions
  ClinicalTrials.gov Identifier: NCT00375427 - Recruiting
  Breast Cancer With Bone Metastasis
  
• Safety and Efficacy Study Comparing ProDisc-C to ACDF Surgery to Treat SCDD
  ClinicalTrials.gov Identifier: NCT00291018 - Active, not recruiting
  Diskectomy; Spinal Fusion; Prostheses and Implants
  
• Safety and Efficacy Study Comparing Thrombin for Arterial Sealing
  ClinicalTrials.gov Identifier: NCT00388284 - Recruiting
  Hemostasis of Arterial Punctures
  
• Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.
  ClinicalTrials.gov Identifier: NCT00306735 - Recruiting
  Multiple Myeloma
  
• Safety and Efficacy Study in Acute Ischaemic Stroke
  ClinicalTrials.gov Identifier: NCT00144014 - Recruiting
  Stroke
  
• Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00507936 - Recruiting
  Diabetic Neuropathic Pain
  
• Safety and Efficacy Study in the Treatment of Intestinal Problems Associated with Autism
  ClinicalTrials.gov Identifier: NCT00110708 - Active, not recruiting
  Autism; Autistic Disorder; Child Development Disorders, Pervasive; Gastrointestinal Diseases; Signs and Symptoms, Digestive
  
• Safety and Efficacy Study in the Treatment of Pediatric Crohn’s Disease
  ClinicalTrials.gov Identifier: NCT00206661 - Terminated
  Crohn Disease
  
• Safety and Efficacy Study in Type 1 Diabetes.
  ClinicalTrials.gov Identifier: NCT00127634 - Active, not recruiting
  Diabetes
  
• Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children
  ClinicalTrials.gov Identifier: NCT00371124 - Recruiting
  Myopia
  
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00157079 - Completed
  Primary Immunodeficiency Disorders; Immune Thrombocytopenic Purpura (ITP); Kawasaki syndrome
  
• Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00080236 - Active, not recruiting
  Liver Transplantation; Hepatitis; Cholestasis; Carcinoma, Hepatocellular
  
• Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation
  ClinicalTrials.gov Identifier: NCT00562471 - Completed
  Myoma
  
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00288249 - Recruiting
  Metastatic Breast Cancer
  
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00185302 - Completed
  Non-Resectable Metastatic Melanoma
  
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00160043 - Active, not recruiting
  Non Small Cell Lung Cancer
  
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00160069 - Recruiting
  Non Small Cell Lung Carcinoma
  
• Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00299390 - Terminated
  Small Cell Lung Cancer
  
• Safety and Efficacy Study of a New Device for Tattoo Removal
  ClinicalTrials.gov Identifier: NCT00409162 - Not yet recruiting
  Tattoo; Healthy
  
• Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
  ClinicalTrials.gov Identifier: NCT00157105 - Completed
  Hemophilia A
  
• Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture
  ClinicalTrials.gov Identifier: NCT00528840 - Recruiting
  Dupuytren's Contracture
  
• Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00555204 - Recruiting
  Alzheimer's Disease
  
• Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2
  ClinicalTrials.gov Identifier: NCT00425035 - Completed
  Advanced Renal Cell Carcinoma
  
• Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00359944 - Recruiting
  Alzheimer's Disease
  
• Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients with Intermittent Claudication
  ClinicalTrials.gov Identifier: NCT00117650 - Recruiting
  Intermittent Claudication; Peripheral Vascular Disease; Atherosclerosis
  
• Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)
  ClinicalTrials.gov Identifier: NCT00235885 - Completed
  Psoriatic Arthritis
  
• Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary Percutaneous Intervention in Patients With ST-Elevation Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00546260 - Recruiting
  Myocardial Infarction
  
• Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum Malaria
  ClinicalTrials.gov Identifier: NCT00149383 - Completed
  Falciparum Malaria
  
• Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Gastrointestinal Graft Vs Host Disease
  ClinicalTrials.gov Identifier: NCT00136903 - Completed
  Graft vs Host Disease
  
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
  ClinicalTrials.gov Identifier: NCT00322270 - Recruiting
  Thrombosis; Venous Thrombosis; Catheter Occlusion
  
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
  ClinicalTrials.gov Identifier: NCT00346424 - Completed
  Thrombosis; Venous Thrombosis
  
• Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies
  ClinicalTrials.gov Identifier: NCT00496860 - Recruiting
  Progressive Metastatic Malignancies
  
• Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00380068 - Recruiting
  Pulmonary Hypertension
  
• Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects
  ClinicalTrials.gov Identifier: NCT00527267 - Completed
  Hyperparathyroidism
  
• Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00515203 - Recruiting
  Idiopathic Thrombocytopenic Purpura; Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00040001 - Completed
  Atrial Fibrillation
  
• Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00354926 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00330265 - Recruiting
  Foot Ulcer; Diabetes
  
• Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization
  ClinicalTrials.gov Identifier: NCT00288418 - Completed
  Bacterial Infections
  
• Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00159250 - Recruiting
  Duchenne Muscular Dystrophy
  
• Safety and Efficacy Study of APD125 in Patient With Insomnia
  ClinicalTrials.gov Identifier: NCT00452179 - Completed
  Insomnia
  
• Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
  ClinicalTrials.gov Identifier: NCT00310518 - Active, not recruiting
  Cancer
  
• Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00286793 - Recruiting
  Prostate Cancer
  
• Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00315133 - Recruiting
  Type 1 Diabetes Mellitus
  
• Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00294346 - Active, not recruiting
  Social Phobia
  
• Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
  ClinicalTrials.gov Identifier: NCT00451256 - Recruiting
  Cardiovascular Disease; Coronary Artery Bypass
  
• Safety and Efficacy Study of Axid Use in Infants Suffering From GERD
  ClinicalTrials.gov Identifier: NCT00373334 - Active, not recruiting
  Gastroesophageal Reflux Disease; GERD; Heartburn
  
• Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. aeruginosa
  ClinicalTrials.gov Identifier: NCT00104520 - Completed
  Cystic Fibrosis
  
• Safety and Efficacy Study of Bee Venom to Treat Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00253942 - Recruiting
  Persons With Mild to Moderate Knee Osteoarthritis
  
• Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00535015 - Recruiting
  Anorexia; Cachexia; Weight Loss; Carcinoma, Non-Small-Cell Lung
  
• Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients with Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00061516 - Completed
  Glaucoma; Ocular Hypertension
  
• Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients with Glaucoma or Ocular Hypertension.
  ClinicalTrials.gov Identifier: NCT00061542 - Completed
  Glaucoma; Ocular Hypertension
  
• Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00300443 - Completed
  Ocular Hypertension
  
• Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00332059 - Completed
  Ocular Hypertension
  
• Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00332540 - Completed
  Ocular Hypertension
  
• Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00332072 - Completed
  Ocular Hypertension
  
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00311376 - Recruiting
  Overactive Bladder
  
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00439140 - Recruiting
  Overactive Bladder
  
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00461292 - Recruiting
  Overactive Bladder
  
• Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00575016 - Recruiting
  Overactive Bladder
  
• Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00284518 - Recruiting
  Benign Prostatic Hyperplasia
  
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00332345 - Completed
  Ocular Hypertension
  
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00332384 - Completed
  Ocular Hypertension
  
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
  ClinicalTrials.gov Identifier: NCT00332436 - Completed
  Ocular Hypertension
  
• Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00509028 - Active, not recruiting
  Asthma
  
• Safety and Efficacy Study of Bugusan (BGS)to Treat Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00202956 - Recruiting
  Osteoporosis
  
• Safety and Efficacy Study of carvedilol to treat children with congestive heart failure
  ClinicalTrials.gov Identifier: NCT00052026 - Active, not recruiting
  Congestive Heart Failure
  
• Safety and Efficacy Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00437749 - Recruiting
  Non-Small Cell Lung Cancer
  
• Safety and Efficacy Study of CEP-10953 in the Treatment of Excessive Sleepiness Associated with Narcolepsy
  ClinicalTrials.gov Identifier: NCT00078377 - Completed
  Narcolepsy
  
• Safety and efficacy study of CEP-1347 in the treatment of Parkinson's disease
  ClinicalTrials.gov Identifier: NCT00040404 - Terminated
  Parkinson Disease
  
• Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
  ClinicalTrials.gov Identifier: NCT00349466 - Recruiting
  Keratoconjunctivitis Sicca
  
• Safety and Efficacy Study of CF101 to Treat Psoriasis
  ClinicalTrials.gov Identifier: NCT00428974 - Recruiting
  Plaque Psoriasis
  
• Safety and Efficacy Study of ChimeriVax(TM)-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age and Possible Interaction With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00441259 - Recruiting
  Japanese Encephalitis
  
• Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV
  ClinicalTrials.gov Identifier: NCT00501124 - Recruiting
  Hepatitis B
  
• Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00202787 - Recruiting
  Colorectal Cancer
  
• Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation
  ClinicalTrials.gov Identifier: NCT00264420 - Recruiting
  Bone Metastases; Breast Cancer; Lung Cancer; Prostate Cancer
  
• Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline
  ClinicalTrials.gov Identifier: NCT00203112 - Completed
  Relapse Remitting Multiple Sclerosis
  
• Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
  ClinicalTrials.gov Identifier: NCT00203099 - Completed
  Relapse Remitting Multiple Sclerosis
  
• Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00488995 - Active, not recruiting
  Human Immunodeficiency Virus
  
• Safety and Efficacy Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00390221 - Not yet recruiting
  Multiple Sclerosis, Relapsing-Remitting
  
• Safety and Efficacy Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone
  ClinicalTrials.gov Identifier: NCT00396279 - Active, not recruiting
  GCT; Giant Cell Tumor of Bone
  
• Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00199966 - Active, not recruiting
  Bipolar Disorder
  
• Safety and Efficacy Study of Depelestat in ARDS Patients
  ClinicalTrials.gov Identifier: NCT00455767 - Recruiting
  ACUTE RESPIRATORY DISTRESS SYNDROM
  
• Safety and Efficacy Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn
  ClinicalTrials.gov Identifier: NCT00251745 - Completed
  Gastroesophageal Reflux Disease
  
• Safety and Efficacy Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn
  ClinicalTrials.gov Identifier: NCT00321984 - Completed
  Gastroesophageal Reflux Disease
  
• Safety and Efficacy Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn.
  ClinicalTrials.gov Identifier: NCT00251758 - Completed
  Gastroesophageal Reflux Disease (GERD)
  
• Safety and Efficacy Study of Dexmethylphenidate in Children with ADHD
  ClinicalTrials.gov Identifier: NCT00141063 - Completed
  ADHD
  
• Safety and Efficacy Study of Dexmethylphenidate in Children with ADHD
  ClinicalTrials.gov Identifier: NCT00141050 - Completed
  ADHD
  
• Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00246324 - Active, not recruiting
  Multiple Sclerosis
  
• Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00485576 - Recruiting
  Allergic Asthma
  
• Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00564421 - Recruiting
  Seasonal Allergic Rhinitis
  
• Safety and Efficacy Study of Eptifibatide in Primary Percutaneous Coronary Intervention (PCI)
  ClinicalTrials.gov Identifier: NCT00251823 - Recruiting
  Myocardial Infarction
  
• Safety and Efficacy Study of Erythropoietin as Add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis
  ClinicalTrials.gov Identifier: NCT00355095 - Recruiting
  Optic Neuritis
  
• Safety and Efficacy Study of Etanercept (Enbrel®) In Children with Systemic Onset Juvenile Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00078806 - Active, not recruiting
  Arthritis, Juvenile Rheumatoid
  
• Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects
  ClinicalTrials.gov Identifier: NCT00091741 - Recruiting
  HIV Infection
  
• Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00399971 - Recruiting
  Anemia, Aplastic
  
• Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects with Burn Wounds
  ClinicalTrials.gov Identifier: NCT00161759 - Completed
  Burns
  
• Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00559871 - Recruiting
  Parkinson's Disease
  
• Safety and Efficacy Study of FLT Radiolabeled Imaging Agent With PET Scan in Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00572728 - Recruiting
  Breast Cancer
  
• Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant with 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients
  ClinicalTrials.gov Identifier: NCT00157131 - Active, not recruiting
  Deep partial or full thickness wounds
  
• Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
  ClinicalTrials.gov Identifier: NCT00409175 - Completed
  Familial Amyloid Polyneuropathy
  
• Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00356460 - Active, not recruiting
  Advanced Renal Cell Carcinoma; Malignant Melanoma
  
• Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
  ClinicalTrials.gov Identifier: NCT00497809 - Recruiting
  Breast Cancer; Neutropenia
  
• Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00442598 - Recruiting
  Ovarian Cancer
  
• Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00435578 - Terminated
  Carcinoma, Small Cell Lung
  
• Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00441467 - Completed
  Soft Tissue Sarcoma
  
• Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00450008 - Recruiting
  Prostatic Neoplasms
  
• Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease
  ClinicalTrials.gov Identifier: NCT00316121 - Recruiting
  Degenerative Disc Disease
  
• Safety and Efficacy Study of Hydromorphone and Morphine
  ClinicalTrials.gov Identifier: NCT00195910 - Active, not recruiting
  Pain
  
• Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00484874 - Recruiting
  Hodgkin's Disease
  
• Safety and Efficacy Study of Ibuprofen l-Lysine Solution in Premature Infants for Treatment of PDA
  ClinicalTrials.gov Identifier: NCT00440804 - Completed
  Patent Ductus Arteriosus
  
• Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers
  ClinicalTrials.gov Identifier: NCT00232973 - Recruiting
  Leg Ulcer
  
• Safety and efficacy study of IL-10 (Tenovil TM) in the prevention of Post-ERCP Acute Pancreatitis
  ClinicalTrials.gov Identifier: NCT00040131 - Terminated
  Bile Duct Diseases; Biliary Tract Diseases; Gallbladder Diseases; Pancreatitis; Pancreatic Diseases
  
• Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00327249 - Active, not recruiting
  Multiple Myeloma
  
• Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00442533 - Recruiting
  Neuroendocrine Tumors
  
• Safety and Efficacy Study of INGN 241 Gene Therapy in Patients with In Transit Melanoma
  ClinicalTrials.gov Identifier: NCT00116363 - Recruiting
  Malignant Melanoma; Neoplasm Metastasis
  
• Safety and Efficacy Study of Intentional Delivery in Women With Preterm and Prelabour Rupture of the Membranes
  ClinicalTrials.gov Identifier: NCT00259519 - Recruiting
  Fetal Membranes, Premature Rupture
  
• Safety and efficacy study of Interferon gamma-1b in hepatitis C patients with liver fibrosis or cirrhosis
  ClinicalTrials.gov Identifier: NCT00043303 - Completed
  Liver Fibrosis; Cirrhosis
  
• Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHAB
  ClinicalTrials.gov Identifier: NCT00236249 - Recruiting
  Colorectal Neoplasms
  
• Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00381368 - Recruiting
  Breast Cancer
  
• Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population.
  ClinicalTrials.gov Identifier: NCT00307528 - Active, not recruiting
  Prophylaxis Invasive Pneumococcal Diseases and Pneumonia
  
• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00022880 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00022893 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00022945 - Completed
  Mantle Cell Lymphoma
  
• Safety and Efficacy Study of IV Artesunate to Treat Malaria
  ClinicalTrials.gov Identifier: NCT00298610 - Active, not recruiting
  Malaria
  
• Safety and Efficacy Study of KP-1461 to Treat ART-Experienced HIV+ Patients
  ClinicalTrials.gov Identifier: NCT00504452 - Recruiting
  HIV Infections
  
• Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
  ClinicalTrials.gov Identifier: NCT00313261 - Terminated
  Hepatitis B
  
• Safety and Efficacy Study of Lithium in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00422331 - Active, not recruiting
  Bipolar Disorder; Mania
  
• Safety and Efficacy Study of LJP 394 (abetimus sodium) to treat lupus kidney disease
  ClinicalTrials.gov Identifier: NCT00035308 - Completed
  Immunologic Diseases; Autoimmune Diseases; Systemic Lupus Erythematosus; Lupus Nephritis; Lupus Glomerulonephritis
  
• Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
  ClinicalTrials.gov Identifier: NCT00353587 - Recruiting
  Type 2 Diabetes
  
• Safety and Efficacy Study of Misoprostol Vaginal Insert for Induction of Labour
  ClinicalTrials.gov Identifier: NCT00346840 - Completed
  Labor Induction; Cervical Ripening
  
• Safety and Efficacy Study of MK0974 in the Acute Migraine
  ClinicalTrials.gov Identifier: NCT00432237 - Active, not recruiting
  Migraine
  
• Safety and Efficacy Study of MM-093 in Patients with Chronic Plaque Psoriasis.
  ClinicalTrials.gov Identifier: NCT00147329 - Completed
  Psoriasis
  
• Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00312364 - Active, not recruiting
  Foot Ulcer, Diabetic; Diabetes Complications
  
• Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00318214 - Recruiting
  Foot Ulcer, Diabetic; Diabetes Complications
  
• Safety and Efficacy Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients with ALS
  ClinicalTrials.gov Identifier: NCT00125203 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Sialorrhea
  
• Safety and Efficacy Study of NatrOVA - 1% Creme Rinse and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
  ClinicalTrials.gov Identifier: NCT00545753 - Recruiting
  Pediculosis Capitis(Head Lice)
  
• Safety and Efficacy Study of NBI-56418 in Endometriosis
  ClinicalTrials.gov Identifier: NCT00437658 - Recruiting
  Endometriosis
  
• Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
  ClinicalTrials.gov Identifier: NCT00551642 - Recruiting
  Lung Disease
  
• Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00570245 - Recruiting
  Lung Transplantation
  
• Safety and Efficacy Study of NV-101 in Dental Patients
  ClinicalTrials.gov Identifier: NCT00154167 - Completed
  Soft Tissue Anesthesia (numbness)
  
• Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
  ClinicalTrials.gov Identifier: NCT00541281 - Completed
  Hormone Resistant Prostate Cancer; Metastatic Prostate Cancer
  
• Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy
  ClinicalTrials.gov Identifier: NCT00329381 - Recruiting
  Asthma
  
• Safety and Efficacy Study of Omnitarg (Pertuzumab) to Treat Castration-Resistant Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00058539 - Terminated
  Prostate Cancer
  
• Safety and Efficacy study of Oral Fampridine-SR on Walking Ability in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00053417 - Completed
  Multiple Sclerosis
  
• Safety and Efficacy Study of Panzem NCD to Treat Glioblastoma
  ClinicalTrials.gov Identifier: NCT00306618 - Active, not recruiting
  Recurrent Glioblastoma Multiforme
  
• Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00400348 - Active, not recruiting
  Ovarian Cancer
  
• Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00216346 - Completed
  Visceral Leishmaniasis
  
• Safety and Efficacy Study of PEG-Uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout
  ClinicalTrials.gov Identifier: NCT00325195 - Active, not recruiting
  Gout
  
• Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency
  ClinicalTrials.gov Identifier: NCT00355264 - Active, not recruiting
  Tetrahydrobiopterin Deficiencies; Hyperphenylalaninemia, Non-Phenylketonuric
  
• Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00054613 - Active, not recruiting
  Graft-Versus-Host Disease
  
• Safety and Efficacy Study of Photopheresis with UVADEX to Prevent Graft-versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00054600 - Active, not recruiting
  Graft-Versus-Host Disease
  
• Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine
  ClinicalTrials.gov Identifier: NCT00509158 - Recruiting
  Healthy
  
• Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
  ClinicalTrials.gov Identifier: NCT00110851 - Completed
  Type 2 Diabetes Mellitus
  
• Safety and Efficacy Study of Pregabalin in Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00151489 - Completed
  Fibromyalgia
  
• Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00286377 - Terminated
  HIV; Peripheral Nervous System Disorders
  
• Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00264888 - Active, not recruiting
  Duchenne Muscular Dystrophy
  
• Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00568035 - Recruiting
  Diabetic Neuropathy
  
• Safety and Efficacy Study of Re-Treatment With Rituximab (MabThera/Rituxan) in Patients With Active Rheumatoid Arthritis Who Respond Poorly to Anti-TNFα Therapies
  ClinicalTrials.gov Identifier: NCT00468377 - Active, not recruiting
  Arthritis, Rheumatoid
  
• Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1
  ClinicalTrials.gov Identifier: NCT00577577 - Recruiting
  Myotonic Dystrophy Type 1
  
• Safety and Efficacy Study of RENEWAL 4 AVT
  ClinicalTrials.gov Identifier: NCT00180336 - Completed
  Heart Failure; Tachycardia; Atrial Fibrillation; Atrial Flutter; Ventricular Fibrillation
  
• Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
  ClinicalTrials.gov Identifier: NCT00503295 - Recruiting
  Osteosarcoma; Ewing Sarcoma Family Tumors; Malignant Fibrous Histiocytoma; Sarcoma, Synovial; Fibrosarcoma; Leiomyosarcoma
  
• Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00528684 - Recruiting
  Malignant Glioma
  
• Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
  ClinicalTrials.gov Identifier: NCT00456508 - Recruiting
  Hereditary Angioedema
  
• Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
  ClinicalTrials.gov Identifier: NCT00362700 - Terminated
  Hepatitis B
  
• Safety and Efficacy Study of rEV131 in Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00247520 - Active, not recruiting
  Hay Fever
  
• Safety and Efficacy Study of rEV131 in the Treatment of Ocular Inflammation After Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00353964 - Recruiting
  Ocular Inflammation
  
• Safety and efficacy study of rhAngiostatin administered in combination with paclitaxel and carboplatin to patients with non-small-cell lung cancer
  ClinicalTrials.gov Identifier: NCT00049790 - Completed
  Carcinoma, Non-Small-Cell Lung
  
• Safety and Efficacy Study of Rituximab in Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00255593 - Completed
  Renal Transplantation
  
• Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria
  ClinicalTrials.gov Identifier: NCT00075049 - Active, not recruiting
  Malaria
  
• Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00367497 - Terminated
  Lymphoma, Non-Hodgkin
  
• Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients with Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00080457 - Completed
  Pulmonary Hypertension
  
• Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00306904 - Completed
  Diabetic Macular Edema
  
• Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00259753 - Active, not recruiting
  Macular Degeneration
  
• Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors
  ClinicalTrials.gov Identifier: NCT00187486 - Active, not recruiting
  Glioblastoma Multiforme; Gliosarcoma
  
• Safety and Efficacy Study of Teduglutide in Subjects with Short Bowel Syndrome
  ClinicalTrials.gov Identifier: NCT00081458 - Completed
  Short Bowel Syndrome; Parenteral Nutrition
  
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004
  ClinicalTrials.gov Identifier: NCT00172185 - Active, not recruiting
  Short Bowel Syndrome
  
• Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis
  ClinicalTrials.gov Identifier: NCT00469703 - Recruiting
  Chronic Pancreatitis
  
• Safety and efficacy study of the combination of CpG 7909 and Herceptin in patients with metastatic breast cancer
  ClinicalTrials.gov Identifier: NCT00031278 - Completed
  Breast Neoplasms; Neoplasm Metastasis
  
• Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00293202 - Recruiting
  End Stage Renal Disease
  
• Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)
  ClinicalTrials.gov Identifier: NCT00239915 - Active, not recruiting
  Persistent Developmental Stuttering
  
• Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
  ClinicalTrials.gov Identifier: NCT00567853 - Recruiting
  Mitral Valve Regurgitation
  
• Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin
  ClinicalTrials.gov Identifier: NCT00239161 - Terminated
  Acute Uncomplicated Pyelonephritis
  
• Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy
  ClinicalTrials.gov Identifier: NCT00377429 - Active, not recruiting
  Ovarian Cancer
  
• Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00351858 - Recruiting
  Breast Neoplasms; Breast Cancer
  
• Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics
  ClinicalTrials.gov Identifier: NCT00262652 - Active, not recruiting
  Mild to Moderate Asthma
  
• Safety and efficacy study of the vasopressin receptor antagonist conivaptan in patients with acute decompensated heart failure
  ClinicalTrials.gov Identifier: NCT00057356 - Completed
  Congestive Heart Failure
  
• Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00441818 - Recruiting
  Hodgkin's Lymphoma
  
• Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00198445 - Completed
  Postoperative Complications; Cataract
  
• Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00280839 - Completed
  Smoking Cessation
  
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00372346 - Recruiting
  Idiopathic Pulmonary Arterial Hypertension
  
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00257413 - Completed
  Idiopathic Pulmonary Arterial Hypertension
  
• Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis
  ClinicalTrials.gov Identifier: NCT00373516 - Completed
  Psoriasis
  
• Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00290914 - Recruiting
  Major Depressive Disorder
  
• Safety and Efficacy Study of VIOKASE 16 for the Correction of Steatorrhea
  ClinicalTrials.gov Identifier: NCT00559364 - Recruiting
  Exocrine Pancreatic Insufficiency; Chronic Pancreatitis
  
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
  ClinicalTrials.gov Identifier: NCT00198497 - Completed
  Vitreous Hemorrhage; Diabetic Retinopathy
  
• Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
  ClinicalTrials.gov Identifier: NCT00198510 - Completed
  Vitreous Hemorrhage; Diabetic Retinopathy
  
• Safety and Efficacy Study of XELOX Vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00202774 - Completed
  Colorectal Cancer
  
• Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.
  ClinicalTrials.gov Identifier: NCT00423605 - Recruiting
  Fibromyalgia
  
• Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness
  ClinicalTrials.gov Identifier: NCT00199940 - Recruiting
  Schizophrenia; Affective Disorders; Psychotic; Psychotic Mood Disorder
  
• Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens
  ClinicalTrials.gov Identifier: NCT00495313 - Recruiting
  Rosacea
  
• Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
  ClinicalTrials.gov Identifier: NCT00411801 - Recruiting
  Thrombotic Thrombocytopenic Purpura (TTP)
  
• Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
  ClinicalTrials.gov Identifier: NCT00317044 - Recruiting
  Asthma; GERD
  
• Safety and Efficacy Study to Evaluate Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00204555 - Completed
  Carcinoma, Basal Cell
  
• Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
  ClinicalTrials.gov Identifier: NCT00556075 - Recruiting
  Endometriosis
  
• Safety and efficacy study to treat recurrent Grade 4 malignant brain tumors
  ClinicalTrials.gov Identifier: NCT00071539 - Completed
  Recurrent Glioblastoma Multiforme
  
• Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00104091 - Recruiting
  Glioblastoma Multiforme
  
• Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00177307 - Active, not recruiting
  Cancer
  
• Safety and Efficacy Study Using Rexin-G for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00505271 - Recruiting
  Breast Cancer
  
• Safety and Efficacy Study Using Rexin-G for Sarcoma
  ClinicalTrials.gov Identifier: NCT00505713 - Recruiting
  Sarcoma
  
• Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00352833 - Completed
  Gastric Cancer; Gastric Adenocarcinoma
  
• Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)
  ClinicalTrials.gov Identifier: NCT00067093 - Completed
  Deep Vein Thrombosis
  
• Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00327600 - Active, not recruiting
  Malignant Melanoma
  
• Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
  ClinicalTrials.gov Identifier: NCT00438776 - Completed
  Pathological Gambling
  
• Safety and Efficacy Trial of Subcutaneously Administered Serostim® in the Treatment of Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome (HARS)
  ClinicalTrials.gov Identifier: NCT00294164 - Completed
  Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome (HARS); HIV Infections
  
• Safety and Efficacy Trial of the Use of A-007 Topical Gel in the Treatment of HSIL of the Cervix
  ClinicalTrials.gov Identifier: NCT00285207 - Active, not recruiting
  Cervical Intraepithelial Neoplasia; Uterine Cervical Dysplasia
  
• Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients with Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00060489 - Completed
  Bipolar Disorder; Depression, Bipolar
  
• Safety and Efficacy Trial with Zoledronic Acid for the Treatment of Paget's Disease of Bone
  ClinicalTrials.gov Identifier: NCT00103740 - Active, not recruiting
  Paget's Disease of Bone
  
• Safety and Efficiency Study of Valproic Acid In HAM/TSP
  ClinicalTrials.gov Identifier: NCT00519181 - Terminated
  HTLV-I-Associated Myelopathy
  
• Safety and Exploratory Biomarker Trial in Relapsed/Refractory Pediatric Solid Tumors
  ClinicalTrials.gov Identifier: NCT00106353 - Recruiting
  Tumors
  
• Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-Risk Primary PCI Patients
  ClinicalTrials.gov Identifier: NCT00474214 - Recruiting
  Myocardial Infarction
  
• Safety and Feasibility of Endovascular Cooling Device in Patients with Hypothermic Cardiopulmonary Resuscitation
  ClinicalTrials.gov Identifier: NCT00154674 - Recruiting
  Cardiac Arrest
  
• Safety and Feasibility of the Injectable BL-1040 Implant
  ClinicalTrials.gov Identifier: NCT00557531 - Not yet recruiting
  Cardiovascular Disease
  
• Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With PAOD
  ClinicalTrials.gov Identifier: NCT00282646 - Recruiting
  Arterial Occlusive Diseases
  
• Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00282685 - Recruiting
  Diabetic Neuropathies
  
• Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium
  ClinicalTrials.gov Identifier: NCT00332995 - Completed
  HIV Infections
  
• Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared with Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00161733 - Completed
  Cardiac surgery requiring cardiopulmonary bypass and median sternotomy
  
• Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00435968 - Completed
  Healthy
  
• Safety and Immune Response of Different Pediatric Combination Vaccines.
  ClinicalTrials.gov Identifier: NCT00255047 - Active, not recruiting
  Diphtheria; Polio; Pertussis
  
• Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.
  ClinicalTrials.gov Identifier: NCT00327522 - Completed
  Prophylactic Pneumococcal Diseases
  
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00027261 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination with AIDSVAX B/B
  ClinicalTrials.gov Identifier: NCT00007332 - Completed
  HIV Infections; HIV Seronegativity
  
• Safety and Immune Response to a Multi-Component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
  ClinicalTrials.gov Identifier: NCT00423254 - Recruiting
  Advanced Cancer
  
• Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00270465 - Active, not recruiting
  HIV
  
• Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children
  ClinicalTrials.gov Identifier: NCT00408395 - Active, not recruiting
  Influenza
  
• Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children
  ClinicalTrials.gov Identifier: NCT00491985 - Active, not recruiting
  Influenza; Orthomyxoviridae Infections; Influenza A Virus Infection
  
• Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccines GSK692342 Given at 0,1 Months to Healthy Adults.
  ClinicalTrials.gov Identifier: NCT00397943 - Active, not recruiting
  Tuberculosis
  
• Safety and Immunogenicity of 3 Lots of Cell-Derived Subunit Influenza Vaccine as Compared to 1 Lot to Egg-Derived Subunit Influenza Vaccine in Healthy Adults (18-60 Years)
  ClinicalTrials.gov Identifier: NCT00310804 - Completed
  Influenza
  
• Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants
  ClinicalTrials.gov Identifier: NCT00213265 - Active, not recruiting
  Organ Transplant; Immunosuppression
  
• Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00561184 - Recruiting
  Avian Influenza
  
• Safety and Immunogenicity of a Cell Culture-Derived Influenza Vaccine in Healthy Adults and Elderly
  ClinicalTrials.gov Identifier: NCT00492063 - Terminated
  Influenza
  
• Safety and Immunogenicity of a Commercailly Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00522236 - Active, not recruiting
  Influenza
  
• Safety and Immunogenicity of a Commercailly Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00518726 - Active, not recruiting
  Influenza
  
• Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00329927 - Completed
  Influenza
  
• Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
  ClinicalTrials.gov Identifier: NCT00329966 - Completed
  Influenza
  
• Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
  ClinicalTrials.gov Identifier: NCT00342940 - Suspended
  Influenza
  
• Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.
  ClinicalTrials.gov Identifier: NCT00316615 - Completed
  Influenza Disease
  
• Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants
  ClinicalTrials.gov Identifier: NCT00548054 - Not yet recruiting
  Cholera, Diarrhea, Vibrio Infections
  
• Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00306514 - Completed
  Melanoma
  
• Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00306553 - Completed
  Malignant Melanoma
  
• Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00306566 - Completed
  Malignant Melanoma
  
• Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation
  ClinicalTrials.gov Identifier: NCT00471133 - Recruiting
  Melanoma (Skin); Intraocular Melanoma
  
• Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00252148 - Recruiting
  HIV Infection
  
• Safety and Immunogenicity of a Plasmid HIV Vaccine, ADVAX e/g + ADVAX p/n-t (ADVAX), in HIV Uninfected Adults.
  ClinicalTrials.gov Identifier: NCT00249106 - Active, not recruiting
  HIV Infection
  
• Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
  ClinicalTrials.gov Identifier: NCT00001906 - Completed
  Cutaneous Leishmaniasis
  
• Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
  ClinicalTrials.gov Identifier: NCT00316628 - Completed
  Influenza
  
• Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00083330 - Active, not recruiting
  Healthy; HIV Infections
  
• Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00535665 - Completed
  Pandemic Influenza; Prevention
  
• Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly
  ClinicalTrials.gov Identifier: NCT00415129 - Active, not recruiting
  Influenza; Orthomyxoviridae Infections
  
• Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
  ClinicalTrials.gov Identifier: NCT00431808 - Recruiting
  Malaria
  
• Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00442169 - Recruiting
  West Nile Fever
  
• Safety and Immunogenicity of Chiron Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.
  ClinicalTrials.gov Identifier: NCT00310817 - Active, not recruiting
  Meningococcal Meningitis
  
• Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers
  ClinicalTrials.gov Identifier: NCT00291473 - Recruiting
  Esophageal Cancer; Lung Cancer; Stomach Cancer; Breast Cancer; Ovarian Cancer
  
• Safety and Immunogenicity of CJ-50300
  ClinicalTrials.gov Identifier: NCT00336635 - Completed
  Smallpox
  
• Safety and Immunogenicity of Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants.
  ClinicalTrials.gov Identifier: NCT00130832 - Active, not recruiting
  Rotavirus disease
  
• Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
  ClinicalTrials.gov Identifier: NCT00258895 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly
  ClinicalTrials.gov Identifier: NCT00347555 - Active, not recruiting
  Plasmodium Falciparum Malaria
  
• Safety and Immunogenicity of FluBlok in Pediatrics
  ClinicalTrials.gov Identifier: NCT00336453 - Active, not recruiting
  Influenza
  
• Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults
  ClinicalTrials.gov Identifier: NCT00380211 - Completed
  Influenza
  
• Safety and Immunogenicity of Fluzone Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.
  ClinicalTrials.gov Identifier: NCT00390884 - Active, not recruiting
  Influenza Vaccine
  
• Safety and Immunogenicity of GSK Biological''s Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-Positive Adults
  ClinicalTrials.gov Identifier: NCT00146744 - Completed
  Prophylaxis - Primary tuberculosis (TB) disease
  
• Safety and Immunogenicity of GSK Biological’s Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-Negative Adults.
  ClinicalTrials.gov Identifier: NCT00291889 - Completed
  Tuberculosis
  
• Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00457509 - Active, not recruiting
  Pandemic Influenza; Influenza A Virus Infection; Orthomyxoviridae Infections
  
• Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00316589 - Recruiting
  HIV Infections
  
• Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age
  ClinicalTrials.gov Identifier: NCT00242424 - Active, not recruiting
  Inactivated Influenza Vaccine
  
• Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age
  ClinicalTrials.gov Identifier: NCT00329849 - Active, not recruiting
  Meningococcal Disease
  
• Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
  ClinicalTrials.gov Identifier: NCT00456183 - Completed
  Tuberculosis
  
• Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
  ClinicalTrials.gov Identifier: NCT00460590 - Active, not recruiting
  Tuberculosis
  
• Safety and Immunogenicity of New Formulation of Bivalent Killed, Whole-Cell Oral Cholera Vaccine
  ClinicalTrials.gov Identifier: NCT00128011 - Completed
  Cholera
  
• Safety and Immunogenicity of Oral Cholera Vaccine in Kolkata
  ClinicalTrials.gov Identifier: NCT00119197 - Active, not recruiting
  Cholera
  
• Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00354016 - Completed
  Influenza
  
• Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062907 - Recruiting
  Non-small cell lung cancer
  
• Safety and Immunogenicity of Smallpox Vaccine MVA-BN
  ClinicalTrials.gov Identifier: NCT00082446 - Active, not recruiting
  Smallpox
  
• Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
  ClinicalTrials.gov Identifier: NCT00467519 - Recruiting
  Tetanus; Diphtheria; Pertussis
  
• Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine
  ClinicalTrials.gov Identifier: NCT00258830 - Active, not recruiting
  Influenza
  
• Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
  ClinicalTrials.gov Identifier: NCT00311428 - Completed
  Influenza
  
• Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008
  ClinicalTrials.gov Identifier: NCT00498303 - Recruiting
  Seasonal Influenza; Vaccine
  
• Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008
  ClinicalTrials.gov Identifier: NCT00511914 - Active, not recruiting
  Seasonal Influenza Vaccine
  
• Safety and Immunogenicity of Two Adjuvanted and One Non-Adjuvanted H5N1 Influenza Vaccine in Adults
  ClinicalTrials.gov Identifier: NCT00382187 - Recruiting
  Influenza
  
• Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-Adjuvanted Influenza Vaccines
  ClinicalTrials.gov Identifier: NCT00478816 - Recruiting
  Prophylaxis of Avian Influenza Vaccine
  
• Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00311480 - Completed
  Pandemic Influenza Disease
  
• Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83
  ClinicalTrials.gov Identifier: NCT00582088 - Not yet recruiting
  Venezuelan Equine Encephalomyelitis
  
• Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years
  ClinicalTrials.gov Identifier: NCT00161746 - Completed
  Encephalitis, Tick-Borne
  
• Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00370227 - Completed
  Pneumococcal Disease
  
• Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine.
  ClinicalTrials.gov Identifier: NCT00370396 - Completed
  Pneumococcal Disease
  
• Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)
  ClinicalTrials.gov Identifier: NCT00530660 - Recruiting
  Influenza
  
• Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
  ClinicalTrials.gov Identifier: NCT00349141 - Completed
  Influenza
  
• Safety and Immunogenicity Study of an Inactivated Hepatitis A Vaccine
  ClinicalTrials.gov Identifier: NCT00534885 - Completed
  Hepatitis A
  
• Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)
  ClinicalTrials.gov Identifier: NCT00424086 - Active, not recruiting
  Influenza
  
• Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived)
  ClinicalTrials.gov Identifier: NCT00289510 - Completed
  Influenza
  
• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-Valent Pneumococcal Conjugate Vaccine.
  ClinicalTrials.gov Identifier: NCT00334334 - Completed
  Prophylaxis Pneumococcal Vaccine
  
• Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals’ 10-Valent Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00344318 - Active, not recruiting
  Pneumococcal Infections
  
• Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.
  ClinicalTrials.gov Identifier: NCT00248833 - Active, not recruiting
  Meningitis, Meningococcal, Serogroup B
  
• Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen
  ClinicalTrials.gov Identifier: NCT00436007 - Recruiting
  Plasmodium Falciparum; Malaria
  
• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines, Each Administered at 2, 4, 6, and 12 to 15 Months of Age.
  ClinicalTrials.gov Identifier: NCT00134719 - Active, not recruiting
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00289783 - Active, not recruiting
  Haemophilus Infections; Meningococcal Infections
  
• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine, Each Administered at 2, 4, and 6 Months of Age; and Compared to Licensed Meningococcal Serogroups A, C, Y, and W-135 Polysaccharide Vaccine Administered at
  ClinicalTrials.gov Identifier: NCT00129129 - Completed
  Invasive bacterial disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y.
  
• Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers
  ClinicalTrials.gov Identifier: NCT00103584 - Active, not recruiting
  Smallpox
  
• Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants
  ClinicalTrials.gov Identifier: NCT00280111 - Completed
  Rotavirus Infections
  
• Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection
  ClinicalTrials.gov Identifier: NCT00386633 - Completed
  HIV Infections
  
• Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
  ClinicalTrials.gov Identifier: NCT00482027 - Completed
  HIV Infections
  
• Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP
  ClinicalTrials.gov Identifier: NCT00374998 - Completed
  Malaria, Falciparum; Malaria
  
• Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00140738 - Recruiting
  Metastatic breast cancer
  
• Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine
  ClinicalTrials.gov Identifier: NCT00582504 - Recruiting
  Venezuelan Equine Encephalomyelitis
  
• Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)
  ClinicalTrials.gov Identifier: NCT00517517 - Active, not recruiting
  Influenza
  
• Safety and Immunological Response Rate Study of THERATOPE® vaccine in Metastatic Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00046371 - Active, not recruiting
  Breast Neoplasms
  
• Safety and Local Tolerability of Prevenar in Indian Children
  ClinicalTrials.gov Identifier: NCT00488800 - Completed
  Pneumococcal Infections
  
• Safety and Long-Term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults
  ClinicalTrials.gov Identifier: NCT00387634 - Recruiting
  Tick Born Encephalitis
  
• Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00280566 - Recruiting
  Bipolar Disorder
  
• Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00357539 - Completed
  Eye Infections, Bacterial
  
• Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products
  ClinicalTrials.gov Identifier: NCT00263809 - Recruiting
  Thrombocytopenia
  
• Safety and Pharmacodynamic Study of CD-NP
  ClinicalTrials.gov Identifier: NCT00482937 - Completed
  Heart Failure, Congestive
  
• Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine
  ClinicalTrials.gov Identifier: NCT00416962 - Completed
  Healthy
  
• Safety and Pharmacokinetic Study of BIO 300 Capsules
  ClinicalTrials.gov Identifier: NCT00504335 - Completed
  Acute Radiation Syndrome
  
• Safety and Pharmacokinetic Study of Intravenous Acetaminophen Administration in Pediatric Inpatients
  ClinicalTrials.gov Identifier: NCT00493246 - Recruiting
  Pain and Fever
  
• Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)
  ClinicalTrials.gov Identifier: NCT00073255 - Completed
  Diabetes Mellitus, Insulin-Dependent
  
• Safety and Pharmacokinetics (PK) of Single Intravenous (IV) Doses of Hematide(TM) in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00097747 - Completed
  Renal Failure, Chronic; Cancer
  
• Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function
  ClinicalTrials.gov Identifier: NCT00416702 - Recruiting
  Hepatic Insufficiency
  
• Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00260026 - Completed
  Non-Small Cell Lung Cancer
  
• Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00414778 - Completed
  Healthy
  
• Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
  ClinicalTrials.gov Identifier: NCT00050687 - Terminated
  Prostatic Neoplasms; Multiple Myeloma; Bladder Neoplasms; Lymphoma
  
• Safety and Pharmacokinetics of Probucol and Cilostazol
  ClinicalTrials.gov Identifier: NCT00549978 - Recruiting
  Healthy
  
• Safety and Pharmacokinetics of Valganciclovir syrup formulation in pediatric solid organ transplant recipients
  ClinicalTrials.gov Identifier: NCT00090766 - Completed
  Cytomegalovirus Infection
  
• Safety and Pharmacokinetics of XL647 Administered Orally to Subjects with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00086528 - Active, not recruiting
  Cancer
  
• Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00431171 - Active, not recruiting
  Spinal Cord Injuries
  
• Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00513214 - Recruiting
  Type 2 Diabetes
  
• Safety and Pharmacology of SNX-5422 Mesylate in Subjects With Refractory Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00506805 - Recruiting
  Solid Tumor Malignancy
  
• Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00380653 - Recruiting
  Leukemias; Myelodysplastic Syndromes
  
• Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00394160 - Completed
  Bronchiolitis
  
• Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy
  ClinicalTrials.gov Identifier: NCT00372983 - Completed
  Hepatitis C
  
• Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to Xagrid Compared to Other Treatments
  ClinicalTrials.gov Identifier: NCT00567502 - Recruiting
  Thrombocythemia, Essential
  
• Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00532532 - Recruiting
  Muscle Spasticity
  
• Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00531466 - Recruiting
  Muscle Spasticity
  
• Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)
  ClinicalTrials.gov Identifier: NCT00245544 - Active, not recruiting
  Neuralgia, Postherpetic
  
• Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers
  ClinicalTrials.gov Identifier: NCT00316537 - Terminated
  Diabetic Foot Ulcers
  
• Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00393809 - Active, not recruiting
  Bladder Neoplasms
  
• Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn.
  ClinicalTrials.gov Identifier: NCT00255190 - Active, not recruiting
  Gastroesophageal Reflux Disease
  
• Safety and Radiation Distribution Study of Iodine 131 chTNT-1/B Monoclonal Antibody (Cotara®) in Patients With Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00509301 - Recruiting
  Recurrent Glioblastoma Multiforme
  
• Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
  ClinicalTrials.gov Identifier: NCT00539864 - Recruiting
  Influenza
  
• Safety and Repeatability of Brochial Challenge With Grass-Pollen
  ClinicalTrials.gov Identifier: NCT00507039 - Recruiting
  Allergic Asthma
  
• Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00329940 - Recruiting
  Breast Cancer
  
• Safety and Survival of Genetically Modified White Blood Cells in HIV-infected Persons - A Study in Identical Twin Pairs
  ClinicalTrials.gov Identifier: NCT00001353 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infection
  
• Safety and Tolerability of 28 Days Treatment With Glycopyrrolate(NVA237) (100 or 200µg Once a Day) in Patients With Moderate to Severe COPD
  ClinicalTrials.gov Identifier: NCT00510510 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
  ClinicalTrials.gov Identifier: NCT00291057 - Active, not recruiting
  Lice Infestations
  
• Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00503022 - Completed
  Wet Age-Related Macular Degeneration
  
• Safety and Tolerability of and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving Anti-HIV Treatment
  ClinicalTrials.gov Identifier: NCT00270205 - Recruiting
  HIV Infections
  
• Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.
  ClinicalTrials.gov Identifier: NCT00418002 - Completed
  Healthy
  
• Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
  ClinicalTrials.gov Identifier: NCT00480571 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)
  ClinicalTrials.gov Identifier: NCT00314509 - Completed
  Asthma
  
• Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 y)
  ClinicalTrials.gov Identifier: NCT00261287 - Completed
  Hay Fever; Allergic Rhinitis; Perennial Allergic Rhinitis
  
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome
  ClinicalTrials.gov Identifier: NCT00548587 - Recruiting
  Acute Coronary Syndrome
  
• Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00312052 - Recruiting
  Coronary Artery Disease
  
• Safety and Tolerability of Enteric-Coated Mycohenolate Sodium (EC-MPS) in Renal Transplant Patients with GI Intolerance
  ClinicalTrials.gov Identifier: NCT00150020 - Recruiting
  Renal Transplantation
  
• Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
  ClinicalTrials.gov Identifier: NCT00548691 - Recruiting
  Anemia
  
• Safety and Tolerability of hCBE-11 in Subjects with Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00105170 - Suspended
  Tumors
  
• Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts
  ClinicalTrials.gov Identifier: NCT00459641 - Recruiting
  Bone Cysts
  
• Safety and Tolerability of I.V. Infusion of MB07133 in Patients with Unresectable Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00073736 - Completed
  Hepatocellular Carcinoma
  
• Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00415636 - Recruiting
  Cancer
  
• Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00570349 - Recruiting
  Cystic Fibrosis
  
• Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients
  ClinicalTrials.gov Identifier: NCT00151801 - Recruiting
  Multiple Sclerosis
  
• Safety and Tolerability of Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Neovascular Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00320775 - Active, not recruiting
  Macular Degeneration
  
• Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)
  ClinicalTrials.gov Identifier: NCT00410748 - Active, not recruiting
  Pain; Analgesics, Opioid
  
• Safety and Tolerability of Long-Term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain
  ClinicalTrials.gov Identifier: NCT00410787 - Active, not recruiting
  Pain; Analgesics, Opioid
  
• Safety and Tolerability of Long-Term Treatment by Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00531609 - Recruiting
  Alzheimer's Disease
  
• Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)
  ClinicalTrials.gov Identifier: NCT00266812 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
  ClinicalTrials.gov Identifier: NCT00299819 - Completed
  Lupus
  
• Safety and Tolerability of Modafinil for Methamphetmaine Dependence
  ClinicalTrials.gov Identifier: NCT00569374 - Recruiting
  Methamphetamine Dependence
  
• Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00401115 - Completed
  Diabetic Macular Edema; Diabetic Retinopathy
  
• Safety and Tolerability of MTS in Children Aged 6-12 Diagnosed with ADHD and Previously Treated with Extended-Release Methylphenidate Therapy
  ClinicalTrials.gov Identifier: NCT00151983 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients
  ClinicalTrials.gov Identifier: NCT00545311 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00482248 - Completed
  Asthma
  
• Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
  ClinicalTrials.gov Identifier: NCT00546143 - Recruiting
  Asthma
  
• Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients
  ClinicalTrials.gov Identifier: NCT00482508 - Completed
  Asthma
  
• Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
  ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
  HIV Infections
  
• Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers
  ClinicalTrials.gov Identifier: NCT00110591 - Completed
  HIV Infections
  
• Safety and Tolerability of QVA149 Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00558285 - Recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00504959 - Active, not recruiting
  Subfoveal Choroidal Neovascularization (CNV); Secondary to Age-Related Macular Degeneration (AMD)
  
• Safety and Tolerability of Repeat Courses of IM Alefacept
  ClinicalTrials.gov Identifier: NCT00233662 - Completed
  Chronic Plaque Psoriasis
  
• Safety and Tolerability of Rituxan With Methotrexate and Etanercept in Patients With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00298272 - Recruiting
  Rheumatoid Arthritis
  
• Safety and Tolerability of Rituximab in Neuromyelitis Optica
  ClinicalTrials.gov Identifier: NCT00501748 - Recruiting
  Neuromyelitis Optica
  
• Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00305903 - Completed
  Alzheimer's Disease
  
• Safety and Tolerability of SPD476 in Maintaining Remission in Patients with Ulcerative Colitis.
  ClinicalTrials.gov Identifier: NCT00151944 - Completed
  Colitis, Ulcerative
  
• Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed with ADHD and Previously Participated in MTS Trials
  ClinicalTrials.gov Identifier: NCT00151957 - Completed
  Attention Deficit Disorder with Hyyperactivity.
  
• Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 with Attention-Deficit/Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00151996 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Safety and Tolerability of the Vaginal Gel PRO 2000/5
  ClinicalTrials.gov Identifier: NCT00006207 - Completed
  HIV Infections
  
• Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-Cholesterol Levels
  ClinicalTrials.gov Identifier: NCT00216463 - Active, not recruiting
  Hypercholesterolemia
  
• Safety and Tolerability of Z-100 in Patients with Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00016692 - Terminated
  HIV Infections
  
• Safety and Tolerability of Ziprasidone in Adolescents With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00265382 - Recruiting
  Schizophrenia
  
• Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00265330 - Recruiting
  Bipolar Disorder
  
• Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients
  ClinicalTrials.gov Identifier: NCT00559624 - Recruiting
  Leukemia, B-Cell, Chronic
  
• Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00532350 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00376714 - Completed
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
  ClinicalTrials.gov Identifier: NCT00411580 - Recruiting
  Alzheimer's Disease
  
• Safety and tolerability study of 131I-TM-601 to treat adult patients with recurrent glioma.
  ClinicalTrials.gov Identifier: NCT00040573 - Completed
  Glioma; Brain Neoplasm
  
• Safety and Tolerability Study of AT1001 in Celiac Disease Subjects
  ClinicalTrials.gov Identifier: NCT00362856 - Completed
  Celiac Disease
  
• Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours
  ClinicalTrials.gov Identifier: NCT00475956 - Recruiting
  Neoplasms
  
• Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00377676 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Safety and Tolerability Study of Drug to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044005 - Active, not recruiting
  Schizophrenia
  
• Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00082602 - Completed
  Alzheimer's Disease
  
• Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination with Gemcitabine and Cisplatin in Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00040534 - Terminated
  Neoplasms
  
• Safety and Tolerability Study of FG-3019 in Patients with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00074698 - Completed
  Idiopathic Pulmonary Fibrosis
  
• Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00329368 - Active, not recruiting
  Cancer
  
• Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00531856 - Recruiting
  Kidney Transplantation
  
• Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00352677 - Recruiting
  Chronic Myeloid Leukemia; Acute Lymphocytic Leukemia
  
• Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
  ClinicalTrials.gov Identifier: NCT00362141 - Recruiting
  Status Epilepticus
  
• Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00422487 - Completed
  Type 2 Diabetes Mellitus
  
• Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
  ClinicalTrials.gov Identifier: NCT00212316 - Completed
  Huntington's Disease
  
• Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00519662 - Recruiting
  Advanced Solid Tumors
  
• Safety and Tolerability Study of SNS-595 and Cytarabine Combination in Acute Myeloid Leukemia in Humans
  ClinicalTrials.gov Identifier: NCT00541866 - Recruiting
  Acute Myeloid Leukemia
  
• Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age
  ClinicalTrials.gov Identifier: NCT00493285 - Recruiting
  Respirovirus Infections; Respiratory Syncytial Virus Infections; Parainfluenza Virus 3, Human
  
• Safety and Tolerability Study With MK0646 in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00282737 - Active, not recruiting
  Tumors; Multiple Myeloma
  
• Safety and Tolerance of Indinavir plus Ritonavir in HIV-Positive Patients Failing Therapy with Amprenavir, Nelfinavir, or Saquinavir
  ClinicalTrials.gov Identifier: NCT00001133 - Completed
  HIV Infections
  
• Safety and Tolerance of Zidovudine with Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks
  ClinicalTrials.gov Identifier: NCT00000670 - Completed
  HIV Infections
  
• Safety and Tolerance on Lipids of Parenteral and Enteral Nutrition in Critically Ill Patients With Liver Failure
  ClinicalTrials.gov Identifier: NCT00522730 - Recruiting
  Liver Failure; Critical Illness
  
• Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients with Acute Myelogenous Leukemia (AML)
  ClinicalTrials.gov Identifier: NCT00064584 - Active, not recruiting
  Acute Myelogenous Leukemia; Myelodysplastic Syndrome
  
• Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00445042 - Recruiting
  Carcinoma, Renal Cell
  
• Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients
  ClinicalTrials.gov Identifier: NCT00040651 - Terminated
  Scleroderma; Systemic Sclerosis
  
• Safety Assessment of a Multipeptide-Gene Vaccine in CML
  ClinicalTrials.gov Identifier: NCT00455221 - Not yet recruiting
  Leukemia, Myeloid, Chronic
  
• Safety Assessment of One-Hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00292864 - Active, not recruiting
  Tumors
  
• Safety Assessment of Succinate Salt Version of GSK961081
  ClinicalTrials.gov Identifier: NCT00550225 - Not yet recruiting
  Healthy Volunteers
  
• Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00246662 - Active, not recruiting
  Leukemia, Lymphocytic, Acute; Leukemia, Nonlymphocytic, Acute; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes
  
• Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors
  ClinicalTrials.gov Identifier: NCT00094159 - Completed
  Neoplasms
  
• Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
  ClinicalTrials.gov Identifier: NCT00386815 - Completed
  Malignant Pleural Mesothelioma
  
• Safety Efficacy of Iron Sucrose in Children
  ClinicalTrials.gov Identifier: NCT00239642 - Recruiting
  Anemia; Chronic Kidney Disease
  
• Safety Evaluation in Subjects With Silicone- and Saline- Breast Implants
  ClinicalTrials.gov Identifier: NCT00443274 - Recruiting
  Breast Implant
  
• Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00185315 - Completed
  Pulmonary Hypertension
  
• Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
  ClinicalTrials.gov Identifier: NCT00452842 - Recruiting
  Cardiovascular Disease; Cerebrovascular Disorders
  
• Safety Investigation of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years
  ClinicalTrials.gov Identifier: NCT00161863 - Completed
  Tick-Borne Encephalitis
  
• Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00247260 - Active, not recruiting
  Liver Cancer
  
• Safety of a Diagnostic Strategy With D-Dimer Testing for PE
  ClinicalTrials.gov Identifier: NCT00182221 - Recruiting
  Venous Thromboembolism
  
• Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions
  ClinicalTrials.gov Identifier: NCT00560066 - Recruiting
  Seasonal Influenza; Vaccine
  
• Safety of a Multitherapy Regimen Containing Alemtuzumab in Children and Adolescents After Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00240994 - Recruiting
  Kidney Failure, Chronic; Kidney Transplantation; Immunosuppression
  
• Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
  ClinicalTrials.gov Identifier: NCT00076557 - Terminated
  Hemophilia B
  
• Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00509938 - Completed
  Hematopoietic Stem Cell Transplantation; Bacterial Infections and Mycoses
  
• Safety of ABR-217620 in Combination with Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00132379 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00416546 - Recruiting
  Healthy
  
• Safety of ALK Ragweed Tablet
  ClinicalTrials.gov Identifier: NCT00330083 - Completed
  Allergy
  
• Safety of AMD11070, a New Anti-HIV Drug, in HIV Uninfected Men
  ClinicalTrials.gov Identifier: NCT00063804 - Active, not recruiting
  HIV Infections
  
• Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects with Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00101894 - Recruiting
  Colon Cancer; Rectal Cancer
  
• Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Subjects with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00101907 - Terminated
  Lung Cancer; Breast Cancer; Bladder Cancer; Ovarian Cancer
  
• Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00043511 - Completed
  HIV Infections
  
• Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa
  ClinicalTrials.gov Identifier: NCT00063778 - Completed
  HIV Infections
  
• Safety of an Investigational Study Drug for Insomnia in the Elderly
  ClinicalTrials.gov Identifier: NCT00095043 - Completed
  Insomnia
  
• Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers
  ClinicalTrials.gov Identifier: NCT00062530 - Not yet recruiting
  HIV Infections
  
• Safety of and Immune Response of a 2-Dose Regimen of rDEN1delta30 Dengue Virus Vaccine
  ClinicalTrials.gov Identifier: NCT00473135 - Recruiting
  Dengue
  
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00347672 - Completed
  Influenza; Virus Diseases
  
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00110279 - Active, not recruiting
  Influenza; Virus Diseases
  
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)
  ClinicalTrials.gov Identifier: NCT00380237 - Active, not recruiting
  Influenza; Virus Diseases
  
• Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00073216 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults
  ClinicalTrials.gov Identifier: NCT00366782 - Recruiting
  Paramyxoviridae Infections; Virus Diseases
  
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00089908 - Active, not recruiting
  Dengue Fever
  
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00094705 - Recruiting
  Dengue Fever
  
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00375726 - Recruiting
  Dengue
  
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00270699 - Recruiting
  Dengue Fever
  
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00322946 - Recruiting
  Dengue
  
• Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00301184 - Recruiting
  HIV Infections
  
• Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
  ClinicalTrials.gov Identifier: NCT00125099 - Completed
  HIV Infections
  
• Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given 3 Different Ways to HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00384787 - Recruiting
  HIV Infections
  
• Safety of and Immune Response to a DNA HIV Vaccine Followed By an Adenoviral Vector HIV Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00125970 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vector HIV Vaccine in HIV Infected Adults on Stable Anti-HIV Therapy
  ClinicalTrials.gov Identifier: NCT00255853 - Not yet recruiting
  HIV Infections
  
• Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00472719 - Recruiting
  HIV Infections
  
• Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00428337 - Recruiting
  HIV Infections
  
• Safety of and Immune Response to a Hepatitis B Virus Vaccine Given with a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People
  ClinicalTrials.gov Identifier: NCT00100633 - Active, not recruiting
  HIV Infections; Hepatitis B
  
• Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00308412 - Recruiting
  Paramyxoviridae Infections; Virus Diseases
  
• Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant
  ClinicalTrials.gov Identifier: NCT00320658 - Recruiting
  Malaria
  
• Safety of and Immune Response to a Meningitis Vaccine in HIV Infected Youth
  ClinicalTrials.gov Identifier: NCT00459316 - Active, not recruiting
  HIV Infections; Meningitis
  
• Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00376090 - Recruiting
  HIV Infections
  
• Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
  ClinicalTrials.gov Identifier: NCT00076037 - Active, not recruiting
  HIV Infections; HIV Seronegativity
  
• Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
  ClinicalTrials.gov Identifier: NCT00339040 - Active, not recruiting
  HIV Infections; Sexually Transmitted Diseases
  
• Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children
  ClinicalTrials.gov Identifier: NCT00099658 - Active, not recruiting
  HIV Infections; Streptococcal Infection
  
• Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00118924 - Recruiting
  Tick-Borne Encephalitis
  
• Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00094718 - Recruiting
  West Nile Fever Encephalitis
  
• Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00537147 - Not yet recruiting
  West Nile Fever
  
• Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) with Or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00124007 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00119873 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
  ClinicalTrials.gov Identifier: NCT00415649 - Not yet recruiting
  HIV Infections
  
• Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 gag DNA Alone or With IL-15 DNA) Given With or Without 3 Different Booster Vaccinations in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00115960 - Recruiting
  HIV Infections
  
• Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant
  ClinicalTrials.gov Identifier: NCT00001019 - Completed
  HIV Infections
  
• Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00069030 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00071851 - Completed
  HIV Infections
  
• Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00097838 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
  ClinicalTrials.gov Identifier: NCT00098163 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults
  ClinicalTrials.gov Identifier: NCT00123968 - Recruiting
  HIV Infections
  
• Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052
  ClinicalTrials.gov Identifier: NCT00091416 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
  ClinicalTrials.gov Identifier: NCT00084149 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00061243 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
  ClinicalTrials.gov Identifier: NCT00458120 - Recruiting
  Dengue Hemorrhagic Fever
  
• Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00270218 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Two Experimental Preventive HIV Vaccines (EP HIV-1090 and EP-1043) Given Alone or in Combination in Healthy, HIV-1 Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00141024 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00083603 - Active, not recruiting
  HIV Infections
  
• Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults
  ClinicalTrials.gov Identifier: NCT00574600 - Not yet recruiting
  HIV Infections
  
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00091702 - Active, not recruiting
  HIV Infections; Influenza
  
• Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00054860 - Completed
  HIV Infections
  
• Safety of and Immune System Response to an HIV Vaccine (EP-HIV-1090) in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00052182 - Completed
  HIV Infections
  
• Safety of Antioxidants During GYN Cancer Care
  ClinicalTrials.gov Identifier: NCT00284427 - Recruiting
  Ovarian Cancer; Cervical Cancer; Uterine Cancer
  
• Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function
  ClinicalTrials.gov Identifier: NCT00386750 - Terminated
  Malaria; Falciparum
  
• Safety of AT-1001 in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00386490 - Completed
  Healthy
  
• Safety of Autologous Stem Cell Treatment for Traumatic Brain Injury in Children
  ClinicalTrials.gov Identifier: NCT00254722 - Recruiting
  Traumatic Brain Injury
  
• Safety of Avonex Treatment in Multiple Sclerosis Patients With Neutralizing Antibodies to Interferon Beta Therapy
  ClinicalTrials.gov Identifier: NCT00493077 - Recruiting
  Multiple Sclerosis
  
• Safety of Cardiac Pacemakers in 1.5T Tesla MRI
  ClinicalTrials.gov Identifier: NCT00336011 - Completed
  Heart Diseases
  
• Safety of Cardiac Pacemakers in 3 Tesla MRI
  ClinicalTrials.gov Identifier: NCT00356330 - Recruiting
  Heart Diseases
  
• Safety of Celecoxib in Patients With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00177866 - Recruiting
  Crohn's Disease
  
• Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00252850 - Active, not recruiting
  Parkinson's Disease
  
• Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00422773 - Recruiting
  Metastatic Colorectal Cancer
  
• Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)
  ClinicalTrials.gov Identifier: NCT00163488 - Completed
  Perennial Allergic Rhinitis; Allergic Rhinitis; Hay Fever
  
• Safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis of the Knee(s)
  ClinicalTrials.gov Identifier: NCT00077935 - Recruiting
  Osteoarthritis, Knee
  
• Safety of Co-Administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
  ClinicalTrials.gov Identifier: NCT00369824 - Active, not recruiting
  Cervical Neoplasms; Papillomavirus Infections
  
• Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents
  ClinicalTrials.gov Identifier: NCT00258479 - Recruiting
  Tobacco Use Disorder
  
• Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
  ClinicalTrials.gov Identifier: NCT00241501 - Completed
  Gastroesophageal Reflux Disease (GERD)
  
• Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00375869 - Recruiting
  Traumatic Brain Injury
  
• Safety of DAVANAT with and without 5-Fluorouracil in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00054977 - Completed
  Colorectal Cancer; Lung Cancer; Breast Cancer; Head and Neck Cancer; Prostate Cancer
  
• Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
  ClinicalTrials.gov Identifier: NCT00237783 - Recruiting
  Hemodialysis; Hypotension
  
• Safety of Diclofenac Sodium Gel in Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00171691 - Completed
  Osteoarthritis
  
• Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
  ClinicalTrials.gov Identifier: NCT00188812 - Active, not recruiting
  Dementia Associated With Cerebrovascular Disease
  
• Safety of Driving After Minor Surgery With Monitored Anesthesia Care
  ClinicalTrials.gov Identifier: NCT00577200 - Not yet recruiting
  Minor Surgical Procedures With Monitored Anesthesia Care.; Driving Performance After Minor Ambulatory Surgery.
  
• Safety of DTaP-IPV-HB-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.
  ClinicalTrials.gov Identifier: NCT00313911 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type B; Hepatitis B
  
• Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine
  ClinicalTrials.gov Identifier: NCT00325143 - Active, not recruiting
  Healthy; Infant
  
• Safety of Estrogens in Lupus: Birth Control Pills
  ClinicalTrials.gov Identifier: NCT00000420 - Completed
  Systemic Lupus Erythematosus
  
• Safety of Estrogens in Lupus: Hormone Replacement Therapy
  ClinicalTrials.gov Identifier: NCT00000419 - Terminated
  Systemic Lupus Erythematosus
  
• Safety of Everolimus and Pemetrexed in Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00434174 - Recruiting
  Non Small Cell Lung Cancer
  
• Safety of Everolimus in Combination Therapy, in Patients With HER2-Overexpressing Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00426530 - Recruiting
  Breast Neoplasms; Neoplasm Metastasis
  
• Safety of Everolimus in Combination Therapy, in Patients With HER2-Overexpressing Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00426556 - Recruiting
  Metastatic Breast Cancer
  
• Safety of Exercise and High-Dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol
  ClinicalTrials.gov Identifier: NCT00531050 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
  ClinicalTrials.gov Identifier: NCT00493896 - Not yet recruiting
  Venous Thromboembolism
  
• Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population
  ClinicalTrials.gov Identifier: NCT00237991 - Completed
  Hepatitis A
  
• Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-Stage Kidney Failure Patients
  ClinicalTrials.gov Identifier: NCT00426712 - Active, not recruiting
  Hepatitis B
  
• Safety of High-Dose Tirofiban During Coronary Angioplasty
  ClinicalTrials.gov Identifier: NCT00566891 - Not yet recruiting
  Coronary Artery Disease
  
• Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients.
  ClinicalTrials.gov Identifier: NCT00430469 - Not yet recruiting
  Fungal Infection; Bacterial Infection
  
• Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
  ClinicalTrials.gov Identifier: NCT00305110 - Recruiting
  Acute Pain
  
• Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients with Iron Overload due to Blood Transfusions
  ClinicalTrials.gov Identifier: NCT00067080 - Completed
  Anemia, Sickle Cell
  
• Safety of Imovax Polio in Chinese Infants and Children
  ClinicalTrials.gov Identifier: NCT00258843 - Active, not recruiting
  Poliomyelitis
  
• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00529529 - Recruiting
  Asthma
  
• Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00472953 - Recruiting
  Diabetes Mellitus; Chronic Obstructive Pulmonary Disease (COPD)
  
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00308737 - Active, not recruiting
  Diabetes Mellitus, Type I; Diabetes Mellitus, Type II
  
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
  ClinicalTrials.gov Identifier: NCT00523042 - Recruiting
  Asthma; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1
  
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00447382 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Safety of Interferon Gamma-1b with Rituximab in Non-Hodgkin's Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00057447 - Terminated
  Non-Hodgkin's Lymphoma
  
• Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00099671 - Active, not recruiting
  HIV Infections
  
• Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00121121 - Completed
  HIV Infections; HIV Seronegativity
  
• Safety of Intravenous Acetaminophen Versus Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males
  ClinicalTrials.gov Identifier: NCT00493311 - Completed
  Fever
  
• Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
  ClinicalTrials.gov Identifier: NCT00473928 - Recruiting
  Age-Related Macular Degeneration
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00419536 - Terminated
  Hormone Refractory Prostate Cancer Disease
  
• Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00493766 - Active, not recruiting
  Hormone Refractory Prostate Cancer
  
• Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV co-Infected Subjects vs Baseline Liver Biopsy Metavir Score
  ClinicalTrials.gov Identifier: NCT00234975 - Active, not recruiting
  HIV Infection
  
• Safety of NGOIS Compared to BSS Plus in Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00346528 - Completed
  Cataract
  
• Safety of Non-Delayed Weight Bearing After Total Hip Replacement With Non-Cemented Fiber Metal Taper Stem
  ClinicalTrials.gov Identifier: NCT00179088 - Active, not recruiting
  Osteoarthritis; Pain
  
• Safety of NXY-059 for the Treatment of Patients who have Suffered from a Stroke
  ClinicalTrials.gov Identifier: NCT00075959 - Completed
  Intracerebral Hemorrhage
  
• Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction
  ClinicalTrials.gov Identifier: NCT00245271 - Recruiting
  Knee Injuries
  
• Safety of ON 01910.Na in Patients With Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00533416 - Recruiting
  Myelodysplastic Syndrome (MDS)
  
• Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00504699 - Recruiting
  Breast Cancer
  
• Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00460408 - Recruiting
  Macular Degeneration
  
• Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00270452 - Active, not recruiting
  Myelodysplastic Syndrome (MDS)
  
• Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy
  ClinicalTrials.gov Identifier: NCT00159731 - Completed
  Diabetic Neuropathies
  
• Safety of Preoperative Oral Administration of a High Caloric Drink with Protein
  ClinicalTrials.gov Identifier: NCT00151099 - Not yet recruiting
  Dysgnathia; anesthesia
  
• Safety of Rabeprazole in Patients Under Multiple Treatments.
  ClinicalTrials.gov Identifier: NCT00511745 - Active, not recruiting
  Gastric Ulcer; Gastroesophageal Reflux
  
• Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00466466 - Recruiting
  Small-Cell Lung Cancer
  
• Safety of Ramelteon in Elderly Subjects
  ClinicalTrials.gov Identifier: NCT00568789 - Completed
  Insomnia
  
• Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy
  ClinicalTrials.gov Identifier: NCT00107549 - Suspended
  HIV Infections
  
• Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
  ClinicalTrials.gov Identifier: NCT00424944 - Recruiting
  Malaria
  
• Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00328757 - Recruiting
  Gynecologic Neoplasms
  
• Safety of REPEVAX® Given One Month After REVAXIS®
  ClinicalTrials.gov Identifier: NCT00400309 - Completed
  Healthy Adult
  
• Safety of RG2077 in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
  Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
  
• Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV
  ClinicalTrials.gov Identifier: NCT00084058 - Active, not recruiting
  HIV Infections
  
• Safety of SBG in Treatment of Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00533728 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Safety of SCH 530348 in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention
  ClinicalTrials.gov Identifier: NCT00132912 - Completed
  Arterial Obstructive Diseases; Coronary Disease
  
• Safety of Single Doses of Hematide in Patients with Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00109291 - Active, not recruiting
  Kidney Diseases
  
• Safety of SPD417 Combined with Other Psychotropic Medications in the Treatment of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00150605 - Completed
  Bipolar Disorder
  
• Safety of SPD465 in Treating Adults with ADHD.
  ClinicalTrials.gov Identifier: NCT00152035 - Completed
  Attention Deficit Disorder with Hyperactivity.
  
• Safety of SPL7013 Gel (VivaGel™) in Sexually Active Women
  ClinicalTrials.gov Identifier: NCT00442910 - Recruiting
  Healthy
  
• Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00428389 - Completed
  Alzheimer's Disease
  
• Safety of Tenofovir Disoproxil Fumarate (TDF) in HIV Infected Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00076791 - Recruiting
  HIV Infections
  
• Safety of Testosterone Undecanoate i.m. in Hypogonadal Men
  ClinicalTrials.gov Identifier: NCT00452322 - Completed
  Hypogonadism
  
• Safety of TG100-115 for Heart Attack Treated with Angioplasty
  ClinicalTrials.gov Identifier: NCT00103350 - Active, not recruiting
  Myocardial Infarction
  
• Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
  ClinicalTrials.gov Identifier: NCT00315835 - Completed
  Postoperative Pain
  
• Safety of the Candidate Vaccine C4-V3 Alone or with Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
  ClinicalTrials.gov Identifier: NCT00005779 - Completed
  HIV Infections
  
• Safety of the EnvPro HIV Vaccine in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00076947 - Completed
  HIV Infections
  
• Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy.
  ClinicalTrials.gov Identifier: NCT00137579 - Completed
  Anticoagulants
  
• Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
  ClinicalTrials.gov Identifier: NCT00303251 - Recruiting
  Melanoma
  
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00388505 - Recruiting
  Cystic Fibrosis
  
• Safety of Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00125333 - Completed
  Atopic Dermatitis
  
• Safety of Tranexamic Acid in Reducing Bleeding in Adults Undergoing Spinal Surgery
  ClinicalTrials.gov Identifier: NCT00444470 - Completed
  Spine Surgery
  
• Safety of TTP488 in Patients with Mild to Moderate Alzheimer''s Disease
  ClinicalTrials.gov Identifier: NCT00141661 - Completed
  Alzheimer Disease
  
• Safety of Two Epidural Catheters in Thoracic Epidural Anaesthesia (TEA)
  ClinicalTrials.gov Identifier: NCT00394459 - Completed
  Anesthesia, Epidural; Paraesthesia
  
• Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use
  ClinicalTrials.gov Identifier: NCT00479180 - Active, not recruiting
  Hemodialysis Access
  
• Safety of VIRACEPT® 625 Mg During Pregnancy
  ClinicalTrials.gov Identifier: NCT00246610 - Recruiting
  HIV Infections; Pregnancy
  
• Safety of Withdrawing Immunosuppressive Drugs in Children Who Have Received a Liver Transplant
  ClinicalTrials.gov Identifier: NCT00320606 - Recruiting
  Liver Transplantation; Immunosuppression
  
• Safety Outcomes of Lower Immunosuppression vs. Traditional Immunosuppression in Heart Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00299221 - Recruiting
  Heart Transplantation
  
• Safety Profile of IGF-I Administration in Adolescents
  ClinicalTrials.gov Identifier: NCT00516386 - Recruiting
  Anorexia Nervosa
  
• Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route
  ClinicalTrials.gov Identifier: NCT00261001 - Terminated
  Healthy Volunteers; HIV Infection
  
• Safety Study for Remicade
  ClinicalTrials.gov Identifier: NCT00036387 - Completed
  Rheumatoid Arthritis
  
• Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
  ClinicalTrials.gov Identifier: NCT00100087 - Recruiting
  Macular Degeneration; Choroidal Neovascularization
  
• Safety Study in Outpatient Japanese Children With ADHD
  ClinicalTrials.gov Identifier: NCT00485628 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Safety Study in Patients Who Were Born Small and Short and Were Treated With Growth Hormone to Achieve Normal Height
  ClinicalTrials.gov Identifier: NCT00396474 - Not yet recruiting
  Infant, Small for Gestational Age
  
• Safety Study in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif
  ClinicalTrials.gov Identifier: NCT00317941 - Recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
  ClinicalTrials.gov Identifier: NCT00346060 - Recruiting
  Dry Age Related Macular Degeneration.
  
• Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
  ClinicalTrials.gov Identifier: NCT00345917 - Recruiting
  Retinitis Pigmentosa.
  
• Safety Study in Subjects With Leber Congenital Amaurosis
  ClinicalTrials.gov Identifier: NCT00516477 - Recruiting
  Leber Congenital Amaurosis
  
• Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW Vs. ENCEPUR
  ClinicalTrials.gov Identifier: NCT00161824 - Completed
  Encephalitis, Tick-Borne
  
• Safety Study of 16.5mg (3.3%) CGC-11047 Injected Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to Age Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00446654 - Active, not recruiting
  Age Related Macular Degeneration
  
• Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00399113 - Not yet recruiting
  Metastatic Melanoma
  
• Safety Study of 2nd Generation Anti-CEA Designer T Cells to Treat Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00429078 - Recruiting
  Gastric Cancer
  
• Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses
  ClinicalTrials.gov Identifier: NCT00360737 - Active, not recruiting
  Healthy
  
• Safety Study of 90Y-hMN14 to Treat Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00040599 - Completed
  Colorectal Cancer; Colon Cancer; Rectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma; Colorectal Tumor
  
• Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients with Limited Residual Disease After Surgery
  ClinicalTrials.gov Identifier: NCT00041691 - Terminated
  Colorectal Neoplasms
  
• Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00041639 - Completed
  Pancreatic Neoplasms
  
• Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00569777 - Active, not recruiting
  Allergic Conjunctivitis
  
• Safety Study of a Dengue Virus DNA Vaccine
  ClinicalTrials.gov Identifier: NCT00290147 - Active, not recruiting
  Dengue
  
• Safety Study of a Gene Transfer Vector for Children with Late Infantile Neuronal Ceroid Lipofuscinosis
  ClinicalTrials.gov Identifier: NCT00151216 - Recruiting
  Batten Disease; Late Infantile Neuronal Lipofuscinosis
  
• Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
  ClinicalTrials.gov Identifier: NCT00562003 - Recruiting
  Ovarian Cancer; Primary Peritoneal Cancer
  
• Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers
  ClinicalTrials.gov Identifier: NCT00169000 - Completed
  Metastatic Breast Cancer
  
• Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00441571 - Recruiting
  Metastatic Prostate Cancer
  
• Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.
  ClinicalTrials.gov Identifier: NCT00418275 - Completed
  Cerebrovascular Accident
  
• Safety Study of a Refrigerator-Stable Formulation of VARIVAX®
  ClinicalTrials.gov Identifier: NCT00432731 - Completed
  Varicella; Measles; Mumps; Rubella
  
• Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
  ClinicalTrials.gov Identifier: NCT00317135 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
  ClinicalTrials.gov Identifier: NCT00317187 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma
  ClinicalTrials.gov Identifier: NCT00386178 - Recruiting
  Asthma
  
• Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00114452 - Active, not recruiting
  Myocardial Infarction
  
• Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00555828 - Recruiting
  Myocardial Infarction
  
• Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
  ClinicalTrials.gov Identifier: NCT00323856 - Recruiting
  Severe Hemophilia A
  
• Safety Study of AMD3100 With G-CSF to Increase Peripheral Blood Stem Cells
  ClinicalTrials.gov Identifier: NCT00291811 - Recruiting
  Multiple Myeloma; Non-Hodgkin's Lymphoma
  
• Safety Study of AMG 531 in Japanese Subjects With ITP
  ClinicalTrials.gov Identifier: NCT00305435 - Completed
  Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
  
• Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population
  ClinicalTrials.gov Identifier: NCT00318058 - Completed
  Influenza
  
• Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects with Alpha 1-Antitrypsin Deficiency
  ClinicalTrials.gov Identifier: NCT00161707 - Completed
  alpha 1-Antitrypsin Deficiency
  
• Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00487786 - Recruiting
  Neoplasms
  
• Safety Study of an Immune Response Modifier in Patients with Refractory Solid Organ Tumors
  ClinicalTrials.gov Identifier: NCT00095160 - Completed
  Neoplasms
  
• Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu
  ClinicalTrials.gov Identifier: NCT00347529 - Completed
  Influenza (Pandemic)
  
• Safety Study of an Intravenous Staphylococcus aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
  ClinicalTrials.gov Identifier: NCT00066989 - Completed
  Staphylococcal Infections
  
• Safety Study of an Oral VEGF Receptor Inhibitor When Combined With an m-Tor Inhibitor in Renal Cell Cancer Patients
  ClinicalTrials.gov Identifier: NCT00563147 - Active, not recruiting
  Renal Cell Carcinoma
  
• Safety Study of Anthrax Immune Globulin Derived From Human Serum
  ClinicalTrials.gov Identifier: NCT00448253 - Recruiting
  Symptoms of Inhalational Anthrax
  
• Safety Study of Anti-Asthma Agent BMEC-1217B
  ClinicalTrials.gov Identifier: NCT00425971 - Recruiting
  Asthma
  
• Safety Study of Anti-IgE Immunotherapy in Allergic Patients
  ClinicalTrials.gov Identifier: NCT00439621 - Recruiting
  Allergy
  
• Safety Study of AP23573 in Patients with Advanced, Refractory or Recurrent Malignancies
  ClinicalTrials.gov Identifier: NCT00060632 - Completed
  Tumors; Lymphoma; Multiple Myeloma
  
• Safety Study of AP23573 in Patients with Advanced, Refractory or Recurrent Malignancies
  ClinicalTrials.gov Identifier: NCT00060645 - Active, not recruiting
  Tumors; Lymphoma; Multiple Myeloma
  
• Safety Study of AP23573 in Patients with Progressive or Recurrent Glioma
  ClinicalTrials.gov Identifier: NCT00087451 - Completed
  Malignant Glioma; Glioblastoma; Gliosarcoma
  
• Safety Study of Apixaban in Recent Acute Coronary Syndrome
  ClinicalTrials.gov Identifier: NCT00313300 - Active, not recruiting
  Acute Coronary Syndrome (ACS)
  
• Safety Study of AT1001 to Treat Celiac Disease.
  ClinicalTrials.gov Identifier: NCT00386165 - Completed
  Celiac Disease
  
• Safety Study of AT2101 in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy
  ClinicalTrials.gov Identifier: NCT00433147 - Recruiting
  Gaucher Disease, Type 1
  
• Safety Study of Autologous Stem Cell in Liver Cirrhosis
  ClinicalTrials.gov Identifier: NCT00382278 - Recruiting
  Liver Cirrhosis
  
• Safety Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke
  ClinicalTrials.gov Identifier: NCT00473057 - Recruiting
  Infarction, Middle Cerebral Artery
  
• Safety Study of Avian Flu Vaccine
  ClinicalTrials.gov Identifier: NCT00408109 - Active, not recruiting
  Influenza A Virus, H5N1 Subtype; Influenza A Virus; Influenzavirus A; Orthomyxoviridae; H5N1 Virus
  
• Safety Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. Aeruginosa
  ClinicalTrials.gov Identifier: NCT00128492 - Active, not recruiting
  Cystic Fibrosis
  
• Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-Small Cell Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00531076 - Recruiting
  Toxicity
  
• Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
  ClinicalTrials.gov Identifier: NCT00318513 - Not yet recruiting
  Lymphedema
  
• Safety Study of BLP25 Liposome Vaccine in Non-Small Cell Lung Cancer Patients with Unresectable Stage III Disease
  ClinicalTrials.gov Identifier: NCT00157196 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung; Lung Neoplasms
  
• Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart Muscle
  ClinicalTrials.gov Identifier: NCT00361855 - Recruiting
  Myocardial Infarction
  
• Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
  ClinicalTrials.gov Identifier: NCT00491166 - Recruiting
  Diabetic Macular Edema
  
• Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali
  ClinicalTrials.gov Identifier: NCT00308061 - Completed
  Malaria
  
• Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
  ClinicalTrials.gov Identifier: NCT00462189 - Recruiting
  Leukemia; Hairy Cell Leukemia; HCL
  
• Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
  ClinicalTrials.gov Identifier: NCT00457860 - Recruiting
  Leukemia
  
• Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
  ClinicalTrials.gov Identifier: NCT00515892 - Recruiting
  Leukemia; Non-Hodgkin's Lymphoma; NHL
  
• Safety Study of CD-NP in Heart Failure
  ClinicalTrials.gov Identifier: NCT00557661 - Recruiting
  Congestive Heart Failure
  
• Safety Study of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-Advanced Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00226941 - Recruiting
  Rectal Cancer
  
• Safety Study Of Cetuximab Plus Dasatinib (BMS-354825) in Treating Advanced Solid Malignancies
  ClinicalTrials.gov Identifier: NCT00388427 - Recruiting
  Advanced Solid Malignancies
  
• Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
  ClinicalTrials.gov Identifier: NCT00311857 - Recruiting
  Glioblastoma Multiforme
  
• Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
  ClinicalTrials.gov Identifier: NCT00314132 - Completed
  Encephalitis Virus, Vaccine
  
• Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00220649 - Recruiting
  Pancreatic Neoplasms
  
• Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00223301 - Completed
  Multiple Sclerosis
  
• Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00367250 - Recruiting
  Metastatic Breast Cancer
  
• Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma
  ClinicalTrials.gov Identifier: NCT00349414 - Recruiting
  Advanced Glaucoma; Refractory Glaucoma
  
• Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00580320 - Recruiting
  Melanoma; Soft Tissue Sarcoma; Parathyroid Carcinoma; Small Cell Carcinoma of the Lung; Carcinoid Tumors
  
• Safety Study of Dasatinib With Bortezomib for Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00560352 - Recruiting
  Multiple Myeloma
  
• Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients
  ClinicalTrials.gov Identifier: NCT00271323 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma
  
• Safety Study of ECO Conversion System For Red Blood Cells.
  ClinicalTrials.gov Identifier: NCT00261274 - Recruiting
  Anemia
  
• Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome
  ClinicalTrials.gov Identifier: NCT00208026 - Recruiting
  Netherton Syndrome
  
• Safety Study of Elvucitabine in HIV-1 Subjects
  ClinicalTrials.gov Identifier: NCT00405249 - Recruiting
  HIV Infections
  
• Safety Study of EMD 72000 in Combination with ECX (Epiribicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer
  ClinicalTrials.gov Identifier: NCT00113581 - Completed
  Esophageal Cancer; Gastric Cancer
  
• Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
  ClinicalTrials.gov Identifier: NCT00461305 - Recruiting
  Dysmenorrhea
  
• Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)
  ClinicalTrials.gov Identifier: NCT00038961 - Active, not recruiting
  Venous Thrombosis
  
• Safety Study of Four Candidate Influenza Vaccines to Prevent Influenza Disease in the Elderly Population
  ClinicalTrials.gov Identifier: NCT00318149 - Active, not recruiting
  Influenza
  
• Safety Study of Galantamine in Tic Disorders
  ClinicalTrials.gov Identifier: NCT00226824 - Terminated
  Tourette's Syndrome; Motor Tic Disorder; Vocal Tic Disorder
  
• Safety Study of Gene Transfer Agent MYDICAR™ (AAV1/SERCA2a) to Treat Heart Failure
  ClinicalTrials.gov Identifier: NCT00454818 - Recruiting
  Heart Failure, Congestive
  
• Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule
  ClinicalTrials.gov Identifier: NCT00572000 - Recruiting
  Human Papillomavirus (HPV) Vaccine
  
• Safety Study of Gleevec® in Children With Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00583115 - Recruiting
  Pulmonary Hypertension
  
• Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection
  ClinicalTrials.gov Identifier: NCT00277576 - Recruiting
  Chronic Hepatitis B
  
• Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
  ClinicalTrials.gov Identifier: NCT00224484 - Active, not recruiting
  Herpes Simplex
  
• Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00041652 - Completed
  Colorectal Cancer; Colon Cancer; Rectal Cancer; Colorectal Neoplasms; Colorectal Carcinoma; Breast Cancer; Breast Neoplasms
  
• Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2
  ClinicalTrials.gov Identifier: NCT00274300 - Completed
  HSV-2
  
• Safety Study of iBalance Axial Knee Realignment System
  ClinicalTrials.gov Identifier: NCT00506220 - Recruiting
  Osteoarthritis, Knee
  
• Safety Study of Idebenone to Treat Friedreich's Ataxia
  ClinicalTrials.gov Identifier: NCT00015808 - Completed
  Friedreich Ataxia
  
• Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00364143 - Recruiting
  Cancer
  
• Safety Study of IL-7 in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00477321 - Not yet recruiting
  HIV Infections; Lymphopenia
  
• Safety Study of IMC-1121B With or Without Dacarbazine to Treat Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00533702 - Recruiting
  Metastatic Malignant Melanoma
  
• Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients
  ClinicalTrials.gov Identifier: NCT00327288 - Recruiting
  Non-Small Cell Lung Cancer; Breast Cancer; Prostate Cancer
  
• Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00327327 - Recruiting
  Pancreatic Adenocarcinoma
  
• Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy
  ClinicalTrials.gov Identifier: NCT00327223 - Active, not recruiting
  Neoplasm Metastasis
  
• Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00395434 - Recruiting
  Tumors
  
• Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00181545 - Recruiting
  Non-Small-Cell Lung Carcinoma
  
• Safety Study of Infant Formula With Partially Hydrolized Whey
  ClinicalTrials.gov Identifier: NCT00548106 - Not yet recruiting
  Infant Behaviour , Growth and Bowel Habits
  
• Safety Study of Infusion of SGT-53 to Treat Solid Tumors
  ClinicalTrials.gov Identifier: NCT00470613 - Recruiting
  Neoplasm
  
• Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00274313 - Completed
  Cystic Fibrosis
  
• Safety Study of Injections of Autologous/Allogeneic TGFbeta-Resistant LMP2A-Specific Cytotoxic T-Lymphocytes (CTL)
  ClinicalTrials.gov Identifier: NCT00368082 - Recruiting
  Relapsed Ebv-Positive Lymphoma
  
• Safety Study of Interferon Beta 1a to for Acute Stroke
  ClinicalTrials.gov Identifier: NCT00097318 - Active, not recruiting
  Cerebrovascular Accident
  
• Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors
  ClinicalTrials.gov Identifier: NCT00308165 - Recruiting
  Brain Neoplasms, Primary Malignant
  
• Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
  ClinicalTrials.gov Identifier: NCT00276302 - Recruiting
  Gastrointestinal Stromal Tumors; Soft Tissue Sarcomas
  
• Safety Study of IPI-504 in Patients with Relapsed and Relapsed Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00113204 - Active, not recruiting
  Multiple Myeloma
  
• Safety Study of ISIS 325568 in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00519727 - Recruiting
  Type 2 Diabetes Mellitus
  
• Safety Study of Lactobacillus Administered Vaginally to Healthy Women
  ClinicalTrials.gov Identifier: NCT00537576 - Not yet recruiting
  Bacterial Vaginosis
  
• Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00532389 - Not yet recruiting
  Multiple Myeloma
  
• Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00532675 - Not yet recruiting
  Multiple Myeloma
  
• Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00555100 - Recruiting
  Multiple Myeloma
  
• Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I
  ClinicalTrials.gov Identifier: NCT00277758 - Active, not recruiting
  Hepatitis C
  
• Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00355888 - Recruiting
  Cancer
  
• Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
  ClinicalTrials.gov Identifier: NCT00375570 - Active, not recruiting
  Herpes Labialis
  
• Safety Study of Membrane Sweeping in Pregnancy
  ClinicalTrials.gov Identifier: NCT00294242 - Not yet recruiting
  Pregnancy; Prelabor Rupture of Membranes
  
• Safety Study of Microbubbles With Transcranial Ultrasound and tPA in the Management of Acute Ischemic Stroke
  ClinicalTrials.gov Identifier: NCT00504842 - Recruiting
  Acute Ischemic Stroke
  
• Safety Study of Mini-Dystrophin Gene to Treat Duchenne Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00428935 - Active, not recruiting
  Duchenne Muscular Dystrophy
  
• Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00408226 - Recruiting
  Advanced Cancer; Non-Small Cell Lung Cancer
  
• Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD)
  ClinicalTrials.gov Identifier: NCT00390767 - Recruiting
  Peripheral Arterial Disease (PAD)
  
• Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00561275 - Recruiting
  Esophageal Cancer
  
• Safety Study of MVA Smallpox Vaccine in HIV-Positive Subjects Who Are Vaccinia Naive
  ClinicalTrials.gov Identifier: NCT00282581 - Terminated
  HIV Infections; Smallpox
  
• Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)
  ClinicalTrials.gov Identifier: NCT00389103 - Terminated
  Smallpox; Atopic Dermatitis
  
• Safety Study Of N-ac For The Prevention Of Contrast Induced Nephropathy (CIN) In Patients With Stage 3 Renal Failure
  ClinicalTrials.gov Identifier: NCT00575419 - Recruiting
  Contrast Induced Nephropathy
  
• Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63
  ClinicalTrials.gov Identifier: NCT00369031 - Active, not recruiting
  HIV Infections
  
• Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00559702 - Recruiting
  Secondary Progressive Multiple Sclerosis
  
• Safety Study of Nicotinamide to Treat Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00580931 - Not yet recruiting
  Alzheimer's Disease
  
• Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00486564 - Recruiting
  Neuroblastoma
  
• Safety Study Of Nucleoside Analog For The Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens
  ClinicalTrials.gov Identifier: NCT00129194 - Active, not recruiting
  HIV
  
• Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
  ClinicalTrials.gov Identifier: NCT00106158 - Completed
  Neoplasms
  
• Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00190749 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Safety Study of Olpatadine Nasal Spray
  ClinicalTrials.gov Identifier: NCT00578331 - Active, not recruiting
  Perennial Allergic Rhinitis
  
• Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00223951 - Active, not recruiting
  Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
  
• Safety Study of Oral BTA9881 to Treat RSV Infection
  ClinicalTrials.gov Identifier: NCT00504907 - Recruiting
  Respiratory Syncytial Virus Infections
  
• Safety Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Condition
  ClinicalTrials.gov Identifier: NCT00491894 - Recruiting
  Sialorrhea; Cerebral Palsy; Neurological Conditions; Mental Retardation
  
• Safety Study of Oral Sodium Phenylbutyrate in Subjects with ALS (Amyotrophic Lateral Sclerosis)
  ClinicalTrials.gov Identifier: NCT00107770 - Active, not recruiting
  Amyotrophic Lateral Sclerosis
  
• Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00219882 - Completed
  Cystic Fibrosis
  
• Safety Study of ORG 34517 for Major Depression With Psychotic Features
  ClinicalTrials.gov Identifier: NCT00226278 - Recruiting
  Major Depressive Disorder; Psychotic Disorders
  
• Safety Study of Outpatient Treatment for Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00425542 - Recruiting
  Pulmonary Embolism
  
• Safety Study of Oxaliplatin and 5-Flurouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
  ClinicalTrials.gov Identifier: NCT00557557 - Recruiting
  Unresectable Colorectal Liver Metastases
  
• Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population
  ClinicalTrials.gov Identifier: NCT00306995 - Completed
  Influenza
  
• Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
  ClinicalTrials.gov Identifier: NCT00299780 - Completed
  Lymphoma; Multiple Myeloma; Acute Myelogenous Leukemia
  
• Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00174525 - Active, not recruiting
  Alzheimer's Disease
  
• Safety Study of Pelvic Organ Prolapse Repair Using Transvaginal Mesh
  ClinicalTrials.gov Identifier: NCT00402844 - Completed
  Pelvic Organ Prolapse
  
• Safety Study of PI-0824 to Treat Pemphigus Vulgaris
  ClinicalTrials.gov Identifier: NCT00063752 - Completed
  Pemphigus Vulgaris
  
• Safety Study of PIF-1 to Treat Acute Steroid-Resistant GVHD
  ClinicalTrials.gov Identifier: NCT00517907 - Not yet recruiting
  Graft vs Host Disease
  
• Safety Study of PLX4032 in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00405587 - Recruiting
  Malignant Melanoma
  
• Safety Study of PPI-1019 in Patients with Mild-Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00100282 - Completed
  Alzheimer's Disease
  
• Safety Study of PPI-1019 in Subjects with Mild-Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00100334 - Completed
  Alzheimer's Disease
  
• Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy
  ClinicalTrials.gov Identifier: NCT00344890 - Recruiting
  Cervical Radiculopathy; Myelopathy
  
• Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00528047 - Recruiting
  Cancer
  
• Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00446368 - Recruiting
  Carcinoma, Renal Cell
  
• Safety Study of Radio-Labeled huA33 Antibody in Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00199862 - Suspended
  Colorectal Neoplasms; Colorectal Cancer; Colorectal Tumor; Colorectal Carcinoma
  
• Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00536861 - Recruiting
  Non-Small Cell Lung Cancer; Brain Metastases
  
• Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
  ClinicalTrials.gov Identifier: NCT00395551 - Recruiting
  Choroidal Neovascularization
  
• Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer
  ClinicalTrials.gov Identifier: NCT00409994 - Recruiting
  Rectum Cancer
  
• Safety study of Recombinant Factor XIII (rFXIII) in Patients with Congenital Factor XIII Deficiency
  ClinicalTrials.gov Identifier: NCT00056589 - Completed
  Congenital Factor XIII deficiency
  
• Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00443573 - Suspended
  Colon Cancer
  
• Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
  ClinicalTrials.gov Identifier: NCT00410566 - Recruiting
  Acid Sphingomyelinase Deficiency; Niemann-Pick Disease
  
• Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00027027 - Completed
  Neoplasms
  
• Safety Study of Rituximab(Rituxan®) in Chronic Urticaria
  ClinicalTrials.gov Identifier: NCT00216762 - Recruiting
  Urticaria
  
• Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00411723 - Recruiting
  Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
  
• Safety Study of S-Caine Peel (skin numbing cream) before a Painful Dermatologic Procedure in Adults
  ClinicalTrials.gov Identifier: NCT00107835 - Completed
  Pain
  
• Safety Study of S-Caine Peel (skin numbing cream) before a Painful Dermatologic Procedure in Children
  ClinicalTrials.gov Identifier: NCT00107822 - Completed
  Pain
  
• Safety Study of S-CKD602 in Patients With Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00177281 - Completed
  Cancer
  
• Safety Study of SCIO-469 to treat Patients with Active Rheumatoid Arthritis Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00043732 - Active, not recruiting
  Arthritis, Rheumatoid
  
• Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
  ClinicalTrials.gov Identifier: NCT00314925 - Recruiting
  Carcinoma
  
• Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents
  ClinicalTrials.gov Identifier: NCT00271258 - Completed
  Bipolar Disorder
  
• Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00440973 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Safety Study of SRX251 Capsules in Healthy Female Volunteers
  ClinicalTrials.gov Identifier: NCT00461370 - Completed
  Healthy
  
• Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement
  ClinicalTrials.gov Identifier: NCT00362492 - Recruiting
  Thromboembolism; Arthroplasty, Replacement, Knee
  
• Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00195143 - Completed
  Parkinson's Disease
  
• Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
  ClinicalTrials.gov Identifier: NCT00489294 - Completed
  Growth Hormone Deficiency
  
• Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
  ClinicalTrials.gov Identifier: NCT00418327 - Recruiting
  Malignant Brain Tumor; Brain Stem Glioma,
  
• Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00189176 - Completed
  Idiopathic Pulmonary Fibrosis
  
• Safety Study of Textile Binder for Abdominal Compression
  ClinicalTrials.gov Identifier: NCT00385892 - Terminated
  Healthy
  
• Safety Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients with Advanced Emphysema
  ClinicalTrials.gov Identifier: NCT00085852 - Completed
  Pulmonary Emphysema
  
• Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00036517 - Terminated
  Colorectal Neoplasms; Diarrhea
  
• Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00216294 - Completed
  Obsessive Compulsive Disorder (OCD)
  
• Safety Study of the iBalance Axial Knee Realignment System (AKRFX)
  ClinicalTrials.gov Identifier: NCT00552123 - Recruiting
  Osteoarthritis, Knee
  
• Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
  ClinicalTrials.gov Identifier: NCT00387270 - Completed
  Huntington's Disease
  
• Safety Study of the Proteasome Inhibitor PR-171 in Patients with Hematological Malignancies
  ClinicalTrials.gov Identifier: NCT00150462 - Recruiting
  Multiple Myeloma; Non-Hodgkin''s Lymphoma; Hodgkin''s Disease; Waldenstrom''s Macroglobulinemia
  
• Safety Study of the VPD Implant System in Heart Failure Patients
  ClinicalTrials.gov Identifier: NCT00573560 - Recruiting
  Heart Failure
  
• Safety Study of Thumb Orthoses in Osteoarthritis in the Base of the Thumb (BTOA)
  ClinicalTrials.gov Identifier: NCT00350896 - Completed
  Osteoarthritis
  
• Safety Study of Tritanrix™-HepB/Hib-MenAC, Tritanrix™-HepB/Hiberix™, and Mencevax™ ACWY Vaccines in Children
  ClinicalTrials.gov Identifier: NCT00228917 - Completed
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Infections; Meningococcal Infections
  
• Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer
  ClinicalTrials.gov Identifier: NCT00445523 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Safety Study of UC-781 Vaginal Microbicide
  ClinicalTrials.gov Identifier: NCT00446979 - Recruiting
  HIV Infections
  
• Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
  ClinicalTrials.gov Identifier: NCT00113243 - Recruiting
  Peripheral Vascular Diseases
  
• Safety Study of Vaccinia Virus to Treat Superficial Injectable Tumors
  ClinicalTrials.gov Identifier: NCT00574977 - Not yet recruiting
  Melanoma; Breast Cancer; Head and Neck Squamous Cell Cancer
  
• Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-Left Cardiac Shunt
  ClinicalTrials.gov Identifier: NCT00442364 - Recruiting
  Varicose Veins
  
• Safety study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).
  ClinicalTrials.gov Identifier: NCT00032747 - Completed
  Chronic Heart Failure
  
• Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers
  ClinicalTrials.gov Identifier: NCT00512928 - Recruiting
  Healthy
  
• Safety Study of VX 770 in Subjects With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00457821 - Recruiting
  Cystic Fibrosis
  
• Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00234481 - Terminated
  Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
  
• Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00491699 - Recruiting
  Non-Small-Cell Lung Cancer
  
• Safety Study of XP12B in Women with Menorrhagia
  ClinicalTrials.gov Identifier: NCT00113568 - Active, not recruiting
  Menorrhagia
  
• Safety Study of Zileuton Injection in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00299065 - Completed
  Asthma
  
• Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
  ClinicalTrials.gov Identifier: NCT00490542 - Recruiting
  Bipolar Disorder; Bipolar Depression; Depression
  
• Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
  ClinicalTrials.gov Identifier: NCT00328887 - Not yet recruiting
  Esophageal Neoplasms
  
• Safety Study To Assess Growth In Pre-Pubertal Children Treated With An Investigational Nasal Spray For Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00109486 - Active, not recruiting
  Hayfever; Allergic Rhinitis; Seasonal rhinitis; Perennial Rhinitis; Non-Seasonal rhinitis
  
• Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System
  ClinicalTrials.gov Identifier: NCT00497367 - Active, not recruiting
  Cardiovascular Diseases
  
• Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.
  ClinicalTrials.gov Identifier: NCT00364364 - Recruiting
  Pancreatic Cancer
  
• Safety Study to Evaluate Daptomycin in Non-Infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis
  ClinicalTrials.gov Identifier: NCT00490737 - Not yet recruiting
  End-Stage Renal Disease
  
• Safety Study to Evaluate FluMist in Immunocompromised Children
  ClinicalTrials.gov Identifier: NCT00112112 - Recruiting
  Cancer
  
• Safety Study to Evaluate Induction and Consolidation Treatment Combination in Mantle Cell Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00505232 - Recruiting
  Mantle Cell Lymphoma
  
• Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation
  ClinicalTrials.gov Identifier: NCT00279097 - Terminated
  Intracranial Pressure
  
• Safety Study to Evaluate the Effect of Lowering Body Temperature During Cochlear Implantation
  ClinicalTrials.gov Identifier: NCT00375882 - Recruiting
  Hypothermia
  
• Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite.
  ClinicalTrials.gov Identifier: NCT00121849 - Completed
  Cutaneous Leishmaniasis
  
• Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00239291 - Completed
  Non-Metastatic Prostate Cancer
  
• Safety Study to Investigate the Bispecific T-Cell Engager MT103 in Patients With Relapsed Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00274742 - Recruiting
  Non-Hodgkin's Lymphoma, Relapsed
  
• Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00493545 - Recruiting
  Cervical Intraepithelial Neoplasia
  
• Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00279019 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00515502 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Safety Study with OROS Paliperidone in Geriatric Subjects with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00085748 - Completed
  Schizophrenia
  
• Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.
  ClinicalTrials.gov Identifier: NCT00199888 - Completed
  Cancer of Kidney; Kidney Cancer; Renal Cancer; Neoplasms, Kidney; Renal Neoplasms
  
• Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00265603 - Recruiting
  Non-Small Cell Lung Cancer
  
• Safety testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying)
  ClinicalTrials.gov Identifier: NCT00056524 - Completed
  Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Alzheimer's Disease; Stroke; Traumatic Brain Injury
  
• Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00195078 - Terminated
  Head and Neck Cancer
  
• Safety Trial of MR Guided FUS in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future
  ClinicalTrials.gov Identifier: NCT00180739 - Recruiting
  Uterine Fibroids; Pregnancy
  
• Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness
  ClinicalTrials.gov Identifier: NCT00088023 - Terminated
  Neoplasms
  
• Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
  ClinicalTrials.gov Identifier: NCT00213018 - Completed
  HIV Infections; Chlamydia Trachomatis; Neisseria Gonorrhoeae; Trichomonas Vaginitis; Syphilis
  
• Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
  ClinicalTrials.gov Identifier: NCT00213031 - Completed
  HIV Infections; Chlamydia Trachomatis; Neisseria Gonorrhoeae; Trichomonas Vaginitis; Syphilis; Herpes Simplex
  
• Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
  ClinicalTrials.gov Identifier: NCT00464672 - Recruiting
  Influenza
  
• Safety, Blood Levels and Effects of GW642444
  ClinicalTrials.gov Identifier: NCT00469040 - Active, not recruiting
  Asthma
  
• Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back Pain
  ClinicalTrials.gov Identifier: NCT00411268 - Active, not recruiting
  Low Back Pain
  
• Safety, Effectiveness, and Tolerability of Ezetimibe Combined with Statins for the Treatment of High Cholesterol in HIV Infected Adults
  ClinicalTrials.gov Identifier: NCT00099684 - Active, not recruiting
  HIV Infections
  
• Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study
  ClinicalTrials.gov Identifier: NCT00303017 - Recruiting
  Osteoarthritis
  
• Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00051662 - Completed
  Psoriatic Arthritis
  
• Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00413439 - Completed
  Acute Myeloid Leukemia
  
• Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis
  ClinicalTrials.gov Identifier: NCT00401271 - Completed
  Pulmonary Tuberculosis
  
• Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
  ClinicalTrials.gov Identifier: NCT00426218 - Recruiting
  Arthritis, Juvenile Rheumatoid
  
• Safety, Efficacy and Pharmacokinetics Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00148148 - Recruiting
  "Hematopoietic Stem Cell Transplantation"
  
• Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid
  ClinicalTrials.gov Identifier: NCT00333684 - Active, not recruiting
  Human Immunodeficiency Virus; Facial Lipoatrophy
  
• Safety, Efficacy and Treatment Satisfaction in Patients With Pulmonary Arterial Hypertension Rapidly Switched From Epoprostenol to Remodulin
  ClinicalTrials.gov Identifier: NCT00373360 - Recruiting
  Pulmonary Hypertension
  
• Safety, Efficacy and Treatment Satisfaction Switching From Flolan to Remodulin Using the CronoFive Ambulatory Pump in Patients With PAH
  ClinicalTrials.gov Identifier: NCT00439946 - Recruiting
  Pulmonary Arterial Hypertension
  
• Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APL
  ClinicalTrials.gov Identifier: NCT00520208 - Recruiting
  Acute Promyelocytic Leukemia; APL
  
• Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00047762 - Completed
  Colorectal Cancer
  
• Safety, Efficacy, Dose-Finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00231166 - Recruiting
  Multiple Myeloma
  
• Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
  ClinicalTrials.gov Identifier: NCT00487708 - Recruiting
  NALP3 Mutation
  
• Safety, feasibility and tolerability of Pegasys plus Copegus in previous intravenous drug users (IVDUs) who are infected with Chronic Hepatitis C and are currently enrolled in a methadone maintenance treatment program
  ClinicalTrials.gov Identifier: NCT00087594 - Completed
  Hepatitis C
  
• Safety, Immunogenicity and Preliminary Efficacy Study of Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine for Patients With Non-Small-Cell Lung Cancer (NSCLC) After Receiving Conventional First Line Chemotherapy
  ClinicalTrials.gov Identifier: NCT00516685 - Recruiting
  Non Small Cell Lung Cancer (NSCLC)
  
• Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
  ClinicalTrials.gov Identifier: NCT00480454 - Recruiting
  TB
  
• Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
  ClinicalTrials.gov Identifier: NCT00241410 - Active, not recruiting
  Type I Hypersensitivity
  
• Safety, PD & PK of Multiple Doses of HematideTM Injections for Anemia in Chronic Kidney Disease Patients
  ClinicalTrials.gov Identifier: NCT00228436 - Active, not recruiting
  Anemia; Chronic Kidney Disease
  
• Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.
  ClinicalTrials.gov Identifier: NCT00417196 - Completed
  Healthy
  
• Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients with Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
  ClinicalTrials.gov Identifier: NCT00161993 - Completed
  Hypogammaglobulinemia; Agammaglobulinemia; Primary immunodeficiency (PID)
  
• Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00503490 - Recruiting
  Cystic Fibrosis
  
• Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
  ClinicalTrials.gov Identifier: NCT00319228 - Recruiting
  Antithrombin III Deficiency
  
• Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00279773 - Terminated
  Acute Myeloid Leukemia
  
• Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects
  ClinicalTrials.gov Identifier: NCT00555451 - Recruiting
  Insulin Resistance
  
• Safety, Pharmacokinetics of Oral Azacitidine in Subjects With MDS and AML
  ClinicalTrials.gov Identifier: NCT00528983 - Recruiting
  Myelogenous Leukemia, Acute; Myelodysplastic Syndromes
  
• Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered Monthly in Women With Low Bone Mineral Density
  ClinicalTrials.gov Identifier: NCT00577837 - Completed
  Postmenopausal
  
• Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis
  ClinicalTrials.gov Identifier: NCT00453401 - Active, not recruiting
  Herpes Labialis
  
• Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00432770 - Completed
  Thrombosis
  
• Safety, PK and PD Study in Healthy Male Japanese Subjects
  ClinicalTrials.gov Identifier: NCT00447941 - Completed
  Schizophrenia
  
• Safety, PK, And Hematological Activity Of AMD3100 In Subjects With Renal Impairment
  ClinicalTrials.gov Identifier: NCT00445302 - Completed
  Renal Impairment
  
• Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals’Hib-MenC Given With Priorix™ in Toddlers (13–14 m) Primed With 3 Doses of Hib and MenC-CRM197
  ClinicalTrials.gov Identifier: NCT00263653 - Completed
  H.Influenzae Type b Diseases; Meningococcal Serogroup C Diseases
  
• Safety, Reactogenicity and Immunogenicity of MVA in HSCT Subjects
  ClinicalTrials.gov Identifier: NCT00565929 - Not yet recruiting
  Variola Major (Smallpox)
  
• Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00546585 - Not yet recruiting
  Influenza
  
• Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V
  ClinicalTrials.gov Identifier: NCT00097396 - Active, not recruiting
  Pneumonic Plague; Preventive therapy
  
• Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
  ClinicalTrials.gov Identifier: NCT00247572 - Completed
  Attention Deficit Disorder With Hyperactivity; Amphetamine-Related Disorders; Substance-Related Disorders
  
• Safety, Tolerability and Effectiveness of Natalizumab in Adolescents with Active Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00055367 - Completed
  Crohn's Disease
  
• Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00163280 - Completed
  Mucositis
  
• Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in De Novo Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00170833 - Completed
  Renal Transplantation
  
• Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17
  ClinicalTrials.gov Identifier: NCT00150592 - Completed
  Attention Deficit Disorder with Hyperactivity
  
• Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
  ClinicalTrials.gov Identifier: NCT00285766 - Completed
  Major Depression
  
• Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers
  ClinicalTrials.gov Identifier: NCT00255359 - Not yet recruiting
  Chronic Hepatitis C Virus Infection
  
• Safety, Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic Colorectal Cancer.
  ClinicalTrials.gov Identifier: NCT00065117 - Terminated
  Colorectal Neoplasms; Metastases, Neoplasm
  
• Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00411424 - Recruiting
  Rheumatoid Arthritis
  
• Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00422981 - Recruiting
  Mild Cognitive Impairment (MCI)
  
• Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00189904 - Completed
  HIV Infections
  
• Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders
  ClinicalTrials.gov Identifier: NCT00189917 - Completed
  Dermatitis, Atopic; Hay Fever
  
• Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age
  ClinicalTrials.gov Identifier: NCT00310635 - Completed
  Meningococcal Infection
  
• Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India
  ClinicalTrials.gov Identifier: NCT00496093 - Completed
  Pneumococcal Infection
  
• Safety, Tolerability and Immunogenicity of Quadrivalent Human Papillomavirus (HPV) Vaccine in Healthy Females 9 to 15 Years of Age in India
  ClinicalTrials.gov Identifier: NCT00380367 - Recruiting
  Papillomavirus Infections
  
• Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed
  ClinicalTrials.gov Identifier: NCT00170469 - Active, not recruiting
  Bacillus Anthracis (Anthrax)
  
• Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
  ClinicalTrials.gov Identifier: NCT00109304 - Active, not recruiting
  Venezuelan Equine Encephalitis
  
• Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy at-Risk Adults
  ClinicalTrials.gov Identifier: NCT00560313 - Recruiting
  Meningococcal Disease
  
• Safety, Tolerability and Immunogenicity of Two Different Formulations of MenB Vaccine in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00381615 - Recruiting
  Healthy
  
• Safety, Tolerability and Immunogenicity of Two Different Formulations of MenB Vaccine, When Administered to Healthy Infants
  ClinicalTrials.gov Identifier: NCT00433914 - Active, not recruiting
  Meningococcal Disease
  
• Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin
  ClinicalTrials.gov Identifier: NCT00288431 - Active, not recruiting
  Cancer; Sarcoma
  
• Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD Patients
  ClinicalTrials.gov Identifier: NCT00483743 - Recruiting
  COPD Patients
  
• Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
  ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
  Allergy
  
• Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-Label Tiotropium Bromide and Placebo in Mild-to-Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.
  ClinicalTrials.gov Identifier: NCT00568503 - Recruiting
  COPD
  
• Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958
  ClinicalTrials.gov Identifier: NCT00311714 - Active, not recruiting
  Influenza
  
• Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.
  ClinicalTrials.gov Identifier: NCT00416442 - Completed
  Healthy
  
• Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00401739 - Recruiting
  Acute Myeloid Leukemia (AML)
  
• Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00364793 - Recruiting
  HIV Infections
  
• Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00428766 - Active, not recruiting
  Epithelial Ovarian Cancer
  
• Safety, Tolerability and Pharmcodynamic Profile of Oral 2101 Once Daily for up to 14 Days in Secondary Raynaud's Disease
  ClinicalTrials.gov Identifier: NCT00528242 - Recruiting
  Secondary Raynaud's Disease
  
• Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)
  ClinicalTrials.gov Identifier: NCT00530699 - Recruiting
  Acute Myeloid Leukaemia
  
• Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment
  ClinicalTrials.gov Identifier: NCT00330330 - Completed
  Type 2 Diabetes Mellitus
  
• Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination with Nelfinavir in HIV-Positive Children
  ClinicalTrials.gov Identifier: NCT00000893 - Active, not recruiting
  HIV Infections
  
• Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
  ClinicalTrials.gov Identifier: NCT00006325 - Active, not recruiting
  HIV Infections
  
• Safety, Tolerability, and Blood Levels of Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
  ClinicalTrials.gov Identifier: NCT00096850 - Recruiting
  HIV Infections
  
• Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00481117 - Not yet recruiting
  Type 2 Diabetes
  
• Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS)
  ClinicalTrials.gov Identifier: NCT00001781 - Completed
  Multiple Sclerosis
  
• Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson’s Disease
  ClinicalTrials.gov Identifier: NCT00203138 - Completed
  Parkinson's Disease
  
• Safety, Tolerability, and Efficacy of Deferasirox in MDS
  ClinicalTrials.gov Identifier: NCT00469560 - Recruiting
  Myelodysplastic Syndromes; Hemosiderosis
  
• Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00458016 - Recruiting
  Type 2 Diabetes Mellitus
  
• Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
  ClinicalTrials.gov Identifier: NCT00079820 - Completed
  Smallpox
  
• Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers
  ClinicalTrials.gov Identifier: NCT00214461 - Recruiting
  Clostridium Infections
  
• Safety, Tolerability, and Immunogenicity of an Investigational Vaccine with Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age
  ClinicalTrials.gov Identifier: NCT00092404 - Active, not recruiting
  Measles; Mumps; Rubella; Varicella
  
• Safety, Tolerability, and Immunogenicity Study of a C Difficile Toxoid Vaccine in Healthy Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00127803 - Active, not recruiting
  Clostridium Difficile
  
• Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
  ClinicalTrials.gov Identifier: NCT00437281 - Recruiting
  Epilepsies, Partial
  
• Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients with Early Stage Diffuse Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00043706 - Completed
  Systemic Sclerosis; Scleroderma
  
• Safety, Tolerability, and Pharmacokinetics of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
  ClinicalTrials.gov Identifier: NCT00478920 - Recruiting
  Advanced Malignancies; Solid Tumors
  
• Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles
  ClinicalTrials.gov Identifier: NCT00109122 - Active, not recruiting
  Shingles
  
• Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers
  ClinicalTrials.gov Identifier: NCT00419887 - Completed
  Healthy
  
• Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine
  ClinicalTrials.gov Identifier: NCT00559975 - Recruiting
  Influenza Infection
  
• Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)
  ClinicalTrials.gov Identifier: NCT00058981 - Active, not recruiting
  Diabetes, Autoimmune
  
• Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects.
  ClinicalTrials.gov Identifier: NCT00417261 - Recruiting
  Healthy
  
• Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb
  ClinicalTrials.gov Identifier: NCT00500786 - Completed
  Essential Hypertension
  
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers
  ClinicalTrials.gov Identifier: NCT00421226 - Active, not recruiting
  Healthy
  
• Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00576277 - Completed
  Diabetic Neuropathy
  
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00506792 - Recruiting
  Cystic Fibrosis
  
• Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00497991 - Recruiting
  Acute Myeloid Leukaemia
  
• Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
  ClinicalTrials.gov Identifier: NCT00056381 - Completed
  Neutropenia
  
• Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals
  ClinicalTrials.gov Identifier: NCT00002087 - Completed
  HIV Infections
  
• Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV
  ClinicalTrials.gov Identifier: NCT00432016 - Completed
  HIV Infections
  
• Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity
  ClinicalTrials.gov Identifier: NCT00367783 - Terminated
  Obesity
  
• Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults
  ClinicalTrials.gov Identifier: NCT00331175 - Completed
  Obesity
  
• Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India
  ClinicalTrials.gov Identifier: NCT00496054 - Not yet recruiting
  Gastroenteritis; Rotavirus
  
• Safety,Tolerability and Immunogenicity of Vaccination With Varivax in Healthy Indian Children
  ClinicalTrials.gov Identifier: NCT00496327 - Completed
  Varicella
  
• Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
  ClinicalTrials.gov Identifier: NCT00232193 - Recruiting
  Relapsing-Remitting Multiple Sclerosis,; Mono-Symptomatic Multiple Sclerosis
  
• Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-Tropic HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00393120 - Completed
  HIV Infections
  
• Safety/Efficacy of a Vaccine Prepared from Dendritic Cells combined with Tumor Cells to Treat Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00050323 - Completed
  Carcinoma, Renal Cell
  
• Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
  ClinicalTrials.gov Identifier: NCT00021697 - Completed
  Amyotrophic Lateral Sclerosis
  
• Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00371670 - Completed
  Knee Osteoarthritis
  
• Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00333918 - Active, not recruiting
  Pain; Inflammation
  
• Safety/Efficacy of Camptosar, Avastin, & 5-FU/LV 2-Schedules w/ Celebrex/Placebo as Colorectal Cancer Initial Treatment
  ClinicalTrials.gov Identifier: NCT00101686 - Active, not recruiting
  Colorectal Cancer; Metastases
  
• Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00387517 - Active, not recruiting
  Hypertension
  
• Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients with Established Allograft Vasculopathy
  ClinicalTrials.gov Identifier: NCT00097968 - Completed
  Graft Rejection
  
• Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
  ClinicalTrials.gov Identifier: NCT00363051 - Completed
  Islet Cell Carcinoma; Neuroendocrine Carcinoma; Neuroendocrine Tumor; Pancreatic Neoplasms
  
• Safety/Efficacy of Induction Agents with Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00113269 - Active, not recruiting
  Kidney Transplantation
  
• Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions
  ClinicalTrials.gov Identifier: NCT00372710 - Terminated
  Breast Cancer With Bone Metastasis
  
• Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00332709 - Recruiting
  Osteoporosis, Postmenopausal
  
• Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00541775 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Safety/Efficacy of Systane Free vs Refresh Liquigel
  ClinicalTrials.gov Identifier: NCT00348517 - Completed
  Dry Eye
  
• Safety/Efficacy of Systane Free Vs Refresh Tears
  ClinicalTrials.gov Identifier: NCT00348322 - Not yet recruiting
  Dry Eye
  
• Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
  ClinicalTrials.gov Identifier: NCT00489255 - Recruiting
  Parkinson's Disease
  
• Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
  ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
  Hypertension
  
• Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Post Menopausal Women With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00404820 - Active, not recruiting
  Osteoporosis
  
• Safety/Efficacy Response to RSD1235 Compared to Placebo in Subjects with Atrial Arrhythmia After Heart Surgery.
  ClinicalTrials.gov Identifier: NCT00125320 - Completed
  Atrial Fibrillation; Atrial Flutter
  
• Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor
  ClinicalTrials.gov Identifier: NCT00308711 - Completed
  Cervical Ripening; Labor, Induced
  
• Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
  ClinicalTrials.gov Identifier: NCT00356447 - Recruiting
  Vasomotor Symptoms
  
• Safety/Efficacy study of immunoconjugate with docetaxel in non-small cell lung carcinoma
  ClinicalTrials.gov Identifier: NCT00051571 - Completed
  Carcinoma, Non-Small-Cell Lung
  
• Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00545545 - Recruiting
  Recurrent Colorectal Carcinoma; Progressive Colorectal Carcinoma
  
• Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
  ClinicalTrials.gov Identifier: NCT00360568 - Not yet recruiting
  Parkinson's Disease; Severe Motor Fluctuations; Dyskinesia
  
• Safety/Efficacy Study of Local Anesthetic Prior to Femoral Artery Sheath Removal
  ClinicalTrials.gov Identifier: NCT00465439 - Not yet recruiting
  Syncope, Vasovagal; Pain Intensity
  
• Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00095186 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00504998 - Recruiting
  Pancreatic Cancer
  
• Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined with Gemcitabine in Patients with Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00051584 - Terminated
  Ovarian Neoplasms
  
• Safety/Efficacy Study with CEP-10953 in Treatment of Excessive Sleepiness associated with Chronic SWSD
  ClinicalTrials.gov Identifier: NCT00080288 - Completed
  Excessive Sleepiness; Shift Work Sleep Disorder
  
• Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin
  ClinicalTrials.gov Identifier: NCT00429715 - Recruiting
  Healthy
  
• Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)
  ClinicalTrials.gov Identifier: NCT00429780 - Recruiting
  Healthy
  
• Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia
  ClinicalTrials.gov Identifier: NCT00300040 - Active, not recruiting
  Peripheral Vascular Disease
  
• Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC
  ClinicalTrials.gov Identifier: NCT00026624 - Active, not recruiting
  HIV Infections
  
• Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine
  ClinicalTrials.gov Identifier: NCT00415051 - Recruiting
  Rift Valley Fever
  
• Safety/tolerability study of Alcohol Injection for Treatment of BPH (enlarged prostate)
  ClinicalTrials.gov Identifier: NCT00037141 - Completed
  Prostate Disease; BPH; Benign Prostatic Hyperplasia; Benign Prostatic Hypertrophy
  
• Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies
  ClinicalTrials.gov Identifier: NCT00381654 - Recruiting
  Tumor
  
• Safety/Tolerance Study of PPI-2458 in Subjects with Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00100347 - Terminated
  Lymphoma, Non-Hodgkin
  
• Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084812 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• SAFIR - Insulin Analogue With CGMS Measurement
  ClinicalTrials.gov Identifier: NCT00354939 - Completed
  Diabetes Mellitus Type 2
  
• Saizen® E-Device User Trial
  ClinicalTrials.gov Identifier: NCT00450190 - Completed
  Growth Disorders
  
• SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex® After Aromatase Inhibitor Failure in Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00272740 - Completed
  Breast Neoplasms
  
• Saline Instillation Before Tracheal Suctioning and the Incidence of Ventilator Associated Pneumonia
  ClinicalTrials.gov Identifier: NCT00432718 - Completed
  Mechanical Ventilation; Critically Ill Patients
  
• Saliva and Dental Calculus in Handicapped People
  ClinicalTrials.gov Identifier: NCT00495989 - Recruiting
  Disabled Persons
  
• Salivary Catecholamines in Aphthous Stomatitis (Canker Sores)
  ClinicalTrials.gov Identifier: NCT00556686 - Recruiting
  Canker Sore
  
• Salivary Evaluation in Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00001390 - Recruiting
  Healthy; Salivary Gland Disease
  
• Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00068237 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; metastatic squamous neck cancer with occult primary; ...
  
• Salivary Proteins in Disease and Health
  ClinicalTrials.gov Identifier: NCT00100204 - Recruiting
  Diabetes Mellitus; Sarcoidosis; Dental Caries; Sjorgren's Syndrome; Cystinosis; Head and Neck Neoplasms
  
• Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00277147 - Active, not recruiting
  Typhoid Fever
  
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00330733 - Recruiting
  NIDDM; Cardiovascular Disease; Atherosclerosis; Insulin Resistance; Inflammation
  
• SALT
  ClinicalTrials.gov Identifier: NCT00180570 - Suspended
  Bradycardia
  
• Salt Reduction on Blood Pressure and Cardiovascular Organ Damage
  ClinicalTrials.gov Identifier: NCT00152074 - Recruiting
  Hypertension or prehypertension
  
• Salt Sensitivity, Cardiovascular and Metabolic Disease
  ClinicalTrials.gov Identifier: NCT00005489 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Angina Pectoris; Cerebrovascular Accident; Myocardial Infarction; Diabetes Mellitus; ...
  
• SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00257543 - Recruiting
  Patients With Severe Sickle Cell Disease
  
• SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00290264 - Completed
  Asthma
  
• Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00480857 - Recruiting
  Prostate Cancer
  
• Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.
  ClinicalTrials.gov Identifier: NCT00196625 - Completed
  HIV Infections
  
• Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
  ClinicalTrials.gov Identifier: NCT00210366 - Recruiting
  Lymphoma, B-Cell
  
• Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment
  ClinicalTrials.gov Identifier: NCT00011128 - Completed
  HIV Infections
  
• Salvage: Postconditioning With Adenosine for STEMI
  ClinicalTrials.gov Identifier: NCT00284323 - Recruiting
  Acute ST Elevation Myocardial Infarction
  
• SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1
  ClinicalTrials.gov Identifier: NCT00313937 - Completed
  Diabetes Mellitus, Type 1
  
• SAM-e for the Treatment of Depression in Patients with Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00070941 - Recruiting
  Parkinson's Disease; Depression
  
• Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00316940 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00551525 - Not yet recruiting
  Prostate Cancer
  
• Samarium Sm 153 Lexidronam Pentasodium and Autologous Stem Cell Transplant Followed By Radiation Therapy in Treating Patients With Recurrent or Refractory, Metastatic, or Unresectable Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00245011 - Recruiting
  Sarcoma
  
• Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00478075 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
  ClinicalTrials.gov Identifier: NCT00482378 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm; Pain
  
• Samarium Sm 153 Lexidronam Pentasodium With or Without Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00450619 - Recruiting
  Metastatic Cancer; Pain; Prostate Cancer
  
• Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00328614 - Recruiting
  Prostate Cancer
  
• SAMBA-Thailand: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
  ClinicalTrials.gov Identifier: NCT00401661 - Active, not recruiting
  Prostatic Hyperplasia
  
• SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
  ClinicalTrials.gov Identifier: NCT00486785 - Active, not recruiting
  Prostatic Hyperplasia
  
• Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)
  ClinicalTrials.gov Identifier: NCT00115414 - Completed
  Breast Cancer; Fever; Neutropenia
  
• Sample Collection for Quality Control of Biologic and Environmental Specimens and Assay Development and Testing
  ClinicalTrials.gov Identifier: NCT00340197 - Recruiting
  Quality Control
  
• Sample Collection From Melanoma Patients
  ClinicalTrials.gov Identifier: NCT00507325 - Recruiting
  Melanoma
  
• Sample Collections from the Airways of Asthmatic Patients
  ClinicalTrials.gov Identifier: NCT00001888 - Recruiting
  Asthma; Healthy
  
• Sandostatin for Patients With Androgen Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00510224 - Recruiting
  Prostate Cancer
  
• Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
  ClinicalTrials.gov Identifier: NCT00001860 - Completed
  Acromegaly; Pituitary Neoplasm
  
• Sandostatin LAR® Depot in Patients with Primary Insulin Hypersecretion (PIH) and at least Moderate Obesity
  ClinicalTrials.gov Identifier: NCT00094146 - Completed
  Primary Insulin Hypersecretion; Obesity
  
• SANTE - Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy
  ClinicalTrials.gov Identifier: NCT00101933 - Active, not recruiting
  Epilepsy
  
• SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
  ClinicalTrials.gov Identifier: NCT00403078 - Recruiting
  Carotid Artery Disease
  
• Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment
  ClinicalTrials.gov Identifier: NCT00379405 - Active, not recruiting
  HIV Infections
  
• SAR3419 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00539682 - Recruiting
  Lymphoma
  
• Sarasar and Temodar for Recurrent or Temodar Refractory Glioblastoma Multiforme (GBM)
  ClinicalTrials.gov Identifier: NCT00102648 - Active, not recruiting
  Glioblastoma Multiforme
  
• SarCNU in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00036660 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma
  
• SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00028015 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Sarcoid Genetic Analysis (SAGA)
  ClinicalTrials.gov Identifier: NCT00005542 - Completed
  Lung Diseases; Sarcoidosis
  
• Sarcopenia Studies for the Elderly Population in Taiwan
  ClinicalTrials.gov Identifier: NCT00174135 - Recruiting
  Sarcopenia
  
• Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004079 - Completed
  unspecified adult solid tumor, protocol specific
  
• Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00328276 - Completed
  Schizophrenias; Psychoses; Psychotic Disorders; Schizophrenic Disorders
  
• Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
  ClinicalTrials.gov Identifier: NCT00491569 - Completed
  Schizophrenias; Psychoses; Psychotic Disorders; Schizophrenic Disorders
  
• Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00276263 - Recruiting
  Schizophrenias; Psychoses; Psychotic Disorders; Schizophrenic Disorders
  
• SARCOTHAL. Thalidomide in Skin Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00305552 - Active, not recruiting
  Sarcoidosis
  
• Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003961 - Completed
  atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Sargramostim and/or Montanide ISA-51 in Treating Patients With Stage I or Stage II Melanoma
  ClinicalTrials.gov Identifier: NCT00089232 - Recruiting
  Recurrent Melanoma; stage I melanoma; stage II melanoma
  
• Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002778 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ...
  
• Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00008398 - Completed
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00053157 - Completed
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment
  ClinicalTrials.gov Identifier: NCT00072579 - Completed
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
  ClinicalTrials.gov Identifier: NCT00006483 - Active, not recruiting
  Stage IV Renal Cell Cancer; lung metastases; recurrent renal cell cancer
  
• Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
  ClinicalTrials.gov Identifier: NCT00004256 - Active, not recruiting
  Laryngeal Cancer
  
• Sarizotan HC1 in Patients with Parkinson's Disease Suffering from Treatment-associated Dyskinesia
  ClinicalTrials.gov Identifier: NCT00105508 - Completed
  Parkinson's Disease; Dyskinesia
  
• Sarizotan HCl in Patients with Parkinson's Disease Suffering from Treatment-Associated Dyskinesia
  ClinicalTrials.gov Identifier: NCT00105521 - Completed
  Parkinson's Disease; Dyskinesia
  
• Sarizotan in Parkinson Patients With L-Dopa-Induced Dyskinesia
  ClinicalTrials.gov Identifier: NCT00314288 - Completed
  Parkinson's Disease; Dyskinesia
  
• Sarizotan in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
  ClinicalTrials.gov Identifier: NCT00310661 - Terminated
  Neuroleptic-Induced Tardive Dyskinesia
  
• Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction(SACCESS) Randomized, Double-Blind, Aspirin-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00129805 - Completed
  Cerebral Infarction
  
• SARS Coronavirus Vaccine (SARS-CoV)
  ClinicalTrials.gov Identifier: NCT00533741 - Not yet recruiting
  SARS
  
• SARS Survivor Evaluations
  ClinicalTrials.gov Identifier: NCT00523276 - Not yet recruiting
  Coronavirus (SARS-CoV)
  
• Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
  ClinicalTrials.gov Identifier: NCT00501722 - Completed
  Ascites; Liver Cirrhosis
  
• Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
  ClinicalTrials.gov Identifier: NCT00501566 - Completed
  Ascites; Liver Cirrhosis
  
• Satavaptan Dose-Ranging Study in the Prevention of Ascites
  ClinicalTrials.gov Identifier: NCT00501384 - Completed
  Ascites; Liver Cirrhosis
  
• Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver (SPARe-2)
  ClinicalTrials.gov Identifier: NCT00366795 - Recruiting
  Ascites; Liver Cirrhosis
  
• Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver (SPARe-1)
  ClinicalTrials.gov Identifier: NCT00359437 - Recruiting
  Ascites; Liver Cirrhosis
  
• Satisfaction and Compliance of Risedronate in PMO
  ClinicalTrials.gov Identifier: NCT00549965 - Completed
  Osteoporosis, Postmenopausal
  
• Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS
  ClinicalTrials.gov Identifier: NCT00391079 - Active, not recruiting
  Multiple Sclerosis
  
• Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
  ClinicalTrials.gov Identifier: NCT00499694 - Recruiting
  Prostate Cancer
  
• Satraplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00268970 - Active, not recruiting
  Non-Small Cell Lung Cancer
  
• Satraplatin for Locally Advanced Non-Small Cell Lung Cancer with Simultaneous Radiotherapy
  ClinicalTrials.gov Identifier: NCT00093132 - Recruiting
  Carcinoma, Non-Small Cell Lung; Lung Cancer
  
• Satraplatin for Patients With Metastatic Breast Cancer (MBC)
  ClinicalTrials.gov Identifier: NCT00265655 - Active, not recruiting
  Metastatic Breast Cancer
  
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated with One Cytotoxic Chemotherapy Regimen
  ClinicalTrials.gov Identifier: NCT00069745 - Active, not recruiting
  Prostate Cancer; Hormone Refractory Prostate Cancer; One Prior Cytotoxic Chemotherapy Regimen
  
• SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction
  ClinicalTrials.gov Identifier: NCT00284830 - Completed
  Sick Sinus Syndrome; Heart Failure, Congestive; Atrial Fibrillation; Bradycardia; Ventricular Dysfunction
  
• Saw Palmetto Extract in Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00037154 - Completed
  Benign Prostatic Hyperplasia
  
• Saxagliptin Treatment in Subjects with Type 2 Diabetes Who Are Not Controlled with Diet and Exercise
  ClinicalTrials.gov Identifier: NCT00121641 - Completed
  Diabetes Mellitus, Type 2
  
• SB-480848 In Subjects With Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00269048 - Completed
  Coronary Heart Disease
  
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo in Adult Cancer Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00102726 - Completed
  Thrombocytopenia; Non-small cell lung cancer; Ovarian Cancer
  
• SB-681323 In Subjects With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00320450 - Completed
  Rheumatoid Arthritis
  
• SB-681323 Study In Patients With Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00390845 - Recruiting
  Neuropathic Pain; Nerve Trauma
  
• SB-681323-Methotrexate Interaction Study
  ClinicalTrials.gov Identifier: NCT00419809 - Completed
  Rheumatoid Arthritis
  
• SB-705498 Dental Pain Study After Tooth Extraction
  ClinicalTrials.gov Identifier: NCT00281684 - Recruiting
  Dental Pain
  
• Sb-705498 Rectal Pain Study
  ClinicalTrials.gov Identifier: NCT00461682 - Terminated
  Fecal Urgency; Irritable Bowel Syndrome
  
• SB-715992 in Combination with Capecitabine in Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00119171 - Active, not recruiting
  Tumors
  
• SB-715992 In Combination With Carboplatin In Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00136578 - Completed
  Solid Tumors
  
• SB-715992 In Combination With Docetaxel In Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00169520 - Completed
  Solid Tumors
  
• SB-715992 In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00085813 - Completed
  Non-small cell lung cancer
  
• SB-715992 In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00097409 - Completed
  Ovarian Cancer
  
• SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00098826 - Recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; acute undifferentiated leukemia; adult acute erythroid leukemia; ...
  
• SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00103311 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00095992 - Completed
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
  
• SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00095953 - Completed
  Recurrent Melanoma; Stage IV Melanoma
  
• SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101244 - Active, not recruiting
  adult Hodgkin's lymphoma; adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; ...
  
• SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel
  ClinicalTrials.gov Identifier: NCT00096499 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095628 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• SB-742457 And Donepezil In Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00348192 - Active, not recruiting
  Alzheimer's Disease
  
• SB-743921 In Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00136513 - Active, not recruiting
  Solid Tumors
  
• SB-773812 Administered In Adults With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00259870 - Completed
  Schizophrenia
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo in Adults with Refractory Immune Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00102739 - Active, not recruiting
  Purpura, Thrombocytopenic, Idiopathic
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
  ClinicalTrials.gov Identifier: NCT00110799 - Active, not recruiting
  Hepatitis C; Thrombocytopenia
  
• SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00504296 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Scalp Psoriasis Treatment with a Fiber Optic Comb
  ClinicalTrials.gov Identifier: NCT00007293 - Completed
  Psoriasis
  
• SCANCAP
  ClinicalTrials.gov Identifier: NCT00180609 - Active, not recruiting
  Bradycardia
  
• Scandinavian Bell's Palsy Study
  ClinicalTrials.gov Identifier: NCT00510263 - Active, not recruiting
  Bell's Palsy
  
• Scandinavian Candesartan Acute Stroke Trial (SCAST)
  ClinicalTrials.gov Identifier: NCT00120003 - Recruiting
  Stroke
  
• Scandinavian Cystic Fibrosis Azithromycin Study
  ClinicalTrials.gov Identifier: NCT00411736 - Not yet recruiting
  Cystic Fibrosis
  
• SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
  ClinicalTrials.gov Identifier: NCT00000677 - Completed
  Meningitis, Cryptococcal; HIV Infections
  
• SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver
  ClinicalTrials.gov Identifier: NCT00005030 - Completed
  recurrent colon cancer; liver metastases; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
  ClinicalTrials.gov Identifier: NCT00015899 - Completed
  childhood brain tumor; childhood meningioma; childhood rhabdoid tumor of the central nervous system; childhood spinal cord tumors
  
• SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00006351 - Active, not recruiting
  recurrent bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; recurrent urethral cancer; anterior urethral cancer; ...
  
• SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
  ClinicalTrials.gov Identifier: NCT00020774 - Active, not recruiting
  recurrent adult primary liver cancer; localized resectable adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia
  ClinicalTrials.gov Identifier: NCT00045812 - Completed
  Lipoidosis
  
• SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00002960 - Completed
  recurrent ovarian epithelial cancer; malignant ascites; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Scheduled Triple-Lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study
  ClinicalTrials.gov Identifier: NCT00250809 - Completed
  Other Female Genital; Cancer
  
• Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-School Children in, Tanzania
  ClinicalTrials.gov Identifier: NCT00347113 - Not yet recruiting
  Anaemia; Malaria; Hepatosplenomegaly
  
• Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes
  ClinicalTrials.gov Identifier: NCT00463593 - Recruiting
  Schistosomiasis; Helminthiasis; Anaemia
  
• Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control
  ClinicalTrials.gov Identifier: NCT00463632 - Recruiting
  Schistosomiasis; Anaemia; Pregnancy
  
• Schizophrenia and Genetic Counseling
  ClinicalTrials.gov Identifier: NCT00111202 - Active, not recruiting
  Schizophrenia
  
• Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study)
  ClinicalTrials.gov Identifier: NCT00560677 - Recruiting
  Schizophrenia; PTSD
  
• Schizophrenia Risperidone vs Olanzapine Study HGMN
  ClinicalTrials.gov Identifier: NCT00373321 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Schizophrenia Sensory Gating Deficit With Quetiapine
  ClinicalTrials.gov Identifier: NCT00536783 - Completed
  Schizophrenia
  
• Schizophrenia Study
  ClinicalTrials.gov Identifier: NCT00049946 - Completed
  Schizophrenia
  
• Schizophrenia Trial of Aripiprazole
  ClinicalTrials.gov Identifier: NCT00237913 - Completed
  Schizophrenia
  
• Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00222807 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Delusional Disorder
  
• School and Family-Based Obesity Prevention for Children
  ClinicalTrials.gov Identifier: NCT00005750 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• School Centered Telemedicine Program for Children With Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00566475 - Active, not recruiting
  Type 1 Diabetes
  
• School Intervention Study of Nutrition, Wellbeing and Dental Health
  ClinicalTrials.gov Identifier: NCT00530153 - Active, not recruiting
  Eating; Oral Health
  
• School Reintegration Outcomes in Pediatric Cancer Patients
  ClinicalTrials.gov Identifier: NCT00477256 - Recruiting
  Advanced Cancer
  
• School- and Home-Based Early Intervention for Toddlers with Autism
  ClinicalTrials.gov Identifier: NCT00106210 - Active, not recruiting
  Autistic Disorder; Autism
  
• School-Based Approaches to Help Pre-Teens Manage Asthma
  ClinicalTrials.gov Identifier: NCT00217776 - Active, not recruiting
  Asthma
  
• School-Based Intervention to Increase Physical Activity Among Adolescent Females
  ClinicalTrials.gov Identifier: NCT00296101 - Completed
  Cardiovascular Diseases; Obesity
  
• School-Based Obesity Prevention Program
  ClinicalTrials.gov Identifier: NCT00142012 - Completed
  Obesity
  
• School-Based Program to Enhance Asthma Medication Adherence
  ClinicalTrials.gov Identifier: NCT00296998 - Recruiting
  Asthma; Tobacco Use Disorder
  
• Science-Based Treatment for Opioid-Dependent Adolescents
  ClinicalTrials.gov Identifier: NCT00182572 - Recruiting
  Opioid-Dependence Among Adolescents
  
• Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe
  ClinicalTrials.gov Identifier: NCT00390949 - Completed
  HIV Infections
  
• Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident
  ClinicalTrials.gov Identifier: NCT00339716 - Active, not recruiting
  Thyroid Cancer; Thyroid Disease
  
• Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy: (Part I) Radioiodide Imaging Study
  ClinicalTrials.gov Identifier: NCT00185809 - Recruiting
  Breast Cancer
  
• Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.
  ClinicalTrials.gov Identifier: NCT00537719 - Not yet recruiting
  Healthy
  
• SCIO-469: Open-Label Study for Patients with Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00113893 - Recruiting
  Myelodysplastic Syndromes
  
• Scleroderma Lung Study
  ClinicalTrials.gov Identifier: NCT00004563 - Completed
  Lung Diseases; Pulmonary Fibrosis; Systemic Scleroderma; Scleroderma, Systemic
  
• Scleroderma Registry
  ClinicalTrials.gov Identifier: NCT00074568 - Recruiting
  Systemic Sclerosis; Scleroderma
  
• Scleroderma: Cyclophosphamide or Transplantation (SCOT)
  ClinicalTrials.gov Identifier: NCT00114530 - Recruiting
  Scleroderma, Systemic; Sclerosis
  
• SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
  ClinicalTrials.gov Identifier: NCT00187512 - Recruiting
  HIV Infections
  
• Scopolamine to Treat Depression
  ClinicalTrials.gov Identifier: NCT00369915 - Recruiting
  Unipolar Depression; Bipolar Depression
  
• Scopolamine Treatment for Patients With Organophosphate Poisoning
  ClinicalTrials.gov Identifier: NCT00389259 - Recruiting
  Neurotoxicity Syndromes
  
• SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00005511 - Completed
  Lung Diseases; Sleep Apnea Syndromes
  
• SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate
  ClinicalTrials.gov Identifier: NCT00578305 - Recruiting
  Rheumatoid Arthritis
  
• Scotoma Reduction in AMD Patients Treated With Ranibizumab
  ClinicalTrials.gov Identifier: NCT00467935 - Recruiting
  Macular Degeneration
  
• Screen and Treat for Cervical Cancer Prevention
  ClinicalTrials.gov Identifier: NCT00233727 - Completed
  Cervical Cancer
  
• SCREEN-HF (Screening Evaluation of the Evolution of New Heart Failure)
  ClinicalTrials.gov Identifier: NCT00400257 - Recruiting
  Heart Failure
  
• Screened Health Assessment & Pacer Evaluation
  ClinicalTrials.gov Identifier: NCT00312611 - Active, not recruiting
  Obesity
  
• Screening adolescents for type 2 diabetes mellitus in a community clinic
  ClinicalTrials.gov Identifier: NCT00042042 - Recruiting
  Diabetes Mellitus
  
• Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions
  ClinicalTrials.gov Identifier: NCT00396188 - Recruiting
  Corneal Diseases
  
• Screening and Brief Advice to Reduce Teen Substance Use - 1
  ClinicalTrials.gov Identifier: NCT00227877 - Not yet recruiting
  Alcohol & Drug Use
  
• Screening and Diagnostic Trial to Compare the Effectiveness of Two Types of Mammography in Detecting Breast Cancer in Women
  ClinicalTrials.gov Identifier: NCT00008346 - Completed
  Breast Cancer
  
• Screening and Interventions in an Acute Care Setting
  ClinicalTrials.gov Identifier: NCT00545155 - Recruiting
  Depression; Medication Errors; Cognitive Impairment
  
• Screening and Natural History of Patients with Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
  ClinicalTrials.gov Identifier: NCT00001727 - Recruiting
  Polyostotic Fibrous Dysplasia
  
• Screening and Treatment of Depression in the Community
  ClinicalTrials.gov Identifier: NCT00430404 - Recruiting
  Depression
  
• Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  ClinicalTrials.gov Identifier: NCT00001673 - Recruiting
  Alcoholic Intoxication; Alcoholism; Healthy
  
• Screening Evaluation for Women with Postpartum Depression
  ClinicalTrials.gov Identifier: NCT00056901 - Recruiting
  Postpartum Depression
  
• Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following Core 64
  ClinicalTrials.gov Identifier: NCT00488033 - Not yet recruiting
  Coronary Artery Disease
  
• Screening for Cancer of the Prostate, Lung, Colon, Rectum, or Ovaries in Older Patients
  ClinicalTrials.gov Identifier: NCT00002540 - Active, not recruiting
  screening for prostate cancer; ovarian germ cell tumor; Small Cell Lung Cancer; ovarian epithelial cancer; screening for ovarian cancer; ...
  
• Screening for Childhood-Onset Psychotic Disorders
  ClinicalTrials.gov Identifier: NCT00049738 - Recruiting
  Childhood Onset Psychotic Disorders
  
• Screening for Colorectal Neoplasm in First Degree Relatives of the Affected
  ClinicalTrials.gov Identifier: NCT00164944 - Recruiting
  Colorectal Cancer Screening
  
• Screening for CRC Using a Mixed Strategy of Sigmoidoscopy and Colonoscopy in Average-Risk Population According to Age
  ClinicalTrials.gov Identifier: NCT00173277 - Recruiting
  Colorectal Cancer
  
• Screening For Early Pancreatic Neoplasia in Individuals With Familial Peutz-Jeghers Syndrome and in Relatives of Individuals With Familial Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00084357 - Active, not recruiting
  Pancreatic Cancer
  
• Screening for Gynecologic Cancers in HNPCC Patients
  ClinicalTrials.gov Identifier: NCT00508846 - Recruiting
  Colon Cancer
  
• Screening for Hematology Branch Protocols
  ClinicalTrials.gov Identifier: NCT00001620 - Recruiting
  Anemia; Hematologic Neoplasm; Neutropenia; Pancytopenia; Thrombocytopenia
  
• Screening for Hepatitis C During Pregnancy at a Toronto Inner City Prenatal Clinic
  ClinicalTrials.gov Identifier: NCT00348660 - Recruiting
  Hepatitis C; Pregnancy
  
• Screening for Hip and Knee Osteoarthritis in the General Population: Predictive Value of a Questionnaire and Prevalence Estimates
  ClinicalTrials.gov Identifier: NCT00522080 - Terminated
  Hip and Knee Osteoarthritis
  
• Screening for HIV-Associated Anal Cancer
  ClinicalTrials.gov Identifier: NCT00188292 - Completed
  HIV Infections; Anal Cancer; Anal Dysplasia; Papillomavirus Infections
  
• Screening for Inherited Heart Disease
  ClinicalTrials.gov Identifier: NCT00001746 - Completed
  Heart Disease; Hypertrophic Cardiomyopathy
  
• Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis
  ClinicalTrials.gov Identifier: NCT00449345 - Recruiting
  Latent Tuberculosis Infection
  
• Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00512746 - Recruiting
  Lung Cancer; Precancerous/Nonmalignant Condition
  
• Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors
  ClinicalTrials.gov Identifier: NCT00433238 - Not yet recruiting
  Major Depressive Disorder; Dementia
  
• Screening for NEI Clinical Studies
  ClinicalTrials.gov Identifier: NCT00001734 - Recruiting
  Conjunctivitis; Iritis; Keratitis; Retinitis; Uveitis
  
• Screening for Occult Malignancy in Idiopathic Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00361647 - Recruiting
  Venous Thromboembolism
  
• Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
  ClinicalTrials.gov Identifier: NCT00001859 - Recruiting
  Diabetes Mellitus; Kidney Failure
  
• Screening for Research Subjects with Anterior Segment Diseases
  ClinicalTrials.gov Identifier: NCT00088348 - Recruiting
  Eye Diseases
  
• Screening for Studies on Autism Spectrum Disorders
  ClinicalTrials.gov Identifier: NCT00271622 - Recruiting
  Autism Spectrum Disorders
  
• Screening for Studies on Inherited Eye Diseases
  ClinicalTrials.gov Identifier: NCT00001732 - Recruiting
  Hereditary Eye Disease
  
• Screening for Studies on Nystagmus and Strabismus
  ClinicalTrials.gov Identifier: NCT00001861 - Completed
  Nystagmus; Strabismus
  
• Screening for Studies on Retinovascular Diseases
  ClinicalTrials.gov Identifier: NCT00001733 - Recruiting
  Diabetic Retinopathy; Macular Degeneration; Pathologic Neovascularization; Retinal Disease
  
• Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
  ClinicalTrials.gov Identifier: NCT00520962 - Completed
  Diabetes Mellitus, Type 2
  
• Screening for Urinary Incontinence by Primary Care Providers
  ClinicalTrials.gov Identifier: NCT00178334 - Completed
  Urinary Incontinence
  
• Screening Herbs for Drug Interactions
  ClinicalTrials.gov Identifier: NCT00029263 - Completed
  Healthy
  
• Screening HIV-Infected Patients for Vaccine Studies
  ClinicalTrials.gov Identifier: NCT00051519 - Recruiting
  HIV Infection
  
• Screening Individuals and Families at High Risk for Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00052234 - Recruiting
  Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Screening Medications for Cocaine Cessation and Relapse Prevention - 7
  ClinicalTrials.gov Identifier: NCT00218023 - Recruiting
  Cocaine Abuse; Cocaine-Related Disorders
  
• Screening of Fibrosing and/or Viral Chronic Hepatopathies in Jail
  ClinicalTrials.gov Identifier: NCT00453869 - Recruiting
  Liver Fibrosis
  
• Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases
  ClinicalTrials.gov Identifier: NCT00068926 - Recruiting
  Healthy
  
• Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis
  ClinicalTrials.gov Identifier: NCT00190385 - Recruiting
  Compensated Cirrhosis
  
• Screening Patients for NCI Protocol Eligibility
  ClinicalTrials.gov Identifier: NCT00026754 - Recruiting
  Cancer; HIV Infection; Skin Disease
  
• Screening Patients With Central Nervous System Tumors for Participation in National Cancer Institute Clinical Trials
  ClinicalTrials.gov Identifier: NCT00040924 - Recruiting
  Brain and Central Nervous System Tumors; Lymphoma
  
• Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
  ClinicalTrials.gov Identifier: NCT00246857 - Recruiting
  Lymphocyte Homeostasis; Genetic Diseases
  
• Screening Protocol for HIV Vaccine Studies
  ClinicalTrials.gov Identifier: NCT00031304 - Recruiting
  HIV Seronegativity; HIV Infections
  
• Screening Protocol for Patients with Neurologic Disorders with Muscle Stiffness
  ClinicalTrials.gov Identifier: NCT00015444 - Recruiting
  Neurological Disorder; Muscle Cramp
  
• Screening Protocol to Determine Eligibility for Studies of the Chemokine Coreceptor 5 (CCR5) Antagonist GW873140.
  ClinicalTrials.gov Identifier: NCT00123890 - Terminated
  HIV Infections
  
• Screening Protocol to Evaluate Acid Alpha-Glucosidase (GAA) Activity and GAA Gene Mutations in Patients with Late Onset Pompe Disease
  ClinicalTrials.gov Identifier: NCT00113035 - Completed
  Pompe Disease
  
• Screening Questionnaire for Depression
  ClinicalTrials.gov Identifier: NCT00480233 - Recruiting
  Depression
  
• Screening Study for the Department of Rehabilitation Medicine
  ClinicalTrials.gov Identifier: NCT00023088 - Recruiting
  Convalescence; Healthy
  
• Screening Study of Patient Eligibility for Participation in National Cancer Institute Radiation Therapy Clinical Trials
  ClinicalTrials.gov Identifier: NCT00020280 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Screening Study of Surgery and CA 125 Levels in Participants at Increased Genetic Risk of Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00049049 - Active, not recruiting
  ovarian epithelial cancer
  
• Screening Tests in Detecting Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00025025 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Screening Trial to Study Eligibility of Patients to Participate in Head and Neck Surgery Clinical Trials
  ClinicalTrials.gov Identifier: NCT00045071 - Recruiting
  Head and Neck Cancer
  
• Screening Women at High Genetic Risk for Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00033488 - Recruiting
  ovarian epithelial cancer
  
• SCRT Vs Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumours
  ClinicalTrials.gov Identifier: NCT00517959 - Recruiting
  Low Grade Gliomas; Craniopharyngioma; Ependymomas; Meningiomas
  
• SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00304148 - Active, not recruiting
  Renal Insufficiency, Chronic
  
• SDSU MOVE/Me Muevo Project
  ClinicalTrials.gov Identifier: NCT00381069 - Recruiting
  Childhood Obesity
  
• SDX-105 in Combination with Rituxan for Patients with Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00076349 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Se-Methyl-Seleno-L-Cysteine in Healthy Adult Men
  ClinicalTrials.gov Identifier: NCT00489372 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Search for Genes Influencing Childhood Absence Epilepsy Study
  ClinicalTrials.gov Identifier: NCT00041951 - Recruiting
  Childhood Absence Epilepsy; Epilepsy; Seizures
  
• Search for New Methods to Detect Acute Renal Failure
  ClinicalTrials.gov Identifier: NCT00026702 - Recruiting
  Kidney Failure
  
• SEARCH: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine
  ClinicalTrials.gov Identifier: NCT00124072 - Active, not recruiting
  Cardiovascular Disease
  
• Searching for the Liver Cancer-Related Biomarkers
  ClinicalTrials.gov Identifier: NCT00154544 - Recruiting
  Hepatocellular Carcinoma
  
• Seasonal Affective Depression (SAD) Study
  ClinicalTrials.gov Identifier: NCT00069459 - Completed
  Seasonal Affective Disorder
  
• Seasonal Affective Disorder (SAD)
  ClinicalTrials.gov Identifier: NCT00046241 - Completed
  Seasonal Affective Disorder (SAD)
  
• Seasonal Allergic Rhinitis and Driving Ability
  ClinicalTrials.gov Identifier: NCT00223587 - Recruiting
  Seasonal Allergic Rhinitis
  
• Seasonal Allergic Rhinitis Study In Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00107757 - Completed
  Seasonal Allergic Rhinitis
  
• Seasonal Variation of Blood Cholesterol Levels
  ClinicalTrials.gov Identifier: NCT00005385 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Second Autologous Stem Cell Transplantation in Treating Patients With Persistent or Recurrent Primary Systemic (AL) Amyloidosis
  ClinicalTrials.gov Identifier: NCT00075608 - Recruiting
  primary systemic amyloidosis
  
• Second Canadian Trial of Physiologic Pacing (CTOPP II): Pilot Trial
  ClinicalTrials.gov Identifier: NCT00182416 - Completed
  Pacemaker Dependence
  
• Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
  ClinicalTrials.gov Identifier: NCT00521118 - Recruiting
  Gestational Trophoblastic Tumor
  
• Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup
  ClinicalTrials.gov Identifier: NCT00579345 - Recruiting
  Influenza Disease
  
• Second Line ColoRectal Cancer Therapy in Combination With FOLFOX
  ClinicalTrials.gov Identifier: NCT00278889 - Active, not recruiting
  Colorectal Cancer
  
• Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00281021 - Recruiting
  Carcinoma, Non-Small Cell Lung
  
• Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
  ClinicalTrials.gov Identifier: NCT00197418 - Recruiting
  Helicobacter Infections; Gastritis; Gastric Ulcer; Duodenal Ulcer
  
• Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00061308 - Terminated
  Ovarian Cancers; Fallopian Cancer; Peritoneal Cancer
  
• Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC
  ClinicalTrials.gov Identifier: NCT00319800 - Active, not recruiting
  Non-Small Cell Lung Cancer
  
• Second-Line Irinotecan vs. ILF for AGC
  ClinicalTrials.gov Identifier: NCT00509964 - Recruiting
  Stomach Neoplasm; Metastatic; Second-Line
  
• Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00316173 - Recruiting
  Ovarian Cancer
  
• Second-Line Treatment Choice for Epilepsy
  ClinicalTrials.gov Identifier: NCT00208520 - Active, not recruiting
  Adults With Tonic Clonic Seizures and/or Partial Seizures
  
• Second-Line Treatment for Patients with Platinum-Sensitive Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00090610 - Recruiting
  Ovarian Cancer
  
• Second-Line Treatment in Patients With Small Cell Lung Cancer (SCLC)
  ClinicalTrials.gov Identifier: NCT00418743 - Recruiting
  Small Cell Lung Cancer
  
• Second-Line Treatments for Anovulatory Infertility in PCOS Patients
  ClinicalTrials.gov Identifier: NCT00558077 - Completed
  Polycystic Ovary Syndrome; Infertility; Anovulation
  
• Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005944 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; peritoneal cavity cancer; liver metastases; recurrent rectal cancer; ...
  
• Secondary Adjuvant Long Term Study With Arimidex
  ClinicalTrials.gov Identifier: NCT00295620 - Recruiting
  Breast Cancer
  
• Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow
  ClinicalTrials.gov Identifier: NCT00248703 - Recruiting
  Breast Cancer
  
• Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00426257 - Recruiting
  Ovarian Cancer
  
• Secondary Prevention of Osteoporosis
  ClinicalTrials.gov Identifier: NCT00421343 - Recruiting
  Osteoporosis
  
• Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities
  ClinicalTrials.gov Identifier: NCT00280943 - Completed
  Hip Fractures; Osteoporosis
  
• Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
  ClinicalTrials.gov Identifier: NCT00059306 - Recruiting
  Cerebrovascular Accident; Hypertension
  
• Secondary Prevention of Venous Thrombo Embolism.
  ClinicalTrials.gov Identifier: NCT00329238 - Recruiting
  Thromboembolism
  
• Secondary Prevention With Paroxetine vs. Placebo in Subthreshold PTSD
  ClinicalTrials.gov Identifier: NCT00560612 - Recruiting
  Stress Disorders, Post-Traumatic
  
• Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
  ClinicalTrials.gov Identifier: NCT00400374 - Recruiting
  Head and Neck Cancer
  
• Secondary Prophylaxis After Variceal Bleeding in Non-Responders
  ClinicalTrials.gov Identifier: NCT00450164 - Completed
  Gastrointestinal Hemorrhage; Portal Hypertension; Cirrhosis
  
• Secondary Pulmonary Hypertension in Adults with Sickle Cell Anemia
  ClinicalTrials.gov Identifier: NCT00011648 - Recruiting
  Pulmonary Hypertension; Sickle Cell Anemia
  
• Secretin for the Treatment of Autism
  ClinicalTrials.gov Identifier: NCT00065962 - Completed
  Autism
  
• SecuraTM ICD Clinical Evaluation Study
  ClinicalTrials.gov Identifier: NCT00526227 - Recruiting
  Tachyarrhythmias
  
• Secured Internet-Mediated Psychotherapy With Psychiatry Patients
  ClinicalTrials.gov Identifier: NCT00184340 - Recruiting
  Psychiatric Disorders
  
• Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00385437 - Completed
  Depression; Excessive Daytime Sleepiness
  
• Sedation and Psychopharmacology in Critical Care
  ClinicalTrials.gov Identifier: NCT00205517 - Terminated
  Sedation; Mechanical Ventilation; Depression; Post-Traumatic Stress Disorder; Quality of Life
  
• Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
  ClinicalTrials.gov Identifier: NCT00355927 - Enrolling by invitation
  Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Dystonia; Tourette Syndrome
  
• Sedation in the Intensive Care Unit
  ClinicalTrials.gov Identifier: NCT00221520 - Active, not recruiting
  Critical Illness; Respiratory Failure
  
• Sedation Management in Pediatric Patients Supported on Mechanical Ventilation
  ClinicalTrials.gov Identifier: NCT00142766 - Recruiting
  Respiratory Failure
  
• Sedation Versus No Sedation in a Spontaneous Breathing Trial
  ClinicalTrials.gov Identifier: NCT00366353 - Recruiting
  Respiratory Insufficiency
  
• Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists'Communication Styles
  ClinicalTrials.gov Identifier: NCT00582192 - Recruiting
  Cancer
  
• Segmental Bronchoalveolar Lavage
  ClinicalTrials.gov Identifier: NCT00001618 - Recruiting
  Asthma; Pulmonary Fibrosis
  
• Segregation/Linkage Analysis for Hypertension
  ClinicalTrials.gov Identifier: NCT00005158 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Seizure Therapy With Intravenous Levetiracetam and Lorazepam
  ClinicalTrials.gov Identifier: NCT00465244 - Recruiting
  Seizures
  
• Seldinger Technique Versus Venous Cut-Down for Placement of Totally Implantable Venous Access Ports
  ClinicalTrials.gov Identifier: NCT00272623 - Recruiting
  Catheters, Indwelling
  
• Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora
  ClinicalTrials.gov Identifier: NCT00354952 - Completed
  Healthy Volunteers
  
• Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest
  ClinicalTrials.gov Identifier: NCT00472147 - Not yet recruiting
  Sudden Cardiac Death; Arrhythmia; Survival
  
• Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00165048 - Active, not recruiting
  Cancer of Stomach
  
• Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
  ClinicalTrials.gov Identifier: NCT00164892 - Active, not recruiting
  Cancer of Stomach
  
• Selective D-Dimer Testing Compared with Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)
  ClinicalTrials.gov Identifier: NCT00157677 - Recruiting
  Deep Vein Thrombosis
  
• Selective Dose Escalation for Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00139633 - Active, not recruiting
  Esophageal Cancer
  
• Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia?
  ClinicalTrials.gov Identifier: NCT00361543 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00432172 - Recruiting
  Breast Cancer
  
• Selective RPE Laser Treatment (SRT) for Various Macular Diseases
  ClinicalTrials.gov Identifier: NCT00403884 - Recruiting
  Age-Related Macular Degeneration; Diabetic Maculopathy; Central Serous Chorioretinopathy
  
• Selective Serotonin Reuptake Inhibitor (SSRI) Administration to Reduce Acute Stress Disorder (ASD) Symptoms and Prevent Depression and Post-Traumatic Stress Disorder (PTSD) in Physical Trauma Victims
  ClinicalTrials.gov Identifier: NCT00114374 - Recruiting
  Anxiety Disorder
  
• Selective T-Cell Depletion to Reduce Graft-Versus-Host-Disease in Patients Receiving Stem Cell Transplantation to Treat Leukemia, Lymphoma or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00016484 - Recruiting
  Graft vs Host Disease; Myelodysplastic Syndromes; Leukemia; Leukemia, Myeloid; Leukemia, Myelomonocytic, chronic; Leukemia, Lymphocytyc; Lymphoma; ...
  
• Selegiline for Smoking Cessation - 1
  ClinicalTrials.gov Identifier: NCT00439413 - Recruiting
  Nicotine
  
• Selegiline in Outpatient Treatment for Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00000336 - Completed
  Cocaine-Related Disorders
  
• Selegiline in Treatment of Cocaine Dependence - 2
  ClinicalTrials.gov Identifier: NCT00000188 - Completed
  Cocaine-Related Disorders
  
• Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
  ClinicalTrials.gov Identifier: NCT00032929 - Active, not recruiting
  Cocaine-Related Disorders
  
• Selenium and Celecoxib, Alone or in Combination, in Preventing Cancer in Patients With Esophageal Dysplasia
  ClinicalTrials.gov Identifier: NCT00005885 - Active, not recruiting
  prevention of esophageal cancer; Esophageal Cancer
  
• Selenium and Immune Function
  ClinicalTrials.gov Identifier: NCT00279812 - Recruiting
  Healthy
  
• Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression
  ClinicalTrials.gov Identifier: NCT00446901 - Recruiting
  Prostatic Neoplasms; Prostate Cancer
  
• Selenium and Vitamin E Cancer Prevention Trial (SELECT)
  ClinicalTrials.gov Identifier: NCT00076128 - Recruiting
  Prostate Cancer
  
• Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00553345 - Recruiting
  Bladder Cancer
  
• Selenium and Vitamin E in Preventing Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006392 - Active, not recruiting
  Prostate Cancer
  
• Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate
  ClinicalTrials.gov Identifier: NCT00030901 - Active, not recruiting
  Prostate Cancer
  
• Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00008385 - Recruiting
  Non-small cell lung cancer; Small Cell Lung Cancer
  
• Selenium in the Prevention of Cancer
  ClinicalTrials.gov Identifier: NCT00022165 - Active, not recruiting
  general prevention of cancer
  
• Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00217516 - Recruiting
  Prostate Cancer
  
• Selenium Supplementation in COPD Patients
  ClinicalTrials.gov Identifier: NCT00186706 - Recruiting
  Chronic Obstructive Pulmonary Disease; Cardiovascular Disease
  
• Selenium Supplementation of Patients With Cirrhosis
  ClinicalTrials.gov Identifier: NCT00271245 - Recruiting
  Liver Disease
  
• Selenium Supplementation of Patients With Cirrhosis
  ClinicalTrials.gov Identifier: NCT00212186 - Completed
  Healthy; Liver Cirrhosis
  
• Selenium Treatment in Autoimmune Thyroiditis (AIT)
  ClinicalTrials.gov Identifier: NCT00271427 - Completed
  Autoimmune Thyroiditis; Hashimotos Thyroiditis
  
• Selenium, as Sodium Selenite, in the Treatment of Septic Shock
  ClinicalTrials.gov Identifier: NCT00207844 - Completed
  Septic Shock; Severe Sepsis
  
• SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using MRI End-Points
  ClinicalTrials.gov Identifier: NCT00124826 - Completed
  Acute ischemic stroke; Hyperglycemia
  
• Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy
  ClinicalTrials.gov Identifier: NCT00122369 - Active, not recruiting
  Breast Cancer; Biopsy
  
• Self Management Education Asthma
  ClinicalTrials.gov Identifier: NCT00005712 - Completed
  Asthma; Lung Diseases
  
• Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control
  ClinicalTrials.gov Identifier: NCT00207207 - Active, not recruiting
  Diabetes Mellitus
  
• Self-Care Behaviour Treatment in Patients With Type 2 Diabetes - a Randomised Controlled Trial
  ClinicalTrials.gov Identifier: NCT00555854 - Recruiting
  Diabetes; Self Care; Behaviour; Compliance
  
• Self-Control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart
  ClinicalTrials.gov Identifier: NCT00494988 - Completed
  Type 2 Diabetes Mellitus
  
• Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00477841 - Completed
  Esophageal Cancer
  
• Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients with Non-Small Cell Lung Cancer: A Feasibility Study
  ClinicalTrials.gov Identifier: NCT00129012 - Recruiting
  -carcinoma; -non-small cell lung
  
• Self-Help Parent Training for Conduct Problems in Children
  ClinicalTrials.gov Identifier: NCT00299442 - Recruiting
  Behavioral Symptoms
  
• Self-hypnotic Relaxation Therapy During Invasive Procedures
  ClinicalTrials.gov Identifier: NCT00087841 - Active, not recruiting
  Uterine Neoplasms; Leiomyoma
  
• Self-Injury: Diagnosis and Treatment
  ClinicalTrials.gov Identifier: NCT00065936 - Active, not recruiting
  Self-Injurious Behavior; Mental Retardation
  
• Self-Management and Care of Heart Failure With Group Clinics (SMAC-HF)
  ClinicalTrials.gov Identifier: NCT00439842 - Recruiting
  Heart Failure, Congestive
  
• Self-Management for Men With Uncomplicated Lower Urinary Tract Symptoms
  ClinicalTrials.gov Identifier: NCT00270309 - Active, not recruiting
  Uncomplicated Lower Urinary Tract Symptoms
  
• Self-Management of Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00288912 - Recruiting
  Osteoarthritis
  
• Self-Management Program for Persons With Limb Loss
  ClinicalTrials.gov Identifier: NCT00198692 - Completed
  Amputation; Depression; Pain; Anxiety
  
• Self-Management Therapy for Youth with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00000387 - Completed
  Schizophrenia
  
• Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(Tm)
  ClinicalTrials.gov Identifier: NCT00333853 - Completed
  Diabetes
  
• Self-Scored Cardiovascular Disease Risk Appraisal
  ClinicalTrials.gov Identifier: NCT00005529 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Heart Disease Risk Reduction
  
• Self-Selected Brief Alcohol Intervention for Adolescents
  ClinicalTrials.gov Identifier: NCT00383838 - Completed
  Alcohol Consumption; Drug Abuse
  
• SEMPERFLO* Pain Management System in Inguinal Hernia Repair
  ClinicalTrials.gov Identifier: NCT00423241 - Suspended
  Inguinal Hernia; Pain
  
• Senior Coordinated Referral Study
  ClinicalTrials.gov Identifier: NCT00404118 - Recruiting
  Aged; Caregivers
  
• Senior Falls Prevention Study
  ClinicalTrials.gov Identifier: NCT00126152 - Completed
  Falls among older adults
  
• Senior PAMI
  ClinicalTrials.gov Identifier: NCT00136929 - Active, not recruiting
  Acute myocardial infarction (AMI), (MI)
  
• SeniorWISE: Improving Everyday Memory in At-Risk Elderly
  ClinicalTrials.gov Identifier: NCT00094731 - Completed
  Aging
  
• SENOC-I Det Sunda Huset II - Sensitization of Occupants of Water Damaged Buildings.
  ClinicalTrials.gov Identifier: NCT00143650 - Completed
  Upper airway, irritation inflammation, discomfort
  
• Sensible Treatment of Obesity in Rural Youth . . .
  ClinicalTrials.gov Identifier: NCT00248677 - Completed
  Obesity
  
• Sensing of Leg Position and Movement
  ClinicalTrials.gov Identifier: NCT00100919 - Active, not recruiting
  Proprioception
  
• Sensitivity and Specificity of Aridol Challenge for a Diagnosis of Asthma by a Specialist Pulmonologist
  ClinicalTrials.gov Identifier: NCT00491153 - Not yet recruiting
  Asthma
  
• Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
  ClinicalTrials.gov Identifier: NCT00361192 - Recruiting
  Temporal Arteritis; Duplex of Temporal Artery; Biopsy of Temporal Artery
  
• Sensitivity of Echography in Arthritis
  ClinicalTrials.gov Identifier: NCT00444691 - Not yet recruiting
  Rheumatoid Arthritis
  
• Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure
  ClinicalTrials.gov Identifier: NCT00400985 - Recruiting
  Heart Failure, Congestive
  
• Sensitization in Osteoarthritic Knees
  ClinicalTrials.gov Identifier: NCT00379184 - Recruiting
  Arthritis
  
• Sensor Measurement of Acupuncture Needle Manipulation
  ClinicalTrials.gov Identifier: NCT00103675 - Completed
  Back Pain
  
• SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients with Secondary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00117052 - Active, not recruiting
  Secondary Hyperparathyroidism; End Stage Renal Disease
  
• Sensorimotor Dysfunction of Individuals With Neck Pain
  ClinicalTrials.gov Identifier: NCT00174148 - Recruiting
  Posterior Neck Pain
  
• Sensorimotor Gating in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00561561 - Recruiting
  Schizophrenia
  
• Sensory Cues for Freezing in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00322426 - Not yet recruiting
  Parkinson's Disease
  
• Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients with Atypical Odontalgia and Matched Healthy Controls
  ClinicalTrials.gov Identifier: NCT00115102 - Completed
  Odontalgia
  
• Sensory Function After Wound Instillation of Capsaicin
  ClinicalTrials.gov Identifier: NCT00583180 - Not yet recruiting
  Primary Hyperalgesia
  
• Sensory Function in Idiopathic Voice Disorders
  ClinicalTrials.gov Identifier: NCT00001922 - Recruiting
  Phonation Disorder; Spastic Dysphonia; Voice Disorder
  
• Sensory Re-Training Following Facial Surgery for Correction of Facial Skeletal Disharmony
  ClinicalTrials.gov Identifier: NCT00078507 - Active, not recruiting
  Mandibular Advancement
  
• Sensory Training to Treat Focal Dystonia
  ClinicalTrials.gov Identifier: NCT00006336 - Completed
  Dystonic Disorder
  
• Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00080860 - Recruiting
  Breast Cancer
  
• Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005821 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• Sentinel Lymph Node Biopsy to Predict Cancer Spread to Axillary Lymph Nodes after Chemotherapy
  ClinicalTrials.gov Identifier: NCT00076895 - Recruiting
  Breast Neoplasms
  
• Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
  ClinicalTrials.gov Identifier: NCT00575744 - Recruiting
  Breast Cancer
  
• Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00089310 - Active, not recruiting
  stage I non-small cell lung cancer
  
• Sentinel Lymph Node Mapping in Early Stage Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00462969 - Recruiting
  Endometrial Cancer
  
• Sentinel Lymph Node Technique in Multifocal Breast Cancer
  ClinicalTrials.gov Identifier: NCT00417495 - Recruiting
  Breast Cancer
  
• Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00128362 - Recruiting
  Cancer of the Breast
  
• Sentinel Node in Colon Cancer
  ClinicalTrials.gov Identifier: NCT00411112 - Not yet recruiting
  Colon Cancer
  
• Sentinel Node With Ultrasound Contrast in Melanoma
  ClinicalTrials.gov Identifier: NCT00370136 - Recruiting
  Malignant Melanoma
  
• Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00051532 - Terminated
  Liver Neoplasms
  
• Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma.
  ClinicalTrials.gov Identifier: NCT00051545 - Terminated
  Liver Neoplasms
  
• Seprafilm® Adhesion Barrier and Cesarean Delivery
  ClinicalTrials.gov Identifier: NCT00565643 - Recruiting
  Adhesions; Cesarean Section; Delivery, Obstetric
  
• Sepsis, Endothelial Function, and Lipids in Critically Ill Patients With Liver Failure (the SELLIFA Study)
  ClinicalTrials.gov Identifier: NCT00488917 - Recruiting
  Liver Diseases; Liver Cirrhosis; Sepsis; Critical Illness
  
• Sepsis: Prognosis and Evaluation of Early Diagnosis and Intervention (SPEEDI Study)
  ClinicalTrials.gov Identifier: NCT00389337 - Active, not recruiting
  SIRS; Sepsis
  
• Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead
  ClinicalTrials.gov Identifier: NCT00180297 - Active, not recruiting
  Ventricular Tachycardia; Ventricular Fibrillation
  
• Sequence Effect in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00431366 - Recruiting
  Parkinson's Disease
  
• Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
  ClinicalTrials.gov Identifier: NCT00021528 - Completed
  Depression
  
• Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003733 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Sequential Compression Devices for Treatment of Restless Legs Syndrome
  ClinicalTrials.gov Identifier: NCT00479531 - Completed
  Restless Legs Syndrome
  
• Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
  ClinicalTrials.gov Identifier: NCT00561483 - Recruiting
  Acute Heart Failure; Renal Failure
  
• Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002680 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Sequential HIV Therapy
  ClinicalTrials.gov Identifier: NCT00128908 - Recruiting
  HIV-1
  
• Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00452998 - Recruiting
  Chronic Angle Closure Glaucoma; Primary Angle Closure; Primary Angle Closure Suspect; Fellow Eyes of Acute Angle Closure Glaucoma
  
• Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00403364 - Completed
  Helicobacter Pylori Infection
  
• Sequential Treatment of Postmenopausal Women With Primary Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00365456 - Recruiting
  Osteoporosis
  
• Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
  ClinicalTrials.gov Identifier: NCT00578669 - Not yet recruiting
  Major Depressive Disorder; Nicotine Dependence; Depression
  
• Sequential Use of Study Drug and Raloxifene HCI in the Treatment of Postmenopausal Women with Osteoporosis
  ClinicalTrials.gov Identifier: NCT00035256 - Completed
  Osteoporosis, Postmenopausal
  
• Sequential Vaccinations in Combination with Standard Adjuvant Chemotherapy in High-Risk Breast Cancer Patients Following Surgical Treatment
  ClinicalTrials.gov Identifier: NCT00047398 - Completed
  Breast Neoplasms
  
• Sequential Vaccinations in Prostate Cancer Patients
  ClinicalTrials.gov Identifier: NCT00060528 - Active, not recruiting
  Prostatic Neoplasms
  
• Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM
  ClinicalTrials.gov Identifier: NCT00378755 - Recruiting
  Multiple Myeloma
  
• Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00312000 - Completed
  Advanced Colorectal Cancer
  
• Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00314977 - Recruiting
  Breast Cancer
  
• Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00322699 - Recruiting
  Superficial Bladder Cancer
  
• Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00201747 - Active, not recruiting
  Esophageal Cancer; Esophagus Cancer; Cancer of Stomach; Stomach Cancer
  
• Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00371410 - Completed
  Diabetic Macular Edema
  
• Sequestration of Platelets Prior to Bypass Reduces Bleeding After Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00359398 - Recruiting
  Cardiac Surgical Procedures; Cardiopulmonary Bypass; Blood Platelet Disorders; Blood Coagulation Disorders
  
• SERCA Gene Therapy Trial
  ClinicalTrials.gov Identifier: NCT00534703 - Not yet recruiting
  Advanced Heart Failure; Patients That Have Received a Left Ventricular Assist Device
  
• SERETIDE 100/50 bd Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
  ClinicalTrials.gov Identifier: NCT00461500 - Recruiting
  Asthma
  
• SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00361959 - Completed
  Chronic Obstructive Pulmonary Disease
  
• SERETIDE Plus Tiotropium Versus Individual Components
  ClinicalTrials.gov Identifier: NCT00325169 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids
  ClinicalTrials.gov Identifier: NCT00353873 - Completed
  Asthma
  
• SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
  ClinicalTrials.gov Identifier: NCT00455923 - Active, not recruiting
  Asthma
  
• SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction
  ClinicalTrials.gov Identifier: NCT00490594 - Recruiting
  ACL Tear; Knee Injuries
  
• Serial BNP Measurements and Time to Disappearance of S3 in Goal-Directed Therapy of ADHF
  ClinicalTrials.gov Identifier: NCT00514384 - Not yet recruiting
  Acute Heart Failure
  
• Serial Changes of sTREM-1 Levels in Patients With Acute Respiratory Distress Syndrome
  ClinicalTrials.gov Identifier: NCT00557414 - Completed
  Acute Respiratory Distress Syndrome
  
• Serial CT Scans in Fractionated Stereotactic Radiotherapy
  ClinicalTrials.gov Identifier: NCT00181350 - Active, not recruiting
  Brain Tumor
  
• Serial Echocardiography After Subarachnoid Hemorrhage
  ClinicalTrials.gov Identifier: NCT00123695 - Recruiting
  Subarachnoid Hemorrhage; Neurogenic myocardial stunning
  
• Serial Exhaled Breath pH Monitoring
  ClinicalTrials.gov Identifier: NCT00330603 - Recruiting
  Gastroesophageal Reflux
  
• Serious Medication Errors in Pediatrics: Evaluation of Prevention Strategies
  ClinicalTrials.gov Identifier: NCT00153205 - Recruiting
  medication errors; medical records systems, computerized; patient safety
  
• Serologic Characterisation of Bone-Healing
  ClinicalTrials.gov Identifier: NCT00377884 - Active, not recruiting
  Arthritis
  
• Serologically Active, Clinically Stable Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00000421 - Completed
  Systemic Lupus Erythematosus
  
• Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00192621 - Active, not recruiting
  HIV Infections; Dyslipidemias; Glucose Metabolism Disorders; Metabolic Diseases; Lipodystrophy; Cardiovascular Disease
  
• Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States
  ClinicalTrials.gov Identifier: NCT00026728 - Completed
  Kaposi's Sarcoma; Herpesviridae Infection
  
• Seroquel Acute Manic
  ClinicalTrials.gov Identifier: NCT00139074 - Active, not recruiting
  Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)
  
• Seroquel in Bipolar Depression Versus Lithium
  ClinicalTrials.gov Identifier: NCT00206141 - Completed
  Bipolar Disorder; Bipolar Depression; Depression
  
• Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II
  ClinicalTrials.gov Identifier: NCT00186043 - Recruiting
  Bipolar II Disorder
  
• Seroquel Long-Term NIS for Schizophrenia Patients
  ClinicalTrials.gov Identifier: NCT00523783 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Seroquel on Glucose Metabolism
  ClinicalTrials.gov Identifier: NCT00214578 - Completed
  Schizophrenia
  
• Seroquel plus Mood Stabilizer Compared to Placebo plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
  ClinicalTrials.gov Identifier: NCT00081380 - Completed
  Bipolar Disorder
  
• Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects
  ClinicalTrials.gov Identifier: NCT00328978 - Completed
  Schizophrenia; Schizoaffective Disorders
  
• Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00234377 - Completed
  Schizophrenia
  
• Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00208143 - Completed
  Schizophrenia; Schizoaffective Disorder; Substance Abuse; Substance Dependence
  
• Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00255515 - Active, not recruiting
  Schizophrenia
  
• Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
  ClinicalTrials.gov Identifier: NCT00376051 - Recruiting
  Frontotemporal Dementia
  
• Serotonergic Pharmacotherapy for Agitation of Dementia
  ClinicalTrials.gov Identifier: NCT00009204 - Completed
  Dementia; Alzheimer Disease; Dementia, Vascular
  
• Serotonin 1A Agonists and Cognition in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00178971 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Serotonin and the Upper Airway in Obstructive Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00100464 - Completed
  Obstructive Sleep Apnea
  
• Serotonin Effect in Functional Dyspepsia
  ClinicalTrials.gov Identifier: NCT00115362 - Completed
  Dyspepsia
  
• Serotonin Function During Depression
  ClinicalTrials.gov Identifier: NCT00033787 - Active, not recruiting
  Depression, Involutional; Healthy
  
• Serotonin in Alcoholism
  ClinicalTrials.gov Identifier: NCT00011752 - Completed
  Alcoholism; Healthy
  
• Serotonin Receptors in Seizure Disorders
  ClinicalTrials.gov Identifier: NCT00001932 - Completed
  Partial Epilepsy
  
• Serotonin Transporter Concentrations in Women With a History of Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00320684 - Recruiting
  Eating Disorders; Anorexia Nervosa
  
• Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant Response
  ClinicalTrials.gov Identifier: NCT00456430 - Active, not recruiting
  Depression
  
• Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00190333 - Recruiting
  Pulmonary Hypertension
  
• Serotonin Transporters in Alcoholism
  ClinicalTrials.gov Identifier: NCT00085865 - Completed
  Alcoholism
  
• Serotonin Transporters in Obsessive-Compulsive-Related Disorders
  ClinicalTrials.gov Identifier: NCT00082550 - Completed
  Obsessive-Compulsive Disorder
  
• Serotonin Treatment of Cocaine Dependence - 2
  ClinicalTrials.gov Identifier: NCT00142779 - Active, not recruiting
  Fluoxetine
  
• Serotonin, Impulsivity, and Cocaine Dependence Treatment
  ClinicalTrials.gov Identifier: NCT00297505 - Completed
  Cocaine Dependence
  
• Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
  ClinicalTrials.gov Identifier: NCT00000309 - Terminated
  Cocaine-Related Disorders
  
• Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
  ClinicalTrials.gov Identifier: NCT00000310 - Terminated
  Cocaine-Related Disorders
  
• Serp-1 for the Treatment of Acute Coronary Syndrome
  ClinicalTrials.gov Identifier: NCT00243308 - Recruiting
  Unstable Angina; Coronary Atherosclerosis; Coronary Restenosis
  
• SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis
  ClinicalTrials.gov Identifier: NCT00155116 - Recruiting
  Non-small cell lung cancer
  
• Sertindole Versus Risperidone Safety Outcome Study: A Randomised, Partially-Blinded, Parallel-Group, Active-Controlled, Post-Marketing Study
  ClinicalTrials.gov Identifier: NCT00563550 - Active, not recruiting
  Schizophrenia
  
• Sertraline and Cognitive Therapy in Depressed Alcoholics
  ClinicalTrials.gov Identifier: NCT00000458 - Completed
  Alcoholism; Depression
  
• Sertraline and Habit Reversal in the Treatment of Patients with Trichotillomania
  ClinicalTrials.gov Identifier: NCT00118014 - Completed
  Impulse Control Disorders
  
• Sertraline and Naltrexone for Alcohol Dependence
  ClinicalTrials.gov Identifier: NCT00000440 - Completed
  Alcoholism
  
• Sertraline Compared With Hypericum Perforatum (St. John's Wort) in Treating Mild to Moderate Depression in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00066859 - Completed
  Depression; unspecified adult solid tumor, protocol specific
  
• Sertraline for Alcohol Dependence and Depression
  ClinicalTrials.gov Identifier: NCT00004554 - Completed
  Alcoholism; Depression
  
• Sertraline for Alcoholism
  ClinicalTrials.gov Identifier: NCT00368550 - Recruiting
  Alcoholism; Alcohol Drinking; Alcohol Dependence
  
• Sertraline for Preventing Post-Stroke Depression and Improving Rehabilitation Outcomes
  ClinicalTrials.gov Identifier: NCT00177424 - Recruiting
  Cerebrovascular Accident; Depression
  
• Sertraline for the Prevention of Recurrent Postpartum Depression
  ClinicalTrials.gov Identifier: NCT00276900 - Completed
  Depression
  
• Sertraline for the Treatment of Patients with Frontal Lobe Dementia (FLD)
  ClinicalTrials.gov Identifier: NCT00001777 - Completed
  
  
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
  ClinicalTrials.gov Identifier: NCT00182533 - Recruiting
  Phobia, Social; Panic Disorder; Agoraphobia; Obsessive-Compulsive Disorder; Anxiety Disorders; Major Depressive Disorder
  
• Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00208585 - Recruiting
  Traumatic Brain Injury
  
• Sertraline vs. Venlafaxine XR
  ClinicalTrials.gov Identifier: NCT00179283 - Completed
  Major Depressive Disorder
  
• Serum and Peritoneal Fluid Bank for Endometriosis Markers
  ClinicalTrials.gov Identifier: NCT00194233 - Active, not recruiting
  Endometriosis
  
• Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer.
  ClinicalTrials.gov Identifier: NCT00265174 - Not yet recruiting
  Primary Brain Tumor
  
• Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens
  ClinicalTrials.gov Identifier: NCT00177333 - Completed
  Abortion, Induced; Vomiting
  
• Serum Levels of Insulin- Like Growth Factor and Fertility
  ClinicalTrials.gov Identifier: NCT00364507 - Not yet recruiting
  Fertility
  
• Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration
  ClinicalTrials.gov Identifier: NCT00560976 - Recruiting
  Hemodialysis Patients
  
• Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin
  ClinicalTrials.gov Identifier: NCT00066664 - Recruiting
  Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00212069 - Recruiting
  Metastatic Breast Cancer
  
• Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA
  ClinicalTrials.gov Identifier: NCT00064532 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases
  
• Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT
  ClinicalTrials.gov Identifier: NCT00021918 - Completed
  Cardiovascular Diseases; Atherosclerosis; Heart Diseases; Diabetes Mellitus, non-insulin dependent; Hypertension; Diabetes Mellitus
  
• Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00412139 - Not yet recruiting
  Chronic Renal Failure
  
• Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
  ClinicalTrials.gov Identifier: NCT00221559 - Completed
  Cystic Fibrosis
  
• Service Development: Assessing Non-Attendance Rates in Outpatient Clinics
  ClinicalTrials.gov Identifier: NCT00129649 - Completed
  Asthma; Sleep Apnea Syndromes; Tuberculosis; COPD
  
• Services Interventions for Injured ED Problem Drinkers
  ClinicalTrials.gov Identifier: NCT00234221 - Not yet recruiting
  Alcohol Abuse
  
• Services Interventions for Injured ED Substance Abusers
  ClinicalTrials.gov Identifier: NCT00251173 - Recruiting
  Drug Abuse
  
• SES, Health Behaviors and CVD Among Vietnam-Era Twins
  ClinicalTrials.gov Identifier: NCT00081679 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases
  
• SESAME -Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide
  ClinicalTrials.gov Identifier: NCT00290953 - Completed
  Lung Cancer; Pulmonary Neoplasms; Small Cell Lung Cancer
  
• Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants
  ClinicalTrials.gov Identifier: NCT00000917 - Terminated
  HIV Infections; Pregnancy
  
• Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
  ClinicalTrials.gov Identifier: NCT00486772 - Completed
  Vascular Diseases
  
• Severe Anemia Treatment Trials, Pakistan
  ClinicalTrials.gov Identifier: NCT00116493 - Active, not recruiting
  Anemia
  
• Severe Hemophilia A Study
  ClinicalTrials.gov Identifier: NCT00037544 - Active, not recruiting
  Hemophilia A
  
• Severe Hemophilia B Study
  ClinicalTrials.gov Identifier: NCT00037557 - Completed
  Hemophilia B
  
• Severe Hypoglycemia in Pregnant Women With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00435565 - Completed
  Pregnancy; Diabetes
  
• Severe Malaria and Anti-Malarial Drug Resistance in Cambodia
  ClinicalTrials.gov Identifier: NCT00341003 - Recruiting
  Severe Malaria; Malaria; Antimalarial Drug Resistance
  
• Severe Mood and Behavioral Dysregulation in Children: Pathophysiology and Treatment with Lithium
  ClinicalTrials.gov Identifier: NCT00025935 - Recruiting
  Mood Disorder
  
• Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks
  ClinicalTrials.gov Identifier: NCT00344929 - Recruiting
  Post Partum Haemorrhage
  
• Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity
  ClinicalTrials.gov Identifier: NCT00573118 - Active, not recruiting
  Pregnancy Complications; Preeclampsia; Placental Abruption; Intrauterine Fetal Growth Restriction; Intrauterine Fetal Death
  
• Severing Nuchal Cord at the Time of Delivery.
  ClinicalTrials.gov Identifier: NCT00345254 - Completed
  Umbilical Cord; Obstetric Delivery; Newborn Infant
  
• Sevoflurane vs Isoflurane Inhalation at Subanesthetic Concentrations - 11
  ClinicalTrials.gov Identifier: NCT00000259 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Sevoflurane vs. Isoflurane for Low-Flow General Anaesthesia for Abdominal Surgery
  ClinicalTrials.gov Identifier: NCT00521612 - Completed
  Anaesthesia
  
• Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea
  ClinicalTrials.gov Identifier: NCT00452855 - Completed
  Nausea; Vomiting
  
• Sevoflurane-Remifentanil Interaction: Multiple Response Surfaces, Validation of Calibration Stimuli, Validation of the Intraoperative Isobole Concept and Investigating Remifentanil Induced Opioid Tolerance
  ClinicalTrials.gov Identifier: NCT00522587 - Recruiting
  Anesthesia
  
• Sex Steroid Hormones and Risk of CHD in Women
  ClinicalTrials.gov Identifier: NCT00006407 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Postmenopause; Coronary Arteriosclerosis
  
• Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
  ClinicalTrials.gov Identifier: NCT00543166 - Active, not recruiting
  Sjogren's Syndrome
  
• Sex Steroids, Obesity and Lipids in Adolescent Females
  ClinicalTrials.gov Identifier: NCT00005210 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity; Hypercholesterolemia
  
• Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
  ClinicalTrials.gov Identifier: NCT00508170 - Active, not recruiting
  Head and Neck Cancer; Oropharyngeal Cancer; Human Papillomavirus Infection
  
• Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery
  ClinicalTrials.gov Identifier: NCT00335634 - Recruiting
  Prostate Cancer; Prostatectomy; Sexual Dysfunction
  
• Sexual Dysfunction and Dental Care
  ClinicalTrials.gov Identifier: NCT00281372 - Recruiting
  Dyspareunia; Hypoactive Sexual Desire Disorder; Erectile Dysfunction; Vaginismus
  
• Sexual Function in Male Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00271830 - Terminated
  Renal Transplant Recipients
  
• Sexual Functioning in Cervical Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00522223 - Active, not recruiting
  Cervical Cancer
  
• Sexual Functioning in Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00543192 - Recruiting
  Endometrial Cancer; Sexual Function
  
• Sexual Functioning Study With Antidepressants
  ClinicalTrials.gov Identifier: NCT00051259 - Completed
  Major Depressive Disorder
  
• Sexual Functioning Study With Antidepressants
  ClinicalTrials.gov Identifier: NCT00316160 - Active, not recruiting
  Major Depressive Disorder
  
• Sexual Functioning Study with Antidepressants in Adults
  ClinicalTrials.gov Identifier: NCT00051272 - Completed
  Major Depressive Disorder
  
• Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
  ClinicalTrials.gov Identifier: NCT00324064 - Not yet recruiting
  Growth Hormone Deficiency
  
• SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00075569 - Completed
  Cervical Cancer
  
• SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia
  ClinicalTrials.gov Identifier: NCT00052897 - Completed
  Anal Cancer
  
• SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00060099 - Active, not recruiting
  Cervical Cancer
  
• SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells
  ClinicalTrials.gov Identifier: NCT00091130 - Active, not recruiting
  Cervical Cancer; high-grade squamous intraepithelial lesion; low-grade squamous intraepithelial lesion; ...
  
• SGN-15 And Docetaxel in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00031603 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
  
• SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00365274 - Recruiting
  Lymphoma
  
• SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00337194 - Recruiting
  Lymphoma
  
• SGO Society of Gynecologic Oncologists Data Outcomes Project
  ClinicalTrials.gov Identifier: NCT00320996 - Completed
  Pelvic Mass
  
• SGS742 in Patients with Mild to Moderate Alzheimer's Disease (AD)
  ClinicalTrials.gov Identifier: NCT00093951 - Completed
  Alzheimer's Disease
  
• SGS: a Structured Treatment and Teaching Programme for Elderly Patients With Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00391040 - Completed
  Diabetes Mellitus
  
• SH L 562BB Phase II/III Dose Justification and Gadoteridol-Controlled Comparative Study
  ClinicalTrials.gov Identifier: NCT00522951 - Recruiting
  Brain Metastasis
  
• SH T00186 in the Treatment of Primary Dysmenorrhea
  ClinicalTrials.gov Identifier: NCT00569244 - Not yet recruiting
  Primary Dysmenorrhea
  
• SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-Controlled Comparative Study
  ClinicalTrials.gov Identifier: NCT00511797 - Recruiting
  Dysmenorrhea
  
• Sham Device, Pill Placebo or Treatment For Arm Pain
  ClinicalTrials.gov Identifier: NCT00029497 - Completed
  Cumulative Trauma Disorders; Repetitive Strain Injury; Carpal Tunnel Syndrome; Pain
  
• Shamanic Healing for Women with Temporomandibular Joint Disorders (TMDs)
  ClinicalTrials.gov Identifier: NCT00071474 - Completed
  Temporomandibular Disorders
  
• Shape Up Somerville: Eat Smart Play Hard
  ClinicalTrials.gov Identifier: NCT00153322 - Completed
  Childhood Obesity
  
• Shapedown BC Program Evaluation
  ClinicalTrials.gov Identifier: NCT00564798 - Not yet recruiting
  Obesity
  
• SHARE - Symbicort and Health Economics in a Real Life Evaluation
  ClinicalTrials.gov Identifier: NCT00259766 - Active, not recruiting
  Asthma
  
• Share Safer Sex Counseling Program for Changing Sexual Risk Behaviors in Mexican Female Sex Workers
  ClinicalTrials.gov Identifier: NCT00338845 - Recruiting
  HIV Infections; Sexually Transmitted Diseases
  
• SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
  ClinicalTrials.gov Identifier: NCT00426296 - Recruiting
  HIV Infections; Lipodystrophy
  
• Shared Decision Making for Schizophrenia
  ClinicalTrials.gov Identifier: NCT00220870 - Active, not recruiting
  Schizophrenia
  
• Shared Decision Making: Prostate Cancer Screening
  ClinicalTrials.gov Identifier: NCT00207649 - Not yet recruiting
  Prostate Cancer
  
• Shared Decision-Making for Colorectal Cancer Screening
  ClinicalTrials.gov Identifier: NCT00251862 - Recruiting
  Colorectal Cancer
  
• Shared Mental Health Care Linking Mental Health Services With Family Medicine Groups
  ClinicalTrials.gov Identifier: NCT00212966 - Recruiting
  Psychosocial Factors
  
• Shared Online Health Records for Patient Safety and Care
  ClinicalTrials.gov Identifier: NCT00251875 - Recruiting
  Diabetes
  
• Shark Cartilage Extract in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005995 - Active, not recruiting
  Stage IV Renal Cell Cancer; Renal Cell Adenocarcinoma; recurrent renal cell cancer
  
• Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00026117 - Completed
  stage IV colon cancer; stage IV breast cancer; recurrent breast cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; ...
  
• SHARP: Study of Heart and Renal Protection
  ClinicalTrials.gov Identifier: NCT00125593 - Active, not recruiting
  Kidney Failure, Chronic
  
• Shear and Pressure Reducing Insoles for the Diabetic Foot
  ClinicalTrials.gov Identifier: NCT00499356 - Completed
  Diabetes; Ulceration; Amputation; Foot Deformity; Neuropathy
  
• SHEPHERD: Safety in Hemolytic PNH Patients Treated with Eculizumab: A Multi-center Open-Label Research Design Study
  ClinicalTrials.gov Identifier: NCT00130000 - Completed
  
  
• Shiatsu Adjuvant Therapy For Schizophrenia
  ClinicalTrials.gov Identifier: NCT00425399 - Recruiting
  Schizophrenia
  
• Shift to RAD Kidney Sparing Study
  ClinicalTrials.gov Identifier: NCT00420537 - Recruiting
  Kidney Dysfunction; Heart Transplantation
  
• Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
  ClinicalTrials.gov Identifier: NCT00485134 - Recruiting
  Shigellosis
  
• Shilla Growth Permitting Spinal Instrumentation System for Treatment of Scoliosis in the Immature Spine
  ClinicalTrials.gov Identifier: NCT00577226 - Recruiting
  Scoliosis
  
• Shingles Prevention Study
  ClinicalTrials.gov Identifier: NCT00007501 - Active, not recruiting
  Herpes Zoster; Postherpetic neuralgia
  
• Shingles: Immune Effects of Tai Chi
  ClinicalTrials.gov Identifier: NCT00118885 - Completed
  Aging; Herpes Zoster
  
• Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00040898 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
  ClinicalTrials.gov Identifier: NCT00000552 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Myocardial Ischemia; Shock, Cardiogenic
  
• Shoe Insert Study
  ClinicalTrials.gov Identifier: NCT00032240 - Completed
  Osteoarthritis, Knee
  
• Shoe Modification and Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00105365 - Active, not recruiting
  Knee Osteoarthritis
  
• Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome
  ClinicalTrials.gov Identifier: NCT00277563 - Completed
  Refractory Carpal Tunnel Syndrome; Neurpathic Pain; Neuromodulaton
  
• Short Course Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB) (750 mg)
  ClinicalTrials.gov Identifier: NCT00042718 - Completed
  Bronchitis, Chronic
  
• Short Course Glucocorticoid Treatment for PTSD
  ClinicalTrials.gov Identifier: NCT00204737 - Recruiting
  Post-Traumatic Stress Disorder
  
• Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis
  ClinicalTrials.gov Identifier: NCT00376012 - Active, not recruiting
  Tuberculosis; Human Immunodeficiency Virus
  
• Short Course Nitrofurantoin for Acute Cystitis
  ClinicalTrials.gov Identifier: NCT00391651 - Completed
  Urinary Tract Infection
  
• Short Course of Interferon Treatment in Patients With HCV Infection
  ClinicalTrials.gov Identifier: NCT00502970 - Active, not recruiting
  Hepatitis C; Chronic Disease; Treatment
  
• Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
  ClinicalTrials.gov Identifier: NCT00537953 - Recruiting
  Cutaneous Leihmaniasis
  
• Short Course of Miltefosine and Liposomal Amphotericin B for Kala-Azar
  ClinicalTrials.gov Identifier: NCT00371995 - Not yet recruiting
  Visceral Leishmaniasis
  
• Short Course of Radiation for Gliomas in Elderly Patients
  ClinicalTrials.gov Identifier: NCT00386919 - Recruiting
  High Grade Gliomas
  
• Short Course Terlipressin for Control of Acute Variceal Bleeding
  ClinicalTrials.gov Identifier: NCT00369694 - Recruiting
  Hemorrhage; Esophageal Varices; Portal Hypertension
  
• Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy
  ClinicalTrials.gov Identifier: NCT00294749 - Recruiting
  Men Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.
  
• Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00468988 - Completed
  Glaucoma
  
• Short Term Effects of FX Dialysers on QOL and Inflammation
  ClinicalTrials.gov Identifier: NCT00291603 - Completed
  Kidney Failure, Chronic
  
• Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
  ClinicalTrials.gov Identifier: NCT00384423 - Recruiting
  Alzheimer's Disease
  
• Short Term Group Therapy for Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00229281 - Completed
  Anxiety Disorder
  
• Short Term Group Therapy for OCD
  ClinicalTrials.gov Identifier: NCT00229320 - Completed
  Obsessive Compulsive Disorder
  
• Short Term Growth in Children With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00236106 - Completed
  Atopic Dermatitis
  
• Short Term Outcomes From Minimally Invasive Surgery for the Treatment of Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00571597 - Recruiting
  Atrial Fibrillation
  
• Short Term Outcomes of Children With Acute Respiratory Distress Syndrome
  ClinicalTrials.gov Identifier: NCT00142376 - Completed
  Acute Respiratory Distress Syndrome
  
• Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
  ClinicalTrials.gov Identifier: NCT00279916 - Recruiting
  Otitis Media, Serous; Negative Middle Ear Pressure; Rhinitis
  
• Short Term Rescue Study of Olanzapine
  ClinicalTrials.gov Identifier: NCT00186017 - Recruiting
  Bipolar Disorders
  
• Short Term Study of Recombinant Human Insulin-like Growth Factor I in Children with Hyperinsulinism
  ClinicalTrials.gov Identifier: NCT00004825 - Completed
  Hyperinsulinism
  
• Short- and Long Term Growth in Children With Asthma
  ClinicalTrials.gov Identifier: NCT00380484 - Recruiting
  Asthma
  
• Short- and Long-Term Group Psychotherapy
  ClinicalTrials.gov Identifier: NCT00521417 - Recruiting
  Non-Psychotic Affective Disorders.; Non-Psychotic Anxiety Disorders.; Personality Disorders.
  
• Short-Course Hypofractionated Radiotherapy for Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00126165 - Recruiting
  Prostate Cancer
  
• Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
  ClinicalTrials.gov Identifier: NCT00397709 - Terminated
  Tuberculosis
  
• Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00286364 - Completed
  Infertility
  
• Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome
  ClinicalTrials.gov Identifier: NCT00114634 - Recruiting
  
  
• Short-Term Effects of Aromatase Inhibition in Obese Men.
  ClinicalTrials.gov Identifier: NCT00138710 - Recruiting
  Hypogonadotrophic hypogonadism; Obesity
  
• Short-Term Effects of Intravitreal Bevacizumab and Trimacinolone in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00563940 - Active, not recruiting
  Diabetic Macular Edema
  
• Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00248378 - Completed
  Multiple Sclerosis
  
• Short-Term Intensive Insulin Therapy Induction of Long-Term Glycemic Control
  ClinicalTrials.gov Identifier: NCT00506194 - Recruiting
  Type 2 Diabetes
  
• Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00082719 - Recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score
  ClinicalTrials.gov Identifier: NCT00553241 - Recruiting
  Ischemic Attack, Transient
  
• Short-Term Study Of A Once-Daily Fixed-Dose Combination Tablet In Antiretroviral-Naive HIV-1 Infected Subjects.
  ClinicalTrials.gov Identifier: NCT00094367 - Completed
  HIV Infections
  
• Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)
  ClinicalTrials.gov Identifier: NCT00318773 - Recruiting
  Premenstrual Syndrome
  
• Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
  ClinicalTrials.gov Identifier: NCT00466817 - Not yet recruiting
  Cytomegalovirus Infections
  
• Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
  ClinicalTrials.gov Identifier: NCT00386230 - Completed
  HIV Infections; Pregnancy
  
• Shorter Radiation Schedule for the Treatment of Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00201916 - Active, not recruiting
  Prostate Cancer
  
• SHORTness of Breath In the Emergency Department (SHORTIE)
  ClinicalTrials.gov Identifier: NCT00206830 - Completed
  Acute Myocardial Infarction; Heart Failure; Pulmonary Embolism
  
• Shortness Of Breath Questionnaire Validation Study
  ClinicalTrials.gov Identifier: NCT00411372 - Terminated
  Chronic Obstructive Pulmonary Disease
  
• Should Low Birth Weight Infants Be Vaccinated with BCG Vaccine at Birth in Developing Countries
  ClinicalTrials.gov Identifier: NCT00146302 - Recruiting
  Mortality; Morbidity
  
• Should Non-Eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?
  ClinicalTrials.gov Identifier: NCT00509197 - Not yet recruiting
  Non-Eosinophilic Asthma
  
• Should Prosthetic Repair of Incisional Abdominal Hernias be Drain or Not?
  ClinicalTrials.gov Identifier: NCT00478348 - Recruiting
  Postoperative Complications; Hernia
  
• Should we Repair Ischemic Mitral Regurgitation?
  ClinicalTrials.gov Identifier: NCT00443365 - Recruiting
  Coronary Disease; Mitral Valve Insufficiency
  
• Shoulder, or Elbow, or Wrist: What Should we Train First After a Stroke?
  ClinicalTrials.gov Identifier: NCT00453843 - Recruiting
  Stroke
  
• Showing Health Information Value in a Community Network
  ClinicalTrials.gov Identifier: NCT00365885 - Active, not recruiting
  Clinical Decision Support; Medical Informatics Interventions; Population Health Management; Quality of Healthcare
  
• SIB-Norwegian Version, Validation and Reliability Study
  ClinicalTrials.gov Identifier: NCT00449384 - Completed
  Dementia; Diagnostic Tests, Routine
  
• Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00186342 - Active, not recruiting
  Myeloproliferative Disorders; Acute Disease; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes
  
• Sibling Donor Cord Blood Banking and Transplantation
  ClinicalTrials.gov Identifier: NCT00029380 - Recruiting
  Blood Disease; Anemia, Sickle Cell; Anemia (Cooley's); Leukemia; Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation
  
• Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
  ClinicalTrials.gov Identifier: NCT00438958 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Secondary Myelofibrosis
  
• Sibling Oocyte Study of Medium for IVF/ICSI With no Human Serum Albumine
  ClinicalTrials.gov Identifier: NCT00541892 - Recruiting
  In Vitro Fertilization; Infertility
  
• Siblings with Ischemic Stroke Study (SWISS)
  ClinicalTrials.gov Identifier: NCT00108940 - Recruiting
  Stroke
  
• SIC-IR Billing and Documentation
  ClinicalTrials.gov Identifier: NCT00529854 - Not yet recruiting
  Medical Record Documenation; Surgical and Trauma Intensive Care Unit Billing
  
• Sickle Cell Anemia in an Arab Bedouin Village in the Jezreel Valley
  ClinicalTrials.gov Identifier: NCT00481039 - Not yet recruiting
  Sickle Cell Disease
  
• Side Effects of Antipsychotic Medications
  ClinicalTrials.gov Identifier: NCT00363181 - Recruiting
  Insulin Resistance; Metabolic Syndrome X; Schizophrenia and Disorders With Psychotic Features; Mood Disorders; Psychotic Disorders
  
• Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00415025 - Active, not recruiting
  Head and Neck Cancer; Long-Term Effects Secondary to Cancer Therapy in Adults; Oral Complications of Cancer and Cancer Therapy; Oral Complications of Chemotherapy and Head/Neck Radiation; Radiation Toxicity
  
• Side Effects of Newer Antipsychotics in Older Adults
  ClinicalTrials.gov Identifier: NCT00245206 - Recruiting
  Schizophrenia; Alzheimer's Disease; Dementia
  
• Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types
  ClinicalTrials.gov Identifier: NCT00386204 - Completed
  Solar Lentigines
  
• Side Effects of Radiation Therapy in Young Patients With CNS Tumors
  ClinicalTrials.gov Identifier: NCT00401037 - Recruiting
  Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Long-Term Effects Secondary to Cancer Therapy in Children; Neurotoxicity; Psychosocial Effects/Treatment; Radiation Toxicity
  
• SIGA-246 to Treat Smallpox
  ClinicalTrials.gov Identifier: NCT00303225 - Completed
  Vaccinia
  
• Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria
  ClinicalTrials.gov Identifier: NCT00385372 - Active, not recruiting
  Urticaria; Angioedema
  
• Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease
  ClinicalTrials.gov Identifier: NCT00217880 - Recruiting
  Respiratory Distress Syndrome, Adult
  
• Signs and Symptoms Associated with Molecular Defects in Genetically Inherited Heart Disease
  ClinicalTrials.gov Identifier: NCT00027196 - Completed
  Congenital Heart Defect
  
• Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease
  ClinicalTrials.gov Identifier: NCT00001881 - Completed
  
  
• Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
  ClinicalTrials.gov Identifier: NCT00452582 - Recruiting
  Ischemic Stroke
  
• Sildenafil After the Fontan Operation
  ClinicalTrials.gov Identifier: NCT00507819 - Recruiting
  Hypoplastic Left Heart Syndrome; Tricuspid Atresia; Other Single Ventricle Anatomy
  
• Sildenafil and Alprostadil in Treating Patients Undergoing Bilateral Nerve-Sparing Robotic-Assisted Prostatectomy for Nonmetastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00544076 - Recruiting
  Prostate Cancer; Sexual Dysfunction and Infertility
  
• Sildenafil and Pulmonary Artery Pressure
  ClinicalTrials.gov Identifier: NCT00145938 - Terminated
  Pulmonary Hypertension
  
• Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
  ClinicalTrials.gov Identifier: NCT00141310 - Terminated
  Pre-Eclampsia
  
• Sildenafil Citrate in Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00165295 - Terminated
  Waldenstrom's Macroglobulinemia
  
• Sildenafil Effects on Pulmonary Haemodynamics and Gas Exchange in COPD
  ClinicalTrials.gov Identifier: NCT00491803 - Recruiting
  COPD; Pulmonary Hypertension
  
• Sildenafil for Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00104637 - Recruiting
  Pulmonary Disease, Chronic Obstructive; Emphysema
  
• Sildenafil For Meniere''s Disease
  ClinicalTrials.gov Identifier: NCT00145483 - Completed
  Meniere''s Disease
  
• Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00057759 - Completed
  sexual dysfunction and infertility; sexuality and reproductive issues; radiation toxicity; stage II prostate cancer; stage III prostate cancer; ...
  
• Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00359736 - Recruiting
  Fibrosis, Pulmonary; Alveolitis, Fibrosing; Hypertension, Pulmonary; Exercise, Aerobic
  
• Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00492531 - Recruiting
  Sickle Cell Disease; Pulmonary Hypertension
  
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00352482 - Completed
  Pulmonary Fibrosis; Hypertension, Pulmonary
  
• Sildenafil to Treat HIV-Associated Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00327080 - Recruiting
  HIV
  
• Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00517933 - Recruiting
  Pulmonary Fibrosis; Hypertension, Pulmonary
  
• Silent Cerebral Infarct Multi-Center Clinical Trial
  ClinicalTrials.gov Identifier: NCT00072761 - Recruiting
  Sickle Cell Anemia; Stroke
  
• Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients
  ClinicalTrials.gov Identifier: NCT00449410 - Completed
  Atrial Fibrillation; Neuropsychology; Magnetic Resonance Imaging; Inflammation; Hemostasis
  
• Silicone Earplugs for VLBW Newborns in Intensive Care
  ClinicalTrials.gov Identifier: NCT00565357 - Completed
  Postnatal Growth
  
• Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
  ClinicalTrials.gov Identifier: NCT00148642 - Completed
  Respiratory Failure
  
• Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00055718 - Active, not recruiting
  Drug Toxicity; childhood acute lymphoblastic leukemia
  
• SimCare: Physician Intervention to Improve Diabetes Care
  ClinicalTrials.gov Identifier: NCT00262704 - Completed
  Diabetes Mellitus
  
• SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00495547 - Not yet recruiting
  Myelodysplastic Syndrome
  
• SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes
  ClinicalTrials.gov Identifier: NCT00111826 - Terminated
  Peripheral Arterial Disease; Arterial Occlusive Diseases; Intermittent Claudication
  
• Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
  ClinicalTrials.gov Identifier: NCT00158457 - Completed
  HIV Infection
  
• Simple Versus Radical Hysterectomy for Stage I Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00506376 - Recruiting
  Cervical Cancer
  
• Simplified Consent for HIV Vaccine Trials
  ClinicalTrials.gov Identifier: NCT00105339 - Completed
  Adolescent; Vulnerable Populations
  
• Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
  ClinicalTrials.gov Identifier: NCT00014937 - Completed
  HIV Infections
  
• Simulation Training as a Tool for Teamwork Improvement in Multidisciplinary Intensive Care Team
  ClinicalTrials.gov Identifier: NCT00229411 - Not yet recruiting
  Education, Health
  
• Simulation Training as a Tool to Decrease Occupational Stress in ICU Personnel
  ClinicalTrials.gov Identifier: NCT00232323 - Suspended
  Education, Health
  
• Simulation-Based Study of Adding Video Communication to Dispatch Instruction
  ClinicalTrials.gov Identifier: NCT00564616 - Completed
  Cardiac Arrest
  
• Simultaneous Care: Linking Palliation to Clinical Trials
  ClinicalTrials.gov Identifier: NCT00283257 - Recruiting
  Solid Tumor; Lymphoma
  
• Simultaneous Integrated Boost (SIB)- IMRT
  ClinicalTrials.gov Identifier: NCT00389727 - Recruiting
  Carcinoma, Squamous Cell
  
• Simultaneous Measurement of EEG and fMRI in Patients With Alcoholism
  ClinicalTrials.gov Identifier: NCT00216905 - Recruiting
  Alcoholism
  
• Simultaneous Pancreas-Kidney Transplantation With Campath Protocol
  ClinicalTrials.gov Identifier: NCT00316810 - Not yet recruiting
  Pancreas-Kidney Transplantation
  
• SIMV Versus NIPPV In Preterm Infants With Respiratory Distress
  ClinicalTrials.gov Identifier: NCT00486850 - Recruiting
  Respiratory Distress Syndrome, Newborn
  
• Simvastatin (Zocor) Therapy in Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00508027 - Recruiting
  Sickle Cell Disease
  
• Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00354640 - Recruiting
  Breast Cancer
  
• Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.
  ClinicalTrials.gov Identifier: NCT00396513 - Recruiting
  Polycystic Ovary Syndrome
  
• Simvastatin as a Treatment for Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00180713 - Recruiting
  Pulmonary Hypertension
  
• Simvastatin as an Add-on Treatment to Copaxone for the Treatment of Relapsing Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00429442 - Not yet recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Simvastatin as an Add-on Treatment to Interferon-Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00492765 - Recruiting
  Multiple Sclerosis
  
• Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
  ClinicalTrials.gov Identifier: NCT00399867 - Completed
  Multiple Myeloma
  
• Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
  ClinicalTrials.gov Identifier: NCT00291863 - Recruiting
  Renal Failure, End Stage; Peritoneal Dialysis
  
• Simvastatin in Patients With Septic Shock
  ClinicalTrials.gov Identifier: NCT00450840 - Recruiting
  Septic Shock
  
• Simvastatin in Preventing a New Breast Cancer in Women Who Are at High Risk for a New Breast Cancer After Undergoing Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00334542 - Recruiting
  Breast Cancer
  
• Simvastatin in Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00575965 - Recruiting
  Waldenstrom's Macroglobulinemia
  
• Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00546182 - Completed
  Hypercholesterolemia
  
• Simvastatin Reduces Circulating Osteoprotegerin Levels in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00471549 - Completed
  Type 2 Diabetes
  
• Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
  ClinicalTrials.gov Identifier: NCT00064792 - Recruiting
  Smith-Lemli-Opitz Syndrome
  
• Simvastatin Therapy in Women With Polycystic Ovary Syndrome.
  ClinicalTrials.gov Identifier: NCT00365638 - Completed
  Polycystic Ovary Syndrome
  
• Simvastatin Treatment of Patients With Acute Optic Neuritis.
  ClinicalTrials.gov Identifier: NCT00261326 - Not yet recruiting
  Optic Neuritis; Multiple Sclerosis
  
• Simvatstatin Used to Treat Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00538044 - Not yet recruiting
  Hypertension, Pulmonary
  
• Sincalide (Cholecystokinin Octapeptide) versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis
  ClinicalTrials.gov Identifier: NCT00004414 - Completed
  Cholestasis
  
• Single Agent Alimta in Poor Performance Status in NSCLC
  ClinicalTrials.gov Identifier: NCT00508144 - Recruiting
  Lung Cancer
  
• Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00517712 - Recruiting
  Acute Promyelocytic Leukemia
  
• Single Agent Erlotinib in Chemotherapy-Naive Androgen Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00272038 - Recruiting
  Prostate Cancer
  
• Single Ascending Dose of GAP-134 as a 24-Hour IV Infusion in Healthy Japanese Males
  ClinicalTrials.gov Identifier: NCT00543946 - Recruiting
  Arrhythmia
  
• Single Ascending Dose Study of SRA-444 in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00452504 - Completed
  Alzheimer Disease
  
• Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously
  ClinicalTrials.gov Identifier: NCT00510029 - Recruiting
  Arrhythmia
  
• Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00374231 - Active, not recruiting
  Liver Transplant
  
• Single Comprehensive Ultrasound to Rule Out DVT in High-Risk Patients
  ClinicalTrials.gov Identifier: NCT00333697 - Recruiting
  Deep Vein Thrombosis
  
• Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
  ClinicalTrials.gov Identifier: NCT00034255 - Completed
  Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
  
• Single Dose Azithromycin in the Treatment of Adult Cholera
  ClinicalTrials.gov Identifier: NCT00229944 - Completed
  Cholera
  
• Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial
  ClinicalTrials.gov Identifier: NCT00142272 - Completed
  Cholera
  
• Single Dose Escalating Study of DAS181 in Adults
  ClinicalTrials.gov Identifier: NCT00527865 - Recruiting
  Influenza
  
• Single Dose Escalation Study in Patients With Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00565565 - Recruiting
  Chronic Heart Failure
  
• Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.
  ClinicalTrials.gov Identifier: NCT00444509 - Completed
  Asthma
  
• Single Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00349726 - Recruiting
  Retinopathy of Prematurity
  
• Single Dose of 1% Tropicamide and 10% Phenylephrine for Pupillary Dilation
  ClinicalTrials.gov Identifier: NCT00120432 - Completed
  Eye Diseases
  
• Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
  ClinicalTrials.gov Identifier: NCT00406003 - Active, not recruiting
  Pharmacokinetics
  
• Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children
  ClinicalTrials.gov Identifier: NCT00494468 - Completed
  Insomnia; Sleep Disorder
  
• Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00000690 - Completed
  HIV Infections
  
• Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00571194 - Recruiting
  Pediatrics Patients on Dialysis
  
• Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis(RA)
  ClinicalTrials.gov Identifier: NCT00256919 - Completed
  Rheumatoid Arthritis
  
• Single Dose Study to Assess the Safety, Tolerability, Concentration in Body and Effect of BAF312
  ClinicalTrials.gov Identifier: NCT00422175 - Completed
  Healthy
  
• Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00235781 - Terminated
  Kidney Transplantation; Antilymphocyte Serum; Graft Rejection
  
• Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
  ClinicalTrials.gov Identifier: NCT00388219 - Terminated
  Healthy
  
• Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)
  ClinicalTrials.gov Identifier: NCT00469404 - Terminated
  Healthy
  
• Single Dose Versus Multiple Doses of Dexamethasone in Children With Acute Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00213226 - Recruiting
  Bronchiolitis
  
• Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma
  ClinicalTrials.gov Identifier: NCT00354666 - Completed
  Asthma
  
• Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00516035 - Recruiting
  Influenza; Virus Diseases
  
• Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00488046 - Completed
  Influenza; Virus Diseases
  
• Single Injection of Dexamethasone for Acute Bronchiolitis in Young Children
  ClinicalTrials.gov Identifier: NCT00122785 - Completed
  Bronchiolitis, Viral
  
• Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese
  ClinicalTrials.gov Identifier: NCT00562926 - Completed
  Schizophrenia
  
• Single or Double Umbilical Cord Blood Unit Transplantation Followed by GVHD Prophylaxis With FK506 and MMF
  ClinicalTrials.gov Identifier: NCT00244036 - Recruiting
  Cord Blood Stem Cell Transplantation
  
• Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders
  ClinicalTrials.gov Identifier: NCT00051337 - Completed
  Hyperkinesis
  
• Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00058721 - Completed
  Parkinson Disease
  
• Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00365612 - Active, not recruiting
  HIV Infections
  
• Single Ventricle Outcome
  ClinicalTrials.gov Identifier: NCT00308217 - Completed
  Heart Disease, Congenital; Single Ventricle; Hypoplastic Left Heart Syndrome
  
• Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00429273 - Recruiting
  Attention Deficit Disorder With Hyperactivity
  
• Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00412360 - Recruiting
  Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome
  
• Single-Blind Study Determining the Efficacy of Polypodium Leucotomos Extract Supplement in Decreasing UVA Premutagenic and Photoaging Markers
  ClinicalTrials.gov Identifier: NCT00520910 - Recruiting
  Skin Aging and Damage
  
• Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection
  ClinicalTrials.gov Identifier: NCT00390078 - Active, not recruiting
  HIV Infections
  
• Single-Breath Measurement Underestimates Ventilatory Volume According to Emphysema Severity
  ClinicalTrials.gov Identifier: NCT00528944 - Completed
  Emphysema
  
• Single-Center, Open Label, Single-Arm Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing
  ClinicalTrials.gov Identifier: NCT00389857 - Active, not recruiting
  Influenza Vaccines
  
• Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
  ClinicalTrials.gov Identifier: NCT00082927 - Recruiting
  Breast Cancer; Lung Cancer; metastatic cancer; Pain; Prostate Cancer
  
• Single-Dose Postpartum Vitamin A Supplementation of Mothers and Neonates
  ClinicalTrials.gov Identifier: NCT00198718 - Active, not recruiting
  Vitamin A Deficiency; HIV
  
• Single-Dose Safety Study of APD791 in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00529646 - Recruiting
  Healthy
  
• Single-Dose Study of Black Cohosh and Red Clover
  ClinicalTrials.gov Identifier: NCT00010959 - Completed
  Menopause
  
• Single-Dose, Dose-Escalation Study of Safety, PK, & Preliminary Efficacy of XOMA 052 in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00541983 - Recruiting
  Type 2 Diabetes
  
• Single-Fraction Radiation Therapy Compared With Multiple-Fraction Reirradiation Therapy in Treating Patients With Painful Bone Metastases
  ClinicalTrials.gov Identifier: NCT00080912 - Recruiting
  bone metastases; Pain
  
• SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen
  ClinicalTrials.gov Identifier: NCT00445107 - Completed
  Asthma
  
• Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
  ClinicalTrials.gov Identifier: NCT00406094 - Recruiting
  Rhinitis
  
• Singulair® In Asthma And Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00545844 - Recruiting
  Asthma, Rhinitis Allergic
  
• Siplizumab in Treating Patients With Lymphoproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00075361 - Active, not recruiting
  Leukemia; Lymphoma
  
• SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00503867 - Not yet recruiting
  Carcinoma, Hepatocellular; Hepatoma
  
• Sirolimus (Rapamune), Mycophenolate Mofetil (MMF) and Steroids to Replace a Standard Treatment Regimen in Heart Transplant Patients
  ClinicalTrials.gov Identifier: NCT00121784 - Terminated
  Heart Diseases; Cardiac transplantation
  
• Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD).
  ClinicalTrials.gov Identifier: NCT00346918 - Recruiting
  Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  
• Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00467194 - Recruiting
  Liver Cancer
  
• Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00319878 - Recruiting
  Anemia, Aplastic
  
• Sirolimus and MMF as GVHD Prophylaxis After RIC Transplantation
  ClinicalTrials.gov Identifier: NCT00548717 - Recruiting
  Graft-vs-Host Disease
  
• Sirolimus and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Myeloablative Matched Related Donor Hematopoietic Cell Transplant
  ClinicalTrials.gov Identifier: NCT00350181 - Active, not recruiting
  Leukemia; Lymphoma, Non-Hodgkin
  
• Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection
  ClinicalTrials.gov Identifier: NCT00006178 - Active, not recruiting
  Kidney Failure
  
• Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
  ClinicalTrials.gov Identifier: NCT00186667 - Completed
  Graft vs Host Disease
  
• Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond to Previous Systemic Treatment
  ClinicalTrials.gov Identifier: NCT00079183 - Active, not recruiting
  Graft Versus Host Disease
  
• Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00388362 - Recruiting
  Graft vs Host Disease
  
• Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program
  ClinicalTrials.gov Identifier: NCT00461357 - Active, not recruiting
  Kidney Function After Transplantation; Outcome After Kidney Transplantation
  
• Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00311623 - Recruiting
  Prostate Cancer
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Sirolimus Eluting Stenting in Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00288210 - Active, not recruiting
  Myocardial Infarction
  
• Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)
  ClinicalTrials.gov Identifier: NCT00151658 - Completed
  Ischaemic heart disease
  
• Sirolimus for Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00040508 - Completed
  Focal Glomerulosclerosis
  
• Sirolimus in Autoimmune Lymphoproliferative Syndrome: A Pilot Series
  ClinicalTrials.gov Identifier: NCT00392951 - Recruiting
  Autoimmune Lymphoproliferative Syndrome (ALPS)
  
• Sirolimus in Preventing Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00077480 - Recruiting
  chronic myeloproliferative disorders; Graft Versus Host Disease; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• Sirolimus in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00499486 - Recruiting
  Pancreatic Cancer
  
• Sirolimus in Treating Patients With Angiomyolipoma of the Kidney
  ClinicalTrials.gov Identifier: NCT00126672 - Recruiting
  Angiomyolipoma
  
• Sirolimus in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00047073 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00450320 - Recruiting
  Sarcoma
  
• Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00368914 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00068302 - Recruiting
  recurrent childhood lymphoblastic lymphoma; recurrent childhood small noncleaved cell lymphoma; recurrent childhood large cell lymphoma; ...
  
• Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
  ClinicalTrials.gov Identifier: NCT00050713 - Active, not recruiting
  Membranous Glomerulonephritis
  
• Sirolimus to Prevent GVHD after Stem Cell Transplant for Blood Cancers
  ClinicalTrials.gov Identifier: NCT00074490 - Recruiting
  Hematologic Neoplasms; Neural Tube Defects; Myeloproliferative Disorders
  
• Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
  ClinicalTrials.gov Identifier: NCT00491517 - Recruiting
  Polycystic Kidney
  
• Sirolimus with Tacrolimus for Graft-Vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00144703 - Completed
  Hematologic Malignancies; Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome; Non-Hodgkin''s Lymphoma; Hodgkin''s Disease
  
• Sirolimus with Tacrolimus for Graft-Vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00144677 - Completed
  Acute Myelogenous Leukemia; Graft Versus Host Disease; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndromes; ...
  
• Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00089037 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer
  
• Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels
  ClinicalTrials.gov Identifier: NCT00146575 - Completed
  Coronary Disease
  
• Sirolimus-Based Immunosuppression in Liver Transplantation for High Risk Hepatocellular Carcinoma Patients
  ClinicalTrials.gov Identifier: NCT00328770 - Recruiting
  Liver Graft Recipients With High Risk Hepato-Cellular Carcinoma
  
• Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
  ClinicalTrials.gov Identifier: NCT00554125 - Recruiting
  Hepatocellular Carcinoma
  
• Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)
  ClinicalTrials.gov Identifier: NCT00231244 - Active, not recruiting
  Coronary Artery Disease
  
• Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
  ClinicalTrials.gov Identifier: NCT00231257 - Active, not recruiting
  In-Stent Restenosis
  
• Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions
  ClinicalTrials.gov Identifier: NCT00258596 - Completed
  Coronary Artery Disease; Coronary Disease; Coronary Stenosis
  
• Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization
  ClinicalTrials.gov Identifier: NCT00297661 - Completed
  Coronary Heart Disease
  
• Sirolimus-Eluting vs Zotarolimus-Eluting Stents for Chronic Total Coronary Occlusions
  ClinicalTrials.gov Identifier: NCT00428454 - Recruiting
  Coronary Artery Disease; Coronary Disease; Coronary Stenosis
  
• Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
  ClinicalTrials.gov Identifier: NCT00406393 - Recruiting
  Leukemia, Myelocytic, Acute; Leukemia, Lymphocytic, Acute; Leukemia, Myeloid, Chronic; Myelodysplastic Syndromes
  
• Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas
  ClinicalTrials.gov Identifier: NCT00202891 - Not yet recruiting
  Pyoderma
  
• Sister Study
  ClinicalTrials.gov Identifier: NCT00047970 - Recruiting
  Breast Cancer
  
• Sit-to-Stand Training for Survivors of Stroke in a Long-Term Care Setting
  ClinicalTrials.gov Identifier: NCT00197509 - Active, not recruiting
  Cerebrovascular Accident
  
• Sitagliptin Added-on to Insulin Study
  ClinicalTrials.gov Identifier: NCT00395343 - Recruiting
  Type 2 Diabetes Mellitus
  
• Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00511108 - Recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Sitagliptin Comparative Study in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00449930 - Recruiting
  Type 2 Diabetes Mellitus
  
• Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00541229 - Recruiting
  Type 2 Diabetes
  
• Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00337610 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on
  ClinicalTrials.gov Identifier: NCT00350779 - Active, not recruiting
  Diabetes Mellitus, Type II
  
• Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
  ClinicalTrials.gov Identifier: NCT00466518 - Recruiting
  Kidney Transplant; Type 2 Diabetes
  
• Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00509262 - Recruiting
  Type 2 Diabetes Mellitus; Renal Insufficiency, Chronic
  
• Sitagliptin vs Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00509236 - Recruiting
  Type 2 Diabetes Mellitus; Renal Disease, End-Stage
  
• SITELINE 2 Polyurethane
  ClinicalTrials.gov Identifier: NCT00180284 - Active, not recruiting
  Bradycardia
  
• Sitigliptin in the Elderly
  ClinicalTrials.gov Identifier: NCT00451113 - Recruiting
  Type 2 Diabetes
  
• Sitosterolemia Extension Study
  ClinicalTrials.gov Identifier: NCT00092807 - Completed
  Lipid Metabolism, Inborn Errors; Heart Disease
  
• Sitosterolemia Extension Study
  ClinicalTrials.gov Identifier: NCT00092820 - Completed
  Lipid Metabolism, Inborn Errors; Heart Disease
  
• Six month clinical research study for patients with moderate or severe dry eye syndrome
  ClinicalTrials.gov Identifier: NCT00025818 - Completed
  Keratoconjunctivitis Sicca; Sjogren's Syndrome; Lupus Erythematosus, Systemic; Arthritis, Rheumatoid; Scleroderma, Systemic
  
• Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00424333 - Completed
  Diabetes Mellitus, Type 1
  
• Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.
  ClinicalTrials.gov Identifier: NCT00424437 - Completed
  Diabetes Mellitus, Type 1
  
• Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00424411 - Completed
  Diabetes Mellitus, Type 2
  
• Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons
  ClinicalTrials.gov Identifier: NCT00451074 - Recruiting
  Duchenne Muscular Dystrophy
  
• Six Month Trial of Lamotrigine Vs. Sodium Valproate for Treatment of Mixed Mania
  ClinicalTrials.gov Identifier: NCT00206778 - Recruiting
  Mixed Mania Bipolar Disorder
  
• Six Months DHEA Treatment in Female Adrenal Failure
  ClinicalTrials.gov Identifier: NCT00471900 - Completed
  Adrenal Insufficiency
  
• Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00500539 - Recruiting
  Asthma
  
• Six-Minute Walk Test in the Evaluation of Patients at High Risk for Complications From Lung Resection
  ClinicalTrials.gov Identifier: NCT00450125 - Recruiting
  Solid Tumor; Lung
  
• SJG-136 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00103220 - Completed
  unspecified adult solid tumor, protocol specific
  
• SJG-136 in Treating Patients with Metastatic Or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00121290 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00301769 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Skeletal Muscle and Platelet Mitochondrial Dysfunction During Sepsis
  ClinicalTrials.gov Identifier: NCT00541827 - Not yet recruiting
  Severe Sepsis; Septic Shock
  
• Skeletal Muscle Dysfunction in Heart Failure
  ClinicalTrials.gov Identifier: NCT00156234 - Recruiting
  Heart Failure, Congestive
  
• Skeletal Muscle Oxygenation in Critically Ill
  ClinicalTrials.gov Identifier: NCT00384644 - Recruiting
  Heart Failure; Sepsis; Septic Shock; Cardiogenic Shock
  
• Skills Based Counseling for Adhrence and Depression in HIV+ Methadone Patients - 1
  ClinicalTrials.gov Identifier: NCT00218634 - Recruiting
  Adherence; Behavior Therapy; Depression; Heroin Dependence; Methadone; Motivational Interviewing; Substance-Related Disorders
  
• Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00369109 - Completed
  Breast Cancer; Colorectal Cancer; Pancreatic Cancer
  
• Skin Cleansing with Chlorhexidine to Decrease Hospital Acquired Infections.
  ClinicalTrials.gov Identifier: NCT00130221 - Completed
  Nosocomial Infection; Bacteremia; Sepsis; Pneumonia; Urinary Tract Infection; Clostridium Difficile
  
• Skin Conduction Device and Patient Diary for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes
  ClinicalTrials.gov Identifier: NCT00427531 - Active, not recruiting
  Hot Flashes
  
• Skin Conduction Device for Measuring Hot Flashes in Postmenopausal Women With Hot Flashes
  ClinicalTrials.gov Identifier: NCT00427622 - Completed
  Hot Flashes
  
• Skin Denervation in Systemic Lupus Erythematosus
  ClinicalTrials.gov Identifier: NCT00155532 - Completed
  Systemic Lupus Erythematosus
  
• Skin Incision Study
  ClinicalTrials.gov Identifier: NCT00107627 - Completed
  Cancer
  
• Skin Problems in Ostomy Patients: An Epidemiological Study
  ClinicalTrials.gov Identifier: NCT00391508 - Active, not recruiting
  Ostomy; Living in Roskilde County; Persons More Than 18 Years of Age; Willingness to Participate
  
• Skin Response to Sunlight
  ClinicalTrials.gov Identifier: NCT00077740 - Recruiting
  Healthy
  
• Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser
  ClinicalTrials.gov Identifier: NCT00576238 - Active, not recruiting
  Atopic Eczema
  
• SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma
  ClinicalTrials.gov Identifier: NCT00293488 - Recruiting
  Lymphoma
  
• Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR
  ClinicalTrials.gov Identifier: NCT00393042 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Sleep Apnea and Oxidative Stress and Nitric Oxide
  ClinicalTrials.gov Identifier: NCT00547937 - Completed
  Sleep Apnea Syndromes
  
• Sleep Apnea and Refractory Hypertension: Prevalence and Effect of CPAP Treatment
  ClinicalTrials.gov Identifier: NCT00459914 - Recruiting
  Hypertension; Sleep Apnea
  
• Sleep Apnea and Tromboembolic Disease
  ClinicalTrials.gov Identifier: NCT00501358 - Recruiting
  Sleep Apnea Syndromes; Venous Thromboembolism
  
• Sleep Apnea in a Non-Clinical Population
  ClinicalTrials.gov Identifier: NCT00005551 - Completed
  Lung Diseases; Sleep Apnea Syndromes; Obesity; Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Sleep Apnea in Elderly Male Twins
  ClinicalTrials.gov Identifier: NCT00005525 - Completed
  Lung Diseases; Sleep Apnea Syndromes; Obesity
  
• Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
  ClinicalTrials.gov Identifier: NCT00194259 - Active, not recruiting
  Obstructive Sleep Apnea; Type 2 Diabetes
  
• Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD
  ClinicalTrials.gov Identifier: NCT00031239 - Active, not recruiting
  Sleep Apnea Syndromes; Diabetes Mellitus, non-insulin dependent; Obesity; Diabetes Mellitus
  
• Sleep Apnea Treatment After Stroke (SATS)
  ClinicalTrials.gov Identifier: NCT00282815 - Recruiting
  Obstructive Sleep Apnea; Stroke
  
• Sleep Apnea-Hypopnea Syndrome and the Pathogenesis of Obesity
  ClinicalTrials.gov Identifier: NCT00456651 - Recruiting
  Sleep Apnea; Obesity
  
• Sleep Apnea. Concordance Between Non-Reference and Reference Centres
  ClinicalTrials.gov Identifier: NCT00424658 - Completed
  Sleep Apnea
  
• Sleep Apnea: Age Effects On Prevalence and Natural History
  ClinicalTrials.gov Identifier: NCT00005296 - Completed
  Lung Diseases; Sleep Apnea Syndromes
  
• Sleep Apnea: Mechanism and Cerebrovascular Consequences
  ClinicalTrials.gov Identifier: NCT00108602 - Recruiting
  Stroke; Sleep Apnea, Obstructive
  
• Sleep Architecture and Chemotherapy-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00178204 - Recruiting
  Fatigue; Sleep; Chemotherapy; Cancer
  
• Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.
  ClinicalTrials.gov Identifier: NCT00229151 - Recruiting
  Bipolar Disorder
  
• Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals
  ClinicalTrials.gov Identifier: NCT00178035 - Completed
  Depression
  
• Sleep Disordered Breathing in Children with Single Ventricle Physiology
  ClinicalTrials.gov Identifier: NCT00156455 - Recruiting
  Hypoplastic Left Heart Syndrome; Obstructive Sleep Apnea Syndrome; Single Ventricle Phsyiology
  
• Sleep Disordered Breathing in Gulf War Syndrome Veterans and the Effect of Continuous Positive Airway Pressure (CPAP) Treatment
  ClinicalTrials.gov Identifier: NCT00252629 - Recruiting
  Gulf War Syndrome; Chronic Fatigue Syndrome; Functional Somatic Syndrome; Upper Airway Resistance Syndrome; Sleep Apnea
  
• Sleep Disordered Breathing, APOE, and Lipid Metabolism
  ClinicalTrials.gov Identifier: NCT00046670 - Active, not recruiting
  Sleep Apnea Syndromes; Lung Diseases
  
• Sleep Disorders and Gastroesophageal Reflux Disease (GERD)
  ClinicalTrials.gov Identifier: NCT00287391 - Completed
  Insomnia; GERD
  
• Sleep Disorders in Children With ADHD
  ClinicalTrials.gov Identifier: NCT00224731 - Recruiting
  Attention Disorder With Hyperactivity (ADHD)
  
• Sleep Disorders in Patients with MS
  ClinicalTrials.gov Identifier: NCT00137904 - Recruiting
  multiple sclerosis, fatigue, sleep disorders
  
• Sleep Disorders Management, Health and Safety in Police
  ClinicalTrials.gov Identifier: NCT00207285 - Recruiting
  Sleep Disorders; Sleep Apnea, Obstructive; Restless Legs Syndrome; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders
  
• Sleep Disorders of Patients with Diseases of the Nervous System
  ClinicalTrials.gov Identifier: NCT00001664 - Recruiting
  Hypersomnia; Narcolepsy; Nervous System Disease; Sleep Disorder
  
• Sleep Disturbance and Sleep Quality in Women With Fibromyalgia Syndrome
  ClinicalTrials.gov Identifier: NCT00482859 - Recruiting
  Fibromyalgia Syndrome
  
• Sleep Disturbance in Lung Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00187980 - Recruiting
  Lung Cancer
  
• Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient
  ClinicalTrials.gov Identifier: NCT00566137 - Completed
  Scleroderma; Pulmonary Hypertension
  
• Sleep Heart Health Study (SHHS)
  ClinicalTrials.gov Identifier: NCT00005275 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes; Cardiovascular Diseases; Heart Diseases; Coronary Disease; Cerebrovascular Accident; Hypertension; ...
  
• Sleep Homeostasis in Primary Insomnia Following Behavioral Treatment
  ClinicalTrials.gov Identifier: NCT00256503 - Recruiting
  Primary Insomnia
  
• Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00266357 - Terminated
  Primary Insomnia
  
• Sleep Loss and Mechanisms of Impaired Glucose Metabolism
  ClinicalTrials.gov Identifier: NCT00555750 - Recruiting
  Primary Insomnia
  
• Sleep Quality in CHIMES (MF101)
  ClinicalTrials.gov Identifier: NCT00454441 - Completed
  Sleep Quality; Menopausal Symptoms
  
• Sleep Specialty Consultation: Improving Management of Sleep Disorders
  ClinicalTrials.gov Identifier: NCT00390572 - Recruiting
  Sleep Disorders
  
• Sleep, Circadian, Hormonal Dysregulation, and Breast Cancer Survival
  ClinicalTrials.gov Identifier: NCT00519168 - Recruiting
  Breast Cancer
  
• Sleep, Fatigue, and Dexamethosone in Children with Leukemia
  ClinicalTrials.gov Identifier: NCT00075101 - Recruiting
  Leukemia
  
• Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00253695 - Recruiting
  Sleep; HIV Infections
  
• Sleepiness and the Risk of Falling
  ClinicalTrials.gov Identifier: NCT00383357 - Completed
  Aging; Balance; Sleep
  
• SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
  ClinicalTrials.gov Identifier: NCT00194402 - Completed
  Dyslipidemia
  
• Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00461435 - Completed
  Retinitis Pigmentosa
  
• SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease
  ClinicalTrials.gov Identifier: NCT00335166 - Active, not recruiting
  Early Stage Parkinson Disease
  
• SLV308 for Treatment of Patients With Early Parkinson''s Disease
  ClinicalTrials.gov Identifier: NCT00269516 - Active, not recruiting
  Early Stage Parkinson''s Disease
  
• SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations
  ClinicalTrials.gov Identifier: NCT00406588 - Active, not recruiting
  Advanced Stage Parkinson's Disease
  
• Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
  ClinicalTrials.gov Identifier: NCT00429507 - Recruiting
  Breast Cancer; Bone Metastases
  
• Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-Year Manometric Follow-Up
  ClinicalTrials.gov Identifier: NCT00213460 - Completed
  Systemic Sclerosis
  
• Small-Incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease
  ClinicalTrials.gov Identifier: NCT00370344 - Recruiting
  Biliary Tract Diseases; Gallbladder Diseases; Cholecystitis; Cholecystolithiasis
  
• Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation
  ClinicalTrials.gov Identifier: NCT00320905 - Recruiting
  Cardiovascular Disease
  
• SMART Trial Longitudinal Follow-Up:Off-Pump Versus On-Pump Coronary Artery Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00209053 - Active, not recruiting
  Coronary Artery Disease
  
• SMART: Somatotrophics, Memory, and Aging Research Trial
  ClinicalTrials.gov Identifier: NCT00257712 - Recruiting
  Aging; Mild Cognitive Impairment
  
• SmartCPR Trial: An Analysis of a Waveform-Based AED Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation
  ClinicalTrials.gov Identifier: NCT00535106 - Recruiting
  Ventricular Fibrillation; Cardiac Arrest
  
• SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study
  ClinicalTrials.gov Identifier: NCT00486369 - Completed
  Osteoarthritis
  
• SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00487448 - Active, not recruiting
  Myelodysplastic Syndrome; Acute Myeloblastic Leukemia
  
• SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma
  ClinicalTrials.gov Identifier: NCT00288379 - Completed
  Asthma
  
• Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking
  ClinicalTrials.gov Identifier: NCT00245076 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence
  ClinicalTrials.gov Identifier: NCT00178685 - Recruiting
  Tobacco Use Disorder
  
• Smoking Abstinence and Response to Smoking Cues
  ClinicalTrials.gov Identifier: NCT00385060 - Recruiting
  Tobacco Smoking
  
• Smoking and Alcohol Initiation
  ClinicalTrials.gov Identifier: NCT00271843 - Active, not recruiting
  Smoking; Alcohol Drinking
  
• Smoking and Body Weight: Analysis of HHANES
  ClinicalTrials.gov Identifier: NCT00005272 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Smoking Cessation Aid for Young Smokers
  ClinicalTrials.gov Identifier: NCT00340483 - Completed
  Smoking Cessation
  
• Smoking Cessation and Postoperative Complications
  ClinicalTrials.gov Identifier: NCT00533000 - Active, not recruiting
  Postoperative Complications; Randomized; Prevention; Smoking Cessation
  
• Smoking Cessation and Relapse Prevention in Women Postpartum
  ClinicalTrials.gov Identifier: NCT00475046 - Completed
  Smoking Cessation
  
• Smoking Cessation Assistance With LIBERTAL, a Phospholipid Mixture
  ClinicalTrials.gov Identifier: NCT00317213 - Terminated
  Smoking Cessation
  
• Smoking Cessation for Adults With ADHD
  ClinicalTrials.gov Identifier: NCT00253747 - Completed
  ADHD; Smoking
  
• Smoking Cessation for Depressed Smokers
  ClinicalTrials.gov Identifier: NCT00494728 - Recruiting
  Smoking; Depression
  
• Smoking Cessation for HIV/AIDS Patients
  ClinicalTrials.gov Identifier: NCT00502827 - Recruiting
  HIV Infections
  
• Smoking Cessation for Young Adults Who Binge Drink - 1
  ClinicalTrials.gov Identifier: NCT00218452 - Recruiting
  Adherence; Tobacco use cessation; alcohol & drug use; nicotine transdermal system
  
• Smoking Cessation in Alcoholism Treatment
  ClinicalTrials.gov Identifier: NCT00000454 - Completed
  Alcoholism; Smoking
  
• Smoking Cessation in Groups and With Tobacco Pastils
  ClinicalTrials.gov Identifier: NCT00265460 - Active, not recruiting
  Smoking
  
• Smoking Cessation in Subjects With Mild-to-Moderate Chronic Obstructive Pulmonary Disease (COPD).
  ClinicalTrials.gov Identifier: NCT00285012 - Recruiting
  COPD
  
• Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study
  ClinicalTrials.gov Identifier: NCT00408265 - Completed
  Nicotine Dependence
  
• Smoking Cessation Intervention After Stroke or Transient Ischaemic Attack.
  ClinicalTrials.gov Identifier: NCT00228098 - Recruiting
  Stroke; Transient Ischemic Attack
  
• Smoking Cessation Intervention for Cancer Patients
  ClinicalTrials.gov Identifier: NCT00575718 - Recruiting
  Newly Diagnosed Cancer Patients
  
• Smoking Cessation Intervention for Patients Undergoing Lung Surgery
  ClinicalTrials.gov Identifier: NCT00580398 - Not yet recruiting
  Lung Cancer
  
• Smoking Cessation Intervention: Effectiveness in Primary Care
  ClinicalTrials.gov Identifier: NCT00296647 - Recruiting
  Tobacco Dependence
  
• Smoking Cessation Interventions in Dental Clinic Smokers
  ClinicalTrials.gov Identifier: NCT00070798 - Active, not recruiting
  Smoking cessation; Motivational interviewing; Cancer risk; Tobacco
  
• Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
  ClinicalTrials.gov Identifier: NCT00332644 - Active, not recruiting
  Nicotine Dependence
  
• Smoking Cessation Program: A Quality Improvement Trial in a Resident Based Outpatient Clinic
  ClinicalTrials.gov Identifier: NCT00436943 - Recruiting
  Smoking
  
• Smoking Cessation Treatment - 1
  ClinicalTrials.gov Identifier: NCT00218647 - Recruiting
  Tobacco Use Disorder
  
• Smoking Cessation Treatment - 1
  ClinicalTrials.gov Identifier: NCT00110825 - Active, not recruiting
  Behavior Therapy; Bupropion; Tobacco Use Disorder; nicotine transdermal system
  
• Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1
  ClinicalTrials.gov Identifier: NCT00067158 - Active, not recruiting
  Tobacco Use Disorder
  
• Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
  ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
  Tobacco Dependence
  
• Smoking Onset in a Biethnic Population
  ClinicalTrials.gov Identifier: NCT00005375 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Lung Diseases
  
• Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial
  ClinicalTrials.gov Identifier: NCT00563329 - Recruiting
  Smoking Cessation
  
• Smoking Relapse Prevention in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00320697 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Smokers
  
• Smoking Status and Body Image in Oral Cancer Patients
  ClinicalTrials.gov Identifier: NCT00412490 - Active, not recruiting
  Oral Cavity Cancer
  
• Smoking Treatment in HIV Clinical Care Settings
  ClinicalTrials.gov Identifier: NCT00297453 - Recruiting
  Nicotine Dependence
  
• Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation
  ClinicalTrials.gov Identifier: NCT00289653 - Completed
  Nicotine Dependence
  
• SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
  ClinicalTrials.gov Identifier: NCT00239538 - Completed
  Hypertension; Diabetes Mellitus, Type 2
  
• SMP-986 Phase 2 Proof of Concept in Patients With OABS
  ClinicalTrials.gov Identifier: NCT00409539 - Recruiting
  Overactive Bladder Syndrome (OABS)
  
• SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)
  ClinicalTrials.gov Identifier: NCT00170287 - Recruiting
  Tachycardia, Ventricular
  
• SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function
  ClinicalTrials.gov Identifier: NCT00225082 - Active, not recruiting
  HIV Infection
  
• SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
  ClinicalTrials.gov Identifier: NCT00438568 - Recruiting
  Mild Cognitive Impairment; Alzheimer's Disease
  
• Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00072228 - Suspended
  unspecified adult solid tumor, protocol specific
  
• Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00064220 - Completed
  adult soft tissue sarcoma
  
• Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00061854 - Completed
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; ...
  
• Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults
  ClinicalTrials.gov Identifier: NCT00270764 - Completed
  HIV Infections
  
• Social Anxiety Disorder Study Of Paroxetine
  ClinicalTrials.gov Identifier: NCT00318669 - Completed
  Phobic Disorders
  
• Social Dominance, Gender, and Cardiovascular Reactivity
  ClinicalTrials.gov Identifier: NCT00005522 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Social Network Based Intervention to Reduce Lead Exposure among Native American Children
  ClinicalTrials.gov Identifier: NCT00011661 - Completed
  Lead Poisoning
  
• Social Phobia Intervention Study of Mannheim
  ClinicalTrials.gov Identifier: NCT00434759 - Recruiting
  Social Phobia
  
• Social Support and CHD Risk Factors--A Community Study
  ClinicalTrials.gov Identifier: NCT00005343 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Social Support and Education in Asthma Follow-Up (SSEA)
  ClinicalTrials.gov Identifier: NCT00149500 - Active, not recruiting
  Asthma
  
• Social Support and Myocardial Ischemia
  ClinicalTrials.gov Identifier: NCT00005449 - Completed
  Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease
  
• Socio-Aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer.
  ClinicalTrials.gov Identifier: NCT00210145 - Completed
  Breast Cancer
  
• Sociodemographic Regulation of Cardiovascular Function and Structure
  ClinicalTrials.gov Identifier: NCT00005476 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Socioeconomic and Age-related Disability in a Biracial Community
  ClinicalTrials.gov Identifier: NCT00042133 - Recruiting
  Healthy
  
• Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00087932 - Completed
  Neoplasms
  
• Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA
  ClinicalTrials.gov Identifier: NCT00091494 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Inflammation; Blood Coagulation Disorders
  
• Socioeconomic Status, John Henryism and Hypertension Risk in Blacks
  ClinicalTrials.gov Identifier: NCT00005172 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Socioenvironmental Determinants of Psychological Functioning, Mental Health and AIDS in Mali
  ClinicalTrials.gov Identifier: NCT00339391 - Active, not recruiting
  AIDS
  
• SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus
  ClinicalTrials.gov Identifier: NCT00371826 - Recruiting
  Renal Transplantation
  
• Sodium Bicarbonate in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00334191 - Completed
  Cardiac Surgery and Cardiopulmonary Bypass
  
• Sodium Bicarbonate in Preventing Contrast Induced Nephropathy
  ClinicalTrials.gov Identifier: NCT00531765 - Recruiting
  Contrast Induced Nephropathy
  
• Sodium Channel Expression in Human Teeth
  ClinicalTrials.gov Identifier: NCT00575263 - Recruiting
  Dental Pulp Disease
  
• Sodium Oxybate in the Treatment of Binge Eating Disorder
  ClinicalTrials.gov Identifier: NCT00514995 - Recruiting
  Binge Eating Disorder
  
• Sodium Phenylbutyrate for Treating Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
  ClinicalTrials.gov Identifier: NCT00345605 - Active, not recruiting
  Argininosuccinic Aciduria; Amino Acid Metabolism, Inborn Errors; Urea Cycle Disorders
  
• Sodium Pyruvate Therapy in COPD Patients
  ClinicalTrials.gov Identifier: NCT00262613 - Completed
  Chronic Obstructive Pulmonary Disease (COPD)
  
• Sodium Restriction in the Management of Cirrhotic Ascites
  ClinicalTrials.gov Identifier: NCT00548366 - Recruiting
  Ascites
  
• Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004245 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Sodium Sensitivity in African Americans
  ClinicalTrials.gov Identifier: NCT00000536 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Sodium Stibogluconate and Interferon Alfa-2b Followed By Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Advanced Melanoma or Other Cancer
  ClinicalTrials.gov Identifier: NCT00498979 - Recruiting
  Brain and Central Nervous System Tumors; Melanoma (Skin)
  
• Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma
  ClinicalTrials.gov Identifier: NCT00311558 - Active, not recruiting
  Cancer
  
• Sodium Thiosulfate Treatment of Vascular Calcification in ESRD
  ClinicalTrials.gov Identifier: NCT00568399 - Recruiting
  Hemodialysis; Cardiovascular Diseases
  
• Sodium Transport: Genetics and Hypertension
  ClinicalTrials.gov Identifier: NCT00005166 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Sodium Tungstate in Obesity
  ClinicalTrials.gov Identifier: NCT00555074 - Not yet recruiting
  Obesity
  
• Sodium-Endothelial Function-CKD Study
  ClinicalTrials.gov Identifier: NCT00141622 - Completed
  Kidney Failure, Chronic
  
• Sodium-Lactate and Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00319345 - Terminated
  Severe Trauma Brain Injury; Intracranial Hypertension
  
• Sodium-Potassium Blood Pressure Trial in Children
  ClinicalTrials.gov Identifier: NCT00000521 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Sodiumpicosulphate vs. Placebo in Functional Constipation
  ClinicalTrials.gov Identifier: NCT00576810 - Recruiting
  Constipation
  
• SOFA: Study on Omega-3 Fatty acids and ventricular Arrhythmia
  ClinicalTrials.gov Identifier: NCT00110838 - Completed
  Arrhythmia
  
• SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).
  ClinicalTrials.gov Identifier: NCT00442572 - Recruiting
  Hepatitis B, Chronic
  
• Soft Drink, Milk and Obesity in Chilean Children
  ClinicalTrials.gov Identifier: NCT00149695 - Completed
  Obesity
  
• Soft Tissue Biomechanical Behavior During Acupuncture in Low Back Pain
  ClinicalTrials.gov Identifier: NCT00487266 - Recruiting
  Low Back Pain
  
• Sole-Therapy Treatment of Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00566176 - Active, not recruiting
  Atrial Fibrillation
  
• SOLIACS: Solian Solution in the Acute Setting
  ClinicalTrials.gov Identifier: NCT00245674 - Completed
  Schizophrenia
  
• SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.
  ClinicalTrials.gov Identifier: NCT00460733 - Recruiting
  Colles' Fracture
  
• Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction
  ClinicalTrials.gov Identifier: NCT00507455 - Recruiting
  Lower Urinary Tract Symptoms; Bladder Outlet Obstruction
  
• Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
  ClinicalTrials.gov Identifier: NCT00006505 - Active, not recruiting
  Insulin Dependent Diabetes Mellitus
  
• SOLMANIA
  ClinicalTrials.gov Identifier: NCT00126009 - Completed
  Bipolar Disorder
  
• SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
  ClinicalTrials.gov Identifier: NCT00238784 - Active, not recruiting
  Asthma
  
• Soluble CD23 Expression in Asthma Patients Treated With OMA
  ClinicalTrials.gov Identifier: NCT00226200 - Terminated
  Asthma
  
• SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractive Glaucoma
  ClinicalTrials.gov Identifier: NCT00382395 - Recruiting
  Glaucoma; Glaucoma, Open Angle
  
• SOLX Titanium Sapphire Laser for Trabeculoplasty
  ClinicalTrials.gov Identifier: NCT00145535 - Recruiting
  Glaucoma; Glaucoma, -open angle
  
• Somatosensory Evoked Potentials and Pain Thresholds in Term and Preterm-Born Adolescents After Early Exposure to Pain; a Quantitative Study
  ClinicalTrials.gov Identifier: NCT00503100 - Not yet recruiting
  Somatosensory Disorders
  
• Somatosensory Processing in Depression
  ClinicalTrials.gov Identifier: NCT00386893 - Recruiting
  Depression
  
• Somatosensory Processing in Focal Hand Dystonia
  ClinicalTrials.gov Identifier: NCT00579033 - Recruiting
  Focal Hand Dystonia; Musician's Dystonia; Writer's Cramp; Dystonic Cramp
  
• Somatostatin in Polycystic Kidney: a Long-Term Three Year Follow up Study
  ClinicalTrials.gov Identifier: NCT00309283 - Recruiting
  Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  
• Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers
  ClinicalTrials.gov Identifier: NCT00222092 - Recruiting
  Post-ERCP Pancreatitis
  
• Somatropin + Leuprorelin vs Somatropin Alone vs Untreated Control in Pubertal Children With Idiopathic Short Stature
  ClinicalTrials.gov Identifier: NCT00355030 - Recruiting
  Idiopathic Short Stature (ISS)
  
• Somatropin Therapy In Short VLBW Children Born AGA.
  ClinicalTrials.gov Identifier: NCT00174460 - Active, not recruiting
  Infant, very low birth weight
  
• Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome
  ClinicalTrials.gov Identifier: NCT00190658 - Active, not recruiting
  Failure to Thrive
  
• Somatropin Treatment to Final Height in Turners
  ClinicalTrials.gov Identifier: NCT00191113 - Active, not recruiting
  Turner Syndrome
  
• Somatuline Autogel: Acromegaly Self/Partner Injection Study
  ClinicalTrials.gov Identifier: NCT00149188 - Completed
  Acromegaly
  
• SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada
  ClinicalTrials.gov Identifier: NCT00323687 - Active, not recruiting
  HIV-1 Infection
  
• SONIC: Study of Biologic and Immunomodulator Naïve Patients in Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00094458 - Active, not recruiting
  Crohn's Disease
  
• SONICS - Effectiveness of Specialist Oncology Nursing
  ClinicalTrials.gov Identifier: NCT00182234 - Recruiting
  unmet supportive care needs; continuity of care; Quality of Life
  
• Sonographic Assessment of Laryngeal Elevation
  ClinicalTrials.gov Identifier: NCT00166751 - Recruiting
  Cerebrovascular Accident; Dysphagia
  
• Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement
  ClinicalTrials.gov Identifier: NCT00548392 - Recruiting
  Breast Cancer
  
• Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis
  ClinicalTrials.gov Identifier: NCT00178789 - Completed
  Deep Venous Thrombosis
  
• Soothe Versus Refresh
  ClinicalTrials.gov Identifier: NCT00284999 - Completed
  Dry Eye Syndromes
  
• Sopran - Omeprazole Treatment Versus Surgery
  ClinicalTrials.gov Identifier: NCT00256737 - Completed
  GERD
  
• Sorafenib (BAY 43-9006) in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00095693 - Completed
  anaplastic thyroid cancer; follicular thyroid cancer; insular thyroid cancer; papillary thyroid cancer; Thyroid Cancer
  
• Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00526799 - Recruiting
  Ovarian Cancer
  
• Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00217399 - Recruiting
  Breast Cancer
  
• Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00572078 - Recruiting
  Solid Tumors
  
• Sorafenib and Bevacizumab in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126503 - Recruiting
  renal clear cell carcinoma; recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Sorafenib and Bevacizumab in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer That is Recurrent or Did Not Respond to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00436215 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Sorafenib and Bevacizumab in Treating Patients With Refractory, Metastatic, or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00098592 - Recruiting
  Cancer
  
• Sorafenib and Bortezomib in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00303797 - Suspended
  Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific
  
• Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00536575 - Recruiting
  Multiple Myeloma
  
• Sorafenib and Cetuximab in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00343772 - Recruiting
  Colorectal Cancer
  
• Sorafenib and Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00516828 - Not yet recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00126620 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00474929 - Recruiting
  Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
  
• Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00095966 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Sorafenib and Gemcitabine in Treating Patients With Recurrent or Refractory Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00096395 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer
  
• Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00547443 - Recruiting
  Lung Cancer
  
• Sorafenib and Interferon alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00098618 - Active, not recruiting
  recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; renal granular cell carcinoma
  
• Sorafenib and Interferon alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00101114 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
  
• Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg
  ClinicalTrials.gov Identifier: NCT00565968 - Recruiting
  Melanoma (Skin)
  
• Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00573755 - Recruiting
  Breast Cancer
  
• Sorafenib and RAD001 Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00384969 - Recruiting
  Renal Cell Carcinoma
  
• Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent
  ClinicalTrials.gov Identifier: NCT00544609 - Not yet recruiting
  Bladder Cancer
  
• Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma
  ClinicalTrials.gov Identifier: NCT00349206 - Recruiting
  Melanoma (Skin)
  
• Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
  ClinicalTrials.gov Identifier: NCT00329719 - Recruiting
  Brain and Central Nervous System Tumors
  
• Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00255658 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00543335 - Not yet recruiting
  Lung Cancer
  
• Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00573690 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
  ClinicalTrials.gov Identifier: NCT00335764 - Recruiting
  Brain and Central Nervous System Tumors
  
• Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00456716 - Recruiting
  Lung Cancer
  
• Sorafenib in Combination With Carboplatin and Paclitaxel in Metastatic or Recurrent Head and Neck Squamous Cell Cancer
  ClinicalTrials.gov Identifier: NCT00494182 - Recruiting
  Head and Neck Cancer; Squamous Cell Carcinoma
  
• Sorafenib in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00510289 - Recruiting
  Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic
  
• Sorafenib in Resected Non-Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00532025 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00492258 - Recruiting
  Kidney Cancer
  
• Sorafenib in Treating Patients Undergoing Radical Prostatectomy for High-Risk Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00466752 - Recruiting
  Prostate Cancer
  
• Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00405366 - Recruiting
  Kidney Cancer
  
• Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126659 - Active, not recruiting
  renal clear cell carcinoma; recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00126568 - Recruiting
  anaplastic thyroid cancer; recurrent thyroid cancer
  
• Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00112671 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter
  
• Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
  ClinicalTrials.gov Identifier: NCT00238121 - Active, not recruiting
  Sarcoma
  
• Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
  ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
  adult soft tissue sarcoma
  
• Sorafenib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00436579 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
  Lung Cancer
  
• Sorafenib in Treating Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00304122 - Recruiting
  Sarcoma
  
• Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain
  ClinicalTrials.gov Identifier: NCT00301847 - Active, not recruiting
  Brain and Central Nervous System Tumors; Kidney Cancer
  
• Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed On or After Previous Treatment With Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00265798 - Recruiting
  Gastrointestinal Stromal Tumor
  
• Sorafenib in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00107432 - Active, not recruiting
  advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
  
• Sorafenib in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096434 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00093457 - Completed
  recurrent prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00496756 - Recruiting
  Kidney Cancer
  
• Sorafenib in Treating Patients with Metastatic Or Unresectable Solid Tumors, Multiple Myeloma, Or Non-Hodgkin''s Lymphoma with Or Without Impaired Liver Or Kidney Function
  ClinicalTrials.gov Identifier: NCT00118170 - Active, not recruiting
  adult non-Hodgkin''s lymphoma; adult solid tumor; Multiple Myeloma; refractory plasma cell neoplasm
  
• Sorafenib in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00093431 - Recruiting
  Prostate Cancer
  
• Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00390325 - Recruiting
  Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
  
• Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
  ClinicalTrials.gov Identifier: NCT00245102 - Recruiting
  Ovarian Cancer; Sarcoma
  
• Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission
  ClinicalTrials.gov Identifier: NCT00522301 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00093626 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Sorafenib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00131911 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Sorafenib in Treating Patients With Recurrent Diffuse Large B-Cell Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00131937 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00278382 - Recruiting
  Lymphoma
  
• Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
  Head and Neck Cancer
  
• Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00093613 - Active, not recruiting
  adult anaplastic oligodendroglioma; adult anaplastic astrocytoma; adult giant cell glioblastoma; adult gliosarcoma; recurrent adult brain tumor
  
• Sorafenib in Treating Patients With Recurrent or Progressive Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00100763 - Recruiting
  Lung Cancer
  
• Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemias, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00217646 - Recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; ...
  
• Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00112905 - Recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00303966 - Recruiting
  Leukemia
  
• Sorafenib in Treating Patients With Relapsed or Refractory Leukemia
  ClinicalTrials.gov Identifier: NCT00131989 - Active, not recruiting
  adult acute erythroid leukemia; adult acute lymphoblastic leukemia; adult acute monoblastic and acute monocytic leukemia; ...
  
• Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00253578 - Recruiting
  Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
  
• Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)
  ClinicalTrials.gov Identifier: NCT00330421 - Recruiting
  Sarcoma
  
• Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00098540 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Sorafenib in Treating Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
  Stage IV Melanoma
  
• Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
  ClinicalTrials.gov Identifier: NCT00238212 - Active, not recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
  ClinicalTrials.gov Identifier: NCT00343694 - Suspended
  Leukemia; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Sorafenib Plus Tegafur/Uracil (UFUR®) for HCC
  ClinicalTrials.gov Identifier: NCT00464919 - Recruiting
  Hepatocellular Carcinoma
  
• Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
  ClinicalTrials.gov Identifier: NCT00452218 - Recruiting
  Pulmonary Arterial Hypertension
  
• Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00414388 - Recruiting
  Prostate Cancer
  
• Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00281957 - Recruiting
  Melanoma (Skin)
  
• Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00114244 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
  renal clear cell carcinoma; Stage IV Renal Cell Cancer
  
• Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00096200 - Recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Sorafenib With TACE to Treat Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00478374 - Recruiting
  Hepatocellular Carcinoma
  
• Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00538005 - Recruiting
  Melanoma (Skin)
  
• Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
  ClinicalTrials.gov Identifier: NCT00329641 - Recruiting
  Intraocular Melanoma
  
• Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00134069 - Active, not recruiting
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Locally Advanced Gastric or Gastroesophageal Junction Cancer That Cannot be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00253370 - Suspended
  Gastric Cancer
  
• Sorafenib, Gemcitabine, and Capecitabine in Treating Patients with Unresectable and/Or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00121251 - Recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; stage III renal cell cancer
  
• Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00492505 - Recruiting
  Melanoma (Skin)
  
• Sorafenib/Docetaxel Dose Escalation Trial
  ClinicalTrials.gov Identifier: NCT00562523 - Recruiting
  Cancer
  
• Sorbinil Retinopathy Trial (SRT)
  ClinicalTrials.gov Identifier: NCT00000159 - Completed
  Diabetic Retinopathy; Diabetes Mellitus
  
• Source Profiling of Biohazardous Aerosols in Hospitals
  ClinicalTrials.gov Identifier: NCT00517660 - Completed
  Respiratory Tract Infections
  
• Sources of the Variability of the Response to Fluindione in Elderly Patients (PREPA)
  ClinicalTrials.gov Identifier: NCT00313469 - Recruiting
  Cardiovascular Disease
  
• Sources of Variability in Peak Expiratory Flow
  ClinicalTrials.gov Identifier: NCT00005382 - Completed
  Asthma; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• South Central Foundation - WISEWOMAN Project
  ClinicalTrials.gov Identifier: NCT00153348 - Active, not recruiting
  CVD risk
  
• South Danish Diabetes Study
  ClinicalTrials.gov Identifier: NCT00121966 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Southern Methodist Alcohol Research Trial (SMART)
  ClinicalTrials.gov Identifier: NCT00374153 - Active, not recruiting
  Alcohol Consumption
  
• Soy and Lipoproteins in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00201162 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Menopause
  
• Soy Estrogen Alternative Study (SEA)
  ClinicalTrials.gov Identifier: NCT00000612 - Completed
  Cardiovascular Diseases; Endometrial Hyperplasia; Heart Diseases; Menopausal Complaints; Uterine Diseases; Menopause
  
• Soy Food and Coronary Heart Disease in Women
  ClinicalTrials.gov Identifier: NCT00241735 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Soy Isoflavone Compared With No Treatment Before Surgery in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022269 - No longer recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer
  
• Soy Isoflavones and Breast Cancer Risk Reduction
  ClinicalTrials.gov Identifier: NCT00204490 - Recruiting
  Breast Cancer
  
• Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate
  ClinicalTrials.gov Identifier: NCT00078923 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
  
• Soy Protein and Breast Cancer Risk Reduction
  ClinicalTrials.gov Identifier: NCT00204477 - Recruiting
  Breast Cancer
  
• Soy Protein in Early Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00067678 - Completed
  Diabetic Nephropathy; Diabetes Mellitus
  
• Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels
  ClinicalTrials.gov Identifier: NCT00031746 - Active, not recruiting
  Prostate Cancer
  
• Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
  ClinicalTrials.gov Identifier: NCT00031720 - Recruiting
  Breast Cancer; breast cancer in situ; Hot Flashes
  
• Soy Protein/Isoflavones and Venlafaxine in Treating Hot Flashes in Patients Receiving Hormone Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00354432 - Recruiting
  Hot Flashes; Prostate Cancer
  
• Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00345813 - Active, not recruiting
  Prostate Cancer
  
• Soy, Bone and Health in College Females
  ClinicalTrials.gov Identifier: NCT00244478 - Completed
  Osteoporosis; Obesity
  
• Soy, Selenium and Breast Cancer Risk
  ClinicalTrials.gov Identifier: NCT00555386 - Recruiting
  Breast Cancer (Risk)
  
• Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight
  ClinicalTrials.gov Identifier: NCT00343434 - Active, not recruiting
  Breast Cancer; Obesity
  
• Soybean Based Diets and CVD Risk Factors
  ClinicalTrials.gov Identifier: NCT00175097 - Completed
  Hypercholesterolemia
  
• SP Resistance and Falciparum Malaria Transmission
  ClinicalTrials.gov Identifier: NCT00299247 - Not yet recruiting
  Plasmodium Falciparum Malaria
  
• SP-303T Applied to the Skin of Patients with Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success with Acyclovir
  ClinicalTrials.gov Identifier: NCT00002310 - Completed
  Herpes Simplex; HIV Infections
  
• SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients
  ClinicalTrials.gov Identifier: NCT00299897 - Active, not recruiting
  HIV Infections; Human Immunodeficiency Virus
  
• Spaced Versus Massed Skill Learning
  ClinicalTrials.gov Identifier: NCT00426465 - Recruiting
  Healthy Volunteer
  
• Spacer Comparison In Adult Asthmatics
  ClinicalTrials.gov Identifier: NCT00369993 - Active, not recruiting
  Asthma
  
• Spanish Cohort for the Study of the Effect of CPAP in Hypertension (CEPECTA)
  ClinicalTrials.gov Identifier: NCT00202527 - Recruiting
  Sleep Apnea; Hypertension
  
• Spanish Diabetes Self-Management Program
  ClinicalTrials.gov Identifier: NCT00496145 - Completed
  Type 2 Diabetes
  
• Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy
  ClinicalTrials.gov Identifier: NCT00264680 - Recruiting
  Epilepsy
  
• SPATAX
  ClinicalTrials.gov Identifier: NCT00140829 - Recruiting
  Cerebellar Ataxias; Spastic Paraplegias
  
• Spatial Neglect and Bias in Near and Far Space
  ClinicalTrials.gov Identifier: NCT00350012 - Recruiting
  Stroke
  
• SPC2996 in Chronic Lymphocytic Leukaemia
  ClinicalTrials.gov Identifier: NCT00285103 - Recruiting
  Chronic Lymphocytic Leukemia
  
• SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms
  ClinicalTrials.gov Identifier: NCT00367835 - Completed
  ADHD
  
• Special Turku Atherosclerosis Risk Factor Intervention Project for Children (STRIP)
  ClinicalTrials.gov Identifier: NCT00223600 - Active, not recruiting
  Atherosclerosis
  
• Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
  ClinicalTrials.gov Identifier: NCT00484302 - Recruiting
  Marijuana Abuse; Psychotic Disorders; Schizophrenia
  
• Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
  ClinicalTrials.gov Identifier: NCT00001875 - Recruiting
  Hematologic Disease; Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome; Myeloproliferative Disorder
  
• Specialized Center of Research in Occupational and Immunologic Lung Disease
  ClinicalTrials.gov Identifier: NCT00005280 - Completed
  Lung Diseases, Obstructive; Asbestosis; Silicosis; Pneumoconiosis; Chronic Obstructive Pulmonary Disease
  
• Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men
  ClinicalTrials.gov Identifier: NCT00218712 - Recruiting
  HIV Infections
  
• Specialized Treatment Early in Psychosis (STEP)
  ClinicalTrials.gov Identifier: NCT00309452 - Recruiting
  Schizophrenia and Disorders With Psychotic Features
  
• Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
  ClinicalTrials.gov Identifier: NCT00369538 - Not yet recruiting
  Proteinuria; Hypertension; End Stage Renal Disease
  
• Specific Care and Assistance Plan for Alzheimer’s Disease
  ClinicalTrials.gov Identifier: NCT00480220 - Recruiting
  Alzheimer's Disease
  
• Specific Effects of Escitalopram on Neuroendocrine Response
  ClinicalTrials.gov Identifier: NCT00150527 - Recruiting
  Cortisol, Adrenocorticotropic hormone
  
• Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV
  ClinicalTrials.gov Identifier: NCT00266526 - Active, not recruiting
  Birch Pollen Allergy
  
• Specific Interventions for Agitation in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00018291 - Completed
  Alzheimer's Disease; Dementia
  
• Specimen Collection for Individuals with Lung Disease Associated with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00001884 - Recruiting
  Pulmonary Fibrosis; Rheumatoid Arthritis
  
• Specimen Collections from Patients with HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
  ClinicalTrials.gov Identifier: NCT00006518 - Recruiting
  HIV Infection; Kaposi's Sarcoma
  
• Specimen Procurement from People with Hereditary Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00084305 - Recruiting
  Pulmonary Fibrosis
  
• Specimens From Normal Controls
  ClinicalTrials.gov Identifier: NCT00341211 - Active, not recruiting
  Viral Infections
  
• Speckle Tracking Imaging in Patients With Low Ejection Fraction Aortic Stenosis (SPArKLE-AS)
  ClinicalTrials.gov Identifier: NCT00535899 - Not yet recruiting
  Aortic Stenosis
  
• Speckle Tracking in Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00489957 - Recruiting
  Cardiomyopathy
  
• SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00443599 - Recruiting
  Cardiopulmonary Bypass; Heart Defects, Congenital; Hyperglycemia
  
• Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With Active Breathing Coordinator
  ClinicalTrials.gov Identifier: NCT00321048 - Recruiting
  Breast Neoplasms; Carcinoma, Ductal; Adenocarcinoma
  
• SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00364429 - Terminated
  Schizophrenia
  
• SPECT Study With SB-773812 In Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00269035 - Terminated
  Schizophrenia
  
• SPECT/CT in Endocrine and Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00230139 - Recruiting
  Endocrine and Neuroendocrine Tumors
  
• SPECTACL: SPECTroscopic Assessment of Coronary Lipid
  ClinicalTrials.gov Identifier: NCT00330928 - Active, not recruiting
  Angina Pectoris; Angina, Unstable; Myocardial Infarction
  
• Spectral Diagnosis of Cutaneous Malignancy
  ClinicalTrials.gov Identifier: NCT00476905 - Recruiting
  Skin Cancer
  
• Spectroscopy in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181831 - Active, not recruiting
  Bipolar Disorder; ADHD
  
• Spectroscopy Versus Standard Care in Cervical Cancer Patients
  ClinicalTrials.gov Identifier: NCT00529464 - Recruiting
  Cervical Cancer
  
• Spectroscopy With Surface Coils and Decoupling
  ClinicalTrials.gov Identifier: NCT00581815 - Recruiting
  Adrenal Cortical Cancer; Brain Cancer; Breast Cancer; CNS Cancer; Colon Cancer; HEENT Cancer; Hodgkin's Disease; Kaposi's Sarcoma; Liver Cancer; Lung Cancer; Non-Hodgkin's Lymphoma; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Sarcoma; Squamous Cell Carcinoma; Thyroid Cancer
  
• SPECTRUM: Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00460265 - Recruiting
  Recurrent and/or Metastatic Head and Neck Cancer
  
• Speech Characteristics in Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005157 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Spheramine® in advanced Parkinson's disease (The STEPS Trial)
  ClinicalTrials.gov Identifier: NCT00059007 - Recruiting
  Parkinson Disease
  
• SPHERE Hypertension Baseline Data Study
  ClinicalTrials.gov Identifier: NCT00444496 - Completed
  Hypertension
  
• SPHERE Hypertension Intervention Study
  ClinicalTrials.gov Identifier: NCT00495833 - Recruiting
  Hypertension
  
• Spherical Aberration and Contrast Sensitivity in IOLs
  ClinicalTrials.gov Identifier: NCT00576485 - Completed
  Cataract; Signs and Symptoms; Pseudophakia; Lens Diseases
  
• Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version
  ClinicalTrials.gov Identifier: NCT00119184 - Recruiting
  Fetal Presentation, Breech
  
• Spinal Anesthesia and Blood Pressure
  ClinicalTrials.gov Identifier: NCT00435422 - Recruiting
  Hypovolemia
  
• Spinal Anesthesia With Articaine and Bupivacaine for Outpatient Lower Limb Surgery
  ClinicalTrials.gov Identifier: NCT00332735 - Completed
  Spinal Anesthesia
  
• Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery.
  ClinicalTrials.gov Identifier: NCT00247741 - Active, not recruiting
  Spinal Anesthesia
  
• Spinal Clearance Study: Expediting the Spinal Clearance Process in the Major Trauma Patient
  ClinicalTrials.gov Identifier: NCT00163826 - Recruiting
  Multiple Trauma; Traumatic Brain Injury; Spinal Injuries
  
• Spinal Cord Injury Vocational Support
  ClinicalTrials.gov Identifier: NCT00117806 - Recruiting
  Spinal Cord Injuries; Rehabilitation, Vocational
  
• Spinal Cord Plasticity
  ClinicalTrials.gov Identifier: NCT00073606 - Active, not recruiting
  Healthy
  
• Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity
  ClinicalTrials.gov Identifier: NCT00399841 - Recruiting
  Intractable Neuropathic Pain; Pain; Back Pain; Lower Extremity Pain
  
• Spinal Cord Stimulation (SCS) in Refractory Angina
  ClinicalTrials.gov Identifier: NCT00121654 - Recruiting
  Angina Pectoris
  
• Spinal Cord Stimulation Efficacy Measures
  ClinicalTrials.gov Identifier: NCT00351208 - Recruiting
  Chronic Pain in the Trunk and Limbs
  
• Spinal Cord Stimulation for Chronic and Intractable Back Pain
  ClinicalTrials.gov Identifier: NCT00370695 - Recruiting
  Back Pain
  
• Spinal Cord Stimulation for Low Back Pain
  ClinicalTrials.gov Identifier: NCT00205868 - Active, not recruiting
  Chronic Pain
  
• Spinal Cord Stimulation for Painful Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00487981 - Recruiting
  Diabetic Neuropathy; Pain; Peripheral Neuropathy
  
• Spinal Cord Stimulation to Restore Cough
  ClinicalTrials.gov Identifier: NCT00116337 - Recruiting
  Spinal Cord Injury
  
• Spinal Magnetic Stimulation in Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00443469 - Recruiting
  Neuropathic Pain
  
• Spinal Manipulation for Treatment of Chronic Headaches
  ClinicalTrials.gov Identifier: NCT00246350 - Completed
  Headache Disorders
  
• Spinal Manipulative Therapy for Low Back Pain
  ClinicalTrials.gov Identifier: NCT00294229 - Active, not recruiting
  Low Back Pain
  
• Spinal Manipulative Therapy: Dual-Task Performance
  ClinicalTrials.gov Identifier: NCT00297934 - Completed
  Balance
  
• Spinal Reflexes in Motor Skill Learning
  ClinicalTrials.gov Identifier: NCT00076583 - Completed
  Healthy
  
• Spinal Surgery-Adult Dose Escalation
  ClinicalTrials.gov Identifier: NCT00102037 - Completed
  Spinal Fusion
  
• Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy
  ClinicalTrials.gov Identifier: NCT00492453 - Recruiting
  Spinal Anesthesia; General Anesthesia; Postoperative Pain
  
• Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone
  ClinicalTrials.gov Identifier: NCT00405600 - Recruiting
  Degenerative Lumbar Disc Disease; Spondylolisthesis; Spinal Stenosis
  
• Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation
  ClinicalTrials.gov Identifier: NCT00000410 - Completed
  Herniated Disc; Low Back Pain
  
• Spine Patient Outcomes Research Trial (SPORT): Degenerative Spondylolisthesis with Spinal Stenosis
  ClinicalTrials.gov Identifier: NCT00000409 - Completed
  Spondylolisthesis; Spinal Stenosis; Low Back Pain
  
• Spine Patient Outcomes Research Trial (SPORT): Spinal Stenosis
  ClinicalTrials.gov Identifier: NCT00000411 - Completed
  Spinal Stenosis; Low Back Pain
  
• Spine Research With Roentgen Stereophotogrammetric Analysis
  ClinicalTrials.gov Identifier: NCT00493558 - Not yet recruiting
  Spondylolisthesis; Degenerative Lumbar Disc Disease; Spinal Stenosis
  
• SPIRIT FIRST Clinical Trial of the Abbott MULTI-LINK VISION®-E RX Drug Eluting Stent System
  ClinicalTrials.gov Identifier: NCT00180453 - Active, not recruiting
  Coronary Artery Disease; Everolimus; Vascular Disease; Myocardial Ischemia; Coronary Artery Stenosis
  
• SPIRIT II: A Clinical Evaluation of the XIENCE™ V Everolimus Eluting Coronary Stent System
  ClinicalTrials.gov Identifier: NCT00180310 - Active, not recruiting
  Coronary Artery Disease
  
• SPIRIT III Clinical Trial of the XIENCE™ V Everolimus Eluting Coronary Stent System (EECSS)
  ClinicalTrials.gov Identifier: NCT00180479 - Active, not recruiting
  Coronary Artery Disease
  
• SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE™ V Everolimus Eluting Coronary Stent System
  ClinicalTrials.gov Identifier: NCT00307047 - Recruiting
  Coronary Artery Disease
  
• SPIRIT V. Post-Marketing Evaluation of the XIENCE™ V Everolimus Eluting Coronary Stent System in Europe
  ClinicalTrials.gov Identifier: NCT00402272 - Recruiting
  Coronary Disease; Coronary Artery Disease; Coronary Restenosis
  
• SPIRITT - Q2W FOLFIRI Regimen Plus Panitumumab or a Q2W FOLFIRI Regimen Plus Bevacizumab for 2nd-Line mCRC
  ClinicalTrials.gov Identifier: NCT00418938 - Recruiting
  Cancer; Colon Cancer; Colorectal Cancer; Metastatic Cancer; Rectal Cancer; Metastatic Colorectal Cancer
  
• Spirituality and Depression Study
  ClinicalTrials.gov Identifier: NCT00322777 - Active, not recruiting
  Unipolar Depression
  
• Spirituality and Will to Live in Patients with HIV/AIDS
  ClinicalTrials.gov Identifier: NCT00122902 - Completed
  HIV Infections
  
• Spirituality, Religiosity, and Immune Functioning
  ClinicalTrials.gov Identifier: NCT00066924 - Completed
  Cancer; Depression; Dying Process
  
• Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
  ClinicalTrials.gov Identifier: NCT00239408 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• SPIRIVA in Ususal Care
  ClinicalTrials.gov Identifier: NCT00274079 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Spiriva® Assessment of FEV1 (SAFE).
  ClinicalTrials.gov Identifier: NCT00277264 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Spirometry and Methacholine Challenge Test in Asthmatic Children Age 3-6years
  ClinicalTrials.gov Identifier: NCT00550758 - Terminated
  Asthma; Recurrent Cough
  
• Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00240656 - Completed
  Hypertension, Pulmonary
  
• Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00498537 - Completed
  Diabetic Nephropathy
  
• Spironolactone in Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00317954 - Completed
  Diabetic Nephropathy
  
• Spironolactone in Patients With Single Ventricle Heart
  ClinicalTrials.gov Identifier: NCT00211081 - Active, not recruiting
  Single Ventricle
  
• Spironolactone Safety in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00328809 - Recruiting
  End Stage Renal Disease; Congestive Heart Failure
  
• Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
  ClinicalTrials.gov Identifier: NCT00276289 - Recruiting
  Idiopathic Hypercalciuria; Hypokalemia Caused by Thiazide Diuretics
  
• SPL7013 Gel - Male Tolerance Study
  ClinicalTrials.gov Identifier: NCT00370357 - Active, not recruiting
  Human Immunodeficiency Virus (HIV)
  
• sPLA2 Inhibition to Decrease Enzyme Release After PCI Trial
  ClinicalTrials.gov Identifier: NCT00533039 - Recruiting
  Coronary Artery Disease
  
• Spleen Size in Peripheral Blood Stem Cell Donors
  ClinicalTrials.gov Identifier: NCT00006148 - Completed
  Splenomegaly
  
• Splinting for Duupuytren's Contracture Release
  ClinicalTrials.gov Identifier: NCT00575458 - Recruiting
  Dupuytren's Disease
  
• Split-Thickness Skin Graft Donor Site Wound Healing Study
  ClinicalTrials.gov Identifier: NCT00392301 - Recruiting
  Split-Thickness Skin Graft Donor Sites
  
• Spontaneous Bacterial Peritonitis: Incidence, Risk Factors and Outcome
  ClinicalTrials.gov Identifier: NCT00490217 - Completed
  Spontaneous Bacterial Peritonitis; Primary Peritonitis; Ascites
  
• Sporozoite Challenge of Polyprotein Vaccinees
  ClinicalTrials.gov Identifier: NCT00375128 - Completed
  Malaria, Falciparum; Malaria
  
• Sports in Hypertension of the Elderly
  ClinicalTrials.gov Identifier: NCT00315224 - Completed
  Hypertension
  
• Sports to Prevent Obesity
  ClinicalTrials.gov Identifier: NCT00318877 - Active, not recruiting
  Obesity
  
• Sports to Prevent Obesity: Feasibility and Pilot RCT
  ClinicalTrials.gov Identifier: NCT00186173 - Active, not recruiting
  Obesity
  
• Spousal Relationships and Pain in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00386620 - Active, not recruiting
  Breast Cancer
  
• SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction
  ClinicalTrials.gov Identifier: NCT00299832 - Completed
  Hypertension
  
• SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00299806 - Completed
  Hypertension
  
• SPP100 Dose Finding Study in Japan
  ClinicalTrials.gov Identifier: NCT00311012 - Completed
  Hypertension
  
• Spread of Dermatophytes Among Families
  ClinicalTrials.gov Identifier: NCT00233493 - Recruiting
  Onychomycosis; Tinea Pedis
  
• SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC
  ClinicalTrials.gov Identifier: NCT00440271 - Recruiting
  HIV Infections
  
• SPRiNG: SCIO-469 Patients with Rheumatoid Arthritis Not Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00089921 - Active, not recruiting
  Rheumatoid Arthritis
  
• SPRINT - Randomized Trial of Tibial Fracture Fixation
  ClinicalTrials.gov Identifier: NCT00038129 - Completed
  Tibial Fracture
  
• Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough
  ClinicalTrials.gov Identifier: NCT00173225 - Recruiting
  Asthma; COPD; Cough
  
• Sputum Cytology in Screening Heavy Smokers For Lung Cancer
  ClinicalTrials.gov Identifier: NCT00103363 - Active, not recruiting
  Non-small cell lung cancer; Small Cell Lung Cancer
  
• SPY Imaging System: Its Role in Pediatric Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00446927 - Recruiting
  Cardiopulmonary Bypass; Congenital Heart Defects
  
• Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00021385 - Active, not recruiting
  recurrent ovarian germ cell tumor; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; stage IV ovarian germ cell tumor; ...
  
• SR-45023A in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003822 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004049 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00206115 - Completed
  Schizophrenic Disorder
  
• SR34006 Compared to Placebo in Patients who have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis
  ClinicalTrials.gov Identifier: NCT00071279 - Completed
  Pulmonary Embolism; Deep Vein Thrombosis
  
• SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00062803 - Completed
  Pulmonary Embolism
  
• SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis
  ClinicalTrials.gov Identifier: NCT00296881 - Active, not recruiting
  Periodontitis
  
• SRS Study in Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00489008 - Active, not recruiting
  Lung Cancer
  
• SSI(dsFv)-PE38 Anti-Mesothelin Immunotoxin to Treat Advanced Cancers
  ClinicalTrials.gov Identifier: NCT00065481 - Recruiting
  Carcinoma
  
• SSR240600C Treatment in Women With Overactive Bladder
  ClinicalTrials.gov Identifier: NCT00564226 - Recruiting
  Overactive Bladder
  
• SSRI and Buprenorphine
  ClinicalTrials.gov Identifier: NCT00475878 - Recruiting
  Opiate Dependence; Depression
  
• SSRI Effects on Semen Parameters in Men
  ClinicalTrials.gov Identifier: NCT00385762 - Active, not recruiting
  Healthy
  
• SSRI-Induced Activation Syndrome in Pediatric Obsessive Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00382291 - Not yet recruiting
  Obsessive-Compulsive Disorder
  
• St. John''s Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
  ClinicalTrials.gov Identifier: NCT00118833 - Completed
  Anxiety Disorders; Mental Health
  
• St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety
  ClinicalTrials.gov Identifier: NCT00451516 - Recruiting
  Depressive Disorder, Major; Anxiety Disorders
  
• St. John's Wort for Tobacco Cessation
  ClinicalTrials.gov Identifier: NCT00405912 - Recruiting
  Smoking; Nicotine Dependence
  
• St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
  ClinicalTrials.gov Identifier: NCT00005805 - Completed
  Lymphoma; Multiple Myeloma; Leukemia; Eye Cancer
  
• St. John's Wort in the Treatment of Raynaud's Phenomenon.
  ClinicalTrials.gov Identifier: NCT00351117 - Not yet recruiting
  Raynaud's Disease
  
• St. John's Wort Versus Placebo in Social Phobia
  ClinicalTrials.gov Identifier: NCT00035412 - Completed
  Phobic Disorders
  
• St. John's Wort vs. Placebo in Obsessive-Compulsive Disorder.
  ClinicalTrials.gov Identifier: NCT00035438 - Completed
  Obsessive Compulsive Disorder
  
• St. Jude Open Label H5 Trial
  ClinicalTrials.gov Identifier: NCT00311675 - Active, not recruiting
  Influenza
  
• ST1571 to Treat Patients with Recurrent Meningiomas
  ClinicalTrials.gov Identifier: NCT00069667 - Recruiting
  Meningioma
  
• STA-4783 and Paclitaxel for Treatment of Solid Tumors
  ClinicalTrials.gov Identifier: NCT00088114 - Completed
  Neoplasms
  
• STA-4783 in Combination with Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients with Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00088088 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• STA-4783 With Paclitaxel Versus Paclitaxel Alone in Melanoma
  ClinicalTrials.gov Identifier: NCT00522834 - Recruiting
  Melanoma
  
• STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma
  ClinicalTrials.gov Identifier: NCT00084214 - Active, not recruiting
  Melanoma
  
• STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients with Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00088101 - Active, not recruiting
  Hematological Malignancies; Leukemia; Lymphoma
  
• STA-5326 in Crohn's Disease Patients
  ClinicalTrials.gov Identifier: NCT00088062 - Completed
  Crohn's Disease
  
• STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00263237 - Active, not recruiting
  Common Variable Immunodeficiency
  
• STAAR-1 Clinical Study
  ClinicalTrials.gov Identifier: NCT00369772 - Completed
  Chronic Kidney Disease; Chronic Renal Insufficiency; Kidney Disease; Pre-Dialysis; Pre-ESRD
  
• STAAR-2 Clinical Study
  ClinicalTrials.gov Identifier: NCT00368901 - Completed
  Chronic Kidney Disease; Chronic Renal Insufficiency; Kidney Disease; Pre-Dialysis; Pre-ESRD
  
• STAAR-3 Clinical Study
  ClinicalTrials.gov Identifier: NCT00369733 - Completed
  Chronic Kidney Disease; Chronic Renal Insufficiency; Kidney Disease; Pre-Dialysis; Pre-ESRD
  
• Staccato Prochlorperazine Thorough QT/QTc Study
  ClinicalTrials.gov Identifier: NCT00543062 - Recruiting
  Migraine
  
• Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection
  ClinicalTrials.gov Identifier: NCT00113126 - Completed
  HIV Infection; AIDS
  
• Staccato™ Alprazolam for Inhalation in Panic Attack
  ClinicalTrials.gov Identifier: NCT00477451 - Recruiting
  Panic Attack
  
• Staccato® Alprazolam for Inhalation in Panic Disorder
  ClinicalTrials.gov Identifier: NCT00444522 - Completed
  Healthy
  
• Staccato® Fentanyl for Inhalation in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00402350 - Completed
  Breakthrough Pain
  
• Staccato® Loxapine for Inhalation in Patients With Migraine Headache
  ClinicalTrials.gov Identifier: NCT00489476 - Recruiting
  Migraine
  
• Staccato® Loxapine for Inhalation in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00444028 - Completed
  Schizophrenia
  
• Staccato® Prochlorperazine for Inhalation in Migraine
  ClinicalTrials.gov Identifier: NCT00422812 - Active, not recruiting
  Migraine Headache; Aura
  
• StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
  ClinicalTrials.gov Identifier: NCT00369577 - Completed
  Schizophrenia
  
• Stachybotrys Induced Hemorrhage in the Developing Lung
  ClinicalTrials.gov Identifier: NCT00011700 - Recruiting
  idiopathic pulmonary hemorrhage
  
• STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
  ClinicalTrials.gov Identifier: NCT00526396 - Recruiting
  Small Cell Lung Cancer
  
• Stage I/II NSCLC Perioperative Chemotherapy
  ClinicalTrials.gov Identifier: NCT00198354 - Active, not recruiting
  Non-Small Cell Lung Cancer Stage I and II; Peri-Operative Chemotherapy
  
• Stage IV Colorectal CA ALIMTA
  ClinicalTrials.gov Identifier: NCT00166465 - Suspended
  Locally Advanced Unresectable or Stage IV Colorectal Cancer
  
• Stage Matched Intervention to Increase Dual Method Use
  ClinicalTrials.gov Identifier: NCT00436306 - Active, not recruiting
  Contraception; Sexually Transmitted Diseases; Pregnancy
  
• Stair Instead of Elevator Use at Work: Cardiovascular Primary Preventive Effects on Hospital Employees.
  ClinicalTrials.gov Identifier: NCT00520195 - Completed
  Cardiovascular Diseases
  
• Stalevo in Early Wearing-Off Patients
  ClinicalTrials.gov Identifier: NCT00125567 - Active, not recruiting
  Idiopathic Parkinson''s Disease
  
• Standard and Immunostimulating Enteral Nutrition in Surgical Patients
  ClinicalTrials.gov Identifier: NCT00576940 - Completed
  Gastric Cancer; Pancreatic Cancer
  
• Standard Antiretroviral Versus Multi-Class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
  ClinicalTrials.gov Identifier: NCT00525733 - Not yet recruiting
  HIV Infections
  
• Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003680 - Active, not recruiting
  inflammatory breast cancer; stage III breast cancer; Quality of Life
  
• Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002755 - Active, not recruiting
  stage IIIA breast cancer; stage II breast cancer
  
• Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00042770 - Recruiting
  Malignant Pleural Effusion; Pulmonary Complications
  
• Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death
  ClinicalTrials.gov Identifier: NCT00524862 - Not yet recruiting
  Coronary Heart Disease; Congestive Heart Failure; Ventricular Dysfunction; Low Cardiac Output; Sudden Cardiac Death
  
• Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
  ClinicalTrials.gov Identifier: NCT00049465 - Active, not recruiting
  Cancer; Depression; Fatigue; menopausal symptoms; psychosocial effects and treatment; transitional care planning
  
• Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
  ClinicalTrials.gov Identifier: NCT00226408 - Recruiting
  Adjuvant; Stage III Malignant Melanoma; Interferon Alpha; Therapy
  
• Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
  ClinicalTrials.gov Identifier: NCT00422591 - Recruiting
  Leukemia; Acute Myeloid Leukemia; AML
  
• Standard Open Surgery versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA)
  ClinicalTrials.gov Identifier: NCT00094575 - Recruiting
  Abdominal Aortic Aneurysm
  
• Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00226473 - Recruiting
  Metastatic Melanoma
  
• Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma
  ClinicalTrials.gov Identifier: NCT00003916 - Active, not recruiting
  adult glioblastoma multiforme; adult anaplastic astrocytoma
  
• Standard Reaming Versus Reaming/Irrigating/Aspirating for Intramedullary Nailing of Femoral Shaft Fractures
  ClinicalTrials.gov Identifier: NCT00534326 - Recruiting
  Femoral Fractures
  
• Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003240 - Active, not recruiting
  stage III non-small cell lung cancer; stage IV non-small cell lung cancer; stage II non-small cell lung cancer; stage I non-small cell lung cancer
  
• Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003674 - Completed
  recurrent colon cancer; extensive stage small cell lung cancer; stage IV prostate cancer; stage IV non-small cell lung cancer; veno-occlusive disease; ...
  
• Standard Versus Continuous Capecitabine in Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00418028 - Recruiting
  Metastatic Breast Cancer
  
• Standard vs. 3-Dimensional Coronary Angiography: a Paired Comparison
  ClinicalTrials.gov Identifier: NCT00447148 - Completed
  Coronary Artery Disease
  
• Standard Vs. Biofilm Susceptibility Testing in CF
  ClinicalTrials.gov Identifier: NCT00153634 - Recruiting
  Cystic Fibrosis; Chronic Bronchitis
  
• Standard Vs. Reduced-Intensity Conditioning in Patients with Acute Myeloid Leukemia in First Remission
  ClinicalTrials.gov Identifier: NCT00150878 - Recruiting
  Acute Myeloid Leukemia
  
• Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer
  ClinicalTrials.gov Identifier: NCT00083304 - Completed
  Breast Cancer; Metastases
  
• Standardized Comparison of Triage in EMS
  ClinicalTrials.gov Identifier: NCT00468780 - Recruiting
  Healthy
  
• Standardized Time- and Score-Oriented Treatment of Moderate and Severe Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00148746 - Completed
  moderate to severe atopic dermatitis
  
• Stanford Coronary Risk Intervention Project (SCRIP)
  ClinicalTrials.gov Identifier: NCT00000508 - Completed
  Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Stanford Five-City Multifactor Risk Reduction Study
  ClinicalTrials.gov Identifier: NCT00005143 - Completed
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Disease; Cerebrovascular Accident; Myocardial Infarction; Hypertension
  
• Stanford Preschool Physical Activity Project
  ClinicalTrials.gov Identifier: NCT00285792 - Completed
  Obesity
  
• StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery
  ClinicalTrials.gov Identifier: NCT00211965 - Active, not recruiting
  Staphylococcal Infections
  
• StaphVAX Immunogenicity in Orthopedic Implant Patients
  ClinicalTrials.gov Identifier: NCT00211926 - Active, not recruiting
  Staphylococcal Infections; Joint Replacement
  
• StaphVAX in Cardiovascular Surgery Patients
  ClinicalTrials.gov Identifier: NCT00211913 - Active, not recruiting
  Staphylococcal Infections; Cardiovascular Diseases; Cardiovascular Surgical Procedures
  
• Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
  ClinicalTrials.gov Identifier: NCT00518076 - Recruiting
  Staphylococcal Infections
  
• Stapled Anopexy Versus Closed Haemorrhoidectomy for Haemorrhoids
  ClinicalTrials.gov Identifier: NCT00397137 - Completed
  Hemorrhoids
  
• Stapled Trans Anal Rectal Resection (STARR) for Outlet Obstruction: Functional and Morphological Outcome
  ClinicalTrials.gov Identifier: NCT00521872 - Recruiting
  Surgery (STARR Operation)
  
• STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
  ClinicalTrials.gov Identifier: NCT00369746 - Active, not recruiting
  Non-Psychotic Major Depressive Disorder; Alcohol Use Disorder
  
• STAR*ICU Trial
  ClinicalTrials.gov Identifier: NCT00100386 - Active, not recruiting
  Bacterial Infections
  
• STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial
  ClinicalTrials.gov Identifier: NCT00367757 - Recruiting
  Atrial Fibrillation
  
• STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure
  ClinicalTrials.gov Identifier: NCT00484770 - Completed
  Congestive Heart Failure
  
• STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)
  ClinicalTrials.gov Identifier: NCT00126360 - Recruiting
  Breast Cancer
  
• START
  ClinicalTrials.gov Identifier: NCT00132431 - Completed
  Chronic Kidney Disease; Secondary Hyperparathyroidism
  
• Starting Basal Rate Profiles Used in Continuous Subcutaneous Insulin Infusion
  ClinicalTrials.gov Identifier: NCT00569452 - Completed
  Diabetes Mellitus, Type 1
  
• Starting Healthy Staying Healthy Pilot Trial
  ClinicalTrials.gov Identifier: NCT00503074 - Active, not recruiting
  Obesity
  
• Starting Treatment With Agonist Replacement Therapies (START)
  ClinicalTrials.gov Identifier: NCT00315341 - Recruiting
  Opiate-Related Disorders
  
• STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair with the Zenith TX2 Endovascular Graft
  ClinicalTrials.gov Identifier: NCT00111176 - Recruiting
  Thoracic Aortic Aneurysm
  
• State of Obesity Care in Canada Evaluation Registry
  ClinicalTrials.gov Identifier: NCT00328081 - Terminated
  Obesity; Morbid Obesity
  
• Statewide (Rhode Island and Neighboring States) Partnerships for Worksite Weight Management
  ClinicalTrials.gov Identifier: NCT00288145 - Recruiting
  Overweight; Obesity
  
• Statewide Implementation of Electronic Health Records
  ClinicalTrials.gov Identifier: NCT00225576 - Not yet recruiting
  Medication Errors
  
• Static and Dynamic Balance in Correlation With Quality of Life, in Primary Total Knee Replacement
  ClinicalTrials.gov Identifier: NCT00256958 - Recruiting
  Osteoarthritis; Total Knee Replacement
  
• Statin and PAF in Patients With Pacemaker
  ClinicalTrials.gov Identifier: NCT00201552 - Recruiting
  Paroxysmal Atrial Fibrillation
  
• Statin for Immunomudulation in Sepsis
  ClinicalTrials.gov Identifier: NCT00452608 - Recruiting
  Sepsis
  
• Statin Therapy in Asymptomatic Aortic Stenosis
  ClinicalTrials.gov Identifier: NCT00176410 - Recruiting
  Aortic Valve Stenosis
  
• Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
  ClinicalTrials.gov Identifier: NCT00233480 - Recruiting
  Heart Failure, Congestive
  
• Statin Therapy Versus Placebo Prior to Prostatectomy
  ClinicalTrials.gov Identifier: NCT00572468 - Not yet recruiting
  Prostate; Cancer
  
• Statin Therapy Vs. Therapeutic Lifestyle Changes and Supplements
  ClinicalTrials.gov Identifier: NCT00365742 - Completed
  Hyperlipidemia
  
• Statin Treatment in Patients With Asthma
  ClinicalTrials.gov Identifier: NCT00292201 - Recruiting
  Asthma
  
• Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-Like Receptors
  ClinicalTrials.gov Identifier: NCT00519363 - Not yet recruiting
  Systemic Lupus Erythematosus
  
• Statins and the Urinary Proteome
  ClinicalTrials.gov Identifier: NCT00464503 - Not yet recruiting
  Statin Induced Proteinuria
  
• Statins for the Early Treatment of Sepsis
  ClinicalTrials.gov Identifier: NCT00528580 - Not yet recruiting
  Sepsis
  
• Statins in Proteinuric Nephropathies
  ClinicalTrials.gov Identifier: NCT00199927 - Recruiting
  Chronic Nephropathy; Proteinuria; Hypertension
  
• Statins to Reduce D-Dimer Levels in Patients With Venous Thrombosis
  ClinicalTrials.gov Identifier: NCT00437892 - Not yet recruiting
  Venous Thromboembolism; Hypercholesterolemia
  
• Statistical Analysis of Pediatric Task Force Data Base
  ClinicalTrials.gov Identifier: NCT00005407 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Statistical Analysis of Vlagtwedde-Vlaardingen Data Set
  ClinicalTrials.gov Identifier: NCT00005425 - Completed
  Asthma; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Statistical Basis for Hemochromatosis Screening
  ClinicalTrials.gov Identifier: NCT00005559 - Completed
  Blood Disease; Hemochromatosis
  
• Staying Well: A Clinical Trial of Mindfulness-Based Stress Reduction and Education Groups for HIV
  ClinicalTrials.gov Identifier: NCT00271856 - Recruiting
  HIV
  
• STD Risk Reduction for Heterosexual Methamphetamine Users
  ClinicalTrials.gov Identifier: NCT00344214 - Recruiting
  Substance-Related Disorders; HIV Infections; Sexually Transmitted Diseases
  
• Steady State Serum and ELF Antibiotics Concentrations Under Continous Infusion
  ClinicalTrials.gov Identifier: NCT00435305 - Recruiting
  Pneumonia; Bacteremia
  
• Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
  ClinicalTrials.gov Identifier: NCT00431197 - Recruiting
  Hypogonadism
  
• Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients with Blood Cancer
  ClinicalTrials.gov Identifier: NCT00005785 - Completed
  Hematologic Neoplasm; HIV Infection
  
• Stem Cell Collection
  ClinicalTrials.gov Identifier: NCT00316069 - Recruiting
  Stem Cells
  
• Stem Cell Collection for Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00033774 - Active, not recruiting
  Healthy
  
• Stem Cell Factor Medication for Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00001398 - Completed
  Aplastic Anemia; Pancytopenia
  
• Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)
  ClinicalTrials.gov Identifier: NCT00028236 - Recruiting
  Severe Combined Immunodeficiency
  
• Stem Cell Injection for Peripheral Vascular Disease
  ClinicalTrials.gov Identifier: NCT00278603 - Recruiting
  Peripheral Vascular Disease
  
• Stem Cell Mobilization and VEGF Gene Transfer for Heart Failure
  ClinicalTrials.gov Identifier: NCT00279539 - Not yet recruiting
  Ischemic Congestive Heart Failure (CHF)
  
• Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair
  ClinicalTrials.gov Identifier: NCT00394498 - Recruiting
  Myocardial Infarction
  
• Stem Cell Mobilization Potential in Patients with Aplastic Anemia in remission
  ClinicalTrials.gov Identifier: NCT00011830 - Completed
  Aplastic Anemia
  
• Stem Cell Mobilization to Treat Chest Pain and Shortness of Breath in Patients with Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00043628 - Completed
  
  
• Stem Cell Study for Patients with Heart Disease
  ClinicalTrials.gov Identifier: NCT00081913 - Active, not recruiting
  Chest Pain; Myocardial Ischemia; Heart Disease; Coronary Arterial Disease (CAD); Angina
  
• Stem Cell Study for Patients With Heart Disease
  ClinicalTrials.gov Identifier: NCT00221182 - Recruiting
  Chest Pain; Chronic Myocardial Ischemia; Coronary Artery Disease; Angina; Myocardial Infarction
  
• Stem Cell Study for Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00346177 - Recruiting
  Myocardial Ischemia; Congestive Heart Failure; Cardiovascular Disease
  
• Stem Cell Study for Patients With Leg Ulcer/Gangrene
  ClinicalTrials.gov Identifier: NCT00221143 - Active, not recruiting
  Leg Pain; Ulcer; Gangrene; Ischemia; Peripheral Vascular Diseases
  
• Stem Cell Support in Patients With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00278551 - Recruiting
  Rheumatoid Arthritis
  
• Stem Cell Therapy as Adjunct to Revascularization
  ClinicalTrials.gov Identifier: NCT00463853 - Not yet recruiting
  Coronary Artery Bypass Graft; Myocardial Revascularization; Coronary Arteriosclerosis
  
• Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study
  ClinicalTrials.gov Identifier: NCT00273364 - Recruiting
  Multiple Sclerosis
  
• Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
  ClinicalTrials.gov Identifier: NCT00260338 - Not yet recruiting
  Myocardial Ischemia; Coronary Heart Disease
  
• Stem Cell Therapy in Chronic Ischemic Heart Failure
  ClinicalTrials.gov Identifier: NCT00235417 - Completed
  Myocardial Ischemia; Heart Failure, Congestive
  
• Stem Cell Therapy to Improve Myocardial Function in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
  ClinicalTrials.gov Identifier: NCT00395811 - Not yet recruiting
  Coronary Disease; Myocardial Infarction
  
• Stem Cell Therapy to Improve Myocardial Function in Patients With Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00316381 - Active, not recruiting
  Myocardial Infarction
  
• Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease
  ClinicalTrials.gov Identifier: NCT00001765 - Completed
  Chronic Granulomatous Disease
  
• Stem Cell Transplant for Advanced Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00001635 - Recruiting
  Neoplasm Metastasis; Renal Cell Carcinoma
  
• Stem Cell Transplant for Bone Marrow Failures
  ClinicalTrials.gov Identifier: NCT00176878 - Recruiting
  Osteopetrosis; Diamond-Blackfan Anemia; Kostmann's Neutropenia; Shwachman-Diamond Syndrome
  
• Stem Cell Transplant for Children Less Then Two Years with Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00145626 - Recruiting
  Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplasia
  
• Stem Cell Transplant for Hematological Malignancy
  ClinicalTrials.gov Identifier: NCT00176930 - Recruiting
  Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-Hodgkin's Lymphoma; Multiple Myeloma
  
• Stem Cell Transplant for Hemoglobinopathy
  ClinicalTrials.gov Identifier: NCT00176852 - Recruiting
  Sickle Cell Disease; Thalassemia
  
• Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
  ClinicalTrials.gov Identifier: NCT00179803 - Recruiting
  Glioblastoma; Astrocytoma; Pineoblastoma; Rhabdoid Tumor; Supratentorial Neoplasms
  
• Stem Cell Transplant for Immunologic or Histiocytic Disorders
  ClinicalTrials.gov Identifier: NCT00176865 - Recruiting
  Hemophagocytic Lymphohistiocytosis; X-Linked Lymphoproliferative Disorders; Chediak-Higashi Syndrome; Griscelli Syndrome; Immunologic Deficiency Syndromes; Langerhans-Cell Histiocytosis
  
• Stem Cell Transplant for Inborn Errors of Metabolism
  ClinicalTrials.gov Identifier: NCT00176904 - Recruiting
  Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Gaucher’s Disease; Fucosidosis; Wolman Disease; Niemann-Pick Disease; Batten Disease; GM1 Gangliosidosis; Tay Sachs Disease; Sandhoff Disease
  
• Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
  ClinicalTrials.gov Identifier: NCT00167219 - Recruiting
  Juvenile Myelomonocytic Leukemia
  
• Stem Cell Transplant for Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00001739 - Completed
  Graft vs Host Disease; Melanoma; Neoplasm Metastasis
  
• Stem Cell Transplant for Patients with Blood Malignancy Using Donors and Less Toxic Chemotherapy with CAMPATH 1H
  ClinicalTrials.gov Identifier: NCT00048412 - Completed
  Myelodysplastic Disorders; Leukemia; Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoproliferative Disorders
  
• Stem Cell Transplant for Patients with Hematologic Diseases and Renal Cell Cancer Using Family Donors and Conditioning with Campath-1H
  ClinicalTrials.gov Identifier: NCT00058825 - Recruiting
  Hematologic Malignancies
  
• Stem Cell Transplant for Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00386568 - Active, not recruiting
  Multiple Myeloma
  
• Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors
  ClinicalTrials.gov Identifier: NCT00186225 - Active, not recruiting
  Blood Cancer
  
• Stem Cell Transplant in Patients With Thalassemia
  ClinicalTrials.gov Identifier: NCT00578292 - Recruiting
  Thalassemia
  
• Stem Cell Transplant in Sickle Cell Disease and Thalassemia
  ClinicalTrials.gov Identifier: NCT00408447 - Recruiting
  Sickle Cell Disease; Beta Thalassemia
  
• Stem Cell Transplant Therapy with Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
  ClinicalTrials.gov Identifier: NCT00042640 - Recruiting
  Mycosis Fungoides; Sezary Syndrome
  
• Stem Cell Transplant to Treat Patients with Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00058578 - Completed
  Systemic Sclerosis
  
• Stem Cell Transplant w/Laronidase for Hurler
  ClinicalTrials.gov Identifier: NCT00176891 - Recruiting
  Mucopolysaccharidosis I
  
• Stem Cell Transplant With Specially Treated Cells in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00246649 - Recruiting
  AML; ALL (High Risk)
  
• Stem Cell Transplant with Th2/Tc2 Cells to Treat Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00079625 - Recruiting
  Breast Neoplasms
  
• Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00499577 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Stem Cell Transplantation (SCT) for Genetic Diseases
  ClinicalTrials.gov Identifier: NCT00004378 - Completed
  Thrombocytopenia; Metachromatic Leukodystrophy; Fanconi's Anemia; Thalassemia Major; Pure Red-Cell Aplasia; Inborn Errors of Metabolism
  
• Stem Cell Transplantation after Reduced-Dose Chemotherapy for Patients with Sickle Cell Disease or Thalassemia
  ClinicalTrials.gov Identifier: NCT00034528 - Active, not recruiting
  Hemoglobinopathies; Anemia, Sickle Cell; Hemoglobin SC Disease; Thalassemia; Thalassemia Major
  
• Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances
  ClinicalTrials.gov Identifier: NCT00076778 - Recruiting
  Leukemia; Bone Marrow Transplantation
  
• Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances
  ClinicalTrials.gov Identifier: NCT00353860 - Active, not recruiting
  Immunosuppression; Leukemia
  
• Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00143559 - Active, not recruiting
  Neoplasm, leukemia, myeloid; Lymphoma, Non-Hodgkin; Stem Cell Transplantation; Myelodysplastic Syndromes; Hepatic Cancer
  
• Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
  ClinicalTrials.gov Identifier: NCT00002514 - Completed
  adult acute lymphoblastic leukemia in remission
  
• Stem Cell Transplantation for Fanconi Anemia
  ClinicalTrials.gov Identifier: NCT00167206 - Recruiting
  Fanconi Anemia
  
• Stem Cell Transplantation for Hematological Malignancies
  ClinicalTrials.gov Identifier: NCT00176839 - Recruiting
  Leukemia, Lymphocytic, Acute; AML; MDS
  
• Stem Cell Transplantation for Hurler
  ClinicalTrials.gov Identifier: NCT00176917 - Recruiting
  Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Mannosidosis; Mucolipidosis Type II (I-Cell Disease)
  
• Stem Cell Transplantation for Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00001880 - Recruiting
  Cholangiocarcinoma; Colon/Rectal Ca; Bladder Ca; Breast Ca; Basal Cell Ca; Adrenal Ca; Esophageal/Gastric Ca; Hepatocellular Ca; Ovarian Ca; ...
  
• Stem Cell Transplantation for Patients With Cancers of the Blood
  ClinicalTrials.gov Identifier: NCT00467961 - Recruiting
  CML (Chronic Myelogenous Leukemia); CLL (Chronic Lymphocytic Leukemia); AML (Acute Myelogenous Leukemia); ALL (Acute B-Lymphoblastic Leukemia); MDS (Myelodysplastic Syndrome)
  
• Stem Cell Transplantation for Patients with Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning with CAMPATH 1H
  ClinicalTrials.gov Identifier: NCT00048399 - Terminated
  Graft Failure
  
• Stem Cell Transplantation for Patients with Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00152139 - Active, not recruiting
  Acute Lymphoblastic Leukemias; Acute Myelocytic Leukemia; Chronic Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; ...
  
• Stem Cell Transplantation for the Treatment of Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00550524 - Not yet recruiting
  Knee Osteoarthritis
  
• Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
  ClinicalTrials.gov Identifier: NCT00278564 - Recruiting
  Myopathy
  
• Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
  ClinicalTrials.gov Identifier: NCT00550498 - Not yet recruiting
  Retinitis; Behcet's Syndrome
  
• Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas
  ClinicalTrials.gov Identifier: NCT00043979 - Recruiting
  Sarcoma
  
• Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
  ClinicalTrials.gov Identifier: NCT00393185 - Recruiting
  Primary Biliary Cirrhosis
  
• Stem Cell Transplantation in Treating Patients with Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004904 - Completed
  Leukemia; Lymphoma; Multiple Myeloma; Eye Cancer
  
• Stem Cell Transplantation in Treating Patients With Previously-Treated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00054353 - Recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• Stem Cell Transplantation to Improve Survival for Patients With Hematological Malignancies
  ClinicalTrials.gov Identifier: NCT00566696 - Recruiting
  Leukemia, Lymphocytic, Acute; Acute Myeloid Leukemia (AML); Leukemia, Myeloid, Chronic; Juvenile Myelomonocytic Leukemia (JMML); Hemoglobinuria, Paroxysmal; Hodgkin Disease; Lymphoma, Non-Hodgkin; Myelodysplastic Syndrome (MDS)
  
• Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency
  ClinicalTrials.gov Identifier: NCT00031005 - Completed
  Leukocyte-Adhesion Deficiency Syndrome
  
• Stem Cell Transplantation to Treat Systemic Mastocytosis
  ClinicalTrials.gov Identifier: NCT00006413 - Completed
  Mastocytosis
  
• Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00052923 - Active, not recruiting
  recurrent adult diffuse large cell lymphoma
  
• Stem Cell Transplants With Identical Donors for Patients With Sickle Cell Disease
  ClinicalTrials.gov Identifier: NCT00186810 - Completed
  Sickle Cell Disease
  
• Stem Cells for Treating Critical Ischemia
  ClinicalTrials.gov Identifier: NCT00488020 - Recruiting
  Critical Limb Ischemia; Ischemic Ulcers
  
• Stem Cells Found in the Abdominal Cavity in Humans
  ClinicalTrials.gov Identifier: NCT00576264 - Recruiting
  Intra-Abdominal Surgery
  
• Stem Cells in Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00135928 - Completed
  Acute Myocardial Infarction
  
• Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00253617 - Not yet recruiting
  Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Unresectable Extrahepatic Bile Duct Cancer; ...
  
• Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term Outcomes
  ClinicalTrials.gov Identifier: NCT00496639 - Recruiting
  Hyperplasia; Stenosis
  
• Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy (SAPPHIRE)
  ClinicalTrials.gov Identifier: NCT00231270 - Completed
  Carotid Artery Disease
  
• STenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis
  ClinicalTrials.gov Identifier: NCT00150943 - Completed
  Renal Artery Obstruction; Kidney Failure
  
• Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis
  ClinicalTrials.gov Identifier: NCT00576693 - Not yet recruiting
  Ischemic Stroke
  
• Stenting vs. Best Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis
  ClinicalTrials.gov Identifier: NCT00497094 - Recruiting
  Asymptomatic; Artery
  
• Stenting vs. Surgery to Prevent Stroke
  ClinicalTrials.gov Identifier: NCT00004732 - Recruiting
  Stroke; Cerebral Infarction; Carotid Stenosis; Atherosclerosis
  
• Stenting With or Without Coating Compared With Angioplasty in Non-Benestent Disease
  ClinicalTrials.gov Identifier: NCT00192881 - Recruiting
  Coronary Artery Disease
  
• Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.
  ClinicalTrials.gov Identifier: NCT00394680 - Not yet recruiting
  Coronary Arteriosclerosis; Angina Unstable; Myocardial Infarction
  
• Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees
  ClinicalTrials.gov Identifier: NCT00302575 - Recruiting
  Substance-Related Disorders
  
• Step-Wise Basal Insulin Dose Titration
  ClinicalTrials.gov Identifier: NCT00115973 - Completed
  Type 2 Diabetes Mellitus
  
• STEP: Social Support To Empower Parents
  ClinicalTrials.gov Identifier: NCT00480493 - Recruiting
  Type 1 Diabetes
  
• STEP: Stilnox Treatment in Elderly Patients With Insomnia
  ClinicalTrials.gov Identifier: NCT00359229 - Recruiting
  Insomnia
  
• STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)
  ClinicalTrials.gov Identifier: NCT00583518 - Recruiting
  Postmenopausal Women With Primary Osteoporosis
  
• STEPP: A Phase 2, Open-Label, Randomized Clinical Trial of Skin Toxicity Treatment in mCRC Subjects Receiving Panitumumab Concomitantly With Second-Line Irinotecan Based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00332163 - Active, not recruiting
  Metastatic Colorectal Cancer; Skin Rash; Skin Toxicities; Colon Cancer; Colorectal Cancer
  
• Stepped Care for Mandated College Students
  ClinicalTrials.gov Identifier: NCT00247182 - Recruiting
  Drinking Behavior; High Risk Alcohol Use
  
• Stepped Care for Treating Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00316355 - Recruiting
  Obsessive-Compulsive Disorder
  
• Stepped Intervention for Meds Adherence and Blood Pressure Control
  ClinicalTrials.gov Identifier: NCT00257101 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Stepped Interventions for Problem Drinkers
  ClinicalTrials.gov Identifier: NCT00391742 - Completed
  Alcohol-Related Disorders; Alcohol Drinking
  
• Stepped Preventive Care to Reduce the Impact of Acute Pediatric Injury
  ClinicalTrials.gov Identifier: NCT00451282 - Recruiting
  Stress Disorders, Posttraumatic
  
• Steppin' Up: Positive Youth Development Program
  ClinicalTrials.gov Identifier: NCT00341224 - Active, not recruiting
  Mentoring
  
• Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African Communities
  ClinicalTrials.gov Identifier: NCT00332878 - Completed
  HIV Infections
  
• Stepping Up To Health
  ClinicalTrials.gov Identifier: NCT00151021 - Recruiting
  Diabetes Mellitus, Type 2
  
• STEPS Trial – Spheramine Safety and Efficacy Study
  ClinicalTrials.gov Identifier: NCT00206687 - Active, not recruiting
  Parkinson Disease
  
• Stereo Photogrammetry Imaging in Normal Volunteers and Patients with Head and Facial Malformations
  ClinicalTrials.gov Identifier: NCT00100529 - Recruiting
  Craniofacial Abnormalities
  
• Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00087438 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; ...
  
• Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00547339 - Recruiting
  Prostate Cancer
  
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00471835 - Completed
  Lung Cancer
  
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00551369 - Not yet recruiting
  Lung Cancer
  
• Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00425841 - Recruiting
  Pancreatic Cancer
  
• Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00006259 - Active, not recruiting
  brain metastases
  
• Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors
  ClinicalTrials.gov Identifier: NCT00445757 - Recruiting
  Kidney Cancer
  
• Stereotactic Radiation Therapy in Treating Patients With Liver Metastases
  ClinicalTrials.gov Identifier: NCT00567970 - Recruiting
  Metastatic Cancer
  
• Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00377156 - Recruiting
  Brain and Central Nervous System Tumors; Breast Cancer; Cognitive/Functional Effects; Lung Cancer; Prostate Cancer
  
• Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00253448 - Recruiting
  Brain and Central Nervous System Tumors
  
• Stereotactic Radiosurgery in Treating Patients With Brain Tumors
  ClinicalTrials.gov Identifier: NCT00019578 - Active, not recruiting
  Adult Central Nervous System Germ Cell Tumor; Adult Malignant Meningioma; Adult Medulloblastoma; Adult Noninfiltrating Astrocytoma; Adult Oligodendroglioma; Adult Craniopharyngioma; Adult Meningioma; Brain Metastases; Adult Ependymoma; Adult Pineal Parenchymal Tumor; Adult Brain Stem Glioma; Adult Infiltrating Astrocytoma; Mixed Gliomas; Stage IV Peripheral Primitive Neuroectodermal Tumor
  
• Stereotactic Radiosurgery in Treating Patients With Liver Metastases
  ClinicalTrials.gov Identifier: NCT00547677 - Recruiting
  Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006456 - Active, not recruiting
  unspecified adult solid tumor, protocol specific; lung metastases; liver metastases
  
• Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis
  ClinicalTrials.gov Identifier: NCT00484978 - Recruiting
  Brain Neoplasms
  
• Stereotactic Radiotherapy (SRT) Liver
  ClinicalTrials.gov Identifier: NCT00152906 - Recruiting
  Liver Neoplasms; Neoplasm Metastases
  
• Steroid Free Immunosuppression in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00296244 - Recruiting
  Liver Cirrhosis; Liver Transplant Recipients
  
• Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status
  ClinicalTrials.gov Identifier: NCT00001376 - Completed
  Arthritis, Rheumatoid; Healthy; Pregnancy
  
• Steroid Therapy in Autoimmune Premature Ovarian Failure
  ClinicalTrials.gov Identifier: NCT00001306 - Recruiting
  Autoimmune Disease; Infertility; Premature Ovarian Failure
  
• Steroid Treatment for Kidney Disease
  ClinicalTrials.gov Identifier: NCT00065611 - Recruiting
  Nephrosis; Focal Lipoid Glomerulosclerosis
  
• Steroid Treatment for Sickle Cell Pain Crisis
  ClinicalTrials.gov Identifier: NCT00263562 - Recruiting
  Sickle Cell Disease; Vaso-Occlusive Crisis
  
• Steroid Withdrawal in Pediatric Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00023244 - Active, not recruiting
  End-Stage Renal Disease
  
• Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine (CyA) and Mycophenolate Mofetil (MMF)
  ClinicalTrials.gov Identifier: NCT00309218 - Recruiting
  Kidney Diseases
  
• Steroid-Free and Long-Term Calcineurin-Free Trial in Islet Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00315627 - Recruiting
  Type 1 Diabetes Mellitus
  
• Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00351052 - Completed
  Atopic Dermatitis
  
• Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss
  ClinicalTrials.gov Identifier: NCT00180778 - Not yet recruiting
  Antiphospholipid Syndrome
  
• Steroids and Methotrexate to Treat Systemic Vasculitis
  ClinicalTrials.gov Identifier: NCT00001256 - Completed
  Inflammation; Vasculitis; Wegener's Granulomatosis
  
• Steroids for Corneal Ulcers Trial
  ClinicalTrials.gov Identifier: NCT00324168 - Recruiting
  Corneal Ulcer; Eye Infections, Bacterial
  
• Steroids In caRdiac Surgery Trial (SIRS Trial)
  ClinicalTrials.gov Identifier: NCT00427388 - Recruiting
  Cardiac Surgical Procedures; Cardiopulmonary Bypass; Systemic Inflammatory Response Syndrome
  
• Steroids in Patients With Early ARDS
  ClinicalTrials.gov Identifier: NCT00562835 - Not yet recruiting
  Acute Lung Injury; ARDS, Human
  
• Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis
  ClinicalTrials.gov Identifier: NCT00539799 - Not yet recruiting
  Lupus Nephritis
  
• SThe Effects of Melatonin on GERD Symptoms
  ClinicalTrials.gov Identifier: NCT00564590 - Not yet recruiting
  Gastroesophageal Reflux Disease
  
• STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00376467 - Recruiting
  Acute Lymphoblastic Leukemia
  
• STI571 Compared With Interferon alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006343 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Quality of Life
  
• STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006052 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis
  ClinicalTrials.gov Identifier: NCT00006475 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; Philadelphia chromosome negative chronic myelogenous leukemia; ...
  
• STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon alfa
  ClinicalTrials.gov Identifier: NCT00006053 - Completed
  Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• STI571 in Treating Patients With Recurrent Leukemia
  ClinicalTrials.gov Identifier: NCT00004932 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; relapsing chronic myelogenous leukemia; ...
  
• STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00006357 - Active, not recruiting
  stage/cell type, small intestine cancer; cellular diagnosis, adult soft tissue sarcoma; cellular diagnosis, uterine sarcoma; Cancer; ...
  
• STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00015860 - Completed
  recurrent adult acute lymphoblastic leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia
  
• STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00015834 - Completed
  relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• STI571 ProspectIve RandomIzed Trial: SPIRIT
  ClinicalTrials.gov Identifier: NCT00219739 - Recruiting
  Chronic Myeloid Leukemia
  
• STI571 to Treat Malignant Brain Tumors
  ClinicalTrials.gov Identifier: NCT00023179 - Completed
  Glioma; Astrocytoma; Meningioma; Gliosarcoma; Oligodendroglioma
  
• STILDEP: Zolpidem in Depressive and Dysthimic Patients
  ClinicalTrials.gov Identifier: NCT00292734 - Completed
  Sleep Initiation and Maintenance Disorders; Depression
  
• STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy
  ClinicalTrials.gov Identifier: NCT00228371 - Recruiting
  Epilepsy; Drug Resistant
  
• Stimulant Abuser Groups to Engage in 12-Step
  ClinicalTrials.gov Identifier: NCT00573183 - Not yet recruiting
  Stimulant Abuse or Dependence
  
• Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
  ClinicalTrials.gov Identifier: NCT00183391 - Recruiting
  Attention Deficit Disorder With Hyperactivity
  
• STIMULATE Study: Aaemia Correction and HRQoL Outcomes in Elderly CKD Patients
  ClinicalTrials.gov Identifier: NCT00364845 - Recruiting
  Anemia
  
• Stimulating Deep Brain Regions with a Magnetic Stimulator
  ClinicalTrials.gov Identifier: NCT00063245 - Completed
  Healthy
  
• Stimulation of Auricular Acupuncture-Point for C/T-Induced Nausea/Vomiting
  ClinicalTrials.gov Identifier: NCT00360841 - Recruiting
  Cancer
  
• STITCH (Simplified Therapeutic Intervention To Control Hypertension)
  ClinicalTrials.gov Identifier: NCT00129909 - Completed
  Hypertension
  
• STN-Stimulation Versus Best Medical Treatment in Advanced PD
  ClinicalTrials.gov Identifier: NCT00196911 - Completed
  Parkinson's Disease
  
• Stop Atherosclerosis in Native Diabetics Study
  ClinicalTrials.gov Identifier: NCT00147251 - Completed
  Cardiovascular Disease; Hypertension; Hyperlipidemia; Diabetes; Carotid Atherosclerosis
  
• Stop Atherosclerosis in Native Diabetics Study (SANDS)
  ClinicalTrials.gov Identifier: NCT00047424 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Diabetes Mellitus; Hypertension
  
• STOP CAP: Pravastatin and Atorvastatin to Prevent Heart Disease in People With High Cholesterol Level, Diabetes or Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00166036 - Recruiting
  Diabetes Mellitus; Metabolic Syndrome X; Hypercholesterolemia
  
• Stop Infliximab in Patients With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00571337 - Recruiting
  Crohn Disease
  
• STOP PAIN: Septal Closure of PFO - Does It Prevent Migraine?
  ClinicalTrials.gov Identifier: NCT00369499 - Not yet recruiting
  Migraine
  
• Stop Smoking Therapy for Ontario Patients
  ClinicalTrials.gov Identifier: NCT00352781 - Recruiting
  Smoking
  
• Stop Smoking Therapy for Ontario Patients (STOP) Phase I
  ClinicalTrials.gov Identifier: NCT00356993 - Recruiting
  Smoking
  
• STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
  ClinicalTrials.gov Identifier: NCT00050635 - Completed
  Neoplasms; Diarrhea
  
• Stopping and Restarting Anti-HIV Drugs in Children and Adolescents with Low Blood Levels of HIV
  ClinicalTrials.gov Identifier: NCT00016783 - Active, not recruiting
  HIV Infections
  
• Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial
  ClinicalTrials.gov Identifier: NCT00448981 - Recruiting
  Respiratory Tract Infections; Common Cold
  
• Storage of Bile From Routine Procedures to Study Risk Factors
  ClinicalTrials.gov Identifier: NCT00414843 - Recruiting
  Gallbladder Cancer; Cholangiocarcinoma; Biliary Tract Cancer
  
• STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study
  ClinicalTrials.gov Identifier: NCT00124332 - Completed
  
  
• STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery
  ClinicalTrials.gov Identifier: NCT00190307 - Recruiting
  Thrombosis
  
• Strategies for Delivering Anti-HIV Therapy in South Africa
  ClinicalTrials.gov Identifier: NCT00080522 - Completed
  HIV Infections
  
• Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS
  ClinicalTrials.gov Identifier: NCT00461643 - Recruiting
  Anovulatory Infertility Related to Polycystic Ovary Syndrome
  
• Strategies for Pulmonary Embolism in Emergency Departments
  ClinicalTrials.gov Identifier: NCT00188032 - Recruiting
  Pulmonary Embolism
  
• Strategies for Transfusion of Platelets (SToP)
  ClinicalTrials.gov Identifier: NCT00420914 - Recruiting
  Thrombocytopenia
  
• Strategies in Maintenance for Patients Receiving Long-Term Therapy" (S.I.M.P.L.E.)
  ClinicalTrials.gov Identifier: NCT00446849 - Recruiting
  Ulcerative Colitis
  
• Strategies Targeting Osteoporosis to Prevent Recurrent Fractures
  ClinicalTrials.gov Identifier: NCT00152321 - Active, not recruiting
  Osteoporosis; Fractures
  
• Strategies to Help Adult ED Patients Quit Smoking
  ClinicalTrials.gov Identifier: NCT00297466 - Recruiting
  Tobacco Use
  
• Strategies To Improve Islet Survival
  ClinicalTrials.gov Identifier: NCT00464555 - Recruiting
  Type 1 Diabetes Mellitus
  
• Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic
  ClinicalTrials.gov Identifier: NCT00358033 - Active, not recruiting
  Diabetes; Dyslipidemia; Hypertension; Coronary Atherosclerosis
  
• Strategies to Prevent Pneumonia (SToP Pneumonia)
  ClinicalTrials.gov Identifier: NCT00234598 - Recruiting
  Ventilator Associated Pneumonia
  
• Strategies to Reduce Transmission of Antibiotic-Resistant Bacteria in Intensive Care Units
  ClinicalTrials.gov Identifier: NCT00342745 - Active, not recruiting
  Methicillin-Resistant StaphylococcusAureus (MRSA)
  
• Strategies to Treat Osteoporosis Following a Fragility Fracture
  ClinicalTrials.gov Identifier: NCT00512499 - Recruiting
  Osteoporosis; Fragility Fractures
  
• Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
  ClinicalTrials.gov Identifier: NCT00181766 - Recruiting
  ADHD NOS
  
• Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
  ClinicalTrials.gov Identifier: NCT00181948 - Recruiting
  ADHD
  
• Stratus Versus Cirrus OCT in AMD
  ClinicalTrials.gov Identifier: NCT00568191 - Recruiting
  Age-Related Macular Degeneration; Choroidal Neovascularization
  
• Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00489125 - Recruiting
  Breast Cancer; Long-Term Effects Secondary to Cancer Therapy in Adults
  
• Strength Training Effectiveness Post-Stroke (STEPS)
  ClinicalTrials.gov Identifier: NCT00389012 - Active, not recruiting
  Cerebrovascular Accident
  
• Strength Training Following Gastric Bypass for Obesity
  ClinicalTrials.gov Identifier: NCT00065013 - Active, not recruiting
  Obesity
  
• Strength Training for Obesity Prevention
  ClinicalTrials.gov Identifier: NCT00030160 - Completed
  Obesity
  
• Strength Training Intervention for Breast Cancer Survivors and the Effects on Lymphedema Status
  ClinicalTrials.gov Identifier: NCT00194363 - Active, not recruiting
  Lymphedema
  
• Strength Training Using Neuromuscular Electrical Stimulation For Children With Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00356343 - Recruiting
  Cerebral Palsy (Spastic Diplegia)
  
• Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji
  ClinicalTrials.gov Identifier: NCT00436891 - Recruiting
  Streptococcus Group A
  
• Stress and the Immune Response in Women with Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00086242 - Active, not recruiting
  Cervix Neoplasms
  
• Stress and Vision Fluctuations in Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00475254 - Recruiting
  Retinitis Pigmentosa
  
• Stress Hormones and Human Cocaine Use - 7
  ClinicalTrials.gov Identifier: NCT00000290 - Completed
  Cocaine-Related Disorders
  
• Stress Management for Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00147446 - Recruiting
  Multiple Sclerosis
  
• Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00377130 - Recruiting
  Psychosocial Effects/Treatment; Unspecified Adult Solid Tumor, Protocol Specific
  
• Stress Management Training in Patients Undergoing Radiation Therapy for Cancer
  ClinicalTrials.gov Identifier: NCT00057733 - Completed
  Quality of Life; Anxiety Disorder; Depression; unspecified adult solid tumor, protocol specific
  
• Stress Reduction & CVD Morbidity and Mortality in Blacks
  ClinicalTrials.gov Identifier: NCT00000537 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases
  
• Stress Reduction and Atherosclerotic CVD in Blacks
  ClinicalTrials.gov Identifier: NCT00000546 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular Diseases; Coronary Disease
  
• Stress Reduction and Prevention of Hypertension in Blacks
  ClinicalTrials.gov Identifier: NCT00005748 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Stress Reduction in Older Women With Stage II, Stage III, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006346 - Completed
  stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; stage II breast cancer; psychosocial effects/treatment; Quality of Life
  
• Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
  ClinicalTrials.gov Identifier: NCT00376818 - Recruiting
  Brain and Central Nervous System Tumors; Psychosocial Effects/Treatment
  
• Stress Response Using Thin and Standard Size Endoscopy.
  ClinicalTrials.gov Identifier: NCT00273130 - Terminated
  Upper Gastrointestinal Disease,Ulcers
  
• Stress, Distress Intolerance, and Drug Dependence
  ClinicalTrials.gov Identifier: NCT00430482 - Recruiting
  Substance Dependence
  
• Stress, Diurnal Cortisol, and Breast Cancer Survival
  ClinicalTrials.gov Identifier: NCT00226967 - Active, not recruiting
  Breast Cancer
  
• Stress, Environment, and Genetics in Urban Asthma
  ClinicalTrials.gov Identifier: NCT00269256 - Recruiting
  Asthma; Lung Diseases
  
• Stress, Immunity & Cervical Cancer: Biobehavioral Outcomes of a Randomized Trial
  ClinicalTrials.gov Identifier: NCT00496106 - Not yet recruiting
  Ovarian Cancer
  
• Stress-Busting Program for Caregivers of Patients with Neurological Diseases
  ClinicalTrials.gov Identifier: NCT00122174 - Completed
  Neurological disease; Parkinson''s Disease
  
• Stress-Relief Management for Treatment of Late Complications in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00263419 - Recruiting
  Albuminuria; Diabetes Mellitus, Type 2; Diabetes Complications
  
• STRETCH Study: Effect of Distensibility on Endothelial-Dependent Vasoreactivity in Patients With ISH
  ClinicalTrials.gov Identifier: NCT00277875 - Active, not recruiting
  Cardiovascular Disease
  
• Strict Glucose Control of Pediatric Intensive Care Unit (ICU) Patients
  ClinicalTrials.gov Identifier: NCT00247468 - Suspended
  Respiratory Failure; Cardiovascular Failure; Sepsis; Trauma
  
• Stroke and MI in Users of Estrogen/Progestogen
  ClinicalTrials.gov Identifier: NCT00005466 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Cerebrovascular Accident; Myocardial Infarction; Postmenopause
  
• Stroke and Panorama - Analyzing Carotid Endocalcifications (SPACE)
  ClinicalTrials.gov Identifier: NCT00514644 - Recruiting
  Carotid Stenoses
  
• Stroke Belt Initiative
  ClinicalTrials.gov Identifier: NCT00005722 - Completed
  Cardiovascular Diseases; Cerebrovascular Accident; Hypertension
  
• Stroke Canada Optimization of Rehabilitation by Evidence Implementation Trial SCORE-IT)
  ClinicalTrials.gov Identifier: NCT00359593 - Not yet recruiting
  Stroke
  
• Stroke in Young Fabry Patients (SIFAP1): Frequency of Fabry Disease in Young Stroke Patients
  ClinicalTrials.gov Identifier: NCT00414583 - Recruiting
  Cerebrovascular Accident
  
• Stroke in Young Fabry Patients (SIFAP2): Characterization of the Stroke Rehabilitation
  ClinicalTrials.gov Identifier: NCT00413595 - Recruiting
  Fabry Disease; Cerebrovascular Accident
  
• Stroke Inpatient Rehabilitation Reinforcement of Walking Speed (SIRROWS)
  ClinicalTrials.gov Identifier: NCT00428480 - Recruiting
  Stroke
  
• Stroke Prevention in Sickle Cell Anemia (STOP 1)
  ClinicalTrials.gov Identifier: NCT00000592 - Completed
  Anemia, Sickle Cell; Cerebral Embolism and Thrombosis; Cerebrovascular Disorders; Hematologic Diseases; Hemoglobinopathies
  
• Stroke Prevention in Sickle Cell Anemia (STOP 2)
  ClinicalTrials.gov Identifier: NCT00006182 - Completed
  Blood Disease; Cerebrovascular Accident; Anemia, Sickle Cell
  
• Stroke Prevention with Abciximab in Carotid Endarterectomy
  ClinicalTrials.gov Identifier: NCT00178451 - Not yet recruiting
  Carotid Stenosis
  
• Stroke Rehabilitation Outcomes with Supported Treadmill Ambulation Training
  ClinicalTrials.gov Identifier: NCT00037895 - Completed
  Cerebrovascular Accident
  
• Stroke Risk in the NAS-NRC Twin Registry
  ClinicalTrials.gov Identifier: NCT00005413 - Completed
  Cardiovascular Diseases; Cerebrovascular Accident; Myocardial Infarction; Coronary Disease
  
• Stroke Team Remote Evaluation Using a Digital Observation Camera (STRokE DOC)
  ClinicalTrials.gov Identifier: NCT00283868 - Active, not recruiting
  Stroke
  
• Stroke Volume Optimisation in Patients With Hip Fracture
  ClinicalTrials.gov Identifier: NCT00444262 - Recruiting
  Hip Fractures
  
• Stroke with Transfusions Changing to Hydroxyurea (SWITCH)
  ClinicalTrials.gov Identifier: NCT00122980 - Recruiting
  Hemochromatosis; Cerebrovascular Accident; Anemia, Sickle Cell; Blood Disease
  
• Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications?
  ClinicalTrials.gov Identifier: NCT00311025 - Completed
  Cerebral Stroke
  
• Stromal Therapy Of Osteodysplasia After Allogeneic Bone Marrow Transplantation: A Phase I Study
  ClinicalTrials.gov Identifier: NCT00186914 - Active, not recruiting
  Osteodysplasia
  
• Strong Heart Study
  ClinicalTrials.gov Identifier: NCT00005134 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Asthma; Carotid Artery Diseases; Coronary Disease; Hypercholesterolemia; Hypertension; ...
  
• Strong Heart Study Analyses Obesity and Lipoproteins
  ClinicalTrials.gov Identifier: NCT00005510 - Completed
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Obesity
  
• Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
  ClinicalTrials.gov Identifier: NCT00002503 - Active, not recruiting
  bone metastases; recurrent prostate cancer
  
• Structural Brain Abnormalities in Children Born Prematurely: New Detection Methods and Clinical-Pathological Correlates
  ClinicalTrials.gov Identifier: NCT00153855 - Terminated
  Infant, Premature; Brain Injuries
  
• Structure and Function of the Human Tongue
  ClinicalTrials.gov Identifier: NCT00007137 - Completed
  Healthy
  
• Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation
  ClinicalTrials.gov Identifier: NCT00001523 - Completed
  Radiation Injuries; Xerostomia
  
• Structure of the Herpes Simplex Virus Receptor
  ClinicalTrials.gov Identifier: NCT00001648 - Recruiting
  Encephalitis; Herpes Simplex; Keratitis; Mouth Disease; Skin Disease
  
• Structured Exercise Training Program Versus Hypocaloric Hyperproteic Diet in Obese Anovulatory Infertile Patients With PCOS
  ClinicalTrials.gov Identifier: NCT00473538 - Completed
  Polycystic Ovary Syndrome; Anovulation; Infertility
  
• Structured Patient Education and Quality of Life of Elderly Patients With Diabetes Mellitus- a Prospective Study
  ClinicalTrials.gov Identifier: NCT00444483 - Completed
  Impact of Structured DTTP on Quality of Life; Insulin Therapy; Metabolic Control; Psychological Aspects
  
• Structured Stroke Management Improves Outcome at 6 Months
  ClinicalTrials.gov Identifier: NCT00544622 - Completed
  Stroke
  
• Structured Treatment Interruption for HIV Patients With Virologic Failure
  ClinicalTrials.gov Identifier: NCT00188851 - Completed
  HIV
  
• Structured Treatment Interruptions in Chronic HIV Infection
  ClinicalTrials.gov Identifier: NCT00324103 - Completed
  HIV Infection
  
• Structuring the Integration of Care Management Services For Medicaid Enrollees Recipients With Chronic Illness, Substance Abuse Problems and Possible Psychiatric Disorders
  ClinicalTrials.gov Identifier: NCT00399373 - Active, not recruiting
  Chronic Illness
  
• Student Athlete Testing Using Random Notification
  ClinicalTrials.gov Identifier: NCT00451854 - Completed
  Drug Abuse; Alcohol Abuse; Substance Abuse
  
• Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
  ClinicalTrials.gov Identifier: NCT00357435 - Recruiting
  Corneal Dystrophies, Hereditary; Corneal Disease
  
• Studies in Porphyria I: Characterization of Enzyme Defects
  ClinicalTrials.gov Identifier: NCT00004331 - Recruiting
  Porphyria
  
• Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
  ClinicalTrials.gov Identifier: NCT00004396 - Completed
  Porphyria
  
• Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
  ClinicalTrials.gov Identifier: NCT00004330 - Completed
  Porphyria
  
• STUDIES OF ACUTE LUNG INJURY (ALI) AND ACUTE RESPIRATORY DISTRESS SYNDROME
  ClinicalTrials.gov Identifier: NCT00159510 - Recruiting
  septic shock, acute lung injury
  
• Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients
  ClinicalTrials.gov Identifier: NCT00451464 - Completed
  Hyperlipidemia
  
• Studies of Biological Changes Related to Weight Loss After Gastric Bypass Surgery
  ClinicalTrials.gov Identifier: NCT00120562 - Not yet recruiting
  Obesity; Morbid Obesity; Weight Loss
  
• Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons
  ClinicalTrials.gov Identifier: NCT00001281 - Recruiting
  HIV Infection
  
• Studies of Blood Flow to the Brain During Thought
  ClinicalTrials.gov Identifier: NCT00001360 - Recruiting
  Cognition Disorder; Healthy
  
• Studies of Children with Metabolic and Other Genetic Disorders
  ClinicalTrials.gov Identifier: NCT00025870 - Recruiting
  Genetic Disorder; Metabolic Disease
  
• Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain
  ClinicalTrials.gov Identifier: NCT00001725 - Completed
  Facial Neuralgia; Pain; Trigeminal Neuralgia
  
• Studies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion.
  ClinicalTrials.gov Identifier: NCT00429884 - Recruiting
  Atrial Fibrillation
  
• Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
  ClinicalTrials.gov Identifier: NCT00266513 - Recruiting
  Hyper-IgM Syndrome
  
• Studies of Elevated Parathyroid Activity
  ClinicalTrials.gov Identifier: NCT00001277 - Recruiting
  Hyperparathyroidism; Hypocalcemia; Hypoparathyroidism; Parathyroid Neoplasm
  
• Studies of Families with Hereditary Cataracts
  ClinicalTrials.gov Identifier: NCT00001609 - Completed
  Cataract; Congenital Anomaly
  
• Studies of Frontal Lobe Brain Functioning in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00001258 - Recruiting
  Healthy; Schizophrenia
  
• Studies of Hereditary Hemorrhagic Telangiectasia
  ClinicalTrials.gov Identifier: NCT00004648 - Completed
  Telangiectasia, Hereditary Hemorrhagic
  
• Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa
  ClinicalTrials.gov Identifier: NCT00006298 - Completed
  HIV Infections; HIV Seronegativity
  
• Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily
  ClinicalTrials.gov Identifier: NCT00339937 - Active, not recruiting
  Human Herpes Virus 8 (HHV8); Kaposi's Sarcoma (KS)
  
• Studies of Immune Responses in Patients with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00155155 - Recruiting
  Hepatitis B
  
• Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
  ClinicalTrials.gov Identifier: NCT00001173 - Completed
  Healthy
  
• Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2
  ClinicalTrials.gov Identifier: NCT00050726 - Active, not recruiting
  HIV Infections
  
• Studies of Inherited Diseases of Metabolism
  ClinicalTrials.gov Identifier: NCT00001345 - Recruiting
  Hypercalcemia; Hyperparathyroidism; Multiple Endocrine Neoplasia
  
• Studies of Left Ventricular Dysfunction (SOLVD)
  ClinicalTrials.gov Identifier: NCT00000516 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Heart Failure; Hypertension; Myocardial Ischemia
  
• Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
  ClinicalTrials.gov Identifier: NCT00000143 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Studies of Patients with Skin Disease, Patients with Neurological Degenerations, and Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00001164 - Completed
  Healthy; Muscular Dystrophy; Retinal Degeneration; Skin Diseases; Virus Diseases
  
• Studies of the Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
  ClinicalTrials.gov Identifier: NCT00230165 - Recruiting
  Glanzmann Thrombasthenia
  
• Studies of the Immune Response in Normal Subjects and Patients with Disorders of the Immune System
  ClinicalTrials.gov Identifier: NCT00001158 - Completed
  Immunologic Deficiency Syndromes; Neoplasms
  
• Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
  ClinicalTrials.gov Identifier: NCT00341679 - Active, not recruiting
  Autoimmune/Connective Tissue Diseases; Idiopathic Inflammatory Myopathies; IIM
  
• Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
  ClinicalTrials.gov Identifier: NCT00000665 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)
  ClinicalTrials.gov Identifier: NCT00000134 - Completed
  HIV Infections; Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis
  
• Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
  ClinicalTrials.gov Identifier: NCT00000136 - Completed
  HIV Infections; Cytomegalovirus Retinitis
  
• Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
  ClinicalTrials.gov Identifier: NCT00000142 - Completed
  HIV Infections; Cytomegalovirus Retinitis
  
• Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)
  ClinicalTrials.gov Identifier: NCT00000135 - Completed
  HIV Infections; Cytomegalovirus Retinitis
  
• Studies of the Prevention of Atrial Fibrillation by ALA
  ClinicalTrials.gov Identifier: NCT00410839 - Active, not recruiting
  Atrial Fibrillation; Diet Therapy
  
• Studies of Thyroid Abnormalities in Northeastern Kazakstan Associated With Nuclear Weapons Testing
  ClinicalTrials.gov Identifier: NCT00341185 - Active, not recruiting
  Thyroid Cancer
  
• Studies of White Blood Cells Derived From HHT Patients
  ClinicalTrials.gov Identifier: NCT00230633 - Recruiting
  Telangiectasia, Hereditary Hemorrhagic
  
• Studies on Abnormal Bone from Patients with Polyostotic Fibrous Dysplasia and McCune Albright Syndrome
  ClinicalTrials.gov Identifier: NCT00001973 - Recruiting
  Polyostotic Fibrous Dysplasia
  
• Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"
  ClinicalTrials.gov Identifier: NCT00155844 - Recruiting
  Acute Myelocytic Leukemia; Acute Lymphocytic Leukemia
  
• Studies on Tumors of the Thyroid
  ClinicalTrials.gov Identifier: NCT00001160 - Recruiting
  Neoplasm Metastasis; Thyroid Neoplasm; Thyroid Nodule
  
• Studies with Vitamin D
  ClinicalTrials.gov Identifier: NCT00001151 - Recruiting
  Hypocalcemia; Rickets
  
• Study 767905/008 Extension Study
  ClinicalTrials.gov Identifier: NCT00135577 - Terminated
  Opioid-induced bowel dysfunction due to opioid treatment of cancer-related pain
  
• Study A - MK0767 Monotherapy Study
  ClinicalTrials.gov Identifier: NCT00543517 - Completed
  Diabetes Mellitus, Type 2
  
• Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
  ClinicalTrials.gov Identifier: NCT00196430 - Completed
  Neurodermatitis
  
• Study About Efficacy and Safety to Treat Multi-System-Atrophy
  ClinicalTrials.gov Identifier: NCT00146809 - Completed
  Multi-System-Atrophy; Minocycline
  
• Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy
  ClinicalTrials.gov Identifier: NCT00328874 - Completed
  Progressive Supranuclear Palsy
  
• Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00525161 - Recruiting
  Breast Cancer
  
• Study Aimed at Improving Height With Genotonorm in Children Born Little and/or Light With Growth Retardation at the Age
  ClinicalTrials.gov Identifier: NCT00174252 - Recruiting
  Fetal Growth Retardation
  
• Study and Surgical Treatment of Syringomyelia
  ClinicalTrials.gov Identifier: NCT00011245 - Recruiting
  Syringomyelia
  
• Study and Treatment of Inflammatory Muscle Diseases
  ClinicalTrials.gov Identifier: NCT00001265 - Recruiting
  Autoimmune Disease; Dermatomyositis; Inclusion Body Myositis; Myositis; Polymyositis
  
• Study and Treatment of Post Lyme Disease (STOP-LD)
  ClinicalTrials.gov Identifier: NCT00000937 - Completed
  Lyme Disease
  
• Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00210028 - Terminated
  Breast Neoplasms
  
• Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled with Metformin Alone
  ClinicalTrials.gov Identifier: NCT00121667 - Completed
  Diabetes Mellitus, Type 2
  
• Study Assessing the Effect of 3-Week Treatment With One of Three Oral Doses of Quinagolide
  ClinicalTrials.gov Identifier: NCT00329693 - Active, not recruiting
  Ovarian Hyperstimulation Syndrome
  
• Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women
  ClinicalTrials.gov Identifier: NCT00235924 - Active, not recruiting
  Postmenopause
  
• Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas
  ClinicalTrials.gov Identifier: NCT00242541 - Completed
  Acromegaly
  
• Study Care Versus Usual Care for Acute Mechanical Lower Back Pain.
  ClinicalTrials.gov Identifier: NCT00135239 - Not yet recruiting
  Lower Mechanical Back Pain, Rehabilitation
  
• Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00438581 - Not yet recruiting
  Non-Hodgkin's Lymphoma
  
• Study Comparing 12 Months versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
  ClinicalTrials.gov Identifier: NCT00116935 - Recruiting
  Sarcoma; Gastrointestinal Stromal Tumor
  
• Study Comparing 13 Valente Pneumococcal Conjugate Vaccine With 7 Valent Pneumococcal Conjugate Vaccine
  ClinicalTrials.gov Identifier: NCT00373958 - Active, not recruiting
  Vaccines, Pneumococcal
  
• Study Comparing 17B Estradiol/TMG CC 1mg vs. Tibolone in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00472004 - Recruiting
  Vasomotor Symptoms
  
• Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.
  ClinicalTrials.gov Identifier: NCT00383916 - Completed
  Healthy Subjects
  
• Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects
  ClinicalTrials.gov Identifier: NCT00498745 - Completed
  Healthy
  
• Study Comparing a 13-Valent Pneumococcal Conjugate Vaccine With 23-Valent Polysaccharide Vaccine in Adults
  ClinicalTrials.gov Identifier: NCT00427895 - Active, not recruiting
  Pneumococcal Infections
  
• Study Comparing a DTaP HB PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00348881 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Influenza
  
• Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis
  ClinicalTrials.gov Identifier: NCT00195208 - Completed
  Gastroesophageal Reflux; Esophagitis
  
• Study comparing ABX-CBL (monoclonal antibody) versus Atgam in Patients with Steroid Resistant Acute Graft versus Host Disease
  ClinicalTrials.gov Identifier: NCT00035880 - Completed
  Graft vs Host Disease
  
• Study Comparing Adjunctive Risperidone in Generalized Anxiety Disorder that Is Not Responding to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00086112 - Completed
  Anxiety Disorders
  
• Study Comparing Adjunctive Risperidone versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00095134 - Active, not recruiting
  Major Depressive Disorder
  
• Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
  ClinicalTrials.gov Identifier: NCT00319969 - Recruiting
  Small Cell Lung Cancer
  
• Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
  ClinicalTrials.gov Identifier: NCT00383422 - Active, not recruiting
  Postmenopausal Osteoporosis
  
• Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients
  ClinicalTrials.gov Identifier: NCT00522418 - Recruiting
  Epilepsy; Partial Epilepsy; Quality of Life
  
• Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint
  ClinicalTrials.gov Identifier: NCT00366704 - Recruiting
  Schizophrenia
  
• Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation
  ClinicalTrials.gov Identifier: NCT00401219 - Completed
  Estrogen Replacement Therapy
  
• Study Comparing Bioavailability of Oral Formulations of Vabicaserin
  ClinicalTrials.gov Identifier: NCT00541996 - Completed
  Schizophrenia
  
• Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.
  ClinicalTrials.gov Identifier: NCT00381251 - Completed
  Postmenopausal Osteoporosis; Postmenopause
  
• Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
  ClinicalTrials.gov Identifier: NCT00168051 - Completed
  Hemophilia A
  
• Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
  ClinicalTrials.gov Identifier: NCT00294385 - Active, not recruiting
  Breast Cancer
  
• Study Comparing Conventional vs. Robotic-Assisted Laparoscopic Hysterectomy
  ClinicalTrials.gov Identifier: NCT00485355 - Recruiting
  Hysterectomy; Laparoscopy.; Robotics
  
• Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00273871 - Completed
  Graft Rejection; Kidney Failure; Kidney Transplantation
  
• Study Comparing Conversion From Tacrolimus to Sirolimus at 3-4 Months Post-Transplant in Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00311311 - Terminated
  Atherosclerosis; Kidney Failure
  
• Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
  ClinicalTrials.gov Identifier: NCT00295178 - Completed
  Cellulitis
  
• Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus
  ClinicalTrials.gov Identifier: NCT00248313 - Completed
  Kidney Disease
  
• Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus
  ClinicalTrials.gov Identifier: NCT00195468 - Completed
  Kidney Failure; Graft vs Host Disease
  
• Study Comparing Cyclosporine With Infliximab in Steroid-Refractory Severe Attacks of Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00542152 - Recruiting
  Steroid-Refractory Ulcerative Colitis
  
• Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
  ClinicalTrials.gov Identifier: NCT00329433 - Recruiting
  Deep Venous Thrombosis
  
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
  ClinicalTrials.gov Identifier: NCT00211536 - Active, not recruiting
  Type 1 Diabetes
  
• Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00421551 - Recruiting
  HIV Infections
  
• Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
  ClinicalTrials.gov Identifier: NCT00244556 - Completed
  Rheumatoid Arthritis
  
• Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00418548 - Completed
  Ankylosing Spondylitis
  
• Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00195494 - Active, not recruiting
  Rheumatoid Arthritis
  
• Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00565409 - Not yet recruiting
  Arthritis, Rheumatoid
  
• Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
  ClinicalTrials.gov Identifier: NCT00393471 - Completed
  Active Rheumatoid Arthritis
  
• Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00422227 - Recruiting
  Rheumatoid Arthritis
  
• Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens
  ClinicalTrials.gov Identifier: NCT00550303 - Completed
  Healthy
  
• Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00380887 - Completed
  Postmenopause
  
• Study Comparing Full-Dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid
  ClinicalTrials.gov Identifier: NCT00172029 - Completed
  Breast Cancer With Metastatic Bone Disease
  
• Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus
  ClinicalTrials.gov Identifier: NCT00518375 - Completed
  Kidney Transplantation
  
• Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00073528 - Active, not recruiting
  Metastatic breast cancer; Advanced Breast Cancer
  
• Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)
  ClinicalTrials.gov Identifier: NCT00199186 - Recruiting
  Philadelphia Positive Acute Lymphoblastic Leukemia; Lymphoid Blastic Phase of Chronic Myeloid Leukemia
  
• Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over
  ClinicalTrials.gov Identifier: NCT00232947 - Completed
  Influenza
  
• Study Comparing Inotuzumab Ozogamicin in Combination With Rituximab Versus Defined Investigator's Choice in Follicular Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00562965 - Recruiting
  Lymphoma, Follicular
  
• Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00494962 - Completed
  Alzheimer Disease
  
• Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
  ClinicalTrials.gov Identifier: NCT00000302 - Completed
  Heroin Dependence
  
• Study Comparing Muraglitazar with Glimepride in Type 2 Diabetics who are not Controlled with Metformin Alone
  ClinicalTrials.gov Identifier: NCT00095030 - Completed
  Diabetes Mellitus, Type 2
  
• Study Comparing Olanzapine with Haloperidol for the Relief of Nausea and Vomitting in Patients with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00124930 - Recruiting
  Refractory Nausea
  
• Study Comparing On-Demand Treatment With Two Prophylaxis Regimens of BeneFIX in Patients With Severe Hemophilia B
  ClinicalTrials.gov Identifier: NCT00364182 - Recruiting
  Hemophilia B
  
• Study Comparing OsseoSpeed™ 6 mm and 11 mm in Posterior Maxilla and Mandible
  ClinicalTrials.gov Identifier: NCT00545818 - Recruiting
  Marginal Bone Level Alteration; Implant Survival; Condition of Periimplant Mucosa; Crown-to-Implant Ratio; Overall Safety
  
• Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses
  ClinicalTrials.gov Identifier: NCT00305565 - Recruiting
  Depression
  
• Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
  ClinicalTrials.gov Identifier: NCT00223418 - Active, not recruiting
  Schizophenia Disorder; Schizoaffective Disorder
  
• Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
  ClinicalTrials.gov Identifier: NCT00459706 - Recruiting
  Active Rheumatoid Arthiritis
  
• Study Comparing Piperacillin-Tazobactam Versus Piperacillin-Tazobactam Plus Glycopeptide in Neutropenic Patients
  ClinicalTrials.gov Identifier: NCT00195533 - Recruiting
  Hematological Malignancy; Leukemia; Myelodysplasia; Lymphoma; Myeloma; Stem Cell Transplantation
  
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00309751 - Active, not recruiting
  Type II Diabetes Mellitus; Dyslipidemia
  
• Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
  ClinicalTrials.gov Identifier: NCT00167921 - Completed
  Atrophic Vaginitis
  
• Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00543634 - Recruiting
  Postmenopause
  
• Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children
  ClinicalTrials.gov Identifier: NCT00580684 - Completed
  Vaccines, Pneumococcal; Vaccines, Pneumococcal Conjugate Vaccine
  
• Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
  ClinicalTrials.gov Identifier: NCT00510627 - Not yet recruiting
  Metastatic Liver Cancer; Secondary Liver Cancer; Liver Neoplasm
  
• Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV
  ClinicalTrials.gov Identifier: NCT00429962 - Active, not recruiting
  Choroidal Neovascularization; Age-Related Macular Degeneration
  
• Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00312832 - Completed
  HIV Infections; Lipoatrophy
  
• Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.
  ClinicalTrials.gov Identifier: NCT00191620 - Completed
  Non-Small-Cell Lung Carcinoma
  
• Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant
  ClinicalTrials.gov Identifier: NCT00188825 - Active, not recruiting
  Lung Transplant
  
• Study Comparing Sirolimus with Cyclosporine in a CNI-Free Regimen in Kidney Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00137345 - Terminated
  Kidney Transplantation
  
• Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00470665 - Completed
  Renal Allograft Recipients
  
• Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00088582 - Active, not recruiting
  Acromegaly
  
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00344110 - Active, not recruiting
  Hypertension
  
• Study Comparing Standard Dose and High-Dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
  ClinicalTrials.gov Identifier: NCT00171899 - Recruiting
  Chronic Myelogenous Leukemia
  
• Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients
  ClinicalTrials.gov Identifier: NCT00518271 - Completed
  Kidney Transplantation
  
• Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00519116 - Completed
  Kidney Transplantation
  
• Study Comparing STR (Skeletal Targeted Radiotherapy) plus Melphalan to Melphalan alone, with Stem Cell Transplant in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00083564 - Terminated
  Multiple Myeloma
  
• Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease.
  ClinicalTrials.gov Identifier: NCT00298363 - Recruiting
  Chronic Hepatitis B
  
• Study Comparing Tension-Free Vaginal Tape With the Monarc Procedure for Stress Urinary Incontinence
  ClinicalTrials.gov Identifier: NCT00475839 - Completed
  Stress Urinary Incontinence
  
• Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00380224 - Completed
  Schizophrenia
  
• Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days
  ClinicalTrials.gov Identifier: NCT00237445 - Completed
  Pneumonia
  
• Study Comparing the DOVER Silver Foley Catheter to a Standard of Care Catheter and a Marketed Silver Coated Foley Catheter
  ClinicalTrials.gov Identifier: NCT00203515 - Active, not recruiting
  Urinary Tract Infections
  
• Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
  ClinicalTrials.gov Identifier: NCT00474708 - Recruiting
  Major Depressive Disorder
  
• Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children
  ClinicalTrials.gov Identifier: NCT00383123 - Active, not recruiting
  Influenza
  
• Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines
  ClinicalTrials.gov Identifier: NCT00197288 - Completed
  Prophylaxis: Influenza virus infection
  
• Study Comparing the Safe